Document:

Investment Agreement

 Exhibit 10.2 
 EXECUTION COPY 
 INVESTMENT AGREEMENT 

dated as of 
 June
12, 2013 
 by and between 
 RTI BIOLOGICS, INC. 
 and 

WSHP BIOLOGICS HOLDINGS, LLC 

 TABLE OF CONTENTS 

 

							
	 	  	 	  	Page	 
	 ARTICLE I PURCHASE AND SALE OF THE SERIES A PREFERRED STOCK
	  	 	1	  
	 1.1
	  	Purchase and Sale of the Series A Preferred Stock	  	 	1	  
	 1.2
	  	The Closing	  	 	2	  
	 1.3
	  	Conditions to the Closing	  	 	2	  
	 1.4
	  	Deliveries at the Closing	  	 	3	  
		
	 ARTICLE II REPRESENTATIONS AND WARRANTIES OF THE COMPANY
	  	 	5	  
	 2.1
	  	Organization, Good Standing and Qualification	  	 	5	  
	 2.2
	  	Authorization	  	 	5	  
	 2.3
	  	No Conflict, Breach, Violation or Default	  	 	5	  
	 2.4
	  	Capitalization	  	 	6	  
	 2.5
	  	Valid Issuance	  	 	7	  
	 2.6
	  	Company Filings; Financial Statements; Liabilities	  	 	7	  
	 2.7
	  	Internal Controls	  	 	8	  
	 2.8
	  	Private Placement	  	 	8	  
	 2.9
	  	Absence of Changes	  	 	8	  
	 2.10
	  	Compliance with Laws	  	 	9	  
	 2.11
	  	Litigation	  	 	10	  
	 2.12
	  	Distributors	  	 	10	  
	 2.13
	  	Suppliers	  	 	11	  
	 2.14
	  	Material Contracts	  	 	11	  
	 2.15
	  	Tax Matters	  	 	12	  
	 2.16
	  	Property	  	 	12	  
	 2.17
	  	Employee Benefits Matters	  	 	13	  
	 2.18
	  	Labor Matters	  	 	13	  
	 2.19
	  	Intellectual Property	  	 	14	  
	 2.20
	  	Environmental Matters	  	 	15	  
	 2.21
	  	Transactions with Affiliates	  	 	15	  
	 2.22
	  	Insurance Coverage	  	 	15	  
	 2.23
	  	Brokers and Finders	  	 	15	  
	 2.24
	  	Pioneer Merger Agreement	  	 	15	  
	 2.25
	  	No Additional Representations	  	 	15	  
		
	 ARTICLE III REPRESENTATIONS AND WARRANTIES OF INVESTOR
	  	 	16	  
	 3.1
	  	Organization and Existence	  	 	16	  
	 3.2
	  	Authorization	  	 	16	  
	 3.3
	  	Private Placement	  	 	16	  
	 3.4
	  	Financial Capability	  	 	16	  
	 3.5
	  	No Conflict, Breach, Violation or Default	  	 	16	  
	 3.6
	  	No Legal, Tax or Investment Advice	  	 	16	  
	 3.7
	  	Restrictive Legend	  	 	17	  
		
	 ARTICLE IV COVENANTS AND AGREEMENTS
	  	 	17	  
	 4.1
	  	Interim Operations of the Company	  	 	17	  
	 4.2
	  	Further Assurances	  	 	18	  
	 4.3
	  	Preparation of the Proxy Statement; Shareholders’ Meeting	  	 	19	  
	 4.4
	  	Restrictions	  	 	20	  

  
 i 

							
	 4.5
	  	Reasonable Access	  	 	21	  
	 4.6
	  	Notification	  	 	21	  
	 4.7
	  	Securities Law Disclosure; Publicity	  	 	21	  
	 4.8
	  	Use of Proceeds	  	 	22	  
	 4.9
	  	NASDAQ Matters	  	 	22	  
	 4.10
	  	Regulatory Filings	  	 	22	  
		
	 ARTICLE V TERMINATION
	  	 	22	  
	 5.1
	  	Termination Prior to the Closing	  	 	22	  
	 5.2
	  	Effect of Termination	  	 	23	  
		
	 ARTICLE VI MISCELLANEOUS AND GENERAL
	  	 	23	  
	 6.1
	  	.Survival	  	 	23	  
	 6.2
	  	Successors and Assigns	  	 	23	  
	 6.3
	  	Counterparts; Electronic Delivery	  	 	23	  
	 6.4
	  	Headings; Interpretation	  	 	24	  
	 6.5
	  	Notices	  	 	24	  
	 6.6
	  	Expenses; Transfer Taxes	  	 	25	  
	 6.7
	  	Amendments and Waivers	  	 	25	  
	 6.8
	  	Equitable Relief	  	 	25	  
	 6.9
	  	Severability	  	 	25	  
	 6.10
	  	Entire Agreement	  	 	26	  
	 6.11
	  	Third Party Beneficiaries	  	 	26	  
	 6.12
	  	Governing Law; CONSENT TO JURISDICTION	  	 	26	  
	 6.13
	  	WAIVER OF JURY TRIAL	  	 	26	  

  
 ii 

					
		 	Exhibits	 	
		 	 Exhibit A
	 	Definitions
		 	 Exhibit B
	 	Series A Certificate of Designation
		 	 Exhibit C
	 	Investor Rights Agreement
		 	 Exhibit D
	 	Management Rights Agreement
		 	 Exhibit E
	 	Director Indemnification Agreement
		 	 Exhibit F
	 	Opinion of Counsel
		 	 Exhibit G
	 	Pioneer Merger Agreement

  
 iii

 INVESTMENT AGREEMENT 

This INVESTMENT AGREEMENT (this “Agreement”) is made as of June 12, 2013 by and between RTI Biologics, Inc., a
Delaware corporation (the “Company”), and WSHP Biologics Holdings, LLC, a Delaware limited liability company (“Investor”). Each of Investor and the Company are from time to time referred to herein as a
“Party” and collectively as the “Parties”. Capitalized terms used, but not otherwise defined, in this Agreement shall have the respective meanings ascribed to such terms in Exhibit A. 

RECITALS 

WHEREAS, simultaneously with the execution and delivery of this Agreement, the Company has entered into that certain Agreement and Plan
of Merger (the “Pioneer Merger Agreement”), dated as of the date hereof, by and among the Company, Rockets MI Corporation (“Merger Sub”), Pioneer Surgical Technology, Inc. (“Pioneer”), and
Shareholder Representative Services LLC, solely in its capacity as Stockholders’ Agent; 
 WHEREAS, upon the consummation
of the transaction contemplated by the Pioneer Merger Agreement, Merger Sub will merge with and into Pioneer with Pioneer surviving such merger as a wholly-owned subsidiary of the Company (the “Merger”); 

WHEREAS, the Company proposes to issue and sell to Investor the aggregate number of shares specified herein of the Company’s
preferred stock designated as Series A Preferred Stock, $0.001 par value per share (the “Series A Preferred Stock”), having the rights, preferences, privileges and designations set forth in the Series A Preferred Stock Certificate
of Designation, in the form set forth on Exhibit B hereto (the “Series A Certificate of Designation”), pursuant to, on the terms of and subject to the satisfaction of the conditions set forth in, this Agreement (collectively,
the “Issuance”); and 
 WHEREAS, the Issuance is being made in a private placement, without registration under
the Securities Act or any other applicable securities Laws, in reliance on one or more exemptions from registration and other requirements thereunder. 
 NOW, THEREFORE, in consideration of the foregoing, the mutual promises made herein, the respective representations, warranties, covenants and agreements set forth herein, and for other good and valuable
consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties, intending to be legally bound, hereby agree as follows: 
 ARTICLE I 
 PURCHASE AND SALE OF THE SERIES A PREFERRED STOCK 

1.1 Purchase and Sale of the Series A Preferred Stock. Subject to all of the terms and conditions of this Agreement, and in
reliance upon the representations and warranties and other agreements hereinafter set forth, at the Closing, the Company hereby agrees to sell, issue and convey to Investor, and Investor hereby agrees to purchase from the Company, 50,000 shares of
Series A Preferred Stock, free and clear of all Liens (except for restrictions on transfer imposed by applicable securities Laws), in exchange for the Purchase Price. The shares of Series A Preferred Stock to be issued and sold by the Company to
Investor pursuant to this Agreement are collectively referred to as the “Series A Shares”. 

 1.2 The Closing. Subject to the satisfaction of the conditions set forth in this
Agreement, or the waiver thereof in writing by the Company and/or Investor as provided in Section 1.3(c), the closing of the purchase and sale of the Series A Shares contemplated by Section 1.1 (the “Closing”) shall be held, and
the parties shall consummate such purchase and sale concurrently with the closing of the Merger (the date that the Closing occurs, the “Closing Date”). 
 1.3 Conditions to the Closing. 
 (a) Conditions to Obligation of
Investor. The obligation of Investor to purchase the Series A Shares and to consummate the transactions contemplated by this Agreement are subject to the satisfaction, or written waiver by Investor, of the following conditions at or prior to the
Closing: 
 (i) No Law, judgment, injunction or Order shall have been enacted, promulgated, entered or enforced by any court or
Government Authority which would prohibit the consummation of the transactions contemplated by this Agreement, and there shall be no Action pending or threatened by any Government Authority or other third party that seeks to enact, issue,
promulgate, enforce or enter into any such Law, judgment, injunction or Order or that seeks to enjoin or prohibit the consummation of the transactions contemplated hereby. 
 (ii) This Agreement shall not have been terminated in accordance with Article V. 
 (iii) The Company shall have duly authorized, approved and adopted, and filed with the Secretary of State of the State of Delaware, the Series A Certificate of Designation. The Series A Certificate of
Designation shall be in full force and effect under the laws of the State of Delaware as of the Closing and shall not have been amended or modified. 
 (iv) The representations and warranties contained in Section 2.2, Section 2.4, Section 2.5 and Section 2.24 shall be true and correct in all respects as of
the Closing, as if such representations and warranties were made as of the Closing. 
 (v) Since the date of this Agreement, no
Material Adverse Change (as defined in the Financing Commitments) shall have occurred. 
 (vi) The Company shall have performed
and complied, in all material respects, with all of the covenants and agreements required to be performed or to be complied with by the Company pursuant to this Agreement at or prior to the Closing. 

(vii) The transactions contemplated by the Pioneer Merger Agreement and shall have been consummated substantially concurrently herewith
on the terms and conditions set forth in the Pioneer Merger Agreement, and the conditions to the obligations of the Company and/or its Subsidiaries to consummate the transactions contemplated by the Pioneer Merger Agreement shall have been satisfied
and not waived without the prior written consent of Investor. 
 (viii) The Company shall have taken no action that has had the
effect of, or could reasonably be likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or delisting or suspending from trading the Common Stock from the NASDAQ Global Select market, nor shall the
Company have received any notice from the SEC or NASDAQ, as applicable, suggesting or otherwise providing that the SEC or NASDAQ, as applicable, is contemplating terminating such registration or listing. 

(ix) The Company shall have paid or reimbursed Investor for the Investor Expenses in accordance with Section 6.6.

  
 2 

 (x) The Company shall have delivered or caused to be delivered to Investor the items
required by Section 1.4(b). 
 (b) Conditions to Obligation of the Company. The obligation of the Company to
sell the Series A Shares and to consummate the transactions contemplated by this Agreement are subject to the satisfaction, or written waiver by the Company, of the following conditions at or prior to the Closing: 

(i) No Law, judgment, injunction or Order shall have been enacted, promulgated, entered or enforced by any court or Government Authority
which would prohibit the consummation of the transactions contemplated by this Agreement, and there shall be no Action pending or threatened by any Government Authority or other third party that seeks to enact, issue, promulgate, enforce or enter
into any such Law, judgment, injunction or Order or that seeks to enjoin or prohibit the consummation of the transactions contemplated hereby. 
 (ii) This Agreement shall not have been terminated in accordance with Article V. 
 (iii) The representations and warranties of Investor contained in Article III shall be true and correct as of the Closing, except for inaccuracies which would not prevent Investor from performing
its obligations pursuant to this Agreement. 
 (iv) Investor shall have performed and complied, in all material respects, with
all of the covenants and agreements required to be performed or to be complied with by Investor pursuant to this Agreement at or prior to the Closing. 
 (v) The transactions contemplated by the Pioneer Merger Agreement shall have been consummated substantially concurrently herewith. 

(vi) Investor shall have delivered or caused to be delivered to the Company the items required by Section 1.4(a).

 (c) Waiver of Conditions. Any conditions specified in Section 1.3(a) may be waived only in a writing
executed and delivered by the Investor specifying the condition being waived. Any conditions specified in Section 1.3(b) may be waived only in writing executed and delivered by the Company specifying the conditions being waived.

 1.4 Deliveries at the Closing. 
 (a) Deliveries by Investor. At the Closing, Investor shall deliver or cause to be delivered to the Company the following items: 

(i) the Purchase Price, by wire transfer of immediately available funds to one or more accounts designated by the Company no later than
two (2) Business Days prior to the Closing Date; 
 (ii) a counterpart to the Investor Rights Agreement, dated as of the
Closing Date and otherwise in the form set forth in Exhibit C hereto (the “Investor Rights Agreement”), executed on behalf of Investor by a duly authorized signatory thereof; and 

(iii) a good standing certificate of Investor from the Secretary of State of the State of Delaware dated not more than ten
(10) prior to the Closing Date; 

  
 3 

 (iv) a certificate, dated as of the Closing Date, signed by an authorized signatory of
Investor, stating that the conditions specified in Section 1.3(b)(iii) and Section 1.3(b)(iv) have been satisfied. 
 (b) Deliveries by the Company. At the Closing, the Company shall deliver or cause to be delivered to Investor the following items: 

(i) stock certificates (such certificate(s) to be in the name of and in the denomination specified by Investor) representing the Series A
Shares in a form reasonably acceptable to Investor; 
 (ii) a counterpart to the Investor Rights Agreement, dated as of the
Closing Date and otherwise in the form set forth in Exhibit C hereto, executed on behalf of the Company by a duly authorized executive officer of the Company; 
 (iii) evidence that each Preferred Director (as defined in the Series A Certificate of Designation) has been duly appointed to the Board concurrently with the issuance of the Series A Shares in accordance
with the terms of the Series A Certificate of Designation; 
 (iv) a counterpart to the Management Rights Agreement, dated as
of the Closing Date and otherwise in the form set forth in Exhibit D hereto (the “Management Rights Agreement”), executed on behalf of the Company by a duly authorized executive officer of the Company; 

(v) a counterpart to a Director Indemnification Agreement with each Preferred Director (as defined in the Series A Certificate of
Designation), dated as of the Closing Date and otherwise in the form set forth in Exhibit E hereto, executed on behalf of the Company by a duly authorized officer of the Company; 

(vi) a good standing certificate of the Company from the Secretary of State of the State of Delaware dated not more than ten
(10) prior to the Closing Date; 
 (vii) evidence of the due filing and acceptance of the Series A Certificate of
Designation with the Secretary of State of the State of Delaware; 
 (viii) a legal opinion of Fulbright & Jaworski
LLP, the Company’s counsel, , dated as of the Closing Date and otherwise covering the matters set forth on Exhibit F hereto; 
 (ix) a certified copy of the unanimous resolutions of the Board, which are in full force and effect, approving this Agreement, the designation of the Series A Preferred Stock, the Investor Rights
Agreement, the Director Indemnification Agreements, the Pioneer Merger Agreement and the consummation of the transactions contemplated hereby and thereby; and 
 (x) a certificate, dated as of the Closing Date, signed by an authorized officer of the Company, stating that the conditions specified in Section 1.3(a)(i), Section 1.3(a)(iii),
Section 1.3(a)(iv), Section 1.3(a)(vi), Section 1.3(a)(vii), Section 1.3(a)(viii), Section 1.3(a)(viii) and Section 1.3(a)(viii) have been satisfied. 

  
 4 

 ARTICLE II 
 REPRESENTATIONS AND WARRANTIES OF THE COMPANY 
 Except as (i) expressly set
forth in the disclosure schedules attached hereto and delivered to Investor by the Company on the date hereof (as may be updated and amended as provided in Section 4.10 collectively, the “Disclosure Schedules”), and (ii)
otherwise disclosed or incorporated by reference in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2012 or its other reports and forms filed with or furnished to the SEC under Sections 12, 13, 14 or 15(d) of the
Exchange Act after December 31, 2012 (other than with respect to the representations and warranties set forth in Section 2.14 and Section 2.21 and all cases excluding disclosures of risks included in any forward-looking statement
disclaimers or other statements that are similarly nonspecific and are predictive and forward-looking in nature) and before the date of this Agreement (all such reports covered by this clause (ii) collectively, the “Company
Filings”) the Company hereby represents and warrants to Investor as of the date hereof as follows: 
 2.1
Organization, Good Standing and Qualification. Each of the Company and its Subsidiaries is an entity duly incorporated or otherwise organized, validly existing and in good standing under the Laws of the jurisdiction of its incorporation or
organization, as applicable, and has all requisite power and authority to carry on its business to own and use its properties. Neither the Company nor any of its Subsidiaries is in violation or default of any of the provisions of its respective
certificate or certificate of incorporation, bylaws, limited partnership agreement, or other organizational or charter documents. Each of the Company and its Subsidiaries is duly qualified to do business as a foreign entity and is in good standing
in each jurisdiction in which the conduct of its business or its ownership or leasing of property makes such qualification necessary, except to the extent such failure to so qualify has not had and would not reasonably be expected to have a Material
Adverse Effect. 
 2.2 Authorization. The Company has all requisite corporate power, and has taken all necessary
corporate action, required for the due authorization, execution, delivery and performance by the Company of the Transaction Documents and the consummation of the transactions contemplated hereby and thereby, and no action on the part of the
shareholders of the Company prior to Closing is required for the consummation of the transactions contemplated by this Agreement. This Agreement has been duly executed and delivered by the Company, and the Transaction Documents and instruments
referred to herein to which the Company is a party will be duly executed and delivered by the Company as of the Closing. This Agreement constitutes, and the Transaction Documents will constitute at the Closing, a valid and binding obligation of the
Company enforceable against it in accordance with its terms, except as such enforceability may be limited by applicable bankruptcy, insolvency, reorganization, moratorium or other similar Laws affecting the enforcement of creditors rights generally,
and general principles of equity (regardless of whether such enforceability is considered in a proceeding in law or equity). The Company (including by the action of its Board of Directors) has taken all necessary actions such that the restrictions
set forth in Section 203 of the Delaware General Corporation Law will not apply to any acquisition by the Investor of Series A Shares to be issued pursuant to this Agreement or the Common Stock to be issued upon the conversion thereof.

 2.3 No Conflict, Breach, Violation or Default. 

(a) The execution, delivery and performance of the Transaction Documents by the Company and the issuance and sale of the Series A Shares
contemplated hereby and thereby will not: (i) conflict with or result in a violation of the Certificate of Incorporation or Bylaws, both as in effect on the Closing (true and complete copies of which have been made available to Investor),
(ii) result in any material violation of any Law to which the Company, any of its Subsidiaries or any of their respective assets is subject, (iii) (A) conflict with or result in a material breach, material violation of, or constitute
a 

  
 5 

 
material default under (whether with or without the passage of time, the giving of notice or both), (B) give any third party the right to modify, terminate or accelerate, or cause any
modification, termination or acceleration of, any obligation under, (C) create any right to payment or any other right (concurrently or with the passage of time and/or upon the occurrence of one or more events or conditions), or
(D) require any authorization, consent or approval under, any material Contract to which the Company or any of its Subsidiaries is a party, or (iv) result in the creation of any Lien upon any of the Company’s or any Subsidiary’s
assets or capital stock, except in the case of any of clauses (ii) through (iv) above, as would not reasonably be expected to be material to the Company and its Subsidiaries taken as a whole. 

(b) Neither the execution, delivery or performance of any Transaction Document by the Company, nor the consummation by it of the
obligations and transactions contemplated hereby and thereby (including the issuance, the reservation for issuance and the delivery, as applicable, of the Series A Shares) requires any consent of, authorization by, exemption from, filing with or
notice to any Governmental Authority or any other Person, other than (i) the filing of the Series A Certificate of Designation with the Secretary of State of the State of Delaware, (ii) the filings required to comply with the
Company’s registration and listing obligations under Investor Rights Agreement, (iii) filings required under applicable U.S. federal and state securities Laws, (iv) the notification of the issuance and sale of the Series A Shares to
NASDAQ, and (v) the Shareholder Approval. 
 2.4 Capitalization. 

(a) Schedule 2.4(a) sets forth as of the date hereof: (i) the authorized capital stock of the Company, (ii) the number
and class of shares of capital stock of the Company outstanding, and (iii) the number of shares of capital stock issuable and reserved for issuance pursuant to the Incentive Plans. 

(b) Except as set forth on Schedule 2.4(b), (i) neither the Company nor any of its Subsidiaries owns or holds the right to
acquire any stock, partnership, interest, joint venture interest or other equity ownership interest in any Person and (ii) the Company owns, directly or indirectly, all of the capital stock or other equity interests of each of its Subsidiaries,
free and clear of any Lien. 
 (c) All of the issued and outstanding equity securities of each of the Company and its
Subsidiaries have been duly authorized and validly issued and are fully paid, nonassessable and were issued in compliance with applicable federal and state securities Laws. Except as set forth in Schedule 2.4(c), no Person is entitled to
preemptive rights, rights of first refusal, rights of participation or similar rights with respect to any securities of the Company or any of its Subsidiaries, including with respect to the issuance of Series A Preferred Stock contemplated hereby.
Except as set forth in Schedule 2.4(c), there are no outstanding warrants, options, convertible securities, stock appreciation rights, phantom stock or other rights, agreements or arrangements under which the Company or any of its
Subsidiaries is or may be obligated to issue any securities of any kind. Except as set forth in Schedule 2.4(c) and except for the Series A Certificate of Designation and the Investor Rights Agreement, there are no voting agreements,
registration rights agreements or other agreements of any kind among the Company and any other Person relating to the securities of the Company. 
 (d) Schedule 2.4(d) sets forth (i) the aggregate number of shares issuable upon the exercise (assuming all conditions to vesting or the satisfaction of any other applicable contingency have
occurred) of all awards and grants outstanding under the Incentive Plans (as amended), (ii) the weighted average exercise and/or conversion price (as applicable) of such awards and grants, and (iii) any acceleration of vesting or other
rights arising under any such award or grant due to the consummation of the transactions contemplated by this Agreement. 

  
 6 

 2.5 Valid Issuance. The Series A Shares have been duly and validly authorized and,
when issued and paid for pursuant to this Agreement, will be validly issued, fully paid and nonassessable, and shall be free and clear of all Liens, except for restrictions on transfer imposed by applicable securities Laws. The Company has reserved
for issuance from its duly authorized capital stock the number of shares of Common Stock issuable upon the conversion of the Series A Shares outstanding as of immediately after the Closing, free and clear of all Liens, except for restrictions on
transfer imposed by applicable securities Laws. 
 2.6 Company Filings; Financial Statements; Liabilities. 

(a) Company Filings. Since January 1, 2011, the Company has filed all reports, schedules, forms, statements and other
documents with the SEC required to be filed by the Company pursuant to the Securities Act and the Exchange Act, including all certifications required pursuant to the Sarbanes-Oxley Act of 2002 (the “Sarbanes-Oxley Act”). As of their
respective effective dates (in the case of Company Filings that are registration statements filed pursuant to the requirements of the Securities Act) and as of their respective dates of filing (in the case of all other Company Filings), the Company
Filings complied in all material respects with the requirements of the Securities Act, the Exchange Act and/or the Sarbanes-Oxley Act, as the case may be, and the rules and regulations promulgated thereunder applicable thereto, and except to the
extent amended or superseded by a subsequent filing with the SEC prior to the date of this Agreement, as of such respective dates, none of the Company Filings contained any untrue statement of a material fact or omitted to state a material fact
required to be stated therein or necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading. None of the Company’s Subsidiaries is subject to the periodic reporting
requirements of the Exchange Act. As of the date hereof, there are no outstanding or unresolved comments in comment letters from the SEC staff with respect to any of the Company Filings. To the Company’s Knowledge, as of the date hereof, none
of the Company Filings is the subject of ongoing SEC review or outstanding SEC investigation. 
 (b) Financial
Statements. Each of the audited consolidated financial statements and each of the unaudited quarterly financial statements (including, in each case, the notes thereto) of the Company included in the Company Filings when filed (i) complied
as to form in all material respects with the published rules and regulations of the SEC applicable thereto, (ii) have been prepared in all material respects in accordance with GAAP consistently applied throughout the periods covered thereby
(except as may be disclosed therein or in the notes thereto, and, in the case of unaudited quarterly statements, to the extent permitted by Form 10-Q of the SEC or other rules and regulations of the SEC) and (iii) fairly present, in all
material respects, the consolidated financial position of the Company and its Subsidiaries as of the dates thereof and the consolidated results of their operations and cash flows for the periods then ended, in conformity with GAAP consistently
applied throughout the periods covered thereby (subject, in the case of unaudited quarterly statements, to normal year end adjustments and the absence of footnotes). Neither the Company nor any of its Subsidiaries has or is subject to any
“Off-Balance Sheet Arrangement” (as defined in Item 303(a)(4)(ii) of Regulation S-K promulgated under the Securities Act). 
 (c) Liabilities. Except as set forth in Section 2.6(b), there are no liabilities or obligations of the Company or any of its Subsidiaries of the type required to be accrued on or
reserved against in a consolidated balance sheet prepared in accordance with GAAP consistently applied, other than liabilities or obligations: (i) reflected in the financial statements included or otherwise disclosed in the Company Filings,
(ii) incurred in the Ordinary Course of Business consistent with past practice (other than any such liabilities related to any breach of Contract, violation of Law or tort), (iii) created under, or incurred in connection with, the
Transaction Documents, or (iv) which would not, individually or in the aggregate, be material to the Company and its Subsidiaries, taken as a whole. 

  
 7 

 (d) Indebtedness. As of the date hereof, except as set forth on Schedule
2.6(d), neither the Company nor any of its Subsidiaries have any outstanding Indebtedness. 
 2.7 Internal Controls.

 (a) The Company has established and maintained a system of internal control over financial reporting (as defined in Rule
13a-15 under the Exchange Act). Such internal controls provide reasonable assurance regarding the reliability of the Company’s financial reporting and the preparation of Company financial statements (including its consolidated Subsidiaries) for
external purposes in conformity with GAAP. Since December 31, 2010, the Company’s principal executive officer and its principal financial officer have disclosed to the Company’s auditors and the audit committee of the Board
(i) all known significant deficiencies and material weaknesses in the design or operation of internal controls over financial reporting that are reasonably likely to adversely affect in any material respects the Company’s ability to
record, process, summarize and report financial information, and (ii) any known fraud, whether or not material, that involves management or other employees who have a significant role in the Company’s internal controls, and the Company has
provided to Investor copies of any written materials relating to each of the foregoing. The Company has made available to Investor all such disclosures made by management to the Company’s auditors and audit committee from December 31, 2010
to the date of this Agreement. 
 (b) The Company has established and maintains disclosure controls and procedures (as defined
in Rule 13a-15 under the Exchange Act). Such disclosure controls and procedures are designed to ensure that material information relating to the Company required to be included in reports filed under the Exchange Act, including its consolidated
Subsidiaries, is made known to the Company’s principal executive officer and its principal financial officer, and such disclosure controls and procedures are effective in timely alerting the Company’s principal executive officer and its
principal financial officer to material information required to be disclosed by the Company in the reports that it files or submits to the SEC under the Exchange Act is recorded, processed, summarized and reported within the time periods specified
in the rules and forms of the SEC. 
 2.8 Private Placement. Neither the Company nor any Person acting on its behalf has
conducted any general solicitation or general advertising (as those terms are used in Regulation D promulgated under the Securities Act) in connection with the offer or sale of any of the Series A Shares. Assuming the accuracy of Investor’s
representations and warranties set forth in Article III, no registration under the Securities Act is required for the offer and sale of the Series A Shares to Investor as contemplated hereby. 

2.9 Absence of Changes. Since December 31, 2012, (x) the Company and its Subsidiaries each has conducted its business
operations in the Ordinary Course of Business and (y) there has not occurred any event, change, development, circumstance or condition that, individually or in the aggregate, has had or would be reasonably expected to have a Material Adverse
Effect. Without limiting the generality of the foregoing, since December 31, 2012, except as contemplated by the Pioneer Merger Agreement, the Financing Commitments and any and all agreements related thereto, there has not occurred: 

(a) any purchase, sale, transfer, assignment, conveyance or pledge of the assets or properties of the Company or any of
its Subsidiaries, except in the Ordinary Course of Business; 
 (b) any incurrence of Indebtedness by the Company
or its Subsidiaries other than pursuant to the Revolving Facilities; 

  
 8 

 (c) any waiver or modification by the Company or any of its Subsidiaries of
any right or rights of material value or of a material debt owed to it other than in the Ordinary Course of Business; 
 (d) any material change in the accounting principles utilized by the Company in connection with the business of the Company and its Subsidiaries, any change in the Company’s independent public
accounting firm, disagreement with its independent public accounting firm over the Company’s and its Subsidiaries’ application of accounting principles or with the preparation of any of their financial statements that was required to be
disclosed in the Company Filings, or, notification to the Company’s audit committee of any facts with respect to the Company’s or its Subsidiaries’ financial statements or methods of accounting that could reasonably be expected to
result in a restatement of or amendment to the Company’s or its Subsidiaries’ financial statements; 

(e) any declaration, setting aside or payment of any dividends in respect of the outstanding shares of capital stock of
the Company or any of its Subsidiaries (other than dividends declared or paid by wholly-owned Subsidiaries to the Company or another wholly-owned Subsidiary of the Company); 

(f) any written notice from the SEC in connection with any investigation or action by the SEC; 

(g) any material change in any compensation agreement or arrangement with any executive officer or director of the
Company, other than in the Ordinary Course of Business; 
 (h) any resignation or termination of employment of
any of the Company’s executive officers; 
 (i) any loans or guarantees made by the Company or any of its
Subsidiaries to or for the benefit of their employees, officers or directors or any members of their immediate families, other than (i) travel advances and other advances made in the Ordinary Course of Business and (ii) loans to employees,
officers or directors in connection with the exercise of stock options or the purchase of restricted stock granted pursuant to the Incentive Plans; 
 (j) any damage, destruction or loss (whether or not covered by insurance) materially and adversely affecting the Company’s and its Subsidiaries’ properties or assets taken as a whole; or

 (k) any arrangement, contract or commitment to do any of the foregoing. 

2.10 Compliance with Laws. 
 (a) Except as set forth on Schedule 2.10(a), (i) each of the Company and its Subsidiaries is, and for the past three (3) years has been in compliance in all material respects with all
Laws applicable to it and its business or operations (including the applicable provisions of the Securities Act, the Exchange Act, the Sarbanes-Oxley Act and the applicable listing and corporate governance rules and regulations of NASDAQ),
(ii) each of the Company and its Subsidiaries has in effect all material approvals, authorizations, registrations, licenses, exemptions, permits and consents of Governmental Authorities (each a “Material License”) necessary for
it to conduct its business and (iii) the Company and 

  
 9 

 
its Subsidiaries are in material compliance with the terms and conditions of such Material Licenses. Except as otherwise set forth on the attached Schedule 2.10(a), to the Company’s
Knowledge, (x) during the past three (3) years, neither the Company nor any of its Subsidiaries has received written or oral notices from any Governmental Authority that it is in violation of any of the terms or conditions of such Material
Licenses, (y) no loss or expiration of any such Material License is pending or threatened, other than expiration in accordance with the terms thereof and (z) no director, officer, agent or employee of the Company or any of the Subsidiaries
has paid, caused to be paid, or agreed to pay, directly or indirectly, any bribe, kickback or similar payment to any Governmental Authority. 
 (b) Except as set forth on Schedule 2.10(b): 
 (i) the Company and each of
its Subsidiaries is, and for the past three (3) years has been, in compliance in all material respects with (1) all applicable FDA Laws, including applicable requirements related to procurement, development, manufacture, processing,
clinical and other testing, establishment registration and product listing, adverse drug experience reporting, quality system regulation, good tissue practices, distribution, storage, importation, exportation, use, handling, quality, sale, labeling,
promotion, or advertising and other premarket and postmarket requirements for any product that is under development, manufactured, distributed, or marketed by the Company and its Subsidiaries, and (2) all applicable Health Care Laws;

 (ii) during the past three (3) years neither the Company nor any of its Subsidiaries nor, to the Company’s
Knowledge, any of the directors, officers, or employees of the Company or any of its Subsidiaries has been charged with, nor received any written notice or other communication from the FDA or any other Governmental Authority alleging, any material
violation of any FDA Laws or Health Care Laws by the Company or any of its Subsidiaries relating to its business or has been or is subject to any enforcement proceedings by the FDA or other Governmental Body and, no such proceedings have been
threatened in writing; no seizure, withdrawal, recall, detention, field notification, field correction, termination or suspension of manufacturing or marketing, import alert, or safety alert relating to the Company’s products has been initiated
by FDA or proposed, requested, or threatened in writing by FDA or a comparable Governmental Authority during the last three (3) years; and 
 (iii) to the Company’s Knowledge, neither the Company nor its Subsidiaries has committed any act, made any statement or failed to make any statement that would reasonably be expected to provide a
basis for the FDA or any other Governmental Authority to invoke its policy with respect to “Fraud, Untrue Statements of Material Facts, Bribery, and Illegal Gratuities”, or similar policies, set forth in any applicable Laws. Neither the
Company, its Subsidiaries, nor, to the Company’s Knowledge, any of its officers, employees, contractors or agents has been convicted of any crime or engaged in any conduct that has resulted, or would reasonably be expected to result, in
debarment under 21 U.S.C. Section § 335a or exclusion from participation in Medicare, Medicaid or any other Federal health care program. 
 2.11 Litigation. There is no, and for the past three (3) years there has not been any, Action brought, conducted or heard by or before any court or other Governmental Authority pending or, to
the Company’s Knowledge, threatened against the Company or any of its Subsidiaries. There is no, and for the past three (3) years there has not been any, Order in effect against the Company or any of its Subsidiaries that is material to
the Company and its Subsidiaries, taken as a whole. 
 2.12 Distributors. Schedule 2.12 sets forth a list of the
top five (5) distributors of the Company and its Subsidiaries, on a consolidated basis, based on revenues (which are also set forth on Schedule 2.12) for the twelve (12) month period ended December 31, 2012 (the “Top
Distributors”). 

  
 10 

 
Except as set forth on Schedule 2.12, no Top Distributor has in writing, or to the Company’s Knowledge otherwise, canceled, communicated its intent to cancel, or has otherwise
terminated: (i) its relationship with the Company or any of its Subsidiaries, (ii) any contract between such Top Distributor and the Company or any of its Subsidiaries or (iii) its distribution arrangements with the Company or any of
its Subsidiaries with respect to any particular division or business segment of such Top Distributor. 
 2.13 Suppliers.
Schedule 2.13 sets forth a list of the top five (5) human tissue suppliers of the Company and its Subsidiaries, on a consolidated basis, based on expense of the Company and its Subsidiaries, for the twelve (12) month period ended
December 31, 2012 (each, a “Top Supplier”). No Top Supplier has in writing, or to the Company’s Knowledge otherwise, canceled, communicated its intent to cancel, or has otherwise terminated its relationship with the
Company or any of its Subsidiaries. 
 2.14 Material Contracts. 

(a) Schedule 2.14(a) lists Contracts of the following types to which either the Company or any of its Subsidiaries is a party or
subject (other than the Transaction Documents): 
 (i) any Contract involving any joint venture, partnership or similar
arrangement; 
 (ii) any material Contract that limits the freedom of the Company of any of its Subsidiaries to compete in any
line of business or with any Person anywhere in the world, including Contracts that contain any non-compete, exclusivity, or similar provisions; 
 (iii) any Contract involving an assignment, license (whether the Company is licensor or licensee), settlement, covenant not to sue, consent, concurrent use, or other agreement with respect to any
Intellectual Property that is material to the business of the Company or its Subsidiaries (other than non-exclusive licenses granted in the Ordinary Course of Business or licenses for commercially available, off-the-shelf software with an aggregate
license fee of less than $200,000 annually); 
 (iv) any settlement, conciliation or similar Contract pursuant to which the
Company or any of its Subsidiaries is obligated to pay consideration after the date of this Agreement in excess of $500,000; and 
 (v) any Contract with any Top Distributor or any Top Supplier. 
 (b) Each Contract
required to be set forth on Schedule 2.14(a) (collectively, each, a “Material Contract”) is valid, binding and in full force and effect upon the Company and/or applicable Subsidiary (and, to the Company’s Knowledge, the
other parties thereto). The Company and each Subsidiary and, to the Company’s Knowledge, each other party to such Material Contract has performed in all material respects all obligations required to be performed by it under such Material
Contract, and there exists no event, occurrence or condition which, with or without the giving of notice, the lapse of time or both, would become a material default by the Company or any of its Subsidiaries or, to the Company’s Knowledge, by
any other party thereto. 

  
 11 

 2.15 Tax Matters. Except as would not reasonably be expected to, individually or in
the aggregate, have a Material Adverse Effect: 
 (a) (i) the Company and each of its Subsidiaries has timely prepared and filed
all federal and all other material Tax Returns required to have been filed by the Company or any of its Subsidiaries with all appropriate Governmental Authorities and timely paid all Taxes shown thereon and any other Taxes otherwise owed by it,
(ii) all such Tax Returns are true, correct and complete in all respects, (iii) all Taxes that the Company or any of its Subsidiaries is required to withhold or to collect for payment have been duly withheld and collected and paid to the
proper Governmental Authority or third party when due, and (iv) to the Company’s Knowledge, no claim has ever been made by a Governmental Authority in a jurisdiction where the Company or any of its Subsidiaries does not file Tax Returns
that the Company or any of its Subsidiaries is or may be subject to taxation by that jurisdiction; 
 (b) Except as set forth on
Schedule 2.15(b), (i) no federal, state, local, or non-U.S. Tax audits or administrative or judicial Tax proceedings are pending or being conducted with respect to the Company or any of its Subsidiaries, (ii) neither the Company nor any of
its Subsidiaries has received from any federal, state, local, or non-U.S. taxing authority any (A) written notice indicating an intent to open an audit or other review related to any material Tax, or (B) written notice of deficiency or
proposed adjustment for any material amount of Tax proposed, asserted, or assessed by any taxing authority against the Company or any of its Subsidiaries; 
 (c) (i) Neither the Company nor any of its Subsidiaries (A) has been a member of an affiliated group filing a consolidated federal income Tax Return (other than a group the common parent of which was
the Company) or (B) has any liability for the Taxes of any Person (other than the Company or any of its Subsidiaries) under U.S. Treas. Reg. § 1.1502-6 (or any similar provision of state, local, or non-U.S. Law), as a transferee or
successor, by Contract, or otherwise; 
 (d) neither the Company nor any of its Subsidiaries has distributed stock of another
Person, or has had its stock distributed by another Person, in a transaction that was purported or intended to be governed in whole or in part by Section 355 or 361 of the Code; 

(e) neither the Company nor any of its Subsidiaries is or has been a party to any “listed transaction,” as defined in
Section 6707A(c)(2) of the Code and U.S. Treas. Reg. § 1.6011-4(b)(2); and 
 (f) Neither the Company nor any
Subsidiary has ever been, nor will they be at the Closing, a United States Real Property Holding Corporation within the meaning of Code §897(c)(2) during the applicable period specified in Code §897(c)(1)(A)(ii). 

2.16 Property. Except as would not reasonably be expected to, individually or in the aggregate, have a Material Adverse Effect:

 (a) with respect to each Owned Real Property, the Company or one of its Subsidiaries (as the case may be) has good and
marketable fee simple title to such Owned Real Property, free and clear of all Liens except Permitted Liens; 
 (b) the Company
and each of its Subsidiaries has the right to use or occupy the Leased Real Property under valid and binding leases; and 
 (c)
except with respect to Owned Real Property and the Leased Real Property (which are addressed above), the Company and its Subsidiaries have good and valid title to, or a valid license to use or leasehold interest in, all of their respective material
assets, free and clear of all Liens (other than Permitted Liens). 

  
 12 

 2.17 Employee Benefits Matters. Except as would not reasonably be expected to,
individually or in the aggregate, have a Material Adverse Effect: 
 (a) each Employee Benefit Plan (and each related trust,
insurance Contract, or fund) has been maintained, funded and administered in compliance with its terms and with the applicable requirements of ERISA, the Code and other applicable Laws; and each Employee Benefit Plan that is intended to meet the
requirements of a “qualified plan” under Section 401(a) of the Code has received a favorable determination letter (or may rely on a favorable opinion letter) from the United States Internal Revenue Service, and, to the Company’s
Knowledge, nothing has occurred that could reasonably be expected to adversely affect the qualification of such Employee Benefit Plan; 
 (b) neither the Company nor any of its Subsidiaries maintains, sponsors, contributes to, has any obligation to contribute to, or has any current or potential liability or obligation under or with respect
to (i) a “defined benefit plan” (as such term is defined in Section 3(35) of ERISA), (ii) a “multiple employer plan” (within the meaning of Section 210 of ERISA or Section 413(c) of the Code), or
(iii) a “multiemployer plan” as defined in Section 3(37) of ERISA, or (iv) a “multiple employer welfare arrangement” (as such term is defined in Section 3(40) of ERISA); and the Company and its Subsidiaries
have no current or potential liability or obligation by reason of at any time being treated as a single employer under Section 414 of the Code with any other Person; 
 (c) to the Company’s Knowledge, (i) there have been no prohibited transactions (as defined in Section 406 of ERISA or Section 4975 of the Code) and no breach of fiduciary duty (as
determined under ERISA) with respect to any Employee Benefit Plan, (ii) the Company and its Subsidiaries have, for purposes of each Employee Benefit Plan, correctly classified those individuals performing services for the Company or any of its
Subsidiaries as employees or non-employees, (iii) neither the Company nor any of its Subsidiaries has any current or potential obligation to provide post-employment health, life or other welfare benefits other than as required under
Section 4980B of the Code or any similar applicable law and (iv) there do not exist any pending or threatened claims (other than routine undisputed claims for benefits) or Actions with respect to any Employee Benefit Plan; 

(d) the transactions contemplated by the Transaction Documents will not cause the acceleration of vesting in, or payment of, any benefits
or compensation under any Employee Benefit Plan and will not otherwise accelerate or increase any liability or obligation under any Employee Benefit Plan; and 
 (e) each benefit or compensation plan, program, agreement or arrangement that is subject to the laws of any jurisdiction outside the United States and is maintained, sponsored or contributed to by the
Company or any of its Subsidiaries or with respect to which the Company or any of its Subsidiaries has any liability or obligation for Persons located outside the United States (each, a “Foreign Benefit Plan”) has been maintained,
funded and administered in compliance with its terms and the requirements of applicable Laws, and no Foreign Benefit Plan has any unfunded or underfunded liabilities. 
 2.18 Labor Matters. 
 (a) Neither the Company nor any of its Subsidiaries
is a party to or bound by any collective bargaining agreement or other Contract or relationship with any union, labor organization, or other collective bargaining representative. There are no strikes, work stoppages or any other material labor
disputes against or affecting the Company or any of its Subsidiaries pending or, to the Company’s Knowledge, threatened, and no such disputes have occurred within the past five (5) years. To the Company’s Knowledge, no union
organization or decertification activities are underway or threatened with respect to employees of the Company or any of its Subsidiaries and no such activities have occurred within the past five (5) years. 

  
 13 

 (b) Each of the Company and its Subsidiaries is, and at all times in the last three
(3) years been, in compliance in all material respects with all applicable Laws respecting employment and employment practices, including provisions thereof relating to terms and conditions of employment, wages and hours, overtime,
classification of employees and independent contractors, immigration, and the withholding and payment of social security and other employment Taxes. 
 (c) Within the past three (3) years, neither the Company nor any of its Subsidiaries has implemented any plant closing or layoff of employees that could implicate the WARN Act. 

(d) To the Company’s Knowledge, no executive officer, manager, or key employee of the Company or any of its Subsidiaries:
(i) has any present intention to terminate his or her employment with the Company or any of its Subsidiaries within the first twelve (12) months following the Closing Date; or (ii) is a party to any confidentiality, non-competition,
proprietary rights or other such agreement that would materially restrict the performance of such employee’s employment duties, or the ability of the Company and/or any of its Subsidiaries to conduct their business. 

2.19 Intellectual Property 
 (a) The Company or one of its Subsidiaries is the sole and exclusive owner of all right, title and interest in and to, or has the valid and enforceable right to use pursuant to a valid and enforceable
written license agreement, all Intellectual Property used in or necessary for the conduct of the business of the Company or any of its Subsidiaries (collectively, the “Company Intellectual Property”) and free and clear of any Liens,
except Permitted Liens. 
 (b) Except as set forth on Schedule 2.19(b) or as would not, individually or in the aggregate,
be material to the Company or any of its Subsidiaries, (i) neither the Company’s nor any of its Subsidiaries’ use of any Intellectual Property, nor the operation of the Company’s or any of its Subsidiaries’ respective
businesses, has infringed, misappropriated, or otherwise violated, or infringes, misappropriates, or otherwise violates, any Intellectual Property of any other Person, (ii) the Company has no Knowledge of any facts which indicate a likelihood
of the foregoing (and no Actions are pending or, to the Company’s Knowledge, threatened alleging any of the foregoing, including any unsolicited offers for the Company or any of its Subsidiaries to obtain a license to any Intellectual Property
of another Person), and (iii) to the Company’s Knowledge, no Person is infringing, misappropriating or violating the rights of the Company or any of its Subsidiaries with respect to any Company Intellectual Property. 

(c) Except as would not be material to the Company or any of its Subsidiaries, the Company and its Subsidiaries have taken commercially
reasonable steps to maintain and protect the secrecy and confidentiality of its trade secrets and other material confidential information of the Company or its Subsidiaries. The Company and its Subsidiaries have entered into with all of its current
and former employees and independent contractors (i) written assignment agreements assigning all Intellectual Property created or developed within the scope of employment or engagement, as applicable, to the Company or its Subsidiary,
respectively, and (ii) written confidentiality agreements protecting the trade secrets and confidential information of the Company or its Subsidiaries, and all such assignment agreements and confidentiality agreements are valid and enforceable
in accordance with their terms. Except as set forth on Schedule 2.19(c) or as would not be material to the Company or any of its Subsidiaries, to the Knowledge of the Company, no employee or independent contractor to any such confidentiality
agreement is in breach thereof. 
 (d) Except as set forth on Schedule 2.19(d), (x) no government funding,
facilities, resources, or Intellectual Property of a university, college, other educational institution, or research center was used in the development of the Intellectual Property that is owned by, and material to the business of, the Company or
its Subsidiaries, and (y) no governmental entity, university, college, other educational institution, or research center has any claim or right in or to such Intellectual Property (including any “march in” rights). 

  
 14 

 2.20 Environmental Matters. Except as would not reasonably be expected to,
individually or in the aggregate, have a Material Adverse Effect: (i) no notice, notification, demand, request for information, citation, summons, complaint or Order has been received within the past three years by, and no Action is pending or,
to the Company’s Knowledge, threatened by any Person against, the Company or any of its Subsidiaries, and no penalty has been assessed against the Company or any of its Subsidiaries, in each case, with respect to any matters relating to or
arising out of any Environmental Law; (ii) the Company and its Subsidiaries are and within the past three years have been in compliance with all applicable Environmental Laws, including any permits or consents required by Environmental Laws;
(iii) the Company and its Subsidiaries have not assumed, become subject to, or provided an indemnity with respect to, any liability of any other Person relating to Environmental Laws; and (iii) there are no liabilities of or relating to
the Company and its Subsidiaries relating to or arising out of any Environmental Law, and there is no existing condition, situation or set of circumstances that would reasonably be expected to result in a such a liability. 

2.21 Transactions with Affiliates. None of the officers or directors or other Affiliates of the Company is presently a party to
any material transaction or contract with the Company or any of its Subsidiaries (other than as holders of stock options, warrants and/or other grants or awards under the Company’s Incentive Plans, and for services as employees, officers and
directors). 
 2.22 Insurance Coverage. Schedule 2.22 sets forth each insurance policy maintained by the Company
and its Subsidiaries on their properties, assets, products, business or personnel that is material to the Company and its Subsidiaries taken as a whole. Except as would not reasonably be expected to, individually or in the aggregate, have a Material
Adverse Effect, with respect to each such insurance policy: (a) the policy is valid, binding and enforceable on the Company or its Subsidiaries, as applicable, and in full force and effect, and all premiums with respect thereto covering all
periods up to and including the date hereof have been paid, and no notice of cancellation, termination or denial of coverage has been received with respect to any such insurance policy and (b) none of the Company and its Subsidiaries has
received a notice of non-renewal from any of its insurers. 
 2.23 Brokers and Finders. Except as set forth on
Schedule 2.23, no Person will have, as a result of the transactions contemplated by the Transaction Documents, any right, interest or claim against or upon the Company or any of its Subsidiaries for any commission, fee or other compensation
pursuant to any agreement, arrangement or understanding entered into by or on behalf of the Company. 
 2.24 Pioneer Merger
Agreement. Attached hereto as Exhibit G is a true, accurate and complete copy of the Pioneer Merger Agreement, as in effect as of the execution and delivery of this Agreement. 

2.25 No Additional Representations. Except for the representations and warranties made by the Company in this Article II, neither
the Company nor any other Person makes any express or implied representation or warranty with respect to the Company or any of its Subsidiaries or their respective businesses, operations, assets, liabilities, conditions (financial or otherwise) or
prospects, and the Company hereby disclaims any such other representations or warranties. In particular, without limiting the foregoing disclaimer, except for the representations and warranties made by the Company in this Article II, neither
the Company nor any other Person makes or has made any representation or warranty to the Investors, or any of their respective Affiliates or representatives with respect to (i) any financial projection, forecast, estimate, budget or prospect
information relating to the Company or any of its 

  
 15 

 
Subsidiaries or their respective businesses, or (ii) any oral or written information presented to the Investors or any of their Affiliates or representatives in the course of their due
diligence investigation of the Company, the negotiation of this Agreement or in the course of the transactions contemplated hereby. 
 ARTICLE III 
 REPRESENTATIONS AND WARRANTIES OF INVESTOR 

Investor hereby represents and warrants to the Company as of the date hereof and as of the Closing as follows: 

3.1 Organization and Existence. Investor has been duly organized and is validly existing and in good standing in the State of
Delaware and has all requisite limited liability company power and authority to consummate the transactions contemplated by this Agreement. 
 3.2 Authorization. The execution, delivery and performance by Investor of the Transaction Documents to which Investor is a party have been duly authorized by Investor and will each constitute the
valid and legally binding obligation of Investor, enforceable against Investor in accordance with their respective terms, except as such enforceability may be limited by applicable bankruptcy, insolvency, reorganization, moratorium or other similar
Laws affecting the enforcement of creditors rights generally, and general principles of equity (regardless of whether such enforceability is considered in a proceeding in law or equity). 

3.3 Private Placement. The Series A Shares to be acquired by Investor hereunder will be acquired for Investor’s own account,
and not with a view to the resale or distribution of any part thereof in violation of the Securities Act or any applicable state securities Laws, and Investor has no present intention of selling, granting any participation in, or otherwise
distributing the same in violation of the Securities Act or any applicable state securities Laws, without prejudice, however, to Investor’s right at all times to sell or otherwise dispose of all or any part of such Series A Shares in compliance
with applicable securities Laws. Nothing contained herein shall be deemed a representation or warranty by Investor to hold the Series A Shares for any period of time. Investor is an “accredited investor” as defined in Rule 501(a) of
Regulation D under the Securities Act. 
 3.4 Financial Capability. At the Closing, Investor will have sufficient funds
to consummate the transactions required to be consummated by it hereunder at the Closing. 
 3.5 No Conflict, Breach,
Violation or Default. The execution, delivery and performance of the Transaction Documents by Investor and the purchase of the Series A Shares contemplated hereby will not: (i) conflict with or result in a violation of the certificate of
formation (or other governing documents) of Investor, (ii) result in any material violation of any Law to which Investor or any of its assets are subject, or (iii) result in a material breach or a material violation of any of the terms and
provisions of, or constitute a default under, any material Contract to which Investor is a party. Neither the execution, delivery or performance of any Transaction Document by Investor, nor the consummation by Investor of the obligations and
transactions contemplated thereby, in each case at the Closing, requires any consent of, authorization by, exemption from, filing with or notice to any Governmental Authority or any other Person, other than filings required under applicable U.S.
federal and state securities Laws. 
 3.6 No Legal, Tax or Investment Advice. Investor understands that nothing in
(i) the Transaction Documents, (ii) the Company Filings or (iii) any other materials presented to Investor in connection with the purchase and sale of the Series A Shares constitutes legal, tax or investment advice. Investor has
consulted such legal, tax and investment advisors as it, in its sole discretion, has deemed necessary or appropriate in connection with its purchase of Series A Shares. Investor acknowledges that it has not relied on any representation or warranty
from the Company or any other Person in making its investment or decision to invest in the Company, except as expressly set forth in this Agreement. 

  
 16 

 3.7 Restrictive Legend. Investor understands that, until such time as a registration
statement covering the Series A Shares and the shares of Common Stock issuable upon the conversion thereof has been declared effective or the Series A Shares and the shares of Common Stock issuable upon the conversion thereof may be sold pursuant to
Rule 144 under the Securities Act without any restriction as to the number of securities as of a particular date that can then be immediately sold, the Series A Shares and the shares of Common Stock issuable upon the conversion thereof shall bear a
restrictive legend in substantially the following form (and a stop-transfer order may be placed against transfer of the certificates for the Series A Shares and the shares of Common Stock issuable upon the conversion thereof): 

“THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. THE SECURITIES
MAY NOT BE SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER SAID ACT, OR AN OPINION OF COUNSEL, IN FORM, SUBSTANCE AND SCOPE REASONABLY ACCEPTABLE TO THE COMPANY, THAT REGISTRATION IS NOT
REQUIRED UNDER SAID ACT OR UNLESS SOLD PURSUANT TO RULE 144 UNDER SAID ACT.” 
 ARTICLE IV 

COVENANTS AND AGREEMENTS 
 4.1 Interim Operations of the Company. Prior to the Closing or the earlier termination of this Agreement in accordance with its terms, the Company and each Subsidiary shall operate in the Ordinary
Course of Business. Except as set forth on Schedule 4.1 or as expressly permitted or required by the Transaction Documents and without limiting the foregoing, prior to the Closing or the earlier termination of this Agreement in accordance with its
terms, unless Investor has previously consented in writing thereto (which consent will not be unreasonably withheld, conditioned or delayed), the Company shall not (and shall cause its Subsidiaries not to): 

(a) amend, modify, supplement or waive any provisions of the Pioneer Merger Agreement or fail to comply with any obligation of the Company
or the Merger Sub (as defined in the Pioneer Merger Agreement) therein; 
 (b) enter into any Contract or make any commitment
that would conflict or interfere in any material respect with the Company’s obligations under the Transaction Documents; 

(c) amend its certificate of incorporation or bylaws or similar organizational documents; 

(d) (i) declare, set aside or pay any dividends on, or make any other distributions (whether in cash, securities or other property) in
respect of, any of its capital stock (other than dividends and distributions by a direct or indirect wholly-owned Subsidiary of the Company to its parent); (ii) adjust, split, combine or reclassify any of its capital stock or issue or authorize
the issuance of any other securities in respect of, in lieu of or in substitution for shares of its capital stock or any of its other securities; or (iii) purchase, redeem or otherwise acquire any shares of its capital stock or any other of its
securities or any rights, warrants or options to acquire any such shares or other securities, other than repurchases of Common Stock pursuant to existing compensation, benefits, option, restricted share or employment agreements or plans existing on
the date of this Agreement and disclosed in the Disclosure Schedules hereto; 

  
 17 

 (e) issue, sell, grant, pledge or otherwise dispose of or encumber any of its capital stock,
any other voting securities or any securities convertible into or exchangeable for, or any rights, warrants or options to acquire, any such capital stock, voting securities or convertible or exchangeable securities, other than any issuance of
(A) Common Stock upon exercise of any stock options outstanding on the date of this Agreement, or (B) capital stock or compensatory stock options to employees or directors of the Company or any of its Subsidiaries in the Ordinary Course of
Business; 
 (f) sell, lease, mortgage, pledge, grant a Lien on, or otherwise dispose of any of its properties or assets, except
in the Ordinary Course of Business; 
 (g) (i) file, or consent by answer or otherwise to the filing against the Company or any
of its Subsidiaries of, a petition for relief or reorganization or arrangement or any other petition in bankruptcy, insolvency, reorganization, moratorium or other similar Law of any jurisdiction, (ii) make an assignment for the benefit of the
creditors of the Company or any of its Subsidiaries, (iii) consent to the appointment of a custodian, receiver, trustee or other officer with similar powers with respect to the Company or any of its Subsidiaries or with respect to any
substantial part of its or their property, or (iv) take any corporate action for the purpose of any of the foregoing; 

(h) dissolve, liquidate or wind up; 
 (i) acquire any interest in any Person or enterprise, whether by a purchase of assets, purchase of stock, merger, loan or otherwise (other than pursuant to the Pioneer Merger Agreement at the Closing), or
enter into any joint venture or similar agreement; 
 (j) enter into any line of business other than the lines of business in
which the Company and/or its Subsidiaries are currently engaged and other activities or lines of business reasonably related thereto in each case; 
 (k) create, incur, guarantee, assume, or issue any Indebtedness (other than in the Ordinary Course of Business or in connection with the Financing Commitments); 

(l) voluntarily delist from any trading market; 
 (m) implement any employee layoffs that could implicate the WARN Act; 
 (n) except
to provide for the appointment of the Preferred Directors (as defined in the Series A Certificate of Designation), increase the size of the Board; or 
 (o) authorize, or commit to agree to take, any of the foregoing actions. 
 4.2
Further Assurances. Each Party agrees to take, or cause to be taken, all actions, and to do, or cause to be done, all things reasonably necessary, proper or advisable to obtain satisfaction of the conditions precedent to the other Party to
the consummation of the transactions contemplated hereby. 

  
 18 

 4.3 Preparation of the Proxy Statement; Shareholders’ Meeting. 

(a) Shareholder Approval; Proxy Statement. The Company agrees to use its reasonable best efforts to call and hold as soon as
reasonably practicable following the Closing a meeting of the shareholders of the Company to obtain the Shareholder Approval (the “Shareholder Meeting”), and as promptly as reasonably practicable in accordance with such timing (and
in any event no later than 75 days following the Closing), the Company will prepare and file with the SEC a proxy statement to be sent to the Company’s shareholders in connection with the Shareholder Meeting (the “Proxy
Statement”). The Company shall cause the Proxy Statement to comply in all material respects with the provisions of the Exchange Act and the rules and regulations promulgated thereunder and to satisfy all applicable NASDAQ rules. The Proxy
Statement shall include the Board’s unanimous recommendation that the shareholders vote in favor of the Shareholder Approval. The Company will cause the Proxy Statement, at the time of the mailing of the Proxy Statement or any amendments or
supplements thereto, and at the time of the Shareholders’ Meeting, to not contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary in order to make the statements therein, in
the light of the circumstances under which they were made, not misleading; provided, however, that no representation or warranty is made by the Company with respect to information supplied by Investor in writing specifically for
inclusion in the Proxy Statement. If the Shareholder Approval is not obtained at the Shareholder Meeting, then the Company shall use its reasonable best efforts to obtain the Shareholder Approval as soon as practicable thereafter. Until the
Shareholder Approval has been obtained, the Company shall use its reasonable best efforts to solicit from its shareholders proxies in favor of the Shareholder Approval and to obtain the Shareholder Approval at each meeting of the Company’s
shareholders occurring after the Closing Date. Investor shall provide to the Company all information concerning Investor as may be reasonably requested by the Company in connection with the Proxy Statement and shall otherwise reasonably assist and
cooperate with the Company in the preparation of the Proxy Statement and resolution of comments of the SEC or its staff related thereto. Investor will cause the information relating to Investor supplied by it for inclusion in the Proxy Statement, at
the time of the mailing of the Proxy Statement or any amendments or supplements thereto, and at the time of the Shareholder Meeting, not to contain any untrue statement of a material fact or omit to state any material fact required to be stated
therein or necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading; provided, however, that no representation or warranty is made by Investor with respect to
information supplied by the Company for inclusion or incorporation by reference in the Proxy Statement. The Company shall respond as soon as reasonably practicable to any comments received from the SEC with respect to the Proxy Statement (and to the
extent reasonably practicable shall address all SEC comments no less than 30 days after the filing of the Proxy Statement), and the Company shall cause the Proxy Statement (containing the recommendation described above) to be mailed to the
Company’s shareholders at the earliest reasonably practicable date (and in any event no later than (i) five Business Days following the SEC’s completion of its review of the Proxy Statement or (ii) if the SEC does not notify the
Company that it will review the preliminary Proxy Statement within 10 calendar days after the Company files the preliminary Proxy Statement with the SEC, five Business Days following such tenth calendar day after the Company files the preliminary
Proxy Statement with the SEC). The Company shall notify Investor, as promptly as reasonably practicable after receipt thereof, of any comments from the SEC or any request from the SEC or its staff for amendments or supplements to the Proxy Statement
(and shall provide copies of any such written comments or requests to Investor) and shall provide Investor with copies of all correspondence between the Company, its Subsidiaries or any of their respective directors, officers, employees, investment
bankers, financial advisors, attorneys, accountants or other advisors, agents or representatives, on the one hand, and the SEC or the staff of the SEC, on the other hand, relating to the Proxy Statement. Notwithstanding anything to the contrary
herein, prior to filing or mailing the Proxy Statement (or, in each case, any amendment or supplement thereto) or responding to any comments of the SEC or its staff with respect thereto, the Company shall provide Investor with a reasonable
opportunity to review and comment on such document or response and the Company shall incorporate in such document or response any reasonable comments provided by Investor or its representatives. 

  
 19 

 (b) Amendments to Proxy Statement. If at any time any event or circumstance relating
to the Company or any of its Subsidiaries or its or their respective officers or directors should be discovered by the Company which, pursuant to the Securities Act or Exchange Act, should be set forth in an amendment or a supplement to the Proxy
Statement, the Company shall promptly inform Investor. Each Party agrees to promptly correct any information provided by it for use in the Proxy Statement which shall have become false or misleading and shall cause all documents that such Party is
responsible for filing with the SEC in connection with transactions contemplated hereby to comply as to form in all material respects with the applicable requirements of the Securities Act and the Exchange Act and, as applicable, not to contain any
untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading. 

4.4 Restrictions. 
 (a) Standstill. Without the prior written consent of independent members of the Board or a duly formed special committee of the Board consisting exclusively of independent directors, Investor will
not (and will ensure that its Affiliates will not) from the date hereof until May 21, 2014 (the “Restricted Period”): except as otherwise contemplated by this Agreement or the Transaction Documents (i) purchase or
otherwise acquire, or offer, seek, propose or agree to acquire, ownership (including, but not limited to, beneficial ownership as defined in Rule 13d-3 under the Exchange Act) of any securities of the Company, or any direct or indirect rights or
options to acquire any such securities or any securities convertible into such securities (collectively, “Securities”); (ii) make, or in any way participate, directly or indirectly, in any “solicitation” of
“proxies” (as such terms are used in the proxy rules under the Exchange Act and the regulations thereunder) to vote, or seek to advise or influence any person with respect to the voting of any voting securities of the Company or any of its
subsidiaries; (iii) form, join, or in any way participate in a “group” (within the meaning of Section 13(d)(3) of the Exchange Act) with respect to the Securities of the Company, (iv) enter, agree to enter, propose, seek or
offer to enter into or facilitate any merger, business combination, recapitalization, restructuring or other extraordinary transaction involving the Company or any of its subsidiaries, (v) disclose any intention, plan or arrangement prohibited
by, or inconsistent with, the foregoing or (vi) advise, assist or encourage or enter into any discussions, negotiations, agreements or arrangements with any other persons in connection with the foregoing. Investor further agrees that during the
Restricted Period none of it or any of its Affiliates (or any person acting on behalf of or in concert with it or any of its Affiliates) will, without the written consent of the Company, (x) request the Company or any of its representatives
directly or indirectly to amend or waive any provision of this Section 4.4 (including this sentence), or (y) take any action that would require the Company to make a public announcement regarding the possibility of a business
combination, merger or other type of transaction described in this paragraph with Investor or its Affiliates. Nothing contained in Agreement shall prevent Investor or any of its Affiliates from making a confidential proposal to the Board, without
public disclosure by such Persons or that would require public disclosure, for a tender offer, exchange offer, merger, other business combination, other extraordinary transaction involving the Company or for an acquisition of all or a material
portion of the securities or the consolidated assets of the Company. Notwithstanding the foregoing, if at any time during the Restricted Period, (i) the Company enters into (or publicly announces) an agreement providing for a Combination, or
(ii) a tender or exchange offer that if consummated would constitute a Combination is made (or has been publicly announced), then the restrictions set forth in clauses (i) through (vi), of this Section 4.4(a) shall
automatically terminate and cease to be of any effect. 
 (b) Exclusivity. During the Restricted Period, the Company
shall not, and shall cause each of its Affiliates and its and their directors, officers, employees, Affiliates, agents, attorneys, consultants and other advisors to not, directly or indirectly, solicit, initiate, or encourage the submission or
receipt of any proposal or indication of interest from any Person other than Investor or its Affiliates 

  
 20 

 
regarding any equity financing relating to a Designated Acquisition, or authorize to enter into any agreement or understanding with any Person other than Investor or its Affiliates with respect
to any equity financing relating to a Designated Acquisition, in any case without Investor’s prior written consent. For purposes hereof, “Designated Acquisition” means the acquisition (whether through merger, stock sale, asset
sale, recapitalization or otherwise) of, or any other debt or equity investment in, or any other transaction outside the Ordinary Course of Business with, a Targeted Person. For purposes hereof, “Targeted Person” shall mean Pioneer
or its Affiliates. During the Restricted Period, the Company shall not, and shall cause each of its Affiliates and its and their directors, officers, employees, affiliates, agents, attorneys, consultants and other advisors to not, directly or
indirectly, consummate a Designated Acquisition, unless the Company offers the right to Investor and its Affiliates, and otherwise permits such Persons, to invest at least $50,000,000 (and up to such greater amount as may be mutually determined by
the Parties) in the Company contemporaneously with the consummation of such Designated Acquisition on the terms set forth herein and the Transaction Documents. During the Restricted Period, Investor shall not, and shall cause each of its Affiliates
and its and their directors, officers, employees, affiliates, agents, attorneys, consultants and other advisors to not, directly or indirectly, consummate a Designated Acquisition with any party other than the Company without the Company’s
written consent. Notwithstanding anything herein to the contrary, nothing in this Section 4.4(b) shall be construed to prevent the Company from consummating its obligations under the Pioneer Merger Agreement. 

4.5 Reasonable Access. Prior to the Closing, the Company will permit Investor and its representatives to have reasonable access at
reasonable times to the premises, properties, personnel, books, records and documents of or pertaining to the Company and its Subsidiaries as is reasonably necessary in order to (a) consummate the transactions contemplated by the Transaction
Documents and/or (b) keep Investor reasonably informed with respect to material events affecting the Company and/or its Subsidiaries. 
 4.6 Notification. After the date hereof and prior to the Closing, the Company shall promptly deliver to Investor a written notice of any change, event, circumstance or development that would render
any representation or warranty of the Company in this Agreement inaccurate or incomplete in any material respect (it being understood that in no event shall any such notice or disclosure be deemed to amend or supplement the Disclosure Schedules or
to prevent or cure any misrepresentation or breach of warranty). 
 4.7 Securities Law Disclosure; Publicity. No public
release or announcement concerning the transactions contemplated hereby or by any other Transaction Document shall be issued by the Company or Investor without the prior consent of the Company (in the case of a release or announcement by Investor)
or Investor (in the case of a release or announcement by the Company) (which consents shall not be unreasonably withheld, conditioned or delayed), except for any such release or announcement as may be required by Law or the applicable rules or
regulations of any securities exchange or securities market, in which case the Company or Investor, as the case may be, shall allow Investor or the Company, as applicable, to the extent reasonably practicable in the circumstances, reasonable time to
comment on such release or announcement in advance of such issuance. The provisions of this Section 4.7 shall not restrict the ability of the Company to summarize or describe the transactions contemplated by this Agreement in any prospectus or
similar offering document so long as Investor is provided a reasonable opportunity to review and comment on such disclosure in advance of the filing or other public dissemination of any such document. Notwithstanding anything herein to the contrary,
from and after the Closing, the Parties acknowledge and agree that Water Street Healthcare Partners, LLC (“Water Street”) and its Affiliates (except for the Company and its Subsidiaries) may provide general information about the
subject matter of this Agreement in connection with Water Street’s or its Affiliates’ and affiliated investment funds’ normal fund raising, marketing, informational, reporting or firm marketing and related press release and
communication activities; provided that Water Street shall not provide any material non-public information regarding the Company pursuant to this sentence. 

  
 21 

 4.8 Use of Proceeds. The net proceeds received by the Company from the Purchase Price
paid by Investor shall be used by the Company to fund a portion of the consideration payable to the stockholders of Pioneer under the Pioneer Merger Agreement and to pay the costs, fees and expenses arising in connection with the Merger. Any excess
net proceeds will be used for general corporate purposes (including future acquisitions). 
 4.9 NASDAQ Matters. Prior to
the Closing, the Company shall (i) take all actions which are necessary, including providing appropriate notice to NASDAQ of the transactions contemplated by this Agreement, for the Common Stock to remain listed on the NASDAQ Global Select
market and (ii) comply with all listing, reporting, filing, and other obligations under the rules of NASDAQ. 
 4.10
Regulatory Filings. The Parties shall make or cause to be made all filings, notices and submissions necessary under any Laws (including any notifications or filings required under the under the Hart Scott Rodino Antitrust Improvements Act of
1976, as amended, and other antitrust or competition laws of any applicable jurisdiction) for the consummation of the transactions contemplated by this Agreement and the Ancillary Agreements (including in connection with any transactions or other
events or circumstances that may occur after the Closing in connection with the terms and provisions of the shares of the Series A Preferred Stock (including in connection with any conversion of shares of Series A Preferred Stock, any dilution
adjustments or any accruals of dividends)). Each Party shall furnish to the other Party such reasonably necessary information and such reasonable assistance and cooperation as the other Party may reasonably request in connection with the foregoing

 ARTICLE V 
 TERMINATION 
 5.1 Termination Prior to the Closing. Notwithstanding any
other provision of this Agreement, this Agreement may be terminated at any time prior to the Closing: 
 (a) by the mutual
written consent of Investor and the Company; 
 (b) by Investor or the Company, upon written notice to the other Party, if the
Closing shall not have been consummated on or prior to the date that is ninety (90) days after the date hereof (the “Termination Date”); provided, however, that the right to terminate this Agreement pursuant to
this Section 5.1(b) shall not be available to any Party whose breach of any provision of this Agreement results in or causes the failure of the Closing to occur by such time; 

(c) by Investor or the Company, upon written notice to the other Party, if a Governmental Authority of competent jurisdiction has issued
an Order or any other action permanently enjoining or otherwise prohibiting the consummation of the transactions contemplated by this Agreement or the other Transaction Documents, and such Order has become final and non-appealable;
provided, however, that the right to terminate this Agreement pursuant to this Section 5.1(c) shall not be available to any Party whose breach of any provision of this Agreement results in or causes such Order or
other action; 
 (d) by Investor or the Company, upon written notice to the other Party, if the Pioneer Merger Agreement has
been duly terminated in accordance with its terms; 

  
 22 

 (e) by Investor, upon written notice to the Company, if (i) there has been a breach of
any representation, warranty, covenant or agreement made by the Company in this Agreement, such that the conditions to Closing set forth in Section 1.3(a) would not be satisfied and (ii) such breach is not cured (if curable) within
ten (10) days after delivery of such notice; provided that this Section 5.1(e) shall only apply if Investor is not in material breach of any of its obligations under this Agreement; or 

(f) by the Company, upon written notice to Investor, if (i) there has been a breach of any representation, warranty, covenant or
agreement made by Investor in this Agreement, such that the conditions to Closing set forth in Section 1.3(b) would not be satisfied and (ii) such breach is not cured (if curable) within ten (10) days after delivery of such
notice; provided that this Section 5.1(f) shall only apply if the Company is not in material breach of any of its obligations under this Agreement. 
 5.2 Effect of Termination. In the event of termination of this Agreement prior to the Closing pursuant to Section 5.1 by the Company and/or Investor (as applicable), this Agreement will become
void and have no effect without any liability or obligation on the part of the Company or Investor (other than the provisions of Section 4.4, this Section 5.2, and Article VI, which will survive any such termination of this Agreement);
provided, however, that nothing herein will relieve any Party from any liability for any breach by such Party of its representations, warranties, covenants or agreements set forth in this Agreement prior to such termination. 

ARTICLE VI 

MISCELLANEOUS AND GENERAL 
 6.1 Survival. The representations, warranties, covenants and agreements contained in this Agreement shall survive the Closing; provided, that (a) the representations and warranties (other than
the Fundamental Representations) contained in this Agreement shall terminate on the first anniversary of the Closing, and (b) the Fundamental Representations shall terminate on the third anniversary of the Closing; provided, further, that any
representation or warranty in respect of which a claim may be made, and any right of recovery with respect thereto, shall survive the time at which it would otherwise terminate pursuant to this Section 6.1 if written notice of the inaccuracy or
breach or potential inaccuracy or breach thereof shall have been given to the Company prior to such time. 
 6.2 Successors
and Assigns. This Agreement may not be assigned by any Party hereto without the prior written consent of the other Party, except that Investor may assign its rights and delegate its duties hereunder in whole or in part (i) to an Affiliate,
in which case no such assignment shall relieve Investor of its obligations hereunder, or (ii) after the Closing to any third party to whom Investor transfers its Series A Shares to in accordance with the terms of the Transaction Documents. The
provisions of this Agreement shall inure to the benefit of and be binding upon the respective successors and permitted assigns of the Parties. 
 6.3 Counterparts; Electronic Delivery. This Agreement may be executed in one or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the
same instrument. This Agreement and any signed agreement or instrument entered into in connection with this Agreement, and any amendments hereto or thereto, to the extent delivered by means of a telecopy machine or electronic mail (any such
delivery, an “Electronic Delivery”), shall be treated in all manner and respects as an original agreement or instrument and shall be considered to have the same binding legal effect as if it were the original signed version thereof
delivered in person. At the request of any party hereto or to any such agreement or instrument, each other party hereto or thereto shall re-execute original forms thereof and deliver them to all other parties. No party hereto or to any such
agreement or instrument shall raise (a) the use of Electronic Delivery to deliver a signature or (b) the fact that any signature or agreement or instrument was transmitted or communicated through the use of Electronic Delivery, as a
defense to the formation of a contract, and each such party forever waives any such defense, except to the extent such defense related to lack of authenticity. 

  
 23 

 6.4 Headings; Interpretation. All headings and subheadings used in this Agreement are
used for convenience only and are not to be considered in construing or interpreting this Agreement. The words “include,” “includes” and “including” will be deemed to be followed by the phrase “without
limitation”. The meanings given to terms defined herein will be equally applicable to both the singular and plural forms of such terms. Whenever the context may require, any pronoun includes the corresponding masculine, feminine and neuter
forms. All references to “dollars” or “$” will be deemed references to the lawful money of the United States of America. Further, the Parties have participated jointly in the negotiation and drafting of this Agreement. In the
event an ambiguity or question of intent or interpretation arises, this Agreement shall be construed as if drafted jointly by the Parties, and no presumption or burden of proof shall arise favoring or disfavoring any Party by virtue of the
authorship of any provisions of this Agreement. All schedules and exhibits attached hereto are hereby incorporated herein by reference and made a part hereof. 
 6.5 Notices. Any notice or request required or permitted to be delivered under this Agreement shall be given in writing and shall be deemed effectively given (a) if given by personal delivery,
upon actual delivery, (b) if given by facsimile, upon receipt of confirmation of a completed transmittal, (c) if given by mail, upon the earlier of (i) actual receipt of such notice by the intended recipient or (ii) three
(3) Business Days after such notice is deposited in first class mail, postage prepaid, and (d) if by an internationally recognized overnight courier, one (1) Business Day after delivery to such courier for overnight delivery. All
notices shall be addressed to the Party to be notified at the address as follows, or at such other address as such Party may designate by ten (10) days’ advance written notice to the other Party: 

If to the Company: 
 RTI
Biologics, Inc. 
 11621 Research Circle 
 Alachua, FL 32615 
 Attention: Board of Directors 

Facsimile: (386) 418-0342 

With a copy to (which shall not constitute notice to the Company): 
 Fulbright & Jaworski LLP 
 666 Fifth Avenue 

New York, NY 10103 
 Attention: Warren J. Nimetz 
 Facsimile: (212) 318-3400 

If to Investor: 
 WSHP
Biologics Holdings, LLC 
 c/o Water Street Healthcare Partners 

333 West Wacker Drive, Suite 2800 
 Chicago, Illinois 60606 
 Attention: Ned H. Villers 

Facsimile: (312) 506-2901 

  
 24 

 With a copy to (which shall not constitute notice to Investor): 

Kirkland & Ellis LLP 
 300 North LaSalle 
 Chicago, IL 60654 

Attention:    Ted H. Zook, P.C. 
           James S. Rowe 

          Martin A. Diloreto, Jr., P.C. 

Facsimile: (312) 862-2200 
 6.6 Expenses; Transfer Taxes. Whether or not the Closing shall occur, all fees, costs and expenses incurred in connection with this Agreement and the transactions contemplated hereby, including
accounting and legal fees, shall be paid by the party incurring such expenses, except that, if the Closing occurs, on the Closing Date the Company shall pay all of the reasonable third party fees and expenses incurred by the Investor in connection
with the transactions contemplated by this Agreement, the Transaction Documents, the Pioneer Merger Agreement, the Ancillary Documents and the definitive financing agreements related thereto, including the fees and expenses of counsel for Investor
(collectively, “Investor Expenses”). In addition, the Company shall pay (i) any and all documentary, sales, use, registration, stamp or similar issue or transfer Taxes due on or in respect of the issuance of (x) the Series A
Shares contemplated hereby and (y) shares of Common Stock upon conversion of any such Series A Share, as applicable and (ii) any fees (including filing fees) and expenses incurred by Investor, whether in respect of the Issuance, the
issuance of Common Stock upon conversion of the Series A Shares or otherwise, in connection with seeking any approval or notification of any Governmental Authority required in connection with the transactions contemplated hereby and the Transaction
Documents (including any fees and expenses incurred in connection with any notifications or the like required to be filed under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, and other antitrust or competition laws of any
applicable jurisdiction). 
 6.7 Amendments and Waivers. No term of this Agreement may be amended or modified without the
prior written consent of each Party. No provision of this Agreement may be waived except in a writing executed and delivered by the Party against whom such waiver is sought to be enforced. Any amendment or waiver effected in accordance with this
Section 6.7 shall be binding upon each holder of any Series A Shares purchased under this Agreement at the time outstanding, each future holder of all such Series A Shares, and the Company. 

6.8 Equitable Relief. Each Party hereby acknowledges and agrees that the failure of the other Party to perform its respective
agreements and covenants hereunder, including any failure to take all actions as are necessary by such Party to consummate the transactions contemplated by the Transaction Documents (to the extent required to be taken by such Party under this
Agreement or the Transaction Documents), will cause irreparable injury to the other Party, for which damages, even if available, will not be an adequate remedy. Accordingly, each Party hereby agrees that any other Party may seek the issuance of
equitable relief by any court of competent jurisdiction to compel performance of such Party’s obligations. 
 6.9
Severability. If any provision of this Agreement or the application of any such provision to any Person or circumstance shall be declared by any court of competent jurisdiction to be invalid, illegal, void or unenforceable in any respect, all
other provisions of this Agreement, or the application of such provision to Persons or circumstances other than those as to which it has been held invalid, illegal, void or unenforceable, shall nevertheless remain in full force and effect and will
in no way be affected, impaired or invalidated thereby. Upon such determination that any provision, or the application of any such provision, is invalid, illegal, void or unenforceable, the Parties shall negotiate in good faith to

  
 25 

 modify this Agreement so as to effect the original intent of the Parties as closely as possible to the
fullest extent permitted by Law in an acceptable manner to the end that the transactions contemplated hereby and the other Transaction Documents are fulfilled to the greatest extent possible. 

6.10 Entire Agreement. This Agreement, including the exhibits and the Disclosure Schedules and the other Transaction Documents (as
and when executed and delivered) constitute the entire agreement among the Parties with respect to the subject matter hereof and thereof and supersede all prior agreements and understandings (including that certain Letter Agreement by and between
Water Street Healthcare Partners, LLC and the Company, dated as of February 21, 2013 and that certain Letter Agreement, between Water Street Healthcare Partners, LLC and the Company, effective as of June 25, 2012), both oral and written,
between the parties with respect to the subject matter hereof and thereof. 
 6.11 Third Party Beneficiaries. Nothing in
this Agreement (implied or otherwise) is intended to confer upon any Person other than the Parties or their respective successors and permitted assigns any rights, remedies, obligations, or liabilities under or by reason of this Agreement.

 6.12 Governing Law; CONSENT TO JURISDICTION. This Agreement and any Action or dispute arising under or related in any
way to this Agreement, the relationship of the Parties, the transactions leading to this Agreement or contemplated hereby and/or the interpretation and enforcement of the rights and duties of the Parties hereunder or related in any way to the
foregoing, shall be governed by and construed in accordance with the internal, substantive Laws of the State of Delaware applicable to agreements entered into and to be performed solely within such state without giving effect to the principles of
conflict of Laws thereof. EACH OF THE PARTIES TO THIS AGREEMENT HEREBY AGREES THAT JURISDICTION AND VENUE IN ANY SUIT, ACTION OR PROCEEDING BROUGHT BY ANY PARTY ARISING OUT OF OR RELATING TO THIS AGREEMENT (INCLUDING ANY SUIT, ACTION OR PROCEEDING
SEEKING EQUITABLE RELIEF) SHALL PROPERLY AND EXCLUSIVELY LIE IN THE COURT OF CHANCERY OF THE STATE OF DELAWARE (THE “COURT OF CHANCERY”) OR, TO THE EXTENT THE COURT OF CHANCERY DOES NOT HAVE SUBJECT MATTER JURISDICTION, THE UNITED STATES
DISTRICT COURT FOR THE DISTRICT OF DELAWARE AND THE APPELLATE COURTS HAVING JURISDICTION OF APPEALS IN SUCH COURTS (THE “DELAWARE FEDERAL COURT”) OR, TO THE EXTENT NEITHER THE COURT OF CHANCERY NOR THE DELAWARE FEDERAL COURT HAS SUBJECT
MATTER JURISDICTION, THE SUPERIOR COURT OF THE STATE OF DELAWARE (COLLECTIVELY, THE “CHOSEN COURTS”). EACH PARTY HERETO FURTHER AGREES NOT TO BRING ANY SUCH SUIT, ACTION OR PROCEEDING IN ANY COURT OTHER THAN THE CHOSEN COURTS PURSUANT TO
THE FOREGOING SENTENCE (OTHER THAN UPON APPEAL). BY EXECUTION AND DELIVERY OF THIS AGREEMENT, EACH PARTY IRREVOCABLY SUBMITS TO THE JURISDICTION OF THE CHOSEN COURTS FOR ITSELF AND IN RESPECT OF ITS PROPERTY WITH RESPECT TO SUCH SUIT, ACTION OR
PROCEEDING. THE PARTIES HERETO IRREVOCABLY AGREE THAT VENUE WOULD BE PROPER IN EACH OF THE CHOSEN COURTS, AND HEREBY WAIVE ANY OBJECTION THAT ANY SUCH CHOSEN COURT IS AN IMPROPER OR INCONVENIENT FORUM FOR THE RESOLUTION OF SUCH SUIT, ACTION OR
PROCEEDING. 
 6.13 WAIVER OF JURY TRIAL. TO THE EXTENT NOT PROHIBITED BY APPLICABLE LAW WHICH CANNOT BE WAIVED, EACH
PARTY HERETO HEREBY WAIVES AND COVENANTS THAT IT WILL NOT ASSERT (WHETHER AS PLAINTIFF, DEFENDANT OR OTHERWISE) ANY RIGHT TO TRIAL BY JURY IN ANY FORUM IN RESPECT OF ANY ISSUE OR ACTION, CLAIM, CAUSE OF ACTION OR SUIT (IN CONTRACT, TORT OR
OTHERWISE) INQUIRY, PROCEEDING OR INVESTIGATION ARISING OUT OF OR BASED UPON THIS AGREEMENT OR THE SUBJECT MATTER HEREOF OR IN ANY WAY CONNECTED WITH OR 

  
 26 

 RELATED OR INCIDENTAL TO THE TRANSACTIONS CONTEMPLATED HEREBY, IN EACH CASE WHETHER NOW EXISTING OR
HEREAFTER ARISING. EACH PARTY HERETO ACKNOWLEDGES THAT IT HAS BEEN INFORMED BY THE OTHER PARTIES HERETO THAT THIS SECTION 6.13 CONSTITUTES A MATERIAL INDUCEMENT UPON WHICH THEY ARE RELYING AND WILL RELY IN ENTERING INTO THIS AGREEMENT. ANY PARTY
HERETO MAY FILE AN ORIGINAL COUNTERPART OR A COPY OF THIS SECTION 6.13 WITH ANY COURT AS WRITTEN EVIDENCE OF THE CONSENT OF EACH SUCH PARTY TO THE WAIVER OF ITS RIGHT TO TRIAL BY JURY. 

[END OF PAGE] 

[SIGNATURE PAGE FOLLOWS] 

  
 27 

 IN WITNESS WHEREOF, the parties hereto have executed this Agreement or caused their duly
authorized officers to execute this Agreement as of the date first above written. 
  

			
	COMPANY
	
	RTI BIOLOGICS, INC.
		
	By:	 	/s/ Brian Hutchison
	Name:	 	Brian Hutchison
	Title:	 	President and CEO

  

			
	INVESTOR
	
	WSHP BIOLOGICS HOLDINGS, LLC
		
	By:	 	/s/ Jeffrey Holway
	Name:	 	Jeffrey Holway
	Title:	 	Authorized Signatory

 Signature Page to Investment Agreement 

 Exhibit A 
 Definitions 
 As used in and for the purposes of this Agreement, the following
terms shall have the meanings set forth below: 
 “Action” means any action, cause or action, suit, prosecution,
grievance, inquiry, investigation, litigation, arbitration, mediation, audit, charge, hearing, order, claim, complaint or other proceeding (whether civil, criminal, administrative, investigative or informal) by or before any Governmental Authority
or arbitrator. 
 “Affiliate” of any Person shall mean any other Person directly or indirectly controlling or
controlled by or under direct or indirect common control with such Person. For purposes of this definition, “control” when used with respect to any Person has the meaning specified in Rule 12b-2 under the Exchange Act; and the terms
“controlling” and “controlled” have meanings correlative to the foregoing. 
 “Agreement”
has the meaning set forth in the introductory paragraph hereto. 
 “Ancillary Documents” means all exhibits
attached to the Pioneer Merger Agreement. 
 “Board” means the board of directors of the Company (or any
successor governing body of the Company). 
 “Business Day” means any day except Saturday, Sunday and any day
on which banking institutions in New York, New York generally are closed as a result of federal, state or local holiday. 

“Bylaws” means the bylaws of the Company, as adopted on February 27, 2008. 

“Certificate of Incorporation” means the amended and restated certificate of incorporation of the Company as filed with
the Secretary of State of the State of Delaware on February 27, 2008. 
 “Closing” has the meaning set
forth in Section 1.2. 
 “Closing Date” has the meaning set forth in Section 1.2.

 “Code” means the United States Internal Revenue Code of 1986, as amended. 

“Combination” means a transaction in which (A) a person or “group” (within the meaning of
Section 13(d) under the Exchange Act) acquires, directly or indirectly, securities representing 50% or more of the voting power of the outstanding securities of the Company or properties or assets constituting 50% or more of the consolidated
assets of the Company and its Subsidiaries, or (B) in any case not covered by (A), (X) the Company issues securities representing 50% or more of its total voting power, including, in the case of (A) and (B), by way of merger or other
business combination with the Company or any of its subsidiaries, or (Y) the Company engages in a merger or other business combination such that the holders of voting securities of the Company immediately prior to the transaction do not own
more than 50% of the voting power of securities of the resulting entity. 
 “Common Stock” means the shares of
the Company’s common stock, par value $0.001 per share, having the rights and privileges set forth in the Certificate of Incorporation and the Bylaws. 

  
 Exhibit A-1

 “Company” has the meaning set forth in the introductory paragraph to this
Agreement. 
 “Company Filings” has the meaning set forth in the introduction to Article II. 

“Company Intellectual Property” has the meaning set forth in Section 2.18(a). 

“Company’s Knowledge” and phrases of similar import mean the actual knowledge and knowledge that would be possessed
after due and reasonable inquiry of the executive officers of the Company (as defined in Rule 405 under the Securities Act). 

“Confidential Information” means trade secrets, confidential information and know-how (including ideas, formulae,
compositions, processes, procedures and techniques, research and development information, computer program code, performance specifications, support documentation, drawings, specifications, designs, business and marketing plans, pricing and cost
information, and customer and supplier lists and related information). 
 “Contract” shall mean, with respect
to any Person, any written or oral agreement, contract, commitment, indenture, note, bond, loan, license, sublicense, lease, sublease, undertaking, statement of work or other arrangement to which such Person is a party or by which any of its
properties or assets are subject. 
 “Disclosure Schedules” has the meaning set forth in the introduction to
Article II. 
 “Electronic Delivery” has the meaning set forth in Section 6.3. 

“Employee Benefit Plan” means each material “employee benefit plan” as defined in Section 3(3) of ERISA,
and each other material bonus, deferred compensation, profit sharing, retirement, welfare, retention, change in control, stock purchase, stock option, equity incentive, or severance plan, program, policy, agreement, or arrangement maintained,
sponsored, contributed or required to be contributed to by the Company or any of its Subsidiaries or with respect to which the Company or any of its Subsidiaries has any current or potential liability or obligation. 

“Environmental Law” mean all national, supra-national, federal, state, local and foreign Laws concerning public health
and safety, worker health and safety, pollution or protection of the environment; including without limitation all those relating to the generation, handling, transportation, treatment, storage, disposal, release, exposure to or cleanup of hazardous
materials, substances or wastes, including petroleum, asbestos, polychlorinated biphenyls, asbestos, noise or radiation. 

“ERISA” means the United States Employee Retirement Income Security Act of 1974, as amended, and the rulings and
regulations thereunder. 
 “Exchange Act” means the United States Securities Exchange Act of 1934, as amended,
or any successor statute, and the rules and regulations promulgated thereunder. 
 “FDA Laws” means all
applicable laws, statutes, rules, and regulations, relating to the development, clinical and non-clinical evaluation, product clearance, manufacture, production, analysis, distribution, use, handling, quality, sale, labeling, promotion, or
postmarket requirements of any product subject to regulation the Federal Food, Drug, and Cosmetic Act (21 U.S.C. § 301 et seq.), as amended, and the regulations promulgated thereunder, the Public Health Service Act (42 U.S.C. § 201 et
seq.) and the regulations promulgated thereunder. 

  
 Exhibit A-2

 “Financing Commitments” means the Commitment Letter, dated June 7,
2013, between the Company and TD Bank, N.A., as Administrative Agent, TD Securities “USA” LLC, as Bookrunner and Joint Lead Arranger and Regions Bank, as Joint Lead Arranger. 

“Foreign Benefit Plan” has the meaning set forth in Section 2.16(e). 

“Fundamental Representations” means the representations and warranties set forth in Sections 2.1 (Organization,
Good Standing and Qualification), 2.2 (Authorization), 2.4 (Capitalization), 2.5 (Valid Issuance), 2.8 (Private Placement), 2.15 (Tax Matters), 2.21, (Transactions with Affiliates) 2.23 (Brokers and
Finders), and 2.24 (Pioneer Merger Agreement). 
 “GAAP” means United States generally accepted
accounting principles as in effect from time to time. 
 “Governmental Authority” means any domestic (federal,
state, municipal or local) or foreign or multinational government or governmental, regulatory, political, judicial or quasi-judicial or administrative subdivision, department, authority, entity, agency, regulator, commission, board, bureau, court,
or instrumentality. 
 “Health Care Laws” means all applicable laws, statutes, ordinances, rules, regulations,
guidance and policies relating to pricing, marketing, promotion, sale, distribution, coverage, or reimbursement of a drug, biological or medical device, including Title XI, Title XVIII and Title XIX of the Social Security Act, including, but not
limited to, Sections 1128, 1128A, 1128B, 1128C or 1877 of the Social Security Act (42 U.S.C. §§ 1320a-7, 1320a-7a, 1320a-7b, 1320a-7c and 1395nn); the federal TRICARE statute (10 U.S.C. § 1071 et seq.); the False Claims Act (31 U.S.C.
§ 3729 et seq.), the False Statements Accountability Act (18 U.S.C. § 1001); the Program Fraud Civil Remedies Act (31 U.S.C. § 3801 et seq.); 18 U.S.C. § 287; and the anti-fraud and related provisions of the Health Insurance
Portability and Accountability Act of 1996 (e.g., 18 U.S.C. §§ 1035 and 1347), together with any rules or regulations promulgated thereunder. 
 “Incentive Plans” means the Company’s 1998 Stock Option Plan, 2004 Equity Incentive Plan, 2010 Equity Incentive Plan, 1996 TMI Stock Option Plan and TMI 2006 Incentive and
Non-Statutory Stock Option Plan. 
 “Indebtedness” means, with respect to any Person at any applicable time of
determination, without duplication, (i) all liabilities and obligations for borrowed money, (ii) all liabilities and obligations evidenced by bonds, debentures, notes or other similar instruments or debt securities, (iii) all
liabilities and obligations under or in respect of swaps, hedges or similar instruments; (iv) all liabilities and obligations in respect of letters of credit and similar instruments, (v) all liabilities and obligations (contingent or
otherwise) arising from or in respect of (a) deferred compensation arrangements, (b) pension plans, or (c) amounts payable as a result of the consummation of the transactions contemplated hereby (regardless of whether any additional
event, in addition to the consummation of the transactions contemplated hereby, is required to give rise to such liabilities and obligations), (vi) all liabilities and obligations for the acquisition of a business or portion thereof, whether
contingent or otherwise, as obligor or otherwise (including any “earn out” or similar payments or obligations at the maximum amount payable in respect thereof), (viii) all guaranties in connection with any of the foregoing, and
(ix) all accrued interest, prepayment premiums, fees, penalties, expenses or other amounts payable in respect of any of the foregoing. 

  
 Exhibit A-3

 “Intellectual Property” means all intellectual property and other similar
proprietary rights in any jurisdiction, including such rights in and to: (i) any patent (including all reissues, divisions, continuations, continuations-in-part and extensions thereof), patent application, patent disclosure or other patent
right, (ii) any trademark, service mark, trade name, business name, brand name, slogan, logo, trade dress and all other indicia of origin together with all goodwill associated therewith, and all registrations, applications for registration, and
renewals for any of the foregoing, and (iii) any copyright, work of authorship (whether or not copyrightable), design, design registration, database rights, and all registrations, applications for registration, and renewals for any of the
foregoing (and including in all website content and software), (iv) any Internet domain names, and (v) any Confidential Information or trade secrets, including know-how, formulae, recipes, methods, processes, technical data,
specifications, documentation and business plans. 
 “Investor” has the meaning set forth in the introductory
paragraph to this Agreement. 
 “Investor Expenses” has the meaning set forth in Section 6.6.

 “Investor Rights Agreement” has the meaning set forth in Section 1.4(a). 

“Issuance” has the meaning set forth in the Recitals to this Agreement. 

“Law” means any federal, state, local, municipal, foreign, international, multinational, or other constitution, law
(including common law), code, ordinance, rule, resolution, regulation, statute, Order or treaty. 
 “Leased Real
Property” means all leasehold or subleasehold estates and all other rights to use or occupy any land, buildings, structures, improvements, fixtures or other interest in real property held by the Company or any of its Subsidiaries pursuant
to any Lease. 
 “Leases” means all leases, subleases, licenses, concessions and other Contracts pursuant to
which the Company or any of its Subsidiaries holds any Leased Real Property as tenant, sublease, licensee or concessionaire (including the rights to all security deposits and other amounts and instruments deposited by or on behalf of the Company
and/or and of its Subsidiaries thereunder) and all material amendments, extensions, renewals, guaranties and other agreements with respect thereto. 
 “Lien” means any mortgage, pledge, security interest, hypothecation, restriction, encumbrance, lien or charge of any kind. 

“Management Rights Agreement” has the meaning set forth in Section 1.4(b). 

“Material Adverse Effect” means a material and adverse effect (a) on the business, operations, assets, liabilities
or condition (financial or otherwise) of the Company and its Subsidiaries taken as a whole or (b) on the ability of the Company or any of its Subsidiaries to perform its obligations under, or to consummate the transactions contemplated by, the
Transaction Documents; provided, however, that none of the following shall be taken into account in determining whether there has been a Material Adverse Effect: any state of facts, event, change, condition, development, circumstance,
effect, factor or occurrence (i) arising out of or resulting from any adverse change in the financial, banking or securities markets or the economy in general (or any disruption of any of the foregoing), (ii) arising out of or resulting
from the announcement, execution or performance of this Agreement or the consummation of the transactions contemplated hereby, (iii) arising out of or resulting from changes in applicable Laws or changes in GAAP, (iv) arising out of or
resulting from changes in the market price or trading volume of the Common Stock, (v) arising out of or resulting from the failure by the Company or any of its Subsidiaries to meet internal or public projections, forecasts or estimates of
revenue or earnings, (vi) arising out of or resulting from any natural disaster or any acts of war, armed hostilities, sabotage or 

  
 Exhibit A-4

 terrorism, or any escalation or worsening thereof, or (vii) compliance with the specific provisions of,
or the taking of any action specifically required by, this Agreement or the Pioneer Merger Agreement; provided that, with respect to each of clauses (i), (iii) and (vi) above, any such any state of facts, event,
change, condition, development, circumstance, effect, factor or occurrence shall only be disregarded and not taken into account in determining whether a Material Adverse Effect has occurred to the extent that such any state of facts, event, change,
condition, development, circumstance, effect, factor or occurrence does not have, and would not reasonably be expected to have, a disproportionate effect on the Company and/or any Subsidiary relative to other similarly situated Persons in the
industry of the Company and its Subsidiaries; provided, further that, with respect to each of clauses (iv) and (v) the underlying causes of any such changes or failures shall be included in determining whether
there has been a Material Adverse Effect. 
 “Material License” has the meaning set forth in
Section 2.10. 
 “Merger” has the meaning set forth in the Recitals to this Agreement. 

“NASDAQ” means The NASDAQ Stock Market LLC. 
 “Order” means any assessment, award, decision, injunction, judgment, order, ruling, verdict or writ entered, issued, made, or rendered by any court, administrative agency, or other
Governmental Authority or by any arbitrator. 
 “Ordinary Course of Business” means the ordinary course of the
business of the Company and its Subsidiaries as currently conducted, consistent in all material respects with past custom and practice of the Company and its Subsidiaries. 
 “Owned Real Property” means all land, together with all buildings, structures, improvements and fixtures located thereon, and all easements and other rights and interests appurtenant
thereto, owned by the Company or any of its Subsidiaries. 
 “Party” and “Parties” have the
respective meanings ascribed to such terms in the introductory paragraph of this Agreement. 
 “Permitted
Liens” means (a) mechanics’, materialman’s, workmens’, repairmen’s’, warehousemen’s, supplier’s, vendor’s, carrier’s and other similar Liens arising or incurred in the Ordinary Course of
Business by operation of Law securing amounts that are not yet due and payable, (b) Liens for Taxes, assessments and other charges of Governmental Authorities not yet due and payable, (c) Liens arising under original purchase price
conditional sales Contracts and equipment leases with third parties, (d) pledges or deposits to secure obligations under workers or unemployment compensation Laws or to secure other statutory obligations, (e) easements, covenants,
conditions and restrictions of record affecting title to the Owned Real Property or Leased Real Property which do not or would not materially impair the use or occupancy of any Owned Real Property or Leased Real Property in the operation of the
business conducted thereon as of the date of this Agreement, and (f) any zoning, or other governmentally established restrictions of encumbrances. 
 “Person” means any individual, corporation, partnership, limited liability company, trust, business trust, association, joint stock company, joint venture, sole proprietorship,
unincorporated organization, Governmental Authority or other entity. 
 “Pioneer” has the meaning set forth in
the Recitals to this Agreement. 

  
 Exhibit A-5

 “Pioneer Merger Agreement” has the meaning set forth in the Recitals to
this Agreement. 
 “Proxy Statement” has the meaning set forth in Section 4.3(a). 

“Purchase Price” means $50,000,000. 
 “Sarbanes-Oxley Act” has the meaning set forth in Section 2.6. 
 “SEC” means the United States Securities and Exchange Commission, or any successor Governmental Authority. 
 “Securities Act” means the United States Securities Act of 1933, as amended, or any successor statute, and the rules and regulations promulgated thereunder. 

“Series A Certificate of Designation” has the meaning set forth in the Recitals to this Agreement. 

“Series A Preferred Stock” has the meaning set forth in the Recitals to this Agreement. 

“Series A Shares” has the meaning set forth in Section 1.1. 

“Shareholder Approval” shall mean all approvals of the stockholders of the Company necessary to approve the transactions
contemplated under this Agreement and the issuance of the Series A Shares with the rights and privileges described in the Series A Certificate of Designation, including any approvals by the holders of Common Stock for the issuance of twenty percent
(20%) or more of the number of shares of Common Stock outstanding before such issuance, and the issuance of twenty percent (20%) or more of the voting power of the Company to any one holder of Series A Shares as may be required under law
or the listing standards of NASDAQ (or any successor thereto or other trading market on which the Common Stock is listed), including NASDAQ Market Place Rule 5635(b) and (d) or NASDAQ Market Place Rule 5640, and Interpretative Material (IM)
5635-2, as applicable. 
 “Shareholder Meeting” has the meaning set forth in Section 4.3(a).

 “Subsidiary” means, when used with respect to any Person, any other Person of which (a) in the case of
a corporation, at least (i) a majority of the equity and (ii) a majority of the voting interests are owned or controlled, directly or indirectly, by such first Person, by any one or more of its Subsidiaries, or by any combination of such
first Person and one or more of its Subsidiaries or (b) in the case of any Person other than a corporation, such first Person, one or more of its Subsidiaries, or such first Person and one or more of its Subsidiaries combined (i) owns a
majority of the equity interests thereof and (ii) has the power to elect or direct the election of a majority of the members of the governing body thereof. As used in this Agreement, unless the context requires otherwise, references to a
Subsidiary or Subsidiaries shall mean a Subsidiary or the Subsidiaries of the Company. For the avoidance of doubt, any reference to any Subsidiary of the Company shall (i) include RTI Donor Services, Inc., and (ii) not include Pioneer or
any entity controlled by Pioneer. 
 “Tax” or “Taxes” means (i) any federal, state,
local, or non-U.S. income, gross receipts, license, payroll, employment, excise, severance, stamp, occupation, premium, windfall profits, environmental (including taxes under Section 59A of the Code), customs duties, capital stock, franchise,
profits, withholding, social security (or similar), unemployment, disability, real property, personal property, sales, use, transfer, unclaimed property or escheat (or similar), registration, value added, alternative or add-on minimum, estimated, or
other tax of any kind whatsoever, including any interest, penalty, or addition thereto, whether disputed or not; (ii) any liability for or in respect of the payment of any amount of a type

  
 Exhibit A-6

 
described in clause (i) of this definition as a result of being a member of an affiliated, combined, consolidated, unitary or other group for Tax purposes; or (iii) any liability for or
in respect of the payment of any amount described in clauses (i) or (ii) of this definition as a transferee or successor, by Contract or otherwise. 
 “Tax Return” means any return, declaration, report, claim for refund, or information return or statement relating to Taxes, including any schedule or attachment thereto, and including any
amendment thereof. 
 “Termination Date” has the meaning set forth in Section 6.1(b). 

“Top Distributors” has the meaning set forth in Section 2.12. 

“Transaction Documents” means this Agreement, the Series A Certificate of Designation, the Investor Rights Agreement,
the Management Rights Agreement, the Director Indemnification Agreements, the Pioneer Merger Agreement and all other documents delivered or required to be delivered by any Party pursuant to this Agreement or any of the foregoing. 

“WARN Act” means the Worker Adjustment and Retraining Notification Act of 1988, as amended and any similar or related
Law 

  
 Exhibit A-7

 Exhibit B 
 CERTIFICATE OF DESIGNATION OF 
 SERIES A CONVERTIBLE PREFERRED STOCK 

OF 
 RTI BIOLOGICS,
INC. 
  
  

Pursuant to Section 151 of the 
 General Corporation Law of the State of Delaware 
  

 
 RTI BIOLOGICS,
INC. (the “Corporation”), a corporation organized and existing under the General Corporation Law of the State of Delaware (the “DGCL”), certifies that, pursuant to authority conferred upon the board of directors of
the Corporation (the “Board”) by the FOURTH Article of the Amended and Restated Certificate of Incorporation of the Corporation, as amended from time to time (the “Certificate of Incorporation”), and pursuant to the
provisions of DGCL Section 151, the Board adopted and approved the following resolution providing for the designations, preferences and relative, participating, optional and other rights, and the qualifications, limitations and restrictions of
the Series A Convertible Preferred Stock: 
 WHEREAS, the Certificate of Incorporation provides for two classes of shares of
capital stock known as common stock, par value $0.001 per share (the “Common Stock”), and preferred stock, par value $0.001 per share (the “Preferred Stock”); 

WHEREAS, the Certificate of Incorporation authorizes the issuance of 5,000,000 shares of Preferred Stock; and 

WHEREAS, the Board is authorized by the Certificate of Incorporation as permitted by the DGCL to provide for the issuance of the shares
of Preferred Stock in one or more series and to establish from time to time the number of shares to be included in each such series and to fix the voting powers, designations, preferences and relative, participating, optional and other rights of the
shares of each such series and the qualifications, limitations and restrictions thereof. 
 NOW, THEREFORE, BE IT RESOLVED, that
the Board does hereby provide for the issuance of a series of Preferred Stock and does hereby establish and fix the number of shares to be included in such series of Preferred Stock and the voting powers, designations, preferences, rights,
qualifications, limitations and restrictions of the shares of such series of Preferred Stock as follows: 

Section 1. Designation. The designation of this series of Preferred Stock is “Series A Convertible Preferred
Stock,” par value $0.001 per share (the “Series A Preferred”). 
 Section 2. Number of
Series A Preferred Shares. The authorized number of shares of Series A Preferred is 50,000. 
 Section 3.
Defined Terms and Rules of Construction. 
 (a) Definitions. As used herein with respect to the Series A
Preferred: 
 “Affiliate” of any Person shall mean any other Person directly or indirectly controlling or
controlled by or under direct or indirect common control with such Person. For purposes of this definition, “control” when used with respect to any Person has the meaning specified in Rule 12b 2 under the Exchange Act; and the terms
“controlling” and “controlled” have meanings correlative to the foregoing. 

 “Board” shall have the meaning set forth in the preamble hereto.

 “Business Day” means any day except Saturday, Sunday and any day on which banking institutions in New York,
New York generally are closed as a result of federal, state or local holiday. 
 “Bylaws” shall mean the Bylaws
of the Corporation in effect on the date hereof and as amended from time to time in accordance with the terms therein and herein. 
 “Capital Stock” shall mean any and all shares, interests, rights to purchase, warrants, options, participations or other equivalents of or interests in (in each case however designated)
stock issued by the Corporation. 
 “Certificate of Designation” shall mean this Certificate of Designation
relating to the Series A Preferred, as it may be amended from time to time in accordance with the terms hereof. 

“Certificate of Incorporation” shall have the meaning set forth in the preamble hereto. 

“Change of Control” shall mean (a) any sale or other disposition of all or substantially all of the assets of the
Corporation and its Subsidiaries on a consolidated basis in any transaction or series of related transactions, (b) any sale, transfer or issuance or series of related sales, transfers and/or issuances of shares of the Capital Stock by the
Corporation or any holder thereof which results in any single Person or group (as defined in Rule 13d-5 of the Exchange Act) becoming the beneficial owners of Capital Stock representing (x) 50% or more of the voting power of all outstanding
voting Capital Stock or (y) the power to elect a majority of the Board (under ordinary circumstances, by contract or otherwise), or (c) any merger or consolidation to which the Corporation is a party unless after giving effect to such
merger no single Person or group (as defined in Rule 13d-5 of the Exchange Act) is the beneficial owner of Capital Stock possessing the voting power to elect a majority of the Board or the surviving Person’s board of directors (or similar
governing body) or becomes the beneficial owner of greater than 50% of the Corporation’s or such surviving Person’s issued and outstanding common stock or securities convertible into common stock of such Person. 

“Closing Price” shall mean the price per share of the final trade of the Common Stock, other Capital Stock or similar
equity interest, as applicable, on the applicable Trading Day (or the last trade of the Capital Stock or similar equity interest preceding the applicable Trading Day if no trades of such securities were made on the applicable Trading Day) on the
principal national securities exchange or securities market on which the Common Stock, other Capital Stock or similar equity interest is listed or admitted to trading; provided that if the Capital Stock is not so listed or traded, the Closing
Price shall be equal to the fair market value, as reasonably determined in good faith by the Board. 

“Commission” shall mean the U.S. Securities and Exchange Commission, including the staff thereof. 

“Common Stock” shall have the meaning set forth in the recitals hereto. 

“Common Stock Deemed Outstanding” shall mean, at any given time, the sum of (a) the number of shares of Common
Stock actually outstanding at such time, plus (b) the number of shares of Common Stock issuable upon exercise of Options actually outstanding at such time, plus (c) the number of shares of Common Stock issuable upon conversion or exchange
of Convertible Securities actually 

  
 2 

 outstanding at such time (treating as actually outstanding any Convertible Securities issuable upon exercise
of Options actually outstanding at such time), in each case, regardless of whether or not the Options or Convertible Securities are actually exercisable at such time. 
 “Conversion Cap” shall have the meaning ascribed to it in Section 8(a). 
 “Conversion Price” shall mean $4.39, but as it may be adjusted from time to time in accordance with Section 9. 

“Conversion Restriction” shall have the meaning set forth in Section 8(a). 

“Conversion Stock” shall mean Common Stock or other capital stock of the Corporation then issuable upon conversion of
the Series A Preferred in accordance with the terms of Section 8. 
 “Convertible Securities” shall
mean any stock , securities (other than Options) or obligations of indebtedness directly or indirectly convertible into or exchangeable for Common Stock. 
 “Corporation” shall have the meaning set forth in the preamble hereto. 
 “Date of Issuance” shall mean, for any Series A Preferred Share, the date on which the Corporation initially issues such Series A Preferred Share (without regard to any subsequent
transfer of such Series A Preferred Share or reissuance of the certificate(s) representing such Series A Preferred Share). 

“Deemed Liquidation” shall have the meaning ascribed to it in Section 5(b). 

“Dividend Reference Date” shall have the meaning set forth in Section 4(a). 

“DGCL” shall have the meaning set forth in the preamble hereto. 

“Event of Noncompliance” shall have the meaning set forth in Section 12. 

“Exchange Act” shall mean the Securities Exchange Act of 1934, as amended. 

“Excluded Issuances” means any issuance or sale (or deemed issuance or sale in accordance with Section 9(d))
by the Corporation after the Date of Issuance of: (a) shares of Common Stock issued on the conversion of the Series A Preferred; (b) up to an aggregate of 2,800,000 shares of Common Stock (as such number of shares is equitably adjusted for
subsequent stock splits, stock combinations, stock dividends and recapitalizations) issued directly or upon the exercise of Options to directors, officers, employees, or consultants of the Corporation in connection with their service as directors of
the Corporation, their employment by the Corporation or their retention as consultants by the Corporation, in each case authorized by the Board and issued pursuant to the Incentive Plans (including all such shares of Common Stock and Options
outstanding prior to the Date of Issuance); or (c) shares of Common Stock issued upon the conversion or exercise of Options (other than Options covered by clause (b) above) issued prior to the Date of Issuance, provided that such
securities are not amended after the date hereof to increase the number of shares of Common Stock issuable thereunder or to lower the exercise or conversion price thereof. 
 “Forced Conversion” shall have the meaning set forth in Section 8(b). 

  
 3 

 “Forced Conversion Noncompliance Event” shall mean (i) the failure of
the Corporation to make any redemption payment with respect to any Series A Preferred Share which it is required to make hereunder, whether or not such payment is legally permissible or is prohibited by any debt financing agreement of the
Corporation or any of its Subsidiaries or any other agreement to which the Corporation is subject or (ii) the breach by the Corporation of its obligations under Section 8(e). The foregoing shall constitute Events of Noncompliance
whatever the reason or cause for any such Event of Noncompliance and whether it is voluntary or involuntary or is effected by operation of law or pursuant to any judgment, decree or order of any court or any order, rule or regulation of any
administrative or governmental body and regardless of the effects of any subordination provisions. 
 “Incentive
Plans” means the Corporation’s 1998 Stock Option Plan, 2004 Equity Incentive Plan, 2010 Equity Incentive Plan, 1996 TMI Stock Option Plan and TMI 2006 Incentive and Non-Statutory Stock Option Plan, in each case as may be amended,
supplemented or modified from time to time as approved by the Board. 
 “Investment Agreement” shall mean that
certain Investment Agreement by and between the Corporation and Investor, dated as of June     , 2013. 
 “Investor Rights Agreement” shall mean that certain Investor Rights Agreement by and between the Corporation and Investor, dated on or about the Date of Issuance. 

“Investor” shall mean WSHP Biologics Holdings, LLC. 

“Junior Securities” shall mean any class or series of Capital Stock other than (i) the Series A Preferred or
(ii) any class or series of Capital Stock that is specifically designated as senior or pari passu to the Series A Preferred in any amendment, modification or supplement to the Certificate of Incorporation (including as a result of a new
certificate of designation), which the holders of Series A Preferred have consented to in accordance with Section 11 hereof and, if applicable, Section 3.5 of the Investor Rights Agreement. 

“Liquidation” shall have the meaning ascribed to it in Section 5(a). 

“Liquidation Preference” shall have the meaning ascribed to it in Section 5(a). 

“Liquidation Value” of any Series A Preferred Share as of any particular date shall mean $1,000. 

“Optional Redemption Eligibility Date” shall mean the earlier of the following: (i) a Change of Control and
(ii) the seventh anniversary of the Date of Issuance. 
 “Options” shall mean any rights, warrants or
options to subscribe for or purchase Common Stock or Convertible Securities. 
 “Organic Change” shall have the
meaning ascribed to it in Section 9(e). 
 “Person” or “person” shall mean an
individual, corporation, limited liability company, association, partnership, group (as such term is used in Section 13(d)(3) of the Exchange Act), trust, joint venture, business trust or unincorporated organization, or a government or any
agency or political subdivision thereof. 
 “Preferred Director” shall have the meaning ascribed to it in
Section 10(b). 

  
 4 

 “Preferred Percentage” shall mean, at any time of determination, the
percentage equal to (i) the number of shares of Common Stock issuable upon the conversion of all of the Series A Preferred Shares outstanding at such time of determination (without regard to any restrictions on conversion (including the
Conversion Cap and the Conversion Restriction)), plus the number of shares of Common Stock outstanding at such time of determination that were issued pursuant to the conversion of any Series A Preferred Shares, divided by (ii) the number
of shares of Common Stock issued and outstanding at such time of determination, plus the number of shares of Common Stock issuable upon conversion of the Series A Preferred outstanding at such time (without regard to any restrictions on conversion
(including the Conversion Cap and the Conversion Restriction)). 
 “Preferred Stock” shall have the meaning set
forth in the recitals hereto. 
 “Purchase Rights” shall have the meaning ascribed to it in
Section 11. 
 “Redemption Date” shall mean, as to any Series A Preferred Share, the date specified
in the notice of any redemption at the Corporation’s option or at the holder’s option; provided that no such date shall be a Redemption Date unless the amount payable to such Series A Preferred Share hereunder is actually paid in
full on such date, and if not so paid in full, the Redemption Date shall be the date on which such amount is fully paid. 

“Registrable Securities” shall have the meaning set forth in the Investor Rights Agreement. 

“Related Party” shall mean (i) any officer or director of the Corporation or other Person that owns at least 5% of
the Common Stock on an as-converted fully diluted basis (which for such calculation shall aggregate stockholdings of Affiliates and of immediate family members sharing the same household with such Persons), (ii) any officer or director of any
of the Corporation’s Subsidiaries, or (iii) any member of any such Person’s immediate family sharing the same household or any of their respective Affiliates. 
 “Series A Dividend Reference Dates” shall have the meaning ascribed to it in Section 4(b). 
 “Series A Preferred Majority Holders” shall mean, as of any time of determination, the holders of a majority of the Series A Preferred Shares outstanding as of such time of determination.

 “Series A Preferred” shall have the meaning ascribed to it in Section 1. 

“Series A Preferred Share” shall have the meaning ascribed to it in Section 4(a). 

“Series A Unpaid Dividends” shall have the meaning ascribed to it in Section 4(a). 

“Shareholder Approval” shall mean all approvals of the stockholders of the Corporation necessary to approve the
transactions contemplated under the Investment Agreement and the issuance of the Series A Shares with the rights and privileges described in this Certificate of Designation, including any approvals by the holders of Common Stock for the issuance of
twenty percent (20%) or more of the number of shares of Common Stock outstanding before such issuance, and the issuance of twenty percent (20%) or more of the voting power of the Company to any one holder of Series A Shares as may be
required under law or the listing standards of NASDAQ (or any successor thereto or other trading market on which the Common Stock is listed), including NASDAQ Market Place Rule 5635(b) and (d) or NASDAQ Market Place Rule 5640, and
Interpretative Material (IM) 5635-2, as applicable. 

  
 5 

 “Shareholder Approval Deadline” shall have the meaning ascribed to it in
Section 4(e). 
 “Shelf Registration Statement” shall have the meaning set forth in Investor Rights
Agreement. 
 “Stock Price Forced Conversion Event” shall have the meaning ascribed to it in
Section 8(b). 
 “Subsidiary” means any Person of which at least (i) a majority of the equity
and (ii) a majority of the voting interests, are owned or controlled, directly or indirectly, by the Corporation, by any one or more of its Subsidiaries, or by any combination of the Corporation and one or more of its Subsidiaries. For the
avoidance of doubt, any reference to any Subsidiary of the Company shall include RTI Donor Services, Inc. 

“Taxes” shall mean any federal, state, local or foreign income, gross receipts, branch profits, license, payroll,
employment, excise, severance, stamp, occupation, premium, windfall profits, escheat, environmental, customs duties, capital stock, franchise, profits, withholding, social security, unemployment, disability, real property, personal property, sales,
use, transfer, registration, ad valorem, value added, alternative or add-on minimum or estimated tax or other tax of any kind whatsoever, including any interest, penalty or addition thereto, whether disputed or not and including any obligation to
indemnify or otherwise assume or succeed to the Tax liability of any other Person by law, by contract or otherwise. 

“Trading Day” shall mean any Business Day on which the Common Stock is traded, or able to be traded, on the principal
national securities exchange on which the Common Stock is listed or admitted to trading. 
 (b) Rules of
Construction. Unless the context otherwise requires: (i) words in the singular include the plural, and in the plural include the singular; (ii) “including” means including without limitation; (iii) references to any
Section or clause refer to the corresponding Section or clause, respectively, of this Certificate of Designation; (iv) any reference to a day or number of days, unless expressly referred to as a Business Day or Trading Day, shall mean the
respective calendar day or number of calendar days; (v) references to Sections of or Rules under the Exchange Act shall be deemed to include substitute, replacement or successor Sections or Rules, and any term defined by reference to a Section
of or Rule under the Exchange Act shall include Commission and judicial interpretations of such Section or Rule; and (vi) headings are for convenience of reference only. 
 Section 4. Dividends. 
 (a) General
Obligations. When, as and if declared by the Board and to the extent permitted under the DGCL, the Corporation shall pay preferential dividends in cash to the holders of the Series A Preferred as provided in this Section 4(a).
Dividends on each share of the Series A Preferred (each a “Series A Preferred Share,” and collectively, the “Series A Preferred Shares”) shall accrue on a daily basis at the rate of six percent (6.0%) per annum
(or twelve percent (12.0%) per annum if, and for so long as, required pursuant to Section 4(e)) on the sum of (x) the Liquidation Value thereof, plus (y) all accrued and accumulated but unpaid dividends on such Series A
Preferred Share (such amount in clause (y), the “Series A Unpaid Dividends”), from and including the Date of Issuance, to and including the first to occur of: (i) the date on which the Liquidation Value of such Series A
Preferred Share, plus all Series A Unpaid Dividends thereon is paid to the holder thereof in connection with a Liquidation pursuant to Section 5, (ii) the 

  
 6 

 Redemption Payment Date for such Series A Preferred Share, (iii) the date on which such
Series A Preferred Share is converted into shares of Conversion Stock hereunder or (iv) the date on which such Series A Preferred Share is otherwise acquired by the Corporation. Such dividends shall accrue whether or not they have been declared
and whether or not there are profits, surplus or other funds of the Corporation legally available for the payment of dividends, and such dividends shall be cumulative such that Series A Unpaid Dividends shall be fully paid or declared with funds
irrevocably set apart for payment before any dividends, distributions, redemptions or other payments may be made with respect to any Junior Securities, other than to (A) declare or pay any dividend or distribution payable on the Common Stock in
shares of Common Stock or (B) repurchase Common Stock held by employees or consultants of the Corporation for not more than $0.001 per share or other de minimis amounts per share upon termination of their employment or services in accordance
with agreements providing for such repurchase existing as of the date of this Certificate or in accordance with any Incentive Plan or any other equity incentive plan of the Corporation adopted and approved by the Board after the date of this
Certificate. 
 (b) Dividend Reference Dates. To the extent not paid in cash on
March 31, June 30, September 30, and December 31 of each year, beginning [            ]1 (the “Series A Dividend Reference Dates”), all dividends which have accrued on each Series A Preferred
Share during the three-month period (or other period, if any, in the case of the initial Series A Dividend Reference Date) ending upon each such Series A Dividend Reference Date shall be accumulated and shall remain accumulated dividends with
respect to such Series A Preferred Share until paid in cash to the holder thereof. 
 (c) Distribution of
Partial Dividend Payments. Except as otherwise provided herein, if at any time the Corporation pays less than the total amount of dividends then accrued and accumulated with respect to the Series A Preferred Shares, such payment shall be made
pro rata among the holders thereof based upon the aggregate Series A Unpaid Dividends in respect of the Series A Preferred Shares held by each such holder. 
 (d) Participating Dividends. In addition to any other dividends accruing, accumulating or declared hereunder, in the event that the Corporation declares or pays any dividends upon the Common Stock
(whether payable in cash, securities or other property), other than (i) dividends payable on the Common Stock solely in shares of Common Stock and (ii) to the extent constituting a dividend, any repurchases of Common Stock held by
employees or consultants of the Corporation for not more than $0.001 per share or other de minimis amounts per share upon termination of their employment or services in accordance with agreements providing for such repurchase existing as of the date
of this Certificate or in accordance with any Incentive Plan or any other equity incentive plan of the Corporation adopted and approved by the Board after the date of this Certificate, the Corporation shall also declare and pay to the holders of the
Series A Preferred at the same time that it declares and pays such dividends to the holders of the Common Stock the dividends which would have been declared and paid with respect to the Common Stock issuable upon conversion of the Series A Preferred
Shares had all (i.e., without regard to any restrictions on conversion (including the Conversion Cap and the Conversion Restriction) at such time) of such outstanding Series A Preferred Shares been converted immediately prior to the record
date for such dividend, or if no record date is fixed, the date as of which the record holders of Common Stock entitled to such dividends are to be determined. 

 

	1 	 To be the first to occur after the Closing of (i) June 30; (ii) September 30; (iii) December 31; or
(4) March 31. 

  
 7 

 (e) Dividend Rate Adjustment. In the event that Shareholder Approval
has not been obtained within 180 days after the Date of Issuance (the “Shareholder Approval Deadline”), then the dividend rate on each Series A Preferred Share shall automatically (without any further action) increase to the rate of
twelve percent (12.0%) per annum, commencing on the day after the Shareholder Approval Deadline and ending on (and including) the date on which Shareholder Approval has been obtained. 

Section 5. Liquidation 
 (a) Normal Liquidation. Upon any liquidation, dissolution or winding up of the Corporation (whether voluntary or involuntary) (collectively with a Deemed Liquidation, a
“Liquidation”), each holder of Series A Preferred then outstanding shall be entitled to be paid, out of the assets of the Corporation available for distribution to its stockholders, before any distribution or payment is made upon
any Junior Securities by reason of their ownership thereof, an amount in cash equal to the greater of (i) the sum of (x) the aggregate Liquidation Value of all Series A Preferred Shares held by such holder, plus (y) all Series A
Unpaid Dividends thereon and (ii) the amount to which such holder would be entitled to receive upon such Liquidation if all (without regard to any restrictions on conversion (including the Conversion Cap and the Conversion Restriction) at such
time) of such holder’s Series A Preferred was converted into Conversion Stock immediately prior to such event (such greater amount, the “Liquidation Preference”), and the holders of Series A Preferred shall not be entitled to
any further payment with respect to their Series A Preferred Shares. If, upon any Liquidation, the Corporation’s assets available to be distributed among the holders of the Series A Preferred are insufficient to permit payment to such holders
of the aggregate amount which they are entitled to be paid under this Section 5(a), then the entire assets available to be distributed to the Corporation’s stockholders shall be distributed pro rata among such holders of Series A
Preferred Shares based upon the aggregate Liquidation Value plus all Series A Unpaid Dividends of the Series A Preferred held by each such holder. Not less than 30 days prior to the payment date stated therein (or such lesser period as may be agreed
by the Series A Preferred Majority Holders), the Corporation shall deliver written notice of any Liquidation to each record holder of Series A Preferred, setting forth in reasonable detail the amount of proceeds to be paid with respect to each
Series A Preferred Share and each Junior Security in connection with such Liquidation. 
 (b) Deemed
Liquidation. The occurrence of a Change of Control shall be deemed to be a liquidation, dissolution and winding up of the Corporation for purposes of this Section 5(b) (a “Deemed Liquidation”), and the holders of the
Series A Preferred shall be entitled to receive from the Corporation the Liquidation Preference with respect to the Series A Preferred upon such occurrence. The Corporation shall mail written notice of any Change of Control to each record holder of
Series A Preferred Shares not less than 30 nor more than 60 days prior to the date on which such Change of Control is consummated. 
 Section 6. Redemption. 
 (a) Redemptions at
the Option of the Holder. Beginning on the Optional Redemption Eligibility Date, any holder of Series A Preferred may, at any time and from time to time, request redemption, out of funds legally available therefor, of all or any portion of the
Series A Preferred Shares held by such holder by delivering written notice of such request to the Corporation specifying the number of Series A Preferred Shares to be so redeemed and the date of such redemption (which may not be earlier than 60 days
after delivery of such redemption notice). The Corporation shall be required to redeem on the date so specified in such holder’s written notice delivered to the Corporation all or any portion of their Series A Preferred Shares with respect to
which such redemption requests have been made at a price per Series A Preferred Share in cash equal to the Series A Liquidation Value thereof, plus all Series A Unpaid Dividends thereon. 

  
 8 

 (b) Redemptions at the Option of the Corporation. Beginning on the
fifth anniversary of the Date of Issuance, the Corporation may at any time and from time to time, redeem, out of funds legally available therefor, all or any portion of the Series A Preferred Shares held by such holder by delivering written notice
of such request to such holder in accordance with Section 6(d). Upon any such redemption, the Corporation shall pay a price per Series A Preferred Share with respect to which such redemption requests have been made in cash equal to the
Series A Liquidation Value thereof, plus all Series A Unpaid Dividends thereon. Notwithstanding anything to the contrary herein, each holder of Series A Preferred Shares to be redeemed by the Corporation may elect to convert all or any portion of
the Series A Preferred Shares held by such holder into Conversion Stock pursuant to Section 8 at any time prior to the applicable Redemption Date. 
 (c) Redemption Payments. For each Series A Preferred Share to be redeemed hereunder, the Corporation shall be obligated on the date specified in the notice of redemption delivered by the holder(s)
of Series A Preferred Shares pursuant to Section 6(a) or by the Corporation pursuant to Section 6(b), as the case may be, to pay to the holder thereof (upon surrender by such holder at the Corporation’s principal office
of the certificate representing such Series A Preferred Share) in immediately available funds the amount required pursuant to Section 6(a) or Section 6(b), as applicable. If the funds of the Corporation legally available for
redemption of Series A Preferred Shares pursuant to Section 6(a) on any Redemption Date are insufficient to redeem the total number of Series A Preferred Shares to be redeemed on such date, then without limiting any rights or remedies
herein or otherwise, those funds which are legally available shall be used to redeem the maximum possible number of Series A Preferred Shares pro rata among the holders of the Series A Preferred Shares to be redeemed pursuant to
Section 6(a) based upon the aggregate Liquidation Value, plus Series A Unpaid Dividends of such Series A Preferred Shares held by each such holder. At any time thereafter when additional funds of the Corporation are legally available for
the redemption of Series A Preferred Shares pursuant to Section 6(a) such funds shall immediately be used to redeem the balance of the Series A Preferred Shares which the Corporation has become obligated to redeem on any Redemption Date
but which it has not redeemed. For the avoidance of doubt, (x) references to “legally available” funds herein shall mean the amount of assets of the Corporation that may be used for a redemption of shares under Section 160 of the
DGCL, and (y) the Corporation shall be required to take all actions as are necessary to obtain available funds to satisfy its redemption obligations, including selling assets and borrowing funds. For the avoidance of doubt, the Corporation
shall be in breach of its obligations under this Certificate of Designation if it fails to pay in cash all amounts required to be paid by the Corporation pursuant to Section 6(a) on the redemption date specified in any redemption notice
delivered by Investor in accordance with Section 6(a). 
 (d) Notice of Redemption by
Corporation. The Corporation shall mail written notice of each redemption of Series A Preferred (other than a redemption at the request of a holder or holders of Series A Preferred) to each record holder thereof not more than 60 nor less than 30
days prior to the date on which such redemption is to be made. Upon mailing any notice of redemption which relates to a redemption at the Corporation’s option, the Corporation shall become obligated to redeem the total number of Series A
Preferred Shares specified in such notice at the time of redemption specified therein except to the extent such holder converts such Series A Preferred Shares into Conversion Stock prior to such redemption. 

  
 9 

 (e) Reissuances of Certificates. In case fewer than the total number
of Series A Preferred Shares represented by any certificate are redeemed, a new certificate representing the number of unredeemed Series A Preferred Shares shall be issued to the holder thereof without cost to such holder within five business days
after surrender of the certificate representing the redeemed Series A Preferred Shares. 
 (f) Determination
of the Number of Each Holder’s Series A Preferred Shares to be Redeemed. Except as otherwise provided in Section 6(c), the number of Series A Preferred Shares to be redeemed from each holder thereof in redemptions hereunder
shall be the number of Series A Preferred Shares determined by multiplying the total number of Series A Preferred Shares to be redeemed times a fraction, the numerator of which shall be the total number of Series A Preferred Shares then held by such
holder and the denominator of which shall be the total number of Series A Preferred Shares then outstanding. 

(g) Redeemed or Otherwise Acquired Series A Preferred Shares. Any Series A Preferred Shares which are redeemed or
otherwise acquired by the Corporation shall be canceled and retired to authorized but unissued shares and shall not be reissued, sold or transferred. 
 (h) Other Redemptions or Acquisitions. The Corporation shall not, nor shall it permit any Subsidiary to, redeem or otherwise acquire any Series A Preferred Shares, except as expressly authorized
herein. 
 Section 7. Priority of Series A Preferred Shares. Except as specifically provided herein, so long
as any Series A Preferred Shares remain outstanding, without the prior written consent of the Series A Preferred Majority Holders, the Corporation shall not, nor shall it permit any Subsidiary to, redeem, purchase or otherwise acquire directly or
indirectly any Junior Securities, nor shall the Corporation directly or indirectly declare or pay any dividend or make any distribution upon any Junior Securities. 
 Section 8. Conversion. 
 (a) Conversion at
the Option of the Holder. Each Series A Preferred Share may be converted, at any time and from time to time, at the option of the holder thereof into a number of shares of Common Stock equal to the quotient determined by dividing (i) the
sum of the Liquidation Value, plus the Series A Unpaid Dividends thereon at such time, by (ii) the Conversion Price then in effect; provided, that (i) prior to the receipt of the Shareholder Approval, the Series A Preferred shall
not be convertible pursuant to this Section 8 into more than 19.99% of the number of shares of Common Stock outstanding immediately prior to the Date of Issuance (subject to a proportionate adjustment in the event of a stock split, stock
dividend, combination or other proportionate reduction or increase for the Common Stock) such conversion (such limitation, the “Conversion Cap”); and (ii) prior to the first vote of the shareholders of the Corporation with
respect to the Shareholder Approval, no Series A Preferred Shares may be converted (the “Conversion Restriction”). Series A Preferred Shares shall immediately and permanently cease to be subject to the Conversion Cap upon receipt of
Shareholder Approval. For the avoidance of doubt, the Conversion Restriction shall no longer apply after the first vote of the shareholders of the Corporation with respect to the Shareholder Approval, whether or not Shareholder Approval is obtained.

 (b) Conversion at the Option of the Corporation. On any date following the earlier to occur of
(i) the date, if any, that the average Closing Price during any 20 consecutive Trading Day period is greater than $7.98 (subject to a proportionate adjustment in the event of a stock split, stock dividend, combination or other proportionate
reduction or increase to the Common 

  
 10 

 Stock) (a “Stock Price Forced Conversion Event”), and (ii) the fifth
anniversary of the Date of Issuance, if (A) no Forced Conversion Noncompliance Event has occurred and is continuing, (B) there is an effective Shelf Registration Statement covering the resale of all of the Registrable Securities and
(C) in the case of a Stock Price Forced Conversion Event, the Closing Price on the Trading Day immediately preceding the date on which the Corporation delivers notice of conversion pursuant to Section 8(c) is greater than $7.98
(subject to a proportionate adjustment in the event of a stock split, stock dividend, combination or other proportionate reduction or increase to the Common Stock), then the Corporation may, cause the conversion of all, but (subject to the
Conversion Cap and the Conversion Restriction) not less than all, of the Series A Preferred Shares into a number of shares of Common Stock per Series A Preferred Share equal to the quotient determined by dividing (x) the sum of the Liquidation
Value, plus the Series A Unpaid Dividends thereon at such time, by (y) the Conversion Price then in effect. Any Series A Preferred Shares not converted due to the Conversion Cap and/or the Conversion Restriction shall continue outstanding on
the terms set forth herein after such conversion. In connection with any such conversion, any Unpaid Series A Dividends shall be deemed to convert into Conversion Stock prior to any Series A Preferred Shares. The exercise by the Corporation of its
rights under this Section 8(b) shall be referred to as the “Forced Conversion”. Notwithstanding the foregoing, no Forced Conversion shall be permitted until all governmental body filings, consents, authorizations and
approvals (including under the Hart-Scott Rodino Antitrust Improvements Act of 1976, as amended) that are required for such Forced Conversion shall have been made and obtained by the Corporation; accordingly, the holders of the Series A Preferred
Shares and the Corporation will promptly take all actions necessary to make any such required filings and cooperate in connection with any such required filings. 

(c) Conversion Procedure. In the case of a conversion pursuant to Section 8(a), the conversion date
shall be the date on which the certificate(s) representing such Series A Preferred Shares and a duly signed and completed notice of conversion of such Series A Preferred Share is received by the Corporation. In the case of a conversion pursuant to
Section 8(b), the conversion date shall be a date specified in the notice from the Corporation to the holder(s) of Series A Preferred, which may not be less than ten (10) days after the holder of such Series A Preferred Shares has
received written notice from the Corporation of its election to convert the Series A Preferred Shares; provided, that, for the avoidance of doubt, at any time after delivery of the Corporation’s conversion notice pursuant to
Section 8(b), any holder of Series A Preferred may cause all or any portion of such holder’s Series A Preferred Shares to be redeemed by the Corporation if permitted by, and in accordance with, Section 6(a). As soon as
possible (but in any event within five (5) business days) after a conversion of Series A Preferred Shares has been effected, the Corporation shall deliver to the converting holder, a certificate or certificates representing the number of shares
of Common Stock issuable by reason of such conversion in such names or names and such denominations as the converting holder has specified. In case fewer than the total number of Series A Preferred Shares represented by any certificate are
converted, a new certificate representing the number of Series A Preferred Shares not converted shall be issued to the holder thereof without cost to such holder within five business days after surrender of the certificate representing the redeemed
Series A Preferred Shares. 
 (d) Cooperation. The Corporation shall not close its books against the
transfer of Series A Preferred Shares or of Common Stock issued or issuable upon conversion of Series A Preferred Shares in any manner which interferes with the timely conversion of the Series A Preferred Shares. Without limiting Section 6.6 of
the Investment Agreement or Section 8(b) above, the Corporation shall assist and cooperate (at its expense) with any holder of Series A Preferred Shares required to make any governmental filings or obtain any governmental approval prior
to or in connection with any conversion of Series A Preferred Shares hereunder (including, without limitation, making any governmental filings required to be made by the Corporation). 

  
 11 

 (e) Common Stock Reserved for Issuance. The Corporation shall at all
times when any Series A Preferred Shares are outstanding reserve and keep available out of its authorized and unissued shares of Common Stock, solely for the purpose of issuance upon the conversion of the Series A Preferred Shares, the number of
shares of Common Stock that would be issuable upon the conversion of all outstanding Series A Preferred Shares, assuming for the purposes of this calculation that at all times the Shareholder Approval has been obtained and that the Conversion
Restriction does not apply. All shares of Common Stock which are so issuable shall, when issued, be duly and validly issued, fully paid and nonassessable and free from all taxes, liens, charges and encumbrances. The Corporation shall take all such
actions as may be necessary to assure that all such shares of Common Stock may be so issued without violation of any applicable law or governmental regulation or any requirements of any domestic securities exchange or market upon which shares of
Common Stock may be listed (except for official notice of issuance which shall be immediately delivered by the Corporation upon each such issuance and except for any such law, regulation or requirement applicable because of the business or nature of
the holder). The Corporation shall not take any action which would cause the number of authorized but unissued shares of Common Stock to be less than the number of such shares required to be reserved hereunder for issuance upon conversion of the
Series A Preferred Shares in accordance with this Section 8(d). 
 (f) Taxes. The Corporation
shall pay any and all transfer Taxes that may be payable in respect of the issue or delivery of shares of Common Stock on conversion of the Series A Preferred Shares; provided that the Corporation shall not be required to pay transfer Taxes in
respect of shares of Conversion Stock issued in the name of, or delivered to, a person other than Investor. 

Section 9. Adjustments to Conversion Price. In order to prevent dilution of the conversion rights granted under
Section 8, the Conversion Price and the number of shares of Conversion Stock issuable on conversion of the Shares of Series A Preferred shall be adjusted from time to time pursuant to this Section 9. 

(a) Adjustment to Conversion Price upon Issuance of Common Stock. Except as provided in Section 9(b)
and except in the case of an event described in either Section 9(d) or Section 9(e), if the Corporation, at any time or from time to time after the Date of Issuance, issues or sells, or in accordance with Section 9(c) is
deemed to have issued or sold, any shares of Common Stock without consideration or for consideration per share less than the Conversion Price in effect immediately prior to such issuance or sale (or deemed issuance or sale), then immediately upon
such issuance or sale (or deemed issuance or sale) the Conversion Price shall be reduced (and in no event increased) to a Conversion Price equal to the quotient determined by dividing: (i) the sum of (1) the product derived by
multiplying the Conversion Price in effect immediately prior to such issuance or sale (or deemed issuance or sale) by the number of shares of Common Stock Deemed Outstanding immediately prior to such issuance or sale (or deemed issuance or sale),
plus (2) the aggregate consideration, if any, received by the Corporation upon such issuance or sale (or deemed issuance or sale); by (ii) the sum of (1) the number of shares of Common Stock Deemed Outstanding immediately prior
to such issuance or sale (or deemed issuance or sale) plus (2) the aggregate number of shares of Common Stock issued or sold (or deemed issued or sold) by the Corporation in such issuance or sale (or deemed issuance or sale). 

  
 12 

 (b) Exceptions To Adjustment Upon Issuance of Common Stock. Anything
herein to the contrary notwithstanding, there shall be no adjustment to the Conversion Price with respect to any Excluded Issuance. 
 (c) Effect on Conversion Price of Certain Events. For purposes of determining the adjusted Conversion Price under Section 9(a), the following shall be applicable: 

(1) Issuance of Rights or Options. If the Corporation, at any time or from time to time after the Date of Issuance,
in any manner grants or sells (whether directly or by assumption in a merger or otherwise) any Options, whether or not such Options or the right to convert or exchange any Convertible Securities issuable upon the exercise of such Options are
immediately exercisable, and the price per share (determined as provided in this paragraph and in Section 9(c)(5)) for which Common Stock is issuable upon the exercise of such Options, or upon the conversion or exchange of Convertible
Securities issuable upon the exercise of such Options, is less than the Conversion Price in effect immediately prior to the time of the granting or sale of such Options, then the total maximum number of shares of Common Stock issuable upon the
exercise of such Options or upon conversion or exchange of the total maximum amount of Convertible Securities issuable upon the exercise of such Options shall be deemed to have been issued by the Corporation at the time of the granting or sale of
such Options (and thereafter shall be deemed to be outstanding for purposes of adjusting the Conversion Price under Section 9(a)), at a price per share equal to the quotient determined by dividing (i) the sum (which sum shall
constitute the applicable consideration received for purposes of Section 9(a)) of (x) the total amount, if any, received or receivable by the Corporation as consideration for the granting or sale of all such Options, plus
(y) the minimum aggregate amount of additional consideration payable to the Corporation upon the exercise of all such Options, plus (z), in the case of such Options which relate to Convertible Securities, the minimum aggregate amount of
additional consideration, if any, payable to the Corporation upon the issuance or sale of all such Convertible Securities and the conversion or exchange of all such Convertible Securities, by (ii) the total maximum number of shares of Common
Stock issuable upon the exercise of all such Options or upon the conversion or exchange of all Convertible Securities issuable upon the exercise of all such Options. Except as otherwise provided in Section 9(c)(3), no further adjustment
of the Conversion Price shall be made when Convertible Securities are actually issued upon the exercise of such Options or when Common Stock is actually issued upon the exercise of such Options or the conversion or exchange of such Convertible
Securities. 
 (2) Issuance of Convertible Securities. If the Corporation, at any time or from time to
time after the Date of Issuance, in any manner issues or sells (whether directly or by assumption in a merger or otherwise) any Convertible Securities, whether or not the right to convert or exchange any such Convertible Securities is immediately
exercisable, and the price per share (determined as provided in this paragraph and in Section 9(c)(5)) for which Common Stock is issuable upon conversion or exchange of such Convertible Securities is less than the Conversion Price in
effect immediately prior to the time of such issue or sale, then the total maximum number of shares of Common Stock issuable upon conversion or exchange of the total maximum amount of such Convertible Securities shall be deemed to have been issued
by the Corporation at the time of the issuance or sale of such Convertible Securities (and thereafter shall be deemed to be outstanding for purposes of adjusting the Conversion Price pursuant to Section 9(a)), at a price per share equal
to the quotient determined by dividing (i) the sum (which sum 

  
 13 

 
shall constitute the applicable consideration received for purposes of Section 9(a)) of (x) the total amount, if any, received or receivable by the Corporation as consideration
for the issue or sale of such Convertible Securities, plus (y) the minimum aggregate amount of additional consideration, if any, payable to the Corporation upon the conversion or exchange of all such Convertible Securities, by (ii) the
total maximum number of shares of Common Stock issuable upon the conversion or exchange of all such Convertible Securities. Except as otherwise provided in Section 9(c)(3), no further adjustment of the Conversion Price shall be made when
Common Stock is actually issued upon the conversion or exchange of such Convertible Securities, and if any such issue or sale of such Convertible Securities is made upon exercise of any Options for which adjustments of the Conversion Price had been
or are to be made pursuant to other provisions of this Section 9(c), no further adjustment of the Conversion Price shall be made by reason of such issue or sale. 

(3) Change in Option Price or Conversion Rate. Upon any change in any of (A) the total amount received or
receivable by the Corporation as consideration for the granting or sale of any Options or Convertible Securities referred to in Section 9(c)(1) or Section 9(c)(2), (B) the minimum aggregate amount of additional
consideration, if any, payable to the Corporation upon the exercise of any Options or upon the issuance, conversion or exchange of any Convertible Securities referred to in Section 9(d)(1) or Section 9(c)(2), (C) the
rate at which Convertible Securities referred to in Section 9(c)(1) or Section 9(c)(2) are convertible into or exchangeable for Common Stock, or (D) the maximum number of shares of Common Stock issuable in connection
with any Options referred to in Section 9(c)(1) or any Convertible Securities referred to in Section 9(c)(2) (in each case, other than in connection with an Excluded Issuance), then (whether or not the original issuance or
sale of such Options or Convertible Securities resulted in an adjustment to the Conversion Price pursuant to this Section 9) the Conversion Price in effect at the time of such change shall be adjusted or readjusted, as applicable, to the
Conversion Price which would have been in effect at such time pursuant to the provisions of this Section 9 had such Options or Convertible Securities still outstanding provided for such changed consideration or conversion rate, as the
case may be, at the time initially granted, issued or sold, but only if as a result of such adjustment or readjustment the Conversion Price then in effect is reduced. 

(4) Treatment of Expired Options and Unexercised Convertible Securities. Upon the expiration of any Option or the
termination of any right to convert or exchange any Convertible Security without the exercise of any such Option or right, the Conversion Price then in effect hereunder shall be adjusted immediately pursuant to the provisions of this
Section 9 to the Conversion Price which would have been in effect at the time of such expiration or termination had such Option or Convertible Security, to the extent outstanding immediately prior to such expiration or termination, never
been issued. 
 (5) Calculation of Consideration Received. If any Common Stock, Option or Convertible
Security is, at any time or from time to time after the Date of Issuance, issued or sold or deemed to have been issued or sold in accordance with Section 9(c) (A) for cash, the consideration received therefor shall be deemed to be
the net amount received by the Corporation therefor; (B) for consideration other than cash, the amount of the consideration other than cash received by the Corporation shall be the fair value of such consideration, except where such
consideration consists of marketable securities, in which case the amount of consideration received by the Corporation shall be the market price (as reflected on any securities exchange, quotation system or association or similar

  
 14 

 
pricing system covering such security) for such securities as of the end of business on the date of receipt of such securities; (C) for no specifically allocated consideration in connection
with an issuance or sale of other securities of the Corporation, together comprising one integrated transaction, the amount of the consideration therefor shall be deemed to be the fair value of such portion of the aggregate consideration received by
the Corporation in such transaction as is attributable to such shares of Common Stock, Options or Convertible Securities, as the case may be, issued in such transaction; or (D) to the owners of the non-surviving entity in connection with any
merger in which the Corporation is the surviving corporation, the amount of consideration therefor shall be deemed to be the fair value of the portion of the net assets and business of the non-surviving entity that is attributable to such Common
Stock, Options or Convertible Securities, as the case may be, issued to such owners. The fair value of any consideration or net assets other than cash and marketable securities shall be determined jointly by the Corporation and the Series A
Preferred Majority Holders. If such parties are unable to reach agreement within a reasonable period of time, the fair value of such consideration shall be determined by an independent appraiser experienced in valuing such type of consideration
jointly selected by the Corporation and the Series A Preferred Majority Holders. The determination of such appraiser shall be final and binding upon the parties, and the fees and expenses of such appraiser shall be borne by the Corporation.

 (6) Integrated Transactions. In case any Option is issued in connection with the issue or sale of other
securities of the Corporation, together comprising one integrated transaction in which no specific consideration is allocated to such Option by the parties thereto, the Option shall be deemed to have been issued for a consideration of $.001.

 (7) Treasury Series A Preferred Shares. The number of shares of Common Stock outstanding at any given
time shall not include shares owned or held by or for the account of the Corporation or any Subsidiary, and the disposition of any shares so owned or held shall be considered an issue or sale of Common Stock for the purpose of this
Section 9. 
 (8) Record Date. For purposes of any adjustment to the Conversion Price in
accordance with this Section 9, if the Corporation takes a record of the holders of Common Stock for the purpose of entitling them (a) to receive a dividend or other distribution payable in Common Stock, Options or Convertible
Securities or (b) to subscribe for or purchase Common Stock, Options or Convertible Securities, then such record date shall be deemed to be the date of the issue or sale of the shares of Common Stock deemed to have been issued or sold upon the
declaration of such dividend or the making of such other distribution or the date of the granting of such right of subscription or purchase, as the case may be. 
 (d) Adjustment to Conversion Price Upon Dividend, Subdivision or Combination of Common Stock. If the Corporation, at any time or from time to time after the Date of Issuance, (i) pays a
dividend or make any other distribution upon the Common Stock or any other capital stock of the Corporation payable in shares of Common Stock or in Options or Convertible Securities, or (ii) subdivides (by any stock split, recapitalization or
otherwise) its outstanding shares of Common Stock into a greater number of shares, the Conversion Price in effect immediately prior to such dividend, distribution or subdivision shall be proportionately reduced, and if the Corporation at any time
combines (by reverse stock split or otherwise) its outstanding shares of Common Stock into a smaller number of shares, the Conversion Price in effect immediately prior to such combination shall be proportionately increased. Any adjustment under this
Section 9(d) shall become effective at the close of business on the date the dividend, subdivision or combination becomes effective. 

  
 15 

 (e) Adjustment to Conversion Price Upon Reorganizations, Mergers,
Consolidation, Merger or Sale. Any recapitalization, reorganization, reclassification, consolidation, merger, sale of all or substantially all of the Corporation’s assets to another Person or other similar transaction (other than any such
transaction covered by Section 9(d)), in each case which entitles the holders of Common Stock to receive (either directly or upon subsequent Liquidation) stock, securities or assets with respect to or in exchange for Common Stock, is
referred to herein as an “Organic Change”. Prior to the consummation of any Organic Change, the Corporation shall make appropriate provisions (in form and substance satisfactory to the Series A Preferred Majority Holders) to insure
that each of the holders of the Series A Preferred shall thereafter have the right to acquire and receive, in lieu of or in addition to (as the case may be) the shares of Common Stock immediately theretofore acquirable and receivable upon the
conversion of such holder’s Series A Preferred Shares, such shares of stock, securities or assets as such holder would have received in connection with such Organic Change if such holder had converted its Series A Preferred Shares immediately
prior to such Organic Change. In each such case, the Corporation shall also make appropriate provisions (in form and substance satisfactory to the Series A Preferred Majority Holders) to insure that the provisions of this Section 9 shall
thereafter be applicable to the Series A Preferred Shares (including, in the case of any such consolidation, merger or sale in which the successor or purchasing Person is other than the Corporation, an immediate adjustment of the Conversion Price to
the value per share for the Common Stock reflected by the terms of such consolidation, merger or, sale or similar transaction, and a corresponding immediate adjustment in the number of shares of Conversion Stock acquirable upon conversion of Series
A Preferred Shares, if the value so reflected is less than the Conversion Price in effect immediately prior to such consolidation, merger or, sale or similar transaction). The Corporation shall not effect any such consolidation, merger or sale,
unless prior to the consummation thereof, the successor Person (if other than the Corporation) resulting from consolidation or merger or the Person purchasing such assets assumes by written instrument (in form and substance satisfactory to the
Series A Preferred Majority Holders), the obligation to deliver to each such holder such shares of stock, securities or assets as, in accordance with the foregoing provisions, such holder may be entitled to acquire. 

(f) Certain Events. If any event occurs of the type contemplated by the provisions of this Section 9
but not expressly provided for by such provisions (including, without limitation, the granting of stock appreciation rights, phantom stock rights or other rights with equity features), then the Board shall make an appropriate adjustment in the
Conversion Price so as to protect the rights of the holders of Series A Preferred Shares in a manner consistent with the provisions of this Section 9; provided that no such adjustment pursuant to this Section 9 shall
increase the Conversion Price or decrease the number of shares of Conversion Stock issuable as otherwise determined pursuant to this Section 9. 
 (g) Notices. Immediately upon any adjustment of the Conversion Price, the Corporation shall give written notice thereof to all holders of Series A Preferred Shares, setting forth in reasonable
detail and certifying the calculation of such adjustment. The Corporation shall give written notice to all holders of Series A Preferred Shares at least 20 days prior to the date on which the Corporation closes its books or takes a record
(i) with respect to any dividend or distribution upon Common Stock, (ii) with respect to any pro rata subscription offer to holders of Common Stock or (iii) for determining rights to vote with respect to any Organic Change or
Liquidation. The Corporation shall also give written notice to the holders of Series A Preferred Shares at least 20 days prior to the date on which any Organic Change shall take place. 

  
 16 

 Section 10. Voting Rights; Election of Directors 

(a) Voting Generally. Without limiting any rights provided to the holders of shares of Series A Preferred under the
DGCL, the holders of shares of Series A Preferred shall be entitled to vote as a single class with the holders of the Common Stock on all matters submitted to a vote of stockholders of the Corporation, except with respect to the Shareholder
Approval; provided that, prior to the first vote of the shareholders of the Corporation with respect to the Shareholder Approval, the Series A Preferred shall have no voting rights, except as otherwise required by applicable law. Each holder
of shares of the Series A Preferred shall be entitled to the number of votes equal to the largest number of full shares of Common Stock into which all shares of Preferred Stock held of record by such holder could then be converted (taking into
account, for the avoidance of doubt, all Unpaid Series A Dividends thereon convertible into shares of Common Stock, any Conversion Price adjustments made pursuant to Section 9 and the Conversion Cap) at the record date for the
determination of the stockholders entitled to vote on such matters or, if no such record date is established, at the date such vote is taken or any written consent of stockholders is first executed; provided, however, that no holder of
Series A Preferred shall be entitled to cast votes for the number of shares of Common Stock issuable upon conversion of such Series A Preferred Shares held by such holder that exceeds (subject to a proportionate adjustment for any stock split, stock
dividend, combination, recapitalization or other proportionate reduction or increase in the Common Stock) the quotient of (x) the aggregate purchase price paid by such holder of Series A Preferred for its Series A Preferred Shares, divided by
(y) the lesser of (i) $4.40 and (ii) the Closing Price of the Common Stock on the Trading Day immediately prior to the Date of Issuance of such holder’s Series A Preferred. The holders of Series A Preferred Shares shall be
entitled to notice of any meeting of stockholders in accordance with the Bylaws of the Corporation. 
 (b)
Election of Directors. In the election of directors of the Board, the holders of the Series A Preferred Shares, in addition to the other voting rights set forth herein, shall be entitled to elect (i) two directors to the Board (each, a
“Preferred Director”) for so long as (x) any Series A Preferred Shares are outstanding and (y) the Preferred Percentage equals or exceeds 10% and (ii) if the Preferred Percentage is less than 10% but at least 5%, one
Preferred Director to the Board for so long as any Series A Preferred Shares are outstanding. Each Preferred Director appointed pursuant to this Section 10(b) shall continue to hold office until such Preferred Director is removed from
office by the affirmative vote of the Series A Preferred Majority Holders or at such time as such Preferred Director’s death, resignation, retirement or disqualification. Any vacancy created by the removal, death, resignation, retirement or
disqualification of a Preferred Director shall be filled by the affirmative vote of the Series A Preferred Majority Holders. If the holders of the Series A Preferred Shares for any reason fail to elect anyone to fill any such directorship or
vacancy, such position shall remain vacant until such time as such holders elect a director to fill such position and shall not be filled by resolution or vote of the Board or the Corporation’s other stockholders. The Corporation shall take all
such action as may be reasonably requested by such holders to effect this Section 10(b) (including nominating and recommending the designees of the holders of the Series A Preferred Shares for election). 

Section 11. Consent Rights. In addition to any rights that the holders of Series A Preferred Shares may have pursuant
to the DGCL, for so long as (x) any Series A Preferred Shares are outstanding and (y) the Preferred Percentage is at least ten percent (10%), the Corporation will not, without first obtaining the written consent or affirmative vote of the
Series A Preferred Majority Holders, voting separately as a class, take any of the following actions: (i) liquidate, dissolve or wind-up the Corporation (whether voluntary or involuntary), (ii) amend, modify, supplement or repeal any
provision of the Certificate of Incorporation or Bylaws that would have a material adverse effect on any right, preference, 

  
 17 

 
privilege or voting power of the Series A Preferred Shares or the holders thereof (it being understood that, for the avoidance of doubt, any amendment, modification or supplement to the
Certificate of Incorporation (including as a result of new certificate of designation) to create, authorize, designate or issue any equity securities of the Corporation senior to or pari passu with the Series A Preferred Shares would have a
material adverse effect on the rights, preferences, privileges and/or voting power of the Series A Preferred Shares or the holders thereof), (iii) change the size of the Board; (iv) enter into, amend, modify or supplement any agreement,
transaction, commitment or arrangement with any Related Party, except for customary employment arrangements and benefit programs; or (v) agree to take any of the foregoing actions. 

Section 12. Events of Noncompliance. 
 (a) Definition. An Event of Noncompliance shall have occurred if: 
 (1) the Corporation fails to make any redemption payment with respect to the Series A Preferred which it is required to make hereunder, whether or not such payment is legally permissible or is prohibited
by any agreement to which the Corporation is subject; 
 (2) the Corporation breaches or otherwise fails to
perform or observe (i) any other covenant or agreement set forth herein or in the Investor Rights Agreement or (ii) any covenant or agreement set forth in the Investment Agreement required to be performed or observed by the Corporation
after the closing of the transactions contemplated by the Investment Agreement; 
 (3) the Corporation or any
material Subsidiary makes an assignment for the benefit of creditors or admits in writing its inability to pay its debts generally as they become due; or an order, judgment or decree is entered adjudicating the Corporation or any material Subsidiary
bankrupt or insolvent; or any order for relief with respect to the Corporation or any material Subsidiary is entered under the Federal Bankruptcy Code; or the Corporation or any material Subsidiary petitions or applies to any tribunal for the
appointment of a custodian, trustee, receiver or liquidator of the Corporation or any material Subsidiary or of any substantial part of the assets of the Corporation or any material Subsidiary, or commences any proceeding (other than a proceeding
for the voluntary liquidation and dissolution of a Subsidiary) relating to the Corporation or any material Subsidiary under any bankruptcy, reorganization, arrangement, insolvency, readjustment of debt, dissolution or liquidation law of any
jurisdiction; or any such petition or application is filed, or any such proceeding is commenced, against the Corporation or any material Subsidiary and either (a) the Corporation or any such Subsidiary by any act indicates its approval thereof,
consent thereto or acquiescence therein or (b) such petition, application or proceeding is not dismissed within 60 days. 

(b) If an Event of Noncompliance occurs, the dividend rate on the Series A Preferred described in Section 4(a) shall increase
immediately by an increment of one (1) percentage point. Thereafter, until such time as no Event of Noncompliance exists, the dividend rate shall increase automatically at the end of each succeeding 90-day period by an additional increment of 1
percentage point (but in no event shall the dividend rate exceed fifteen percent (15%)). Any increase of the dividend rate resulting from the operation of this paragraph shall terminate as of the close of business on the date on which no Event of
Noncompliance exists, subject to subsequent increases pursuant to this paragraph. 

  
 18 

 Section 13. Other Rights. If any Event of Noncompliance exists, each
holder of Series A Preferred shall also have any other rights which such holder is entitled to under any contract or agreement at any time and any other rights which such holder may have pursuant to applicable law. 

Section 14. Corporate Opportunities. To the fullest extent permitted by DGCL Section 122, the Corporation
renounces any interest or expectancy of the Corporation in, or in being offered an opportunity to participate in, business opportunities that are presented to any Preferred Director. 

Section 15. Registration of Transfer. The Corporation shall keep at its principal office a register for the
registration of Series A Preferred Shares. Upon the surrender of any certificate representing Series A Preferred Shares at such place, the Corporation shall, at the request of the record holder of such certificate, execute and deliver (at the
Corporation’s expense) a new certificate or certificates in exchange therefor representing in the aggregate the number of Series A Preferred Shares represented by the surrendered certificate. Each such new certificate shall be registered in
such name and shall represent such number of Series A Preferred Shares as is requested by the holder of the surrendered certificate and shall be substantially identical in form to the surrendered certificate, and dividends shall accrue on the Series
A Preferred Shares represented by such new certificate from the date to which dividends have been fully paid on such Series A Preferred Shares represented by the surrendered certificate. 

Section 16. Replacement. Upon receipt of evidence reasonably satisfactory to the Corporation (it being understood that
an affidavit of the registered holder shall be satisfactory) of the ownership and the loss, theft, destruction or mutilation of any certificate evidencing Series A Preferred Shares, and in the case of any such loss, theft or destruction, upon
receipt of indemnity reasonably satisfactory to the Corporation (provided that if the holder is a financial institution or other institutional investor its own agreement shall be satisfactory), or, in the case of any such mutilation upon surrender
of such certificate, the Corporation shall (at its expense) execute and deliver in lieu of such certificate a new certificate of like kind representing the number of Series A Preferred Shares of such class represented by such lost, stolen, destroyed
or mutilated certificate and dated the date of such lost, stolen, destroyed or mutilated certificate, and dividends shall accrue on the Series A Preferred Shares represented by such new certificate from the date to which dividends have been fully
paid on such lost, stolen, destroyed or mutilated certificate. 
 Section 17. Amendment and Waiver. No
amendment, modification, alteration, repeal or waiver of any provision of this Certificate of Designation shall be binding or effective without the prior written consent of the Series A Preferred Majority Holders, voting separately as a class;
provided that no amendment, modification, alteration, repeal or waiver of the terms or relative priorities of the Series A Preferred may be accomplished by the merger, consolidation or other transaction of the Corporation with another Person
unless the Corporation has obtained the prior written consent of the Series A Preferred Majority Holders. 

Section 18. Notices. Except as otherwise expressly provided hereunder, all notices referred to herein shall be given
in writing and shall be deemed effectively given (a) if given by personal delivery, upon actual delivery, (b) if given by facsimile, upon receipt of confirmation of a completed transmittal, (c) if given by mail, upon the earlier of
(i) actual receipt of such notice by the intended recipient or (ii) five (5) Business Days after such notice is deposited in first class mail, postage prepaid, and (d) if by an internationally recognized overnight courier for
overnight delivery, one (1) Business Day after delivery to such courier for overnight delivery, in each case, (i) to the Corporation, at its principal executive offices and (ii) to any stockholder, at such holder’s address as it
appears in the stock records of the Corporation (unless otherwise indicated by any such holder). 

  
 19 

 IN WITNESS WHEREOF, the Corporation has caused this Certificate of Designation to be duly
executed and acknowledged by its undersigned duly authorized officer this              day of
                        , 2013. 

 

			
	RTI BIOLOGICS, INC.
		
	By:	 	 

 
			
	Name:	 	
	Title:	 	

 Signature Page to Certificate of Designation 

 EXHIBIT C 
 INVESTOR RIGHTS AGREEMENT 
 dated as of 

[                      
  ], 2013 
 by and between 
 RTI BIOLOGICS, INC. 
 and 

WSHP BIOLOGICS HOLDINGS, LLC 

 Table of Contents 

 

							
	 	  	 	  	Page	 
	 ARTICLE I DEFINITIONS
	  	 	3	  
			
	 SECTION 1.1.
	  	Definitions	  	 	3	  
	 SECTION 1.2.
	  	General Interpretive Principles	  	 	7	  
		
	 ARTICLE II REGISTRATION RIGHTS
	  	 	7	  
			
	 SECTION 2.1.
	  	Shelf Registration	  	 	7	  
	 SECTION 2.2.
	  	Demand Registration	  	 	9	  
	 SECTION 2.3.
	  	Piggyback Registration	  	 	10	  
	 SECTION 2.4.
	  	Registration Expenses	  	 	11	  
	 SECTION 2.5.
	  	Registration Procedures	  	 	12	  
	 SECTION 2.6.
	  	Indemnification	  	 	14	  
	 SECTION 2.7.
	  	Miscellaneous	  	 	16	  
		
	 ARTICLE III OTHER RIGHTS
	  	 	17	  
			
	 SECTION 3.1.
	  	Information Rights	  	 	17	  
	 SECTION 3.2.
	  	Preemptive Rights	  	 	17	  
	 SECTION 3.3.
	  	Investor Directors	  	 	18	  
	 SECTION 3.4.
	  	Director Provisions	  	 	19	  
	 SECTION 3.5.
	  	Consent Rights	  	 	19	  
		
	 ARTICLE IV MISCELLANEOUS
	  	 	19	  
			
	 SECTION 4.1.
	  	Amendment and Modification	  	 	19	  
	 SECTION 4.2.
	  	Successors and Assigns; Binding Effect	  	 	20	  
	 SECTION 4.3.
	  	Severability	  	 	20	  
	 SECTION 4.4.
	  	Notices and Addresses	  	 	20	  
	 SECTION 4.5.
	  	Governing Law; CONSENT TO JURISDICTION	  	 	21	  
	 SECTION 4.6.
	  	WAIVER OF JURY TRIAL	  	 	21	  
	 SECTION 4.7.
	  	Headings	  	 	22	  
	 SECTION 4.8.
	  	Counterparts; Electronic Delivery	  	 	22	  
	 SECTION 4.9.
	  	Further Assurances	  	 	22	  
	 SECTION 4.10.
	  	Remedies	  	 	22	  

 INVESTOR RIGHTS AGREEMENT 

THIS INVESTOR RIGHTS AGREEMENT, dated as of
[                ], 2013 (this “Agreement”), by and between RTI Biologics, Inc., a Delaware corporation (the “Company”), and
WSHP Biologics Holdings, LLC (the “Investor”). Each of the Investor and the Company are from time to time referred to herein as a “Party” and collectively as the “Parties”. 

RECITALS 

WHEREAS, the Investor and the Company have entered into that certain Investment Agreement, dated as of June 12, 2013 (the
“Investment Agreement”), pursuant to which the Investor has agreed to purchase, subject to the satisfaction and/or waiver of the conditions set forth therein, 50,000 shares of Series A Convertible Preferred Stock of the Company, par
value $0.001 per share (the “Preferred Stock”); and 
 WHEREAS, it is a condition precedent to the
Investor’s obligation to purchase such Preferred Stock that the Company enter into this Agreement with the Investor to provide for certain rights and obligations of the Parties following the closing of the transactions contemplated by the
Investment Agreement (the “Closing”). 
 NOW, THEREFORE, in consideration of the foregoing premises and the
mutual covenants and agreements contained herein and for other good and valuable consideration, the receipt and adequacy of which are hereby acknowledged, the Parties, intending to be legally bound, hereby agree as follows: 

ARTICLE I 

DEFINITIONS 

SECTION 1.1. Definitions. The following terms shall have the meanings ascribed to them below: 

“Affiliate” of any Person means any other Person directly or indirectly controlling or controlled by or under direct or
indirect common control with such Person. For purposes of this definition, “control” when used with respect to any Person has the meaning specified in Rule 12b-2 under the Exchange Act; and the terms “controlling” and
“controlled” have meanings correlative to the foregoing. 
 “Agreement” means this Agreement, as
amended, modified or supplemented from time to time, in accordance with the terms hereof, together with any exhibits, schedules or other attachments hereto. 
 “Beneficially Own” with respect to any securities means having “beneficial ownership” of such securities (as determined pursuant to Rule 13d-3 under the Exchange Act, including
without limitation, the 60-day provision in paragraph (d)(1)(i) thereof). The terms “Beneficial Ownership” and “Beneficial Owner” have correlative meanings. 

“Board Threshold” has the meaning set forth in Section 3.3(a). 

“Capital Stock” means any and all shares, interests, rights to purchase, warrants, options, participations or other
equivalents of or interests in (in each case however designated) stock issued by the Company. 

 “Certificate of Designation” means the Certificate of Designation of Series
A Convertible Preferred Stock of the Company, adopted on or about the date hereof and as amended, supplemented or modified from time to time. 
 “Closing” has the meaning ascribed thereto in the recitals of this Agreement. 
 “Common Stock” means the common stock, par value $0.001 per share, of the Company. 
 “Company” has the meaning set forth in the preamble of this Agreement. 
 “Conversion Cap” has the meaning set forth in the Certificate of Designation. 
 “Conversion Restriction” has the meaning set forth in the Certificate of Designation. 
 “Convertible Securities” has the meaning set forth in the Certificate of Designation. 
 “Demand Notice” has the meaning set forth in Section 2.2(a). 
 “Demand Registration” has the meaning set forth in Section 2.2(a). 
 “Demand Registration Statement” has the meaning set forth in Section 2.2(a). 
 “Designated Director” means each Investor Director appointed to the Board pursuant to Section 2.9 and each Preferred Director appointed to the Board pursuant to the
Certificate of Designation. 
 “Equity Securities” means any Common Stock, Options or Convertible Securities.

 “Exchange Act” means the Securities Exchange Act of 1934, as amended. 

“Forced Conversion” has the meaning set forth in the Certificate of Designation. 

“Governmental Entity” means any domestic (federal, state, municipal or local) or foreign or multinational government or
governmental, regulatory, political, judicial or quasi-judicial or administrative subdivision, department, authority, entity, agency, regulator, commission, board, bureau, court, or instrumentality. 

“Indemnified Party” has the meaning set forth in Section 2.6(c). 

“Indemnifying Party” has the meaning set forth in Section 2.6(c). 

“Investment Agreement” has the meaning ascribed thereto in the recitals of this Agreement. 

“Investor” has the meaning set forth in the preamble of this Agreement. 

“Investor Director” has the meaning set forth in Section 3.3(a). 

“Investor Parties” means the Investor, its Affiliates and their respective transferees. 

“Investor Party Indemnitees” has the meaning set forth in Section 2.6(a). 

  
 -4-

 “Law” means any applicable federal, state, local or foreign law, statute,
ordinance, rule, guideline, regulation, order, writ, decree, agency requirement, license or permit of any Governmental Entity. 

“Losses” has the meaning set forth in Section 2.6(a). 

“Majority Investor Parties” means the Investor Parties holding a majority of the Registrable Securities held by all
Investor Parties. 
 “Notice and Questionnaire” means a written notice executed by the Investor Parties and
delivered to the Company containing the information required by Item 507 of Regulation S-K to be included in any Shelf Registration Statement regarding the Investor Parties seeking to sell Common Stock pursuant thereto. 

“Options” means any rights, warrants or options to subscribe for or purchase Common Stock or Convertible Securities.

 “Other Securities” means the Common Stock or other securities of the Company which the Company is
registering pursuant to a Registration Statement covered by Section 2.3. 
 “Parties” has the
meaning ascribed thereto in the recitals of this Agreement. 
 “Permitted Issuance” means any issuance by the
Company of Equity Securities (1) to the Company or a Subsidiary of the Company, (2) to officers, employees, directors or consultants of the Company and its Subsidiaries pursuant to the Company’s Board-approved equity incentive plans
and the securities issued upon exercise of such grants, (3) as consideration in a merger or acquisition of the stock or assets of another Person, (4) upon the occurrence of a stock split, stock dividend or any subdivision of the Common
Stock, or any other reclassification, reorganization or other similar recapitalization, (5) pursuant to the conversion or exchange of any securities of the Company into Capital Stock, or the exercise of any warrants or other rights to acquire
Capital Stock; (6) pursuant to a bona fide firm commitment underwritten public offering; (7) in connection with any private placement of warrants to purchase Capital Stock to lenders or other institutional investors (excluding the
Company’s stockholders) in any arm’s length transaction approved by the Board in which such lenders or investors provide debt financing to the Company or any Company Subsidiary; (8) in connection with a joint venture, strategic
alliance or other commercial relationship with any Person (including Persons that are customers, suppliers and strategic partners of the Company or any Subsidiary) relating to the operation of the Company’s or any Subsidiary’s business and
for which a primary purpose thereof is not raising capital; or (9) in connection with any office lease or equipment lease or similar equipment financing transaction approved by the Board in which the Company or any Subsidiary obtains from a
lessor or vendor the use of such office space or equipment for its business. 
 “Person” means any individual,
corporation, partnership, limited liability company, trust, business trust, association, joint stock company, joint venture, sole proprietorship, unincorporated organization, Governmental Entity or other entity. 

“Piggyback Notice” has the meaning set forth in Section 2.3(a). 

“Piggyback Registration” has the meaning set forth in Section 2.3(a). 

“Preferred Stock” has the meaning ascribed thereto in the recitals of this Agreement. 

  
 -5-

 “Pro Rata Share” means, for any Investor Party at any time of
determination, the quotient of (i) the sum of, without duplication, (A) the number of shares of Common Stock Beneficially Owned by such Investor Party, plus (B) the number of shares of Common Stock issuable upon conversion of
the Preferred Stock Beneficially Owned by such Investor Party (assuming for this calculation that Shareholder Approval has been obtained and all shares of Preferred Stock are convertible into Common Stock), divided by, (ii) the sum of,
without duplication, (A) the number of shares of Common Stock outstanding at such time of determination, plus (B) the number of shares of Common Stock issuable upon conversion of the outstanding Preferred Stock at such time of
determination (assuming for this calculation that Shareholder Approval has been obtained and all shares of Preferred Stock are convertible into Common Stock). 
 “Prospectus” means the prospectus included in any Registration Statement, as amended or supplemented by any prospectus supplement and by all other amendments thereto, including
post-effective amendments, and all material incorporated by reference into such prospectus. 
 “Purchase
Rights” has the meaning set forth in Section 3.2. 
 “Registrable Securities” means shares
of Common Stock issued by the Company upon conversion of any shares of Preferred Stock, as well as any shares of Common Stock or other securities issued as (or issuable upon the conversion or exercise of any warrant, right or other security which is
issued as) a dividend or other distribution with respect to, or in exchange generally for, or in replacement generally of, such Preferred Stock or other Registrable Securities and any securities issued in exchange for such Preferred Stock or other
Registrable Securities in any merger, reorganization, consolidation, share exchange, recapitalization, restructuring or other comparable transaction of the Company. As to any particular Registrable Securities, once issued such securities shall cease
to be Registrable Securities when (a) a Registration Statement with respect to the sale by the Investor Parties holding such securities has been declared effective by the SEC and such securities have been disposed of pursuant to such effective
Registration Statement, (b) such securities shall have been or could be sold by the holder, without being subject to any holding period or volume limitations pursuant to Rule 144, under circumstances in which all of the applicable conditions
(including any holding period or volume limitations) of Rule 144 (or any similar provisions then in force) under the Securities Act are met, (c) such securities have been otherwise transferred and the Company has delivered a new certificate or
other evidence of ownership for such securities not bearing a restrictive legend and not subject to any stop order, and such securities may be publicly resold by the Person receiving such certificate without complying with the registration
requirements of the Securities Act or (d) such securities shall have ceased to be outstanding. 
 “Registration
Statement” means any registration statement of the Company under the Securities Act which permits the public offering of any of the Registrable Securities pursuant to the provisions of this Agreement, including the Prospectus, amendments
and supplements to such registration statement, including post-effective amendments, all exhibits and all material incorporated by reference or deemed to be incorporated by reference in such registration statement. 

“Related Party” means (i) any officer or director of the Company or other Person that owns at least 5% of the
Common Stock on an as-converted fully diluted basis (which for such calculation shall aggregate stockholdings of Affiliates and of immediate family members sharing the same household with such Persons), (ii) any officer or director of any of
the Company’s Subsidiaries, or (iii) any member of any such Person’s immediate family sharing the same household or any of their respective Affiliates. 
 “SEC” means the U.S. Securities and Exchange Commission. 

“Securities Act” means the Securities Act of 1933, as amended. 

  
 -6-

 “Shareholder Approval” has the meaning set forth in the Certificate of
Designation. 
 “Shelf Effective Period” has the meaning set forth in Section 2.1(a). 

“Shelf Filing Date” has the meaning set forth in Section 2.1(a). 

“Shelf Registration Statement” has the meaning set forth in Section 2.1(a). 

“Shelf Take-Down Notice” has the meaning set forth in Section 2.1(b). 

“Subsidiary” means, when used with respect to any Person, any other Person of which (a) in the case of a
corporation, at least (i) a majority of the equity and (ii) a majority of the voting interests are owned or controlled, directly or indirectly, by such first Person, by any one or more of its Subsidiaries, or by any combination of such
first Person and one or more of its Subsidiaries or (b) in the case of any Person other than a corporation, such first Person, one or more of its Subsidiaries, or such first Person and one or more of its Subsidiaries combined (i) owns a
majority of the equity interests thereof and (ii) has the power to elect or direct the election of a majority of the members of the governing body thereof. As used in this Agreement, unless the context requires otherwise, references to a
Subsidiary or Subsidiaries shall mean a Subsidiary or the Subsidiaries of the Company. 
 “Voting Stock” means
Capital Stock of the class or classes pursuant to which the holders thereof have the general voting power under ordinary circumstances (determined without regard to any classification of directors). 

SECTION 1.2. General Interpretive Principles. Unless the context otherwise requires: (i) words in the singular include the
plural, and in the plural include the singular; (ii) “including” means including without limitation; (iii) references to any Section or clause refer to the corresponding Section or clause, respectively, of this Agreement;
(iv) any reference to a day or number of days, unless expressly referred to as a business day shall mean the respective calendar day or number of calendar days; (v) references to Sections of or Rules under the Exchange Act shall be deemed
to include substitute, replacement or successor Sections or Rules, and any term defined by reference to a Section of or Rule under the Exchange Act shall include SEC and judicial interpretations of such Section or Rule; and (vi) headings are
for convenience of reference only. 
 ARTICLE II 
 REGISTRATION RIGHTS 
 SECTION 2.1. Shelf Registration. 

(a) The Company shall use its reasonable efforts to prepare and file with the SEC within 75 days after the Closing (the “Shelf
Filing Date”) a Registration Statement providing for registration and resale, on a continuous or delayed basis pursuant to Rule 415 under the Securities Act, as such rule may be amended from time to time, or any similar rule or regulation
hereafter adopted by the SEC, of all of the Registrable Securities (the “Shelf Registration Statement”). The Shelf Registration Statement shall be on Form S-3 (or any comparable or successor form or forms then in effect) under the
Securities Act (or to the extent the Company is not eligible to use Form S-3 or any comparable or successor form or forms, on Form S-1 or any comparable or successor form or forms). The Company shall use its reasonable efforts to cause the Shelf
Registration Statement to be declared effective under the Securities Act by the SEC within 90 days after the Shelf Filing Date. The Company shall use its reasonable efforts to keep the Shelf Registration Statement (or any successor Shelf
Registration Statement) continuously effective under the Securities Act until the earlier of (i) the date when all of the 

  
 -7-

 
Registrable Securities covered by such Shelf Registration Statement have been sold and (ii) the date on which the Investor Parties own, in the aggregate, a number of shares of Common Stock
and Preferred Stock which together represent less than two percent (2%) of the total number of shares of Common Stock issued and outstanding and issuable upon conversion of the Preferred Stock (with each share of Preferred Stock deemed to
represent the number of shares of Common Stock issuable upon conversion of such share of Preferred Stock at such time of determination, without regard to any restrictions on conversion (including the Conversion Cap and the Conversion Restriction) at
such time) (the “Shelf Effective Period”). 
 (b) If any Investor Party wishes to sell Registrable Securities
pursuant to a Shelf Registration Statement and related Prospectus, it will do so in accordance with this Section 2.1(b) and Section 2.5. Any Investor Party wishing to sell Registrable Securities pursuant to a Shelf
Registration Statement and related Prospectus, whether in an underwritten offering or otherwise, shall notify the Company of such intent (a “Shelf Take-Down Notice”) and shall deliver a Notice and Questionnaire to the Company at
least five (5) Business Days prior to any intended distribution of Registrable Securities under the Shelf Registration Statement, it being agreed that if any such Investor Party intends to distribute any Registrable Securities by means of an
underwritten offering it shall promptly so advise the Company and the Company shall take all reasonable steps to facilitate such distribution, including the actions required pursuant to Section 2.5(a)(vii). From and after the date the
Shelf Registration Statement is declared effective, the Company shall, as promptly as practicable after the date a Notice and Questionnaire is delivered to it in connection with a Shelf Take-Down Notice: 

(i) if required by applicable Law, file with the SEC a post-effective amendment to the Shelf Registration Statement or
prepare and, if required by applicable Law, file a supplement to the related Prospectus or a supplement or amendment to any document incorporated therein by reference or file any other required document so that the Investor Parties are named as a
selling security holder in the Shelf Registration Statement and the related Prospectus in such a manner as to permit the Investor Parties to deliver such Prospectus to purchasers of Registrable Securities in accordance with applicable Law and, if
the Company shall file a post-effective amendment to the Shelf Registration Statement, use its reasonable efforts to cause such post-effective amendment to be declared effective under the Securities Act as promptly as is practicable; 

(ii) provide the Investor Parties copies of any documents to filed pursuant to Section 2.1(b)(i) a reasonable
period of time prior to such filing; and 
 (iii) notify the Investor Parties as promptly as practicable after
the effectiveness under the Securities Act of any post-effective amendment filed pursuant to Section 2.1(b)(i). 
 Notwithstanding
anything contained herein to the contrary, the Company shall be under no obligation to name any Investor Party as a selling security holder in any Shelf Registration Statement or related Prospectus if such Investor Party has not delivered a Notice
and Questionnaire to the Company. 
 (c) If any of the Registrable Securities to be sold pursuant to a Shelf Registration
Statement are to be sold in a firm commitment underwritten offering which underwritten offering was initially requested by any Investor Party pursuant to a Shelf Take-Down Notice, and the managing underwriter(s) of such underwritten offering advise
the Investor Parties in writing that it is their good faith opinion that the total number or dollar amount of Registrable Securities proposed to be sold in such offering, together with any Other Securities proposed to be included by holders thereof
which are entitled to include securities in such Registration Statement, exceeds the total number or dollar amount of such 

  
 -8-

 
securities that can be sold without having an adverse effect on the price, timing or distribution of the Registrable Securities to be so included, together with all such Other Securities, then
there shall be included in such firm commitment underwritten offering the number or dollar amount of Registrable Securities and such Other Securities that in the opinion of such managing underwriter(s) can be sold without so adversely affecting such
offering, and such number of Registrable Securities and Other Securities shall be allocated for inclusion as follows: 
 (i) first, the Registrable Securities for which inclusion in such underwritten offering was requested by any Investor Party based on the number of Registrable Securities Beneficially Owned by such
Investor Party; and 
 (ii) second, among any holders of Other Securities, pro rata, based on the number of Other
Securities Beneficially Owned by each such holder of Other Securities. 
 SECTION 2.2. Demand Registration. 

(a) If the Company is unable to file within 75 days after the Closing, cause to be effective within 90 days thereafter or thereafter
maintain the effectiveness of a Shelf Registration Statement during the Shelf Effective Period as required under Section 2.1, the Majority Investor Parties shall have the right, by delivering a written notice to the Company (a
“Demand Notice”), to require the Company to register under and in accordance with the provisions of the Securities Act the number of Registrable Securities Beneficially Owned by the Investor Parties and requested by such Demand
Notice to be so registered (a “Demand Registration”); provided, however, that the Company shall not be required to effect a Demand Registration pursuant to this Section 2.2(a) after the Company has effected
two (2) Demand Registrations pursuant to this Section 2.2(a); and provided further, that the Investor Parties shall not be entitled to deliver to the Company more than two (2) Demand Registrations in any 12-month
period and, in any event, a Demand Notice may only be made if the sale of the Registrable Securities requested to be registered by the Investor Parties includes at least 5% of the originally issued shares of the Registrable Securities issued upon
conversion of Preferred Stock originally issued to Investor Parties or is reasonably expected to result in aggregate gross cash proceeds in excess of $1,000,000 (without regard to any underwriting discount or commission). A Demand Notice shall also
specify the expected method or methods of disposition of the applicable Registrable Securities. Following receipt of a Demand Notice, the Company shall use its reasonable efforts to file, as promptly as reasonably practicable, but not later than 30
days after receipt by the Company of such Demand Notice, a Registration Statement relating to the offer and sale of the Registrable Securities requested to be included therein by the Investor Parties in accordance with the methods of distribution
elected by the Majority Investor Parties (a “Demand Registration Statement”) and shall use its reasonable efforts to cause such Registration Statement to be declared effective under the Securities Act as promptly as practicable
after the filing thereof. 
 (b) If any of the Registrable Securities registered pursuant to a Demand Registration are to be
sold in a firm commitment underwritten offering, and the managing underwriter(s) of such underwritten offering advise the Investor Parties in writing that it is their good faith opinion that the total number or dollar amount of Registrable
Securities proposed to be sold in such offering, together with any Other Securities proposed to be included by holders thereof which are entitled to include securities in such Registration Statement, exceeds the total number or dollar amount of such
securities that can be sold without having an adverse effect on the price, timing or distribution of the Registrable Securities to be so included together with all such Other Securities, then there shall be included in such firm commitment
underwritten offering the number or dollar amount of Registrable Securities and such Other Securities that in the opinion of such managing underwriter(s) can be sold without so adversely affecting such offering, and such number of Registrable
Securities and Other Securities shall be allocated for inclusion as follows: 

  
 -9-

 (i) first, the Registrable Securities for which inclusion in such
underwritten offering was requested by any Investor Party based on the number of Registrable Securities Beneficially Owned by such Investor Party; and 
 (ii) second, among any holders of Other Securities, pro rata, based on the number of Other Securities Beneficially Owned by each such holder of Other Securities. 

(c) In the event of a Demand Registration, the Company shall be required to maintain the continuous effectiveness of the applicable
Registration Statement for a period of at least 180 days after the effective date thereof or such shorter period in which all Registrable Securities included in such Registration Statement have actually been sold. 

(d) The Majority Investor Parties shall have the right to notify the Company that it has determined that the Registration Statement
relating to a Demand Registration be abandoned or withdrawn, in which event the Company shall promptly abandon or withdraw such Registration Statement. The Company shall not be required to pay for the expenses of the Investor Parties in connection
with any registration proceeding begun pursuant to Section 2.2(a) that has been subsequently withdrawn pursuant to this Section 2.2(d) at the request of the Majority Investor Parties, unless the withdrawal is based upon
material adverse information concerning the Company that the Company had not publicly disclosed at least two (2) Business Days prior to the Company’s receipt of such Demand Notice. 

(e) With the prior written consent of the Majority Investor Parties (which consent shall not be unreasonably withheld, conditioned or
delayed), the Company shall be entitled to coordinate any offerings under this Section 2.2 with any offerings to be effected pursuant to similar agreements with the holders of Other Securities, including, if practicable, by filing one
Registration Statement for any Registrable Securities being registered pursuant to this Section 2.2 and all Other Securities. 
 SECTION 2.3. Piggyback Registration. 
 (a) At any time after the Closing,
if, other than pursuant to Sections 2.1 and 2.2, the Company proposes to file a registration statement under the Securities Act with respect to an offering by the Company for its own account (other than a registration statement
(a) on Form S-4, Form S-8 or any successor forms thereto, (b) filed solely in connection with any employee benefit or dividend reinvestment plan or (c) for the purpose of effecting a rights offering relating to the Common Stock) or
for the account of any of its security holders, the Company will give to the Investor Parties written notice of such filing at least fifteen (15) days prior to the anticipated filing date (the “Piggyback Notice”). The Piggyback
Notice shall offer the Investor Parties the opportunity to include in such registration statement the number of Registrable Securities (for purposes of this Section 2.3, “Registrable Securities” shall be deemed to mean solely
securities of the same type and class as those proposed to be offered by the Company for its own account) as it may request (a “Piggyback Registration”). Subject to Section 2.3(b), the Company shall include in each such
Piggyback Registration all Registrable Securities with respect to which the Company has received written requests for inclusion therein within seven (7) days after notice has been given to the Investor Parties. The Company shall be required to
maintain the effectiveness of the Registration Statement for a Piggyback Registration for a period of 180 days after the effective date thereof or such shorter period in which all Registrable Securities included in such Registration Statement have
actually been sold. 
 (b) If any of the securities to be registered pursuant to the registration giving rise to the Investor
Parties’ rights under this Section 2.3 are to be sold in an underwritten offering, the Investor Parties shall be permitted to include all Registrable Securities requested to be included in such registration

  
 -10-

 
in such offering on the same terms and conditions as any other shares of Capital Stock, if any, of the Company included therein; provided, however, that if such offering involves a
firm commitment underwritten offering and the managing underwriter(s) of such underwritten offering advise the Investor Parties in writing that it is their good faith opinion that the total number or dollar amount of Registrable Securities proposed
to be sold in such offering, together with all Other Securities that the Company and any other Persons having rights to participate in such registration intend to include in such offering, exceeds the total number or dollar amount of such securities
that can be sold without having an adverse effect on the price, timing or distribution of the Registrable Securities to be so included together with all such Other Securities, then there shall be included in such firm commitment underwritten
offering the number or dollar amount of Registrable Securities and such Other Securities that in the opinion of such managing underwriter(s) can be sold without so adversely affecting such offering, and such number of Registrable Securities and
Other Securities shall be allocated for inclusion as follows: 
 (i) first, all Other Securities being sold by
the Company or by any Person (other than the Investor Parties) exercising a contractual right to demand registration pursuant to which such registration statement was filed; and 

(ii) second, among any other holders of Registrable Securities or Other Securities requesting such registration, pro rata,
based on the aggregate number of Registrable Securities and Other Securities Beneficially Owned by each such holder. 
 (c) The
Company shall have the right to terminate or withdraw any registration initiated by it under this Section 2.3 prior to the effectiveness of the related Registration Statement and shall have no obligation to register any Registrable
Securities in connection with such registration, except to the extent provided herein. 
 (d) Each Investor Party shall have the
right to withdraw its request for inclusion of its Registrable Securities in any Piggyback Registration by giving written notice to the Company of its request to withdraw at least two (2) Business Days prior to the planned effective date of the
related Registration Statement. Notwithstanding Section 2.4, the Company shall not be required to pay for the expenses of any Investor Party in connection with any registration proceeding begun pursuant to this Section 2.3
from which the Investor Parties has subsequently withdrawn pursuant to this Section 2.3(d), unless such Investor Party’s withdrawal is based upon material adverse information concerning the Company that the Company had not publicly
disclosed at least two (2) Business Days prior to the Company’s delivery of such Piggyback Notice. 
 SECTION 2.4.
Registration Expenses. In connection with registrations pursuant to Sections 2.1, 2.2 and 2.3 (including any subsequently abandoned or withdrawn registration statement), the Company shall pay all of the registration
expenses incurred in connection with the registration thereunder, including, without limitation, all: (a) registration and filing fees, (b) fees and expenses of compliance with securities or blue sky laws (including reasonable fees and
disbursements of counsel in connection with blue sky qualifications of the Registrable Securities), (c) processing, duplicating and printing expenses, (d) internal expenses of the Company (including, without limitation, all salaries and
expenses of its officers and employees performing legal or accounting duties), (e) fees and expenses incurred in connection with the listing of the Registrable Securities, (f) reasonable fees and disbursements of counsel for the Company,
reasonable fees and expenses for independent certified public accountants retained by the Company (including the expenses of any comfort letters or costs associated with the delivery by any registered public accounting firms of a comfort letter or
comfort letters requested but not the cost of any audit other than a year end audit) and reasonable fees and expenses of one counsel (and applicable local counsel as necessary) for the Investor Parties and (g) reasonable fees and expenses of
any special experts retained by the Company in connection with such registration. Notwithstanding the foregoing, the 

  
 -11-

 Investor Parties shall be responsible for (i) any underwriting fees, discounts or commissions,
(ii) any commissions of brokers and dealers, and (iii) capital gains, income and transfer taxes, if any, relating to the sale of Registrable Securities of the Investor Parties. 

SECTION 2.5. Registration Procedures. 
 (a) In connection with the registration of any Registrable Securities pursuant to this Agreement: 
 (i) The Company shall prepare and file with the SEC a Registration Statement with respect to such Registrable Securities as provided herein, make all required filings with FINRA and use its reasonable
efforts to keep each Registration Statement continuously effective during the period such Registration Statement is required to remain effective pursuant to the terms of this Agreement; upon the occurrence of any event that would cause the
Registration Statement or the Prospectus contained therein (A) to contain a material misstatement or omission or (B) not to be effective and usable for resale of Registrable Securities during the period such Registration Statement is
required to remain effective pursuant to the terms of this Agreement, the Company shall file promptly an appropriate amendment to the Registration Statement, a supplement to the Prospectus or a report filed with the SEC pursuant to
Section 13(a), 13(c), 14 or 15(d) of the Exchange Act, in the case of clause (A), correcting any such misstatement or omission, and, in the case of either clause (A) or (B), the Company shall use its reasonable efforts to cause such
amendment to be declared effective and the Registration Statement and the related Prospectus to become usable for their intended purposes as soon as practicable thereafter. 

(ii) The Company shall prepare and file with the SEC such amendments and post-effective amendments to each Registration
Statement as may be necessary to keep such Registration Statement effective during the periods provided herein. 

(iii) The Company shall advise the Investor Parties promptly (which notice pursuant to clauses (B) through
(D) below shall be accompanied by an instruction to suspend the use of the Prospectus until the Company shall have remedied the basis for such suspension): 
 (A) when the Prospectus or any Prospectus supplement or post-effective amendment is proposed to be or has been filed, and, with respect to the Registration Statement or any post-effective amendment
thereto, when the same has become effective; 
 (B) of any request by the SEC or any other Governmental Entity for amendments to
the Registration Statement or amendments or supplements to the Prospectus or for additional information relating thereto; 
 (C)
of the issuance by the SEC of any stop order suspending the effectiveness of the Registration Statement under the Securities Act or of the suspension by any state securities commission of the qualification of the Registrable Securities for offering
or sale in any jurisdiction, or the threatening or initiation of any proceeding for any of the preceding purposes; 
 (D) of the
receipt by the Company of any notification with respect to the suspension of the qualification or exemption from qualification of any of the Registrable Securities for sale in any jurisdiction, or the initiation or threatening of any proceeding for
such purpose; or 

  
 -12-

 (E) of the existence of any fact or the happening of any event, during the period in which
a Registration Statement remains effective under the Securities Act, that makes any statement of a material fact made in such Registration Statement, the Prospectus, any amendment or supplement thereto, or any document incorporated by reference
therein untrue, or that requires the making of any additions to or changes in the Registration Statement or the Prospectus in order to make the statements therein not misleading. 

(iv) The Company shall, unless any Registrable Securities shall be in book-entry form only, cooperate with the Investor
Parties to facilitate the timely preparation and delivery of certificates representing Registrable Securities to be sold and not bearing any restrictive legends (unless required by applicable securities Laws), and enable such Registrable Securities
to be in such denominations and registered in such names as the Investor Parties may request at least two (2) Business Days before any sale of Registrable Securities. In connection therewith, if reasonably required by the Company’s
transfer agent, the Company shall promptly deliver any authorizations, certificates and directions required by the transfer agent which authorize and direct the transfer agent to issue such Registrable Securities without legend upon sale by the
holder of such shares of Registrable Securities under the Registration Statement. 
 (v) The Company shall use
its reasonable efforts to promptly register or qualify any Registrable Securities under such other securities or blue sky laws of such jurisdictions within the United States as any Investor Party reasonably requests and which may be reasonably
necessary or advisable to enable such Investor Party to consummate the disposition in such jurisdictions of the Registrable Securities owned by such Investor Parties, keep such registrations or qualifications in effect for so long as the
Registration Statement remains in effect and do any and all other acts and things which may be reasonably necessary or advisable to enable such Investor Parties to consummate the disposition in such jurisdictions of the Registrable Securities owned
by such Investor Parties; provided, however, that the Company will not be required to (A) qualify generally to do business in any jurisdiction where it would not otherwise be required to qualify but for this Agreement,
(B) subject itself to taxation in any jurisdiction where it would not otherwise be subject to taxation but for this Agreement or (C) consent to general service of process in any jurisdiction where it would not otherwise be subject to such
service but for this Agreement. 
 (vi) The Company shall use its reasonable efforts to promptly cause any
Registrable Securities covered by a Registration Statement to be registered with or approved by such other Governmental Entity within the United States as may be necessary to enable the seller or sellers thereof to consummate the disposition of such
Registrable Securities in accordance with the intended methods of disposition set forth in such Registration Statement. 
 (vii) The Company shall, in the event that any Investor Party advises the Company that the Investor Party intends to distribute any Registrable Securities by means of an underwritten offering, whether
pursuant to Sections 2.1, 2.2 or 2.3, enter into an underwriting agreement in customary form, scope and substance and take all such other actions reasonably requested by such Investor Party or by the managing underwriter(s), if
any, to expedite or facilitate the underwritten disposition of such Registrable Securities and deliver such documents and certificates as may be reasonably requested by such Investor Party, its counsel and the managing underwriter(s), if any.

  
 -13-

 (b) No Investor Party by acquisition of a Registrable Security shall be entitled to sell any
of such Registrable Securities pursuant to a Registration Statement, or to receive a Prospectus relating thereto, unless it has furnished the Company with a Notice and Questionnaire (including the information required to be included in such Notice
and Questionnaire) and the information set forth in the next sentence. The Company may require the Investor Parties selling Registrable Securities pursuant to a Registration Statement to furnish to the Company such information regarding the Investor
Parties and the distribution of such Common Stock as the Company may from time to time reasonably require for inclusion in such Registration Statement. The Investor Parties shall promptly furnish to the Company all information required to be
disclosed in order to make the information previously furnished to the Company by the Investor Parties not misleading. Any sale of any Registrable Securities by such Investor Parties shall constitute a representation and warranty by such Investor
Party that the information relating to the Investor Party and its plan of distribution is as set forth in the Prospectus delivered in connection with such disposition, that such Prospectus does not as of the time of such sale contain any untrue
statement of a material fact relating to or provided by such Investor Party or its plan of distribution and that such Prospectus does not as of the time of such sale omit to state any material fact relating to or provided by the Investor Party or
its plan of distribution necessary to make the statements in such Prospectus, in light of the circumstances under which they were made, not misleading. The Company may exclude from such Registration Statement the Registrable Securities of any
Investor Party that fails to furnish such information within a reasonable time after receiving such request. The Company shall not include in any Registration Statement any information regarding, relating to or referring to such Investor Party or
its plan of distribution without the approval of such Investor Party in writing. 
 (c) No Investor Party shall use any free
writing prospectus (as defined in Rule 405 under the Securities Act) in connection with the sale of Registrable Securities without the prior written consent of the Company (which consent shall not be unreasonably withheld, conditioned or delayed).

 SECTION 2.6. Indemnification. 
 (a) The Company shall indemnify and hold harmless, to the fullest extent permitted by Law, the Investor Parties, the officers, directors, partners (limited and general), members, managers,
representatives, agents and employees of the Investor Parties, each Person who controls (within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act) the Investor Parties, each underwriter (including the
Investor Parties if they are deemed to be an underwriter pursuant to any SEC comments or policies), if any, and each Person who controls (within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act) such
underwriter (collectively, the “Investor Party Indemnitees”), from and against all losses, claims, damages, liabilities and expenses (collectively, “Losses”) in connection with any sale of Registrable Securities
pursuant to a Registration Statement arising out of or based upon (i) any violation or alleged violation of the Securities Act or any rule or regulation promulgated thereunder by the Company or any of its Affiliates, employees, officers,
directors or agents or (ii) any untrue or alleged untrue statement of a material fact contained in any Registration Statement or preliminary or final Prospectus relating to the registration of such Registrable Securities or any amendment or
supplement thereto or any document incorporated by reference therein or any omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances in
which they were made, not misleading; provided, however, that the Company shall not be liable to such Investor Party Indemnitee in any such case to the extent that any such loss, claim, damage, liability or expense arises out of or is
based upon (A) an untrue statement or alleged untrue statement or omission or alleged omission made in such Registration Statement, including any such preliminary or final Prospectus contained therein or any such amendments or supplements
thereto, or contained in any free writing prospectus (as such term is defined in Rule 405 under the Securities Act) prepared by the Company or authorized by it in writing for use by such Investor Party Indemnitee (or any amendment or supplement
thereto), in reliance upon and in conformity with information regarding such Investor Party Indemnitee or its plan of distribution or ownership interests which was furnished in writing to the Company for use in connection with such Registration
Statement, 

  
 -14-

 
including any such preliminary or final Prospectus contained therein or any such amendments or supplements thereto, (B) offers or sales effected by or on behalf of such Investor Party
Indemnitee “by means of” (as defined in Rule 159A under the Securities Act) a “free writing prospectus” (as defined in Rule 405 under the Securities Act) that was not authorized in writing by the Company or (C) the failure
of any Investor Party Indemnitee to deliver or make available to a purchaser of Registrable Securities a copy of any Registration Statement, including any preliminary or final Prospectus contained therein or any amendments or supplements thereto (if
the same was required by applicable Law to be delivered or made available); provided that the Company shall have delivered to such Investor Party Indemnitee such Registration Statement, including such preliminary or final Prospectus contained
therein and any amendments or supplements thereto. 
 (b) In connection with any Registration Statement in which an Investor
Party is participating by registering Registrable Securities, such Investor Party shall indemnify and hold harmless, to the fullest extent permitted by Law, severally and not jointly, the Company, the officers, directors, agents, representatives or
other employees of the Company, each Person who controls (within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act) the Company, each underwriter, if any, and each Person who controls (within the meaning of
Section 15 of the Securities Act or Section 20 of the Exchange Act) such underwriter, from and against all Losses, as incurred, arising out of or based on any untrue or alleged untrue statement of a material fact contained in any such
Registration Statement or preliminary or final Prospectus relating to the registration of such Registrable Securities or any amendment or supplement thereto or any document incorporated by reference therein, or any omission or alleged omission to
state therein a material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances in which they were made, not misleading, in each case solely to the extent that such untrue or alleged untrue
statement or omission or alleged omission is made in such Registration Statement or in any preliminary or final Prospectus contained therein or any such amendments or supplements thereto or contained in any free writing prospectus (as such term is
defined in Rule 405 under the Securities Act) in reliance upon and in conformity with written information furnished to the Company by the Investor Parties expressly for inclusion in such document. 

(c) If any Person shall be entitled to indemnity hereunder (an “Indemnified Party”), such Indemnified Party shall give
prompt notice to the party from which such indemnity is sought (the “Indemnifying Party”) of any claim or of the commencement of any Action with respect to which such Indemnified Party seeks indemnification or contribution pursuant
hereto; provided, however, that the delay or failure to so notify the Indemnifying Party shall not relieve the Indemnifying Party from any obligation or liability except to the extent that the Indemnifying Party has been actually
prejudiced by such delay or failure. The Indemnifying Party shall have the right, exercisable by giving written notice to an Indemnified Party promptly after the receipt of written notice from such Indemnified Party of such claim or Action, to
assume, at the Indemnifying Party’s expense, the defense of any such Action, with counsel reasonably satisfactory to such Indemnified Party; provided, however, that an Indemnified Party shall have the right to employ separate
counsel in any such Action and to participate in the defense thereof, but the fees and expenses of such counsel shall be at the expense of such Indemnified Party unless: (i) the Indemnifying Party agrees to pay such fees and expenses;
(ii) the Indemnifying Party fails promptly to assume, or in the event of a conflict of interest cannot assume, the defense of such Action or fails to employ counsel reasonably satisfactory to such Indemnified Party, in which case the
Indemnified Party shall also have the right to employ counsel and to assume the defense of such Action or (iii) in the Indemnified Party’s reasonable judgment a conflict of interest between such Indemnified Party and Indemnifying Party may
exist in respect of such Action; provided, further, that the Indemnifying Party shall not, in connection with any one such Action or separate but substantially similar or related Actions in the same jurisdiction, arising out of the
same general allegations or circumstances, be liable for the fees and expenses of more than one firm of attorneys (together with appropriate local counsel) at any time for all of the Indemnified Parties, or for fees and expenses that are not
reasonable. Whether or not such 

  
 -15-

 
defense is assumed by the Indemnifying Party, neither the Indemnifying Party nor the Indemnified Party will be subject to any liability for, or otherwise effect, any settlement made without the
consent of the other (but such consent shall not be unreasonably withheld, conditioned or delayed). 
 (d) Neither Party shall
settle, compromise, discharge or consent to an entry of judgment with respect to a claim or liability subject to indemnification under this Section 2.6 without the other Parties’ prior written consent (which consent shall not be
unreasonably withheld, conditioned or delayed); provided that the Indemnifying Party may agree without the prior written consent of the Indemnified Party to any settlement, compromise, discharge or consent to an entry of judgment, in each
case that relates only to money damages and by its terms obligates the Indemnifying Party to pay the full amount of the liability in connection with such claim and which unconditionally releases the Indemnified Party from all liability in connection
with such claim. 
 (e) If the indemnification provided for in this Section 2.6 is unavailable to hold harmless each
of the Indemnified Parties against any losses, claims, damages, liabilities and expenses to which such parties may become subject under the Securities Act, then the Indemnifying Party shall, in lieu of indemnifying each party entitled to
indemnification hereunder, contribute to the amount paid or payable by such party as a result of such losses, claims, damages, liabilities or expenses in such proportion as is appropriate to reflect the relative fault of the Indemnifying Party on
the one hand and such Indemnified Parties on the other in connection with the statements or omissions or alleged statements or omissions that resulted in such losses, claims, damages, liabilities or expenses. The relative fault of such parties shall
be determined by reference to, among other things, whether the untrue or alleged untrue statement of a material fact, or omission or alleged omission to state a material fact, relates to information supplied by or concerning the Indemnifying Party
on the one hand, or by such Indemnified Party on the other, and such party’s relative intent, knowledge, access to information and opportunity to have corrected or prevented such statement or omission. No Person guilty of fraudulent
misrepresentation (within the meaning of the Securities Act) shall be entitled to contribution from any Person that is not guilty of such fraudulent misrepresentation. 
 SECTION 2.7. Miscellaneous. 
 (a) With a view to making available the
benefits of certain rules and regulations of the SEC which may at any time permit the sale of the Registrable Securities to the public without registration, the Company agrees, so long as there are outstanding Registrable Securities, to use its
reasonable efforts to: 
 (i) make and keep public information available, as those terms are understood and
defined in Rule 144 under the Securities Act or any similar or analogous rule promulgated under the Securities Act, at all times after the effective date of this Agreement; 

(ii) file with the SEC in a timely manner all reports and other documents as the SEC may prescribe under the Exchange Act
at any time while the Company is subject to such reporting requirements of the Exchange Act; and 
 (iii) furnish
to the Investor Parties upon a reasonable request a written statement by the Company as to its compliance with the reporting requirements of Rule 144 and of the Securities Act and of the Exchange Act; a copy of the most recent annual or quarterly
report of the Company; and such other reports and documents as any Investor Party may reasonably request in availing itself of any rule or regulation of the SEC allowing it to sell any such Registrable Securities without registration. 

  
 -16-

 (b) Subject to the provisions hereof, in the event the Company proposes to enter into an
underwritten public offering, the Investor Parties shall enter into a customary agreement with the managing underwriters not to effect any sale or distribution of equity securities of the Company, or any securities convertible, exchangeable or
exercisable for or into such securities, during the period beginning up to two (2) days prior to the date of such offering and extending for up to 90 days following the effective date of such offering if so requested by the Company and the
underwriters. The Company may impose stop-transfer restrictions with respect to the securities subject to the foregoing restriction until the end of the required stand-off period and shall lift such stop-transfer restrictions immediately upon the
end of such period. 
 ARTICLE III 
 OTHER RIGHTS 
 SECTION 3.1. Information Rights. So long as the Investor
Parties own in the aggregate, a number of shares of Common Stock and Preferred Stock which together represent at least five percent (5%) of the total number of shares of Common Stock issued and outstanding and issuable upon conversion of the
Preferred Stock (with each share of Preferred Stock deemed to represent the number of shares of Common Stock issuable upon conversion of such share of Preferred Stock at such time of determination without giving effect to the Conversion Cap and the
Conversion Restriction), the Company shall provide the Investor Parties with (i) as soon as available, but within 30 days after the end of each fiscal month, consolidated unaudited financial statements of the Company and its Subsidiaries
consisting of an unaudited income statement for such quarter, statement of cash flows for such quarter and balance sheet as of the end of such quarter and, in each case, prepared in accordance with GAAP; (ii) as soon as available, but in any
event within forty-five (45) days after the end of each of the first three quarters of each fiscal year of the Company, consolidated unaudited financial statements of the Company and its Subsidiaries consisting of an unaudited income statement
for such quarter, statement of cash flows for such quarter and balance sheet as of the end of such quarter and, in each case, prepared in accordance with GAAP; (iii) as soon as available, but in any event within ninety (90) days after the
end of each fiscal year of the Company, consolidated audited financial statements of the Company and its Subsidiaries consisting of an audited income statement for such fiscal year, statement of cash flows for such fiscal year and balance sheet as
of the end of such fiscal year and, in each case, prepared in accordance with GAAP; (iv) a copy of the financial plan of the Company and its Subsidiaries in the form approved by the Board prior to the beginning of each fiscal year and any
Board-approved revisions thereof, and (v) such other financial information the Investor Parties may reasonably request; provided that any documents or other information that is filed with the SEC need not be separately provided by the
Company to the Investor Parties. 
 SECTION 3.2. Preemptive Rights. If at any time the Company proposes to grant, issue
or sell any Equity Securities (in each case, other than any Permitted Issuances) to any Person (the “Purchase Rights”) then it shall give the Investor Parties written notice of its intention to do so, describing the Equity
Securities and the price and the terms and conditions upon which the Company proposes to issue the same. Each Investor Party shall be entitled to acquire, upon the terms applicable to such Purchase Rights, its Pro Rata Share of the Equity Securities
proposed to be granted, issued or sold by the Company triggering the Purchase Rights. Each Investor Party shall have thirty (30) days from the giving of such notice to agree to purchase its Pro Rata Share of the Equity Securities for the price
and upon the terms and conditions specified in the notice by giving written notice to the Company and stating therein the quantity of such Equity Securities to be purchased. If not all of the Investor Parties elect to purchase their Pro Rata Share
of the Equity Securities subject to the Purchase Rights, then the Company shall promptly notify in writing the Investor Parties who have elected to purchase their full Pro Rata Share of such Equity Securities and shall offer such Investor Parties
the right to acquire such unsubscribed shares on a pro rata basis (based on Pro Rata Shares). The Investor Parties shall have fifteen (15) days after receipt of such 

  
 -17-

 
notice to notify the Company of their election to purchase all or a portion thereof of the unsubscribed shares. If the Investor Parties have, in the aggregate elected to purchase more than the
number of unsubscribed shares being offered in such notice, then the unsubscribed shares shall be allocated according to each Investor Party’s Pro Rata Share up to the number of unsubscribed shares set forth in the notice to the Investor
Parties. If the Investor Parties fail to exercise in full its Purchase Rights, the Company shall have ninety (90) days thereafter to sell the Equity Securities in respect of which the purchasers’ rights were not exercised, at a price and
upon terms and conditions no more favorable to the purchasers thereof than specified in the Company’s notice to the Investor Parties pursuant to this Section 3.2. If the Company has not sold such Equity Securities within such ninety (90)
days, the Company shall not thereafter issue or sell any Equity Securities (other than Permitted Issuances) without first again complying with this Section 3.2. 
 SECTION 3.3. Investor Directors. 
 (a) Investor Party Nomination.
From time to time and at any time after the date on which the Majority Investor Parties no longer hold a right to elect any Preferred Directors (as defined in the Certificate of Designation) pursuant to Section 10(b) of the Certificate of
Designation, the Majority Investor Parties shall be entitled to nominate (i) two directors to the Board (each, an “Investor Director”) for so long as the Investor Parties Beneficially Own, in the aggregate, a number of shares
of Common Stock and Preferred Stock which together represent at least ten percent (10%) of the total number of shares of Common Stock issued and outstanding and issuable upon conversion of the Preferred Stock (with each share of Preferred Stock
deemed to represent the number of shares of Common Stock issuable upon conversion of such share of Preferred Stock at such time of determination (without regard to any restrictions on conversion)) and (ii) if the Investor Parties Beneficially
Own, in the aggregate, a number of shares of Common Stock and Preferred Stock which together represent less than ten percent (10%) but at least five percent (5%) of the total number of shares of Common Stock issued and outstanding and
issuable upon conversion of the Preferred Stock (with each share of Preferred Stock deemed to represent the number of shares of Common Stock issuable upon conversion of such share of Preferred Stock at such time of determination (without regard to
any restrictions on conversion)), one Investor Director to the Board (each nomination threshold in clauses (i) and (ii), a “Board Threshold”). 
 (b) Company Nomination. Subject to the applicable Board Threshold, at each meeting of the Company’s stockholders at which the election of directors is to be considered, the Company shall
nominate the Investor Director(s) designated by the Majority Investor Parties for election to the Board by the holders of Voting Stock and solicit proxies from the Company’s stockholders in favor of the election of the Investor Directors (with
it being understood that the Company shall cause each Investor Director to be nominated to the class of directors of the Board with the longest remaining tenure on the Board of all classes of directors of the Board). The Company shall use reasonable
best efforts to cause each Investor Director to be elected to the Board (including voting all unrestricted proxies in favor of the election of such the Investor Director and including recommending approval of such the Investor Director’s
appointment to the Board) and shall not take any action designed to diminish the prospects of such the Investor Director(s) of being elected to the Board. 
 (c) Removal. The Company shall use all reasonable best efforts to ensure that any Investor Director is removed only if so directed in writing by the Majority Investor Parties, unless otherwise
required by applicable law. 
 (d) Vacancies. In the event of a vacancy on the Board resulting from the death,
disqualification, resignation, retirement or termination of the term of office of an the Investor Director, the Company shall use reasonable best efforts to cause the Board to fill such vacancy or new directorship with a representative designated by
the Majority Investor Parties as provided hereunder, in either case, to 

  
 -18-

 
serve until the next annual or special meeting of the stockholders (and at such meeting, such representative, or another representative designated by such holders, will be nominated to be elected
to the Board in the manner set forth in Section 2.9). If the Majority Investor Parties fail or decline to fill the vacancy, then the directorship shall remain open until such time as the Majority Investor Parties elect to fill it with a
representative designated hereunder. 
 SECTION 3.4. Director Provisions. 

(a) Fees and Expenses. Each Designated Director shall be entitled to reimbursement of expenses incurred in such capacities on the
same basis as the Company provides such reimbursement to the other non-management members of its Board. 
 (b) Committees;
Subsidiary Boards. At the request of the Majority Investor Parties, the Company shall use its reasonable best efforts to cause the Designated Directors to have proportional representation (relative to their percentage on the whole Board, but in
no event less than one representative) on each committee of the Board, so long as consistent with the independence and other applicable requirements of the principal trading market of the Company’s Common Stock or under applicable law. At the
request of the Majority Investor Parties, the Company shall use its reasonable best efforts to cause the Designated Directors to have proportional representation (relative to their percentage on the whole Board, but in no event less than one
representative) on the boards (or equivalent governing body) and committees of each Subsidiary of the Company. 
 SECTION 3.5.
Consent Rights. For so long as the Investor Parties own in the aggregate, a number of shares of Common Stock and Preferred Stock which together represent at least ten percent (10%) of the total number of shares of Common Stock issued and
outstanding and issuable upon conversion of the Preferred Stock (with each share of Preferred Stock deemed to represent the number of shares of Common Stock such share of Preferred Stock issuable upon conversion of such share of Preferred Stock at
such time of determination (without regard to any restrictions on conversion)), the Company will not, without first obtaining the written consent or affirmative vote of the Majority Investor Parties, take any of the following actions:
(i) liquidate, dissolve or wind-up the Company (whether voluntary or involuntary), (ii) amend, modify, supplement or repeal any provision of the Certificate of Incorporation or Bylaws that would have a material adverse effect on any right,
preference, privilege or voting power of the Series A Preferred Shares or the holders thereof (provided, that for the avoidance of doubt, any amendment, modification, supplement or repeal any provision of the Certificate of Incorporation or Bylaws
that would have the effect of limiting, restricting, delaying or prohibiting any rights of the Investor Parties, including modification of the nomination rights set forth in Section 3.3, shall constitute a material adverse effect on the
rights, preferences, privileges and voting power of the Series A Preferred Shares or the holders thereof), (iii) change the size of the Board; (iv) enter into, amend, modify or supplement any agreement, transaction, commitment or
arrangement with any Related Party, except for customary employment arrangements and benefit programs; or (v) agree to take any of the foregoing actions. 
 ARTICLE IV 
 MISCELLANEOUS 

SECTION 4.1. Amendment and Modification. No term of this Agreement may be amended or modified without the prior written consent of
each Party. No provision of this Agreement may be waived except in a writing executed and delivered by the Party against whom such waiver is sought to be enforced. Any amendment or waiver effected in accordance with this Section 4.1 shall be
binding upon the Investor Parties and the Company. 

  
 -19-

 SECTION 4.2. Successors and Assigns; Binding Effect. The provisions of this Agreement
shall be binding upon and inure to the benefit of the Investors and their respective successors and assigns. This Agreement may not be assigned by any Party hereto without the prior written consent of the Company and the Majority Investor Parties,
except that any Investor Party may transfer or assign, in whole or from time to time in part, to one or more Persons the Preferred Stock or any Common Stock issued on conversion thereof; provided that (a) such Investor Party complies with all
laws applicable thereto and provides written notice of assignment to the Company promptly after such assignment is effected and (b) the transferee agrees in writing to be bound by this Agreement as if it were a party hereto and an Investor
hereunder. For the avoidance of doubt, the rights set forth herein applicable to Investor and/or any Investor Party shall inure to any transferee of an Investor Party. 
 SECTION 4.3. Severability. If any provision of this Agreement or the application of any such provision to any Person or circumstance shall be declared by any court of competent jurisdiction to be
invalid, illegal, void or unenforceable in any respect, all other provisions of this Agreement, or the application of such provision to Persons or circumstances other than those as to which it has been held invalid, illegal, void or unenforceable,
shall nevertheless remain in full force and effect and will in no way be affected, impaired or invalidated thereby. Upon such determination that any provision, or the application of any such provision, is invalid, illegal, void or unenforceable, the
Parties shall negotiate in good faith to modify this Agreement so as to effect the original intent of the Parties as closely as possible to the fullest extent permitted by Law in an acceptable manner. 

SECTION 4.4. Notices and Addresses. Unless otherwise provided, any notice or request required or permitted to be delivered under
this Agreement shall be given in writing and shall be deemed effectively given as hereinafter described (a) if given by personal delivery, upon actual delivery, (b) if given by facsimile, upon receipt of confirmation of a completed
transmittal, (c) if given by mail, upon the earlier of (i) actual receipt of such notice by the intended recipient or (ii) three (3) Business Days after such notice is deposited in first class mail, postage prepaid, and
(d) if by an internationally recognized overnight air courier, one (1) Business Day after delivery to such carrier. All notices shall be addressed to the Party to be notified at the address as follows, or at such other address as such
Party may designate by ten (10) days’ advance written notice to the other Party: 
 If to the Company:

 RTI Biologics, Inc. 
 11621 Research Circle 
 Alachua, FL 32615 

Attention: Board of Directors 
 Facsimile: 386-418-0342 
 With a copy to (which shall not constitute notice to
the Company): 
 Fulbright & Jaworski LLP 
 666 Fifth Avenue 
 New York, NY 10103 

Attention: Warren J. Nimetz 
 Facsimile: (212) 318-3400 
 If to the Investor Parties: 

WSHP Biologics Holdings, LLC 
 c/o Water Street Healthcare Partners 

  
 -20-

 333 West Wacker Drive, Suite 2800 

Chicago, Illinois 60606 
 Attention: Ned H. Villers 
 Facsimile: 312-506-2901 

With a copy to (which shall not constitute notice to the Investor Parties): 

Kirkland & Ellis LLP 
 300 North LaSalle Chicago, IL 60654 

	 	Attention:	Ted H. Zook, P.C. 

	 	    	James S. Rowe 

	 	    	Martin A. DiLoreto, Jr., P.C. 

	 	Facsimile:	(312) 862-2200 

 SECTION 4.5.
Governing Law; CONSENT TO JURISDICTION. This Agreement and any Action or dispute arising under or related in any way to this Agreement, the relationship of the Parties, the transactions leading to this Agreement or contemplated hereby and/or
the interpretation and enforcement of the rights and duties of the Parties hereunder or related in any way to the foregoing, shall be governed by and construed in accordance with the internal, substantive Laws of the State of Delaware applicable to
agreements entered into and to be performed solely within such state without giving effect to the principles of conflict of Laws thereof. EACH OF THE PARTIES TO THIS AGREEMENT HEREBY AGREES THAT JURISDICTION AND VENUE IN ANY SUIT, ACTION OR
PROCEEDING BROUGHT BY ANY PARTY ARISING OUT OF OR RELATING TO THIS AGREEMENT (INCLUDING ANY SUIT, ACTION OR PROCEEDING SEEKING EQUITABLE RELIEF) SHALL PROPERLY AND EXCLUSIVELY LIE IN THE COURT OF CHANCERY OF THE STATE OF DELAWARE (THE “COURT
OF CHANCERY”) OR, TO THE EXTENT THE COURT OF CHANCERY DOES NOT HAVE SUBJECT MATTER JURISDICTION, THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE AND THE APPELLATE COURTS HAVING JURISDICTION OF APPEALS IN SUCH COURTS (THE
“DELAWARE FEDERAL COURT”) OR, TO THE EXTENT NEITHER THE COURT OF CHANCERY NOR THE DELAWARE FEDERAL COURT HAS SUBJECT MATTER JURISDICTION, THE SUPERIOR COURT OF THE STATE OF DELAWARE (COLLECTIVELY, THE “CHOSEN
COURTS”). EACH PARTY HERETO FURTHER AGREES NOT TO BRING ANY SUCH SUIT, ACTION OR PROCEEDING IN ANY COURT OTHER THAN THE CHOSEN COURTS PURSUANT TO THE FOREGOING SENTENCE (OTHER THAN UPON APPEAL). BY EXECUTION AND DELIVERY OF THIS AGREEMENT,
EACH PARTY IRREVOCABLY SUBMITS TO THE JURISDICTION OF THE CHOSEN COURTS FOR ITSELF AND IN RESPECT OF ITS PROPERTY WITH RESPECT TO SUCH SUIT, ACTION OR PROCEEDING. THE PARTIES HERETO IRREVOCABLY AGREE THAT VENUE WOULD BE PROPER IN EACH OF THE CHOSEN
COURTS, AND HEREBY WAIVE ANY OBJECTION THAT ANY SUCH CHOSEN COURT IS AN IMPROPER OR INCONVENIENT FORUM FOR THE RESOLUTION OF SUCH SUIT, ACTION OR PROCEEDING. 
 SECTION 4.6. WAIVER OF JURY TRIAL. TO THE EXTENT NOT PROHIBITED BY APPLICABLE LAW WHICH CANNOT BE WAIVED, EACH PARTY HERETO HEREBY WAIVES AND COVENANTS THAT IT WILL NOT ASSERT (WHETHER AS
PLAINTIFF, DEFENDANT OR OTHERWISE) ANY RIGHT TO TRIAL BY JURY IN ANY FORUM IN RESPECT OF ANY ISSUE OR ACTION, CLAIM, CAUSE OF ACTION OR SUIT (IN CONTRACT, TORT OR OTHERWISE) INQUIRY, PROCEEDING OR INVESTIGATION ARISING OUT OF OR BASED UPON THIS
AGREEMENT OR THE SUBJECT MATTER HEREOF OR IN ANY WAY CONNECTED WITH OR RELATED OR INCIDENTAL TO THE TRANSACTIONS CONTEMPLATED HEREBY, IN EACH CASE WHETHER NOW EXISTING OR HEREAFTER ARISING. EACH PARTY HERETO

  
 -21-

 
ACKNOWLEDGES THAT IT HAS BEEN INFORMED BY THE OTHER PARTIES HERETO THAT THIS SECTION 4.6 CONSTITUTES A MATERIAL INDUCEMENT UPON WHICH THEY ARE RELYING AND WILL RELY IN ENTERING INTO
THIS AGREEMENT. ANY PARTY HERETO MAY FILE AN ORIGINAL COUNTERPART OR A COPY OF THIS SECTION 4.6 WITH ANY COURT AS WRITTEN EVIDENCE OF THE CONSENT OF EACH SUCH PARTY TO THE WAIVER OF ITS RIGHT TO TRIAL BY JURY. 

SECTION 4.7. Headings. The headings in this Agreement are for convenience of reference only and shall not constitute a part of
this Agreement, nor shall they affect its meaning, construction or effect. 
 SECTION 4.8. Counterparts; Electronic
Delivery. This Agreement may be executed in one or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument. This Agreement and any signed agreement or instrument
entered into in connection with this Agreement, and any amendments hereto or thereto, to the extent delivered by means of a telecopy machine or electronic mail (any such delivery, an “Electronic Delivery”), shall be treated in all
manner and respects as an original agreement or instrument and shall be considered to have the same binding legal effect as if it were the original signed version thereof delivered in person. At the request of any party hereto or to any such
agreement or instrument, each other party hereto or thereto shall re-execute original forms thereof and deliver them to all other parties. No party hereto or to any such agreement or instrument shall raise (a) the use of Electronic Delivery to
deliver a signature or (b) the fact that any signature or agreement or instrument was transmitted or communicated through the use of Electronic Delivery, as a defense to the formation of a contract, and each such party forever waives any such
defense, except to the extent such defense related to lack of authenticity. 
 SECTION 4.9. Further Assurances. Each
Party shall cooperate and take such action as may be reasonably requested by another Party in order to carry out the provisions and purposes of this Agreement and the transactions contemplated hereby. 

SECTION 4.10. Remedies. Each Party hereby acknowledges and agrees that the failure of the other Party to perform its respective
agreements and covenants hereunder, including any failure to take all actions as are necessary by such Party to consummate the transactions contemplated hereby (to the extent required to be taken by such Party under this Agreement), will cause
irreparable injury to the other Party, for which damages, even if available, will not be an adequate remedy. Accordingly, each Party hereby agrees that any other Party may seek the issuance of equitable relief by any court of competent jurisdiction
to compel performance of such Party’s obligations. 
 [REMAINDER OF PAGE INTENTIONALLY LEFT BLANK] 

  
 -22-

 IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed as of
the date and year first above written. 
  

			
	RTI BIOLOGICS, INC.
		
	By:	 	 
		 	Name:
		 	Title:

  

			
	WSHP BIOLOGICS HOLDINGS, LLC
		
	By:	 	 
		 	Name:
		 	Title:

 Signature Page to the Investor Parties Rights Agreement 

 Exhibit D 
 RTI Biologics 
 11621 Research Circle 

Alachua, Florida 32615 
 [                    ], 2013 
 Water Street Healthcare Partners III, L.P. 
 333 West Wacker Drive, Suite 2800 

Chicago, Illinois 60606 
 Attention: Ned H.
Villers 
 Re: VCOC Management Rights  
 Ladies and Gentlemen: 
 This letter will confirm our agreement that, in connection
with the ownership by WSHP Biologics Holdings, LLC (“Owner Sub”) of certain shares of Series A Convertible Preferred Stock (the “Shares”) issued by, and Owner Sub’s investment in, RTI Biologics, Inc. (the
“Company”), Owner Sub has obtained and delegated to its managing member, Water Street Healthcare Partners III, L.P. (the “Fund”), certain management rights with respect to the Company as described below. 

Pursuant to the Certificate of Designation of Series A Convertible Preferred Stock of the Company, filed with the Secretary of State of
the State of Delaware on or about the date hereof (the “Certificate”), Owner Sub constitutes, by itself, the Series A Preferred Majority Holders (as defined in the Certificate), and is thus individually entitled to exercise all
rights granted by the Certificate to the Series A Preferred Majority Holders, including the right to elect, remove and replace up to two directors to the board of directors of the Company (the “Preferred Directors”) pursuant to
Section 10(b) of the Certificate. Owner Sub hereby delegates such right to the Fund, and the Fund is accordingly entitled to independently elect, remove and replace such Preferred Directors in accordance with the Certificate. The Company hereby
agrees to such delegation. 
 Additionally, pursuant to the Investor Rights Agreement by and between the Company and Owner Sub,
dated as of [                ], 2013 (the “Investor Rights Agreement”), Owner Sub constitutes, by itself, the Majority Investor Parties (as
defined in the Investor Rights Agreement), and is thus individually entitled to exercise all rights granted by the Investor Rights Agreement to the Majority Investor Parties, including certain information rights pursuant to Section 3.1 of the
Investor Rights Agreement, the right to nominate up to two directors to the board of directors of the Company in certain circumstances pursuant to Section 3.3(a) of the Investor Rights Agreement and certain consent rights pursuant to
Section 3.5 of the Investor Rights Agreement. Owner Sub hereby delegates such rights to the Fund, and the Fund is accordingly entitled to independently exercise such information, board nomination and consent rights. The Company hereby agrees to
such delegation. 
 The rights set forth herein shall terminate and be of no further force or effect upon the time at which the
Fund no longer directly or indirectly owns any Shares or other securities of the Company. 
 [Signature pages follows]

 
			
	 Sincerely,
  

RTI BIOLOGICS, INC.

		
	By:	 	 

 
			
	Name:	 	
	Title:	 	

 Acknowledged and Agreed: 
 WATER STREET HEALTHCARE PARTNERS III, L.P. 

			
		
	By:	 	 
	Its:	 	General Partner

			
	
		
	By:	 	 

			
	Name:	 	
	Title:	 	

  

			
	WSHP BIOLOGICS HOLDINGS, LLC
		
	By:	 	 

			
	Name:	 	
	Title:	 	

 [Signature Page to Management Rights Letter] 

 Exhibit E 
 INDEMNIFICATION AGREEMENT 
 THIS INDEMNIFICATION AGREEMENT (this
“Agreement”) is made and entered into as of [                    ], 2013 between RTI Biologies, Inc., a Delaware corporation
(the “Company”), and [                    ] (“Indemnitee”). 

WHEREAS, Indemnitee is either a member of the board of directors of the Company (the “Board”) or an officer of the
Company, or both, and in such capacity or capacities is performing a valuable service for the Company; 
 WHEREAS, the Company
is aware that competent and experienced persons are increasingly reluctant to serve as directors or officers of corporations or other business entities unless they are protected by comprehensive indemnification and liability insurance, due to
increased exposure to litigation costs and risks resulting from their service to such corporations, and because the exposure frequently bears no reasonable relationship to the compensation of such directors and officers; 

WHEREAS, Section 145 of the General Corporation Law of the State of Delaware (the “DGCL”), under which the Company
is organized, empowers the Company to indemnify by agreement its officers, directors, employees and agents, and persons who serve, at the request of the Company, as directors, officers, employees or agents of other corporations or enterprises, and
expressly provides that the indemnification provided by the DGCL is not exclusive; 
 WHEREAS, the Company desires and has
requested the Indemnitee to serve or continue to serve as a director or officer of the Company free from undue concern for claims for damages arising out of or related to such services to the Company; 

WHEREAS, Indemnitee is willing to serve, continue to serve and to take on additional service for or on behalf of the Company on the
condition that he or she be indemnified as herein provided; 
 WHEREAS, it is intended that Indemnitee shall be paid promptly by
the Company all amounts necessary to effectuate in full the indemnity provided herein; 
 WHEREAS, Indemnitee has certain rights
to indemnification and/or insurance provided by Water Street Healthcare Partners, LLC (“Water Street”) or affiliates of and investment funds directly or indirectly managed by Water Street (the “Water Street Rights”)
that Indemnitee and Water Street intend to be secondary to the primary obligation of the Company to indemnify Indemnitee as provided herein, with the Company’s acknowledgment of and agreement to the foregoing being a material condition to
Indemnitee’s willingness to serve as a director or in any other capacity for the Company and its subsidiaries; and 

WHEREAS, this Agreement is a supplement to and in furtherance of the Water Street Rights and the Amended and Restated Certificate of
Incorporation of the Company (the “Charter”) and the Amended and Restated Bylaws of the Company (the “Bylaws”), and shall not be deemed a substitute therefor, nor to diminish or abrogate any rights of Indemnitee
thereunder. 
 NOW, THEREFORE, in consideration of Indemnitee’s agreement to serve as a director or officer from and after
the date hereof, the parties hereto agree as follows: 
 1. Indemnity of Indemnitee. The Company hereby agrees to hold
harmless and indemnify Indemnitee to the fullest extent permitted by applicable law, as such may be amended from time to time. In furtherance of the foregoing indemnification, and without limiting the generality thereof: 

 (a) Proceedings Other Than Proceedings by or in the Right of the
Company. Indemnitee shall be entitled to the rights of indemnification provided in this Section l(a) if, by reason of Indemnitee’s Corporate Status (as hereinafter defined), Indemnitee is, or is threatened to be made, a party to or
participant in any Proceeding (as hereinafter defined) other than a Proceeding by or in the right of the Company. Pursuant to this Section 1(a), Indemnitee shall be indemnified against all Liabilities and Expenses (each as hereinafter
defined) actually incurred by or on behalf of Indemnitee in connection with such Proceeding or any claim, issue or matter therein, if Indemnitee acted in good faith and in a manner Indemnitee reasonably believed to be in or not opposed to the best
interests of the Company, and, with respect to any criminal Proceeding, had no reasonable cause to believe Indemnitee’s conduct was unlawful. 
 (b) Proceedings by or in the Right of the Company. Indemnitee shall be entitled to the rights of indemnification provided in this Section 1(b) if, by reason of Indemnitee’s
Corporate Status, Indemnitee is, or is threatened to be made, a party to or participant in any Proceeding brought by or in the right of the Company. Pursuant to this Section 1(b), Indemnitee shall be indemnified against all Liabilities
and Expenses actually incurred by or on behalf of Indemnitee in connection with such Proceeding if Indemnitee acted in good faith and in a manner Indemnitee reasonably believed to be in or not opposed to the best interests of the Company;
provided, however, if applicable law so provides, no indemnification against such Liabilities or Expenses shall be made in respect of any claim, issue or matter in such Proceeding as to which Indemnitee shall have been adjudged to be
liable to the Company, unless and to the extent that the Court of Chancery of the State of Delaware shall determine that such indemnification may be made. 
 (c) Indemnification for Expenses of a Party Who is Wholly or Partly Successful. Notwithstanding any other provision of this Agreement, to the extent that Indemnitee is, by reason of
Indemnitee’s Corporate Status, a party to and is successful, on the merits or otherwise, in any Proceeding, Indemnitee shall be indemnified to the maximum extent permitted by law, as such may be amended from time to time, against all Expenses
actually incurred by or on behalf of Indemnitee in connection therewith. If Indemnitee is not wholly successful in such Proceeding but is successful, on the merits or otherwise, as to one or more but less than all claims, issues or matters in such
Proceeding, the Company shall indemnify Indemnitee against all Expenses actually incurred by or on behalf of Indemnitee in connection with each successfully resolved claim, issue or matter. For purposes of this Section 1(c) and without
limitation, if any action, suit or proceeding is disposed of or dismissed, on the merits or otherwise (including a disposition or dismissal without prejudice), without (i) an adjudication that Indemnitee was liable to the Company, (ii) a
plea of guilty or nolo contendere by Indemnitee, (iii) an adjudication that Indemnitee did not act in good faith and in a manner Indemnitee reasonably believed to be in or not opposed to the best interests of the Company, and
(iv) with respect to any criminal proceeding, an adjudication that Indemnitee had reasonable cause to believe Indemnitee’s conduct was unlawful, Indemnitee shall be considered for the purposes hereof to have been successful with respect
thereto. 
 2. Additional Indemnity. In addition to, and without regard to any limitations on, the indemnification
provided for in Section 1 of this Agreement, the Company shall and hereby does, to the fullest extent permitted by applicable law, indemnify and hold harmless Indemnitee against all Liabilities and Expenses actually incurred by or on
behalf of Indemnitee if, by reason of Indemnitee’s Corporate Status, Indemnitee is, or is threatened to be made, a party to or participant in any Proceeding (including a Proceeding by or in the right of the Company), including, without
limitation, all liability arising out of the negligence or active or passive wrongdoing of Indemnitee. The only limitation that shall exist upon the Company’s obligations pursuant to this Agreement, other than those set forth in
Section 9 hereof, shall be that the Company shall not be obligated to make any payment to Indemnitee that is finally determined (under the procedures, and subject to the presumptions, set forth in Sections 6 and 7 hereof)
to be unlawful. 

  
 2 

 3. Contribution. To the fullest extent permissible under applicable law, if the
indemnification provided for in this Agreement is unavailable to Indemnitee for any reason whatsoever, the Company, in lieu of indemnifying Indemnitee, shall contribute to the amount incurred by Indemnitee, whether for Liabilities and/or for
Expenses actually incurred, in connection with any claim relating to a Proceeding under this Agreement, in such proportion as is deemed fair and reasonable in light of all of the circumstances of such Proceeding in order to reflect (i) the
relative benefits received by the Company and Indemnitee as a result of the event(s) and/or transaction(s) giving cause to such Proceeding, and/or (ii) the relative fault of the Company (and its directors, officers, employees and agents), on
the one hand, and Indemnitee, on the other hand, in connection with such event(s) and/or transaction(s). To the fullest extent permitted by applicable law, the Company hereby agrees to fully indemnify and hold Indemnitee harmless from any claims of
contribution which may be brought by officers, directors, employees, agents or other service providers of the Company, other than Indemnitee, who may be jointly liable with Indemnitee. 

4. Indemnification for Expenses of a Witness. Notwithstanding any other provision of this Agreement, to the fullest extent
permitted by applicable law and to the extent that Indemnitee is, by reason of Indemnitee’s Corporate Status, a witness, or is made (or asked) to respond to discovery requests, in any Proceeding to which Indemnitee is not a party, Indemnitee
shall be indemnified against all Expenses actually incurred by or on behalf of Indemnitee in connection therewith. 
 5.
Advancement of Expenses. Notwithstanding any other provision of this Agreement, the Company shall advance, to the extent not prohibited by law, all Expenses incurred by or on behalf of Indemnitee in connection with any Proceeding by reason of
Indemnitee’s Corporate Status within fifteen (15) days after the receipt by the Company of a statement or statements from Indemnitee requesting such advance or advances from time to time, whether prior to or after final disposition of such
Proceeding. Such statement or statements shall reasonably evidence the Expenses incurred by Indemnitee and shall, if and to the extent required by the DGCL, include or be preceded or accompanied by a written undertaking by or on behalf of Indemnitee
to repay any Expenses advanced if it shall ultimately be determined that Indemnitee is not entitled to be indemnified against such Expenses. Any advances and undertakings to repay pursuant to this Section 5 shall be unsecured and
interest-free. In accordance with Sections 7(d) and 7(e) of this Agreement, advances shall include any and all Expenses incurred pursuing an action to enforce this right of advancement, including Expenses incurred preparing and
forwarding statements to the Company to support the advances claimed. 
 6. Procedures and Presumptions for Determination of
Entitlement to Indemnification. It is the intent of the parties to this Agreement to secure for Indemnitee rights of indemnity that are as favorable as may be permitted under the DGCL and public policy of the State of Delaware. Accordingly, the
parties agree that the following procedures and presumptions shall apply in the event of any question as to whether Indemnitee is entitled to indemnification under this Agreement: 

(a) To obtain indemnification under this Agreement, Indemnitee shall submit to the Company a written request, including
therein or therewith such documentation and information as is reasonably available to Indemnitee and is reasonably necessary to determine whether and to what extent Indemnitee is entitled to indemnification. The Secretary (or comparable officer) of
the Company shall, promptly upon receipt of such a request for indemnification, advise the Board in writing that Indemnitee has requested indemnification. Notwithstanding the foregoing, any failure of Indemnitee to provide such a request to the
Company, or to provide such a request in a timely fashion, shall not relieve the Company of any liability that it may have to Indemnitee unless, and to the extent that, such failure actually and materially prejudices the interests of the Company.

  
 3 

 (b) Upon written request by Indemnitee for indemnification pursuant to the
first sentence of Section 6(a) hereof, a determination with respect to Indemnitee’s entitlement thereto shall be made in the specific case by one of the following four methods, which shall be at the election of the Board:
(1) by a majority vote of the Disinterested Directors (as hereinafter defined), even though less than a quorum, (2) by a committee of Disinterested Directors designated by a majority vote of the Disinterested Directors, even though less
than a quorum or (3) if there are no Disinterested Directors, or if the Disinterested Directors so direct, by Independent Counsel in a written opinion to the Board, a copy of which shall be delivered to Indemnitee; provided,
however, that if a Change in Control has occurred, the determination with respect to Indemnitee’s entitlement to indemnification shall be made by Independent Counsel. 

(c) In the event the determination of entitlement to indemnification is to be made by Independent Counsel, the Independent
Counsel shall be selected as provided in this Section 6(c). If a Change in Control has not occurred, the Independent Counsel shall be selected by the Board (including a vote of a majority of the Disinterested Directors if obtainable),
and the Company shall give written notice to the Indemnitee advising Indemnitee of the identity of the Independent Counsel so selected. Indemnitee may, within 10 days after such written notice of selection shall have been given, deliver to the
Company a written objection to such selection; provided, however, that such objection may be asserted only on the ground that the Independent Counsel so selected does not meet the requirements of “Independent Counsel” as
defined in Section 12 of this Agreement, and the objection shall set forth with particularity the factual basis of such assertion. If a Change in Control has occurred, the Independent Counsel shall be selected by the Indemnitee (unless
the Indemnitee shall request that such selection be made by the Board, in which event the preceding sentence shall apply), and the Indemnitee shall give written notice to the Company advising the Company of the identity of the Independent Counsel so
selected. The Company may, within 10 days after such written notice of selection shall have been given, deliver to the Indemnitee a written objection to such selection; provided, however, that such objection may be asserted only on the
ground that the Independent Counsel so selected does not meet the requirements of “Independent Counsel” as defined in Section 12 of this Agreement, and the objection shall set forth with particularity the factual basis of such
assertion. Absent a proper and timely objection, the Person so selected shall act as Independent Counsel. If a written objection is made, the Independent Counsel selected may not serve as Independent Counsel unless and until such objection is
withdrawn or a court has determined that such objection is without merit. If a Change in Control has occurred, the Independent Counsel shall be selected by the Indemnitee (unless the Indemnitee shall request that such selection be made by the Board,
in which event the preceding sentence shall apply), and approved by the Board within 20 days after notification by Indemnitee. Absent a proper and timely objection, the Person so selected shall act as Independent Counsel. If a written objection is
made, the Independent Counsel selected may not serve as Independent Counsel unless and until such objection is withdrawn or a court has determined that such objection is without merit. The Company shall pay any and all reasonable fees and expenses
of Independent Counsel incurred by such Independent Counsel in connection with acting pursuant to Section 6(b) hereof, and the Company shall pay all reasonable fees and expenses incident to the procedures of this
Section 6(c), regardless of the manner in which such Independent Counsel was selected or appointed. 

(d) In making a determination with respect to entitlement to indemnification hereunder, the Person making such
determination shall presume that Indemnitee is entitled to indemnification under this Agreement. Anyone seeking to overcome this presumption shall have 

  
 4 

 
the burden of proof and the burden of persuasion by clear and convincing evidence. Neither the failure of the Company (including by its directors, Independent Counsel or stockholders) to have
made a determination prior to the commencement of any action pursuant to this Agreement that indemnification is proper in the circumstances because Indemnitee has met the applicable standard of conduct, nor an actual determination by the Company
(including by its directors, Independent Counsel or stockholders) that Indemnitee has not met such applicable standard of conduct, shall be a defense to the action or create a presumption that Indemnitee has not met the applicable standard of
conduct. 
 (e) For purposes of this Agreement, it shall be presumed that Indemnitee has at all times acted in
good faith and in a manner Indemnitee reasonably believed to be in or not opposed to the best interests of the Company. Anyone seeking to overcome this presumption of good faith shall have the burden of proof and the burden of persuasion by clear
and convincing evidence. Without limiting the generality of the foregoing, Indemnitee shall be deemed to have acted in good faith if Indemnitee’s action that is the subject of any actual or threatened Proceeding is based on (i) the records
or books of account of the Enterprise (as hereinafter defined), including financial statements, (ii) information supplied to Indemnitee by the officers of the Enterprise in the course of their duties, (iii) the advice of legal counsel for
the Enterprise or (iv) information or records given or reports made to the Enterprise by an independent certified public accountant or by an appraiser or other expert selected with reasonable care by the Enterprise. In addition, the knowledge
and/or actions, or failure to act, of any director, officer, agent or employee of the Enterprise shall not be imputed to Indemnitee for purposes of determining the right to indemnification under this Agreement. 

(f) If the Person empowered or selected under this Section 6 to determine whether Indemnitee is entitled to
indemnification shall not have made a determination within thirty (30) days (or in the case of an advancement of Expenses in accordance with Section 4, fifteen (15) days; provided that Indemnitee has, if and to the
extent required by the DGCL, delivered the undertaking contemplated in Section 4) after receipt by the Company of the request therefor, the requisite determination of entitlement to indemnification shall be deemed to have been made and
Indemnitee shall be entitled to such indemnification absent (i) a misstatement by Indemnitee of a material fact, or an omission of a material fact necessary to make Indemnitee’s statement not materially misleading, in connection with the
request for indemnification, or (ii) a prohibition of such indemnification under applicable law, and such right to indemnification shall be enforceable by Indemnitee in any court of competent jurisdiction; provided that the foregoing
provisions of this Section 6(f) shall not apply if the determination of entitlement to indemnification is to be made by the stockholders pursuant to Section 6(b) of this Agreement and if (A) within fifteen (15) days
after receipt by the Company of the request for such determination, the Board or the Disinterested Directors, if appropriate, resolve to submit such determination to the stockholders for their consideration at an annual meeting thereof to be held
within sixty (60) days after such receipt and such determination is made at such stockholders meeting, or (B) a special meeting of stockholders is called within fifteen (15) days after such receipt for the purpose of making such
determination, such meeting is held for such purpose within sixty (45) days after having been so called and such determination is made at such meeting. 
 (g) Indemnitee shall cooperate with the Person making a determination with respect to Indemnitee’s entitlement to indemnification hereunder, including providing to such Person upon reasonable advance
request any documentation or information which is not privileged or otherwise protected from disclosure and which is reasonably available to Indemnitee and reasonably necessary to such determination. Any Expenses incurred by Indemnitee in so
cooperating with the Person making such determination shall be borne by the Company (irrespective of the determination as to Indemnitee’s entitlement to indemnification) and the Company hereby indemnifies and agrees to hold Indemnitee harmless
therefrom. 

  
 5 

 (h) Any Person making a determination as to Indemnitee’s entitlement to
indemnification shall act reasonably and in good faith in making a determination regarding Indemnitee’s entitlement to indemnification under this Agreement. 

(i) With respect to any Proceeding as to which Indemnitee notifies the Company of the commencement thereof the Company
will be entitled to participate therein at its own expense. The Company, jointly with any other indemnifying party similarly notified, will be entitled to assume the defense thereof, with counsel reasonably satisfactory to Indemnitee;
provided, however, that the Company shall not be entitled to assume the defense of any Proceeding if there has been a Change in Control or if Indemnitee shall have reasonably concluded that there may be a conflict of interest between
the Company and Indemnitee with respect to such Proceeding. After the Company provides written notice to Indemnitee of its election to assume the defense of any Proceeding pursuant to this Section 6(i), the Company will not be liable to
Indemnitee under this Agreement for any Expenses subsequently incurred by Indemnitee in connection with the defense thereof, other than reasonable costs of investigation or otherwise; provided, however, that Indemnitee shall have the
right to employ Indemnitee’s own counsel, but the fees and expenses of such counsel incurred after notice from the Company of its assumption of the defense thereof shall be at the expense of Indemnitee unless: 

(i) the employment of counsel by Indemnitee has been authorized by the Company; 

(ii) Indemnitee shall have reasonably concluded that counsel engaged by the Company may not adequately represent
Indemnitee due to, among other things, actual or potential differing interests; or 
 (iii) the Company shall not
in fact have employed counsel to assume the defense in such Proceeding or shall not in fact have assumed such defense and be acting in connection therewith with reasonable diligence; in each of which cases the fees and expenses of such counsel shall
be at the expense of the Company. 
 (j) The Company acknowledges that a settlement or other disposition short of
final judgment may be successful if it permits a party to avoid expense, delay, distraction, disruption and uncertainty. In the event that any Proceeding to which Indemnitee is a party is resolved in any manner other than by adverse judgment against
Indemnitee (including, without limitation, settlement of such action, claim or proceeding with or without payment of money or other consideration) it shall be presumed that Indemnitee has been successful on the merits or otherwise in such
Proceeding. Anyone seeking to overcome this presumption shall have the burden of proof and the burden of persuasion by clear and convincing evidence. The Company shall not settle any Proceeding in any manner unless such settlement (i) provides
for a full and final release of all claims against Indemnitee and (ii) does not impose any penalty (including any admissions of fault) or limitation on Indemnitee without Indemnitee’s written consent. 

(k) The termination of any Proceeding or of any claim, issue or matter therein, by judgment, order, settlement or
conviction, or upon a plea of nolo contendere or its equivalent, shall not (except as otherwise expressly provided in this Agreement) of itself adversely affect the right of Indemnitee to indemnification or create a presumption that Indemnitee did
not act in good faith and in a manner which Indemnitee reasonably believed to be in or not opposed to the best interests of the Company or, with respect to any criminal Proceeding, that Indemnitee had reasonable cause to believe that
Indemnitee’s conduct was unlawful. 

  
 6 

 7. Remedies of Indemnitee. 

(a) Subject to Section 9, in the event that (i) a determination is made pursuant to Section 6
of this Agreement that Indemnitee is not entitled to indemnification under this Agreement, (ii) advancement of Expenses is not timely made pursuant to Section 5 of this Agreement, (iii) no determination of entitlement to
indemnification is made pursuant to Section 6(b) of this Agreement within thirty (30) days (or in the case of an advancement of Expenses in accordance with Section 4, fifteen (15) days; provided that
Indemnitee has, if and to the extent required by the DGCL, delivered the undertaking contemplated in Section 4) after receipt by the Company of the request for indemnification, (iv) payment of indemnification is not made pursuant to
this Agreement within ten (10) days after receipt by the Company of a written request therefor or (v) payment of indemnification is not made within ten (10) days after a determination has been made that Indemnitee is entitled to
indemnification or such determination is deemed to have been made pursuant to Section 6 of this Agreement, then Indemnitee shall be entitled to an adjudication in an appropriate court of the State of Delaware, or in any other court of
competent jurisdiction, of Indemnitee’s entitlement to such indemnification, contribution or advancement of Expenses. Alternatively, Indemnitee, at Indemnitee’s option, may seek an award in arbitration to be conducted by a single
arbitrator pursuant to the Commercial Arbitration Rules of the American Arbitration Association. Indemnitee shall commence such proceeding seeking an adjudication or an award in arbitration within 180 days following the date on which Indemnitee
first has the right to commence such proceeding pursuant to this Section 7. Except as set forth herein, the provisions of Delaware law (without regard to its conflict-of-law rules) shall apply to any such arbitration. The Company shall
not oppose Indemnitee’s right to seek any such adjudication or award in arbitration. 
 (b) In the event
that a determination shall have been made pursuant to Section 6(b) of this Agreement that Indemnitee is not entitled to indemnification, any judicial proceeding commenced pursuant to this Section 7 shall be conducted in all
respects as a de novo trial, or arbitration, on the merits, and Indemnitee shall not be prejudiced by reason of the adverse determination under Section 6(b). In any judicial proceeding or arbitration commenced pursuant to this
Section 7, Indemnitee shall be presumed to be entitled to indemnification under this Agreement and the Company shall have the burden of proving by clear and convincing evidence that Indemnitee is not entitled to indemnification or
advancement of Expenses, as the case may be, and the Company may not refer to or introduce into evidence any determination pursuant to Section 6(b) of this Agreement adverse to Indemnitee for any purpose. If Indemnitee commences a
judicial proceeding or arbitration pursuant to this Section 7, Indemnitee shall not be required to reimburse the Company for any advances pursuant to Section 5 until a final determination is made with respect to
Indemnitee’s entitlement to indemnification (as to which all rights of appeal have been exhausted or lapsed). 
 (c) If a determination shall have been made pursuant to Section 6(b) of this Agreement that Indemnitee is entitled to indemnification, the Company shall be bound by such determination in any
judicial proceeding commenced pursuant to this Section 7, absent (i) a misstatement by Indemnitee of a material fact, or an omission of a material fact necessary to make Indemnitee’s misstatement not materially misleading, in
connection with the application for indemnification, or (ii) a prohibition of such indemnification under applicable law. 

  
 7 

 (d) In the event that Indemnitee, pursuant to this Section 7,
seeks a judicial adjudication of Indemnitee’s rights under, or to recover damages for breach of, this Agreement, or to recover under any directors’ and officers’ liability insurance policies maintained by the Company, the Company
shall pay on Indemnitee’s behalf, in advance, any and all Expenses actually incurred by Indemnitee in such judicial adjudication, regardless of whether Indemnitee ultimately is determined to be entitled to such indemnification, advancement of
Expenses or insurance recovery, to the fullest extent permitted by applicable law. 
 (e) The Company shall, to
the extent not prohibited by law, be precluded from asserting in any judicial proceeding or arbitration commenced pursuant to this Section 7 that the procedures and presumptions of this Agreement are not valid, binding and enforceable
and shall stipulate in any such court or before any such arbitrator that the Company is bound by all the provisions of this Agreement. It is the intent of the Company that, to the fullest extent permitted by applicable law, Indemnitee not be
required to incur Expenses associated with the interpretation, enforcement or defense of Indemnitee’s rights under this Agreement by litigation or otherwise because the cost and expense thereof would substantially detract from the benefits
intended to be extended to Indemnitee hereunder. The Company shall indemnify Indemnitee against any and all Expenses and, if requested by Indemnitee, shall advance, to the extent not prohibited by law and in accordance with Section 5 of
this Agreement, such Expenses to Indemnitee, which are incurred by Indemnitee in connection with any action brought by Indemnitee for indemnification or advance of Expenses from the Company under this Agreement or under any directors’ and
officers’ liability insurance policies maintained by the Company. 
 8. Non-Exclusivity; Survival of Rights; Insurance;
Primacy of Indemnification; Subrogation. 
 (a) The rights of indemnification and to receive advancement of
Expenses as provided by this Agreement shall not be deemed exclusive of any other rights to which Indemnitee may at any time be entitled under applicable law, the Charter, the Bylaws, any agreement, a vote of stockholders, a resolution of directors
or otherwise, of the Company. No amendment, alteration or repeal of this Agreement or of any provision hereof shall limit or restrict any right of Indemnitee under this Agreement in respect of any action taken or omitted by Indemnitee in
Indemnitee’s Corporate Status prior to such amendment, alteration or repeal. To the extent that a change in the DGCL, whether by statute or judicial decision, permits greater indemnification than would be afforded currently under the Charter,
Bylaws and this Agreement, it is the intent of the parties hereto that Indemnitee shall enjoy by this Agreement the greater benefits so afforded by such change. No right or remedy herein conferred is intended to be exclusive of any other right or
remedy, and every other right and remedy shall be cumulative and in addition to every other right and remedy given hereunder or now or hereafter existing at law or in equity or otherwise. The assertion or employment of any right or remedy hereunder,
or otherwise, shall not prevent the concurrent assertion or employment of any other right or remedy. 
 (b)

 (i) The Company shall, if commercially reasonable, obtain and maintain in effect during the entire period
described in Section 10 for which the Company is obligated to indemnify Indemnitee under this Agreement, one or more policies of insurance with reputable insurance companies to provide the directors and officers of the Company with
coverage for losses from wrongful acts and omissions and to ensure the Company’s performance of its indemnification obligations under this Agreement (“D&O Insurance”); provided, that in connection with a Change of
Control that occurs prior to 

  
 8 

 
the termination of the period described in Section 10 for which the Company is obligated to indemnify Indemnitee, the Company shall instead purchase a six (6) year pre-paid
“tail policy” (a “Tail Policy”) on terms and conditions (in both amount and scope) providing substantially equivalent benefits to Indemnitee as the D&O Insurance in effect as of the closing of the Change of Control
(the “Change of Control Closing Date”) with respect to matters arising on or prior to the earlier of (i) the Change of Control Closing Date and (ii) the date on which Indemnitee ceased serving as a director, officer or
fiduciary of the Company, any direct or indirect subsidiary of the Company or of any other corporation, partnership, joint venture, trust or other enterprise at the express written consent of the Company. 

(ii) Indemnitee shall be covered by such D&O Policies (including any Tail Policy) in accordance with its or their
terms to the maximum extent of the coverage available for any such officer or director under such D&O Policies. In all such D&O Policies, Indemnitee shall be named as an insured in such a manner as to provide Indemnitee with the same rights
and benefits as are accorded to the most favorably insured of the Company’s directors and officers. At the time of the receipt of a notice of a claim pursuant to the terms hereof, the Company shall give prompt notice of the commencement of such
proceeding to the insurers in accordance with the procedures set forth in the respective D&O Policies. The Company shall thereafter take all necessary or desirable action to cause such insurers to pay, on behalf of Indemnitee, all amounts
payable as a result of such proceeding in accordance with the terms of such D&O Policies. 
 (c) The Company hereby
acknowledges that Indemnitee has the Water Street Rights provided by Water Street and/or certain of Water Street’s affiliates that, directly or indirectly, (i) are controlled by, (ii) control or (iii) are under common control
with Water Street (collectively, the “Fund Indemnitors”). The Company hereby agrees (A) that the Company is the indemnitor of first resort (i.e., its obligations to Indemnitee are primary and any obligation of the Fund
Indemnitors to advance Expenses or to provide indemnification for the same Liabilities or Expenses incurred by Indemnitee is secondary), (B) that it shall be required to advance the full amount of Expenses actually incurred by Indemnitee and
shall be liable for the full amount of all Liabilities and Expenses to the extent legally permitted and as required by the terms of this Agreement and the Charter or Bylaws of the Company (or any other agreement between the Company and Indemnitee),
without regard to any rights Indemnitee may have against the Fund Indemnitors, and (C) that it irrevocably waives, relinquishes and releases the Fund Indemnitors from any and all claims against the Fund Indemnitors for contribution, subrogation
or any other recovery of any kind in respect thereof. The Company further agrees that no advancement or payment by the Fund Indemnitors on behalf of Indemnitee with respect to any claim for which Indemnitee has sought indemnification from the
Company shall affect the foregoing, and the Fund Indemnitors shall have a right of contribution and/or be subrogated to the extent of such advancement or payment to all of the rights of recovery of Indemnitee against the Company. The Company and
Indemnitee agree that the Fund Indemnitors are express third party beneficiaries of the terms of this Section 8(c). 

(d) Except as provided in Section 8(c) above, in the event of any payment under this Agreement, the Company shall be
subrogated to the extent of such payment to all of the rights of recovery of Indemnitee (other than against the Fund Indemnitors), who shall execute all papers required and take all action necessary to secure such rights, including execution of such
documents as are necessary to enable the Company to bring suit to enforce such rights. 

  
 9 

 (e) Except as provided in Section 8(c) above, the Company shall
not be liable under this Agreement to make any payment of amounts otherwise indemnifiable hereunder if and to the extent that Indemnitee has otherwise actually received such payment under any insurance policy, contract, agreement or otherwise.

 (f) Except as provided in Section 8(c) above, the Company’s obligation to indemnify or
advance Expenses hereunder to Indemnitee who is or was serving at the request of the Company as a director, officer, employee or agent of any other corporation, limited liability company, partnership, joint venture, trust, employee benefit plan or
other enterprise shall be reduced by any amount Indemnitee has actually received as indemnification or advancement of Expenses from such other corporation, partnership, joint venture, trust, employee benefit plan or other enterprise. 

9. Exception to Right of Indemnification. Notwithstanding any provision in this Agreement, the Company shall not be obligated
under this Agreement to make any indemnity in connection with any claim made against Indemnitee: 
 (a) for an
accounting of profits made from the purchase and sale (or sale and purchase) by Indemnitee of securities of the Company within the meaning of Section 16(b) of the Exchange Act (as hereinafter defined), or similar provisions of state statutory
law or common law; or 
 (b) for Indemnitee’s reimbursement to the Company of any bonus or other
incentive-based or equity-based compensation or of any profits realized by Indemnitee from the sale of securities of the Company, in each case as required under the Exchange Act; or 

(c) in connection with any Proceeding (or any part of any Proceeding) initiated by Indemnitee, including any Proceeding
(or any part of any Proceeding) initiated by Indemnitee against the Company or its directors, officers, employees or other indemnitees, unless (i) the Company has joined in or the Board authorized the Proceeding (or any part of any Proceeding)
prior to its initiation, (ii) the Company provides the indemnification, in its sole discretion, pursuant to the powers vested in the Company under applicable law, or (iii) the Proceeding is one to enforce Indemnitee’s rights under
this Agreement, the Charter or the Bylaws. 
 10. Duration of Agreement. All agreements and obligations of the Company
contained herein shall continue until and terminate upon the later of (i) ten (10) years after the date that Indemnitee shall have ceased to serve as a director or officer of the Company or a director, officer, trustee, partner, managing
member, fiduciary, employee or agent of any other corporation, limited liability company, partnership, joint venture, trust, employee benefit plan or other enterprise which Indemnitee served at the request of the Company, and (ii) two
(2) years after the final termination of any Proceeding (including any rights of appeal thereto) in respect of which Indemnitee is granted rights of indemnification or advancement of Expenses hereunder and of any Proceeding commenced by
Indemnitee pursuant to Section 7 of this Agreement relating thereto (including any rights of appeal of any Section 7 Proceeding). 
 11. Security. To the extent requested by Indemnitee and approved by the Board, the Company shall provide security to Indemnitee for the Company’s obligations hereunder through an irrevocable
bank line of credit, funded trust or other collateral. Any such security, once provided to Indemnitee, may not be revoked or released without the prior written consent of Indemnitee. 

  
 10 

 12. Definitions. For purposes of this Agreement: 

(a) “Change in Control” shall be deemed to occur upon the earliest to occur after the date of this
Agreement of any of the following events: 
 (i) Acquisition of Stock by Third Party. Any Person, other
than WSHP Biologics Holdings, LLC, Water Street or any of their respective affiliates and other than a trustee or other fiduciary holding securities under an employee benefit plan of the Company or a corporation owned directly or indirectly by the
stockholders of the Company in substantially the same proportions as their ownership of stock of the Company, is or becomes the “beneficial owner” (as defined in Rule 13d-3 under the Exchange Act), directly or indirectly, of securities of
the Company representing more than 50% of the combined voting power of the Company’s then outstanding securities, unless the change in relative “beneficial ownership” (as defined in Rule 13d-3 under the Exchange Act) of the
Company’s securities by any Person results solely from a reduction in the aggregate number of outstanding securities entitled to vote generally in the election of directors; 

(ii) Change in Board of Directors. During any period of two (2) consecutive years (not including any period
prior to the execution of this Agreement), individuals who at the beginning of such period constitute the Board, and any new director (other than a director designated by a Person who has entered into an agreement with the Company to effect a
transaction described in Section 12(a)(i), 12(a)(iii) or 12(a)(iv)) whose election by the Board or nomination for election by the Company’s stockholders was approved by a vote of at least a majority of the directors
then still in office who either were directors at the beginning of the period or whose election or nomination for election was previously so approved or who was otherwise nominated by WSHP Biologics Holdings, LLC, Water Street or any of their
respective affiliates, cease for any reason to constitute at least a majority of the members of the Board; 

(iii) Corporate Transactions. The effective date of a merger or consolidation of the Company with any other entity,
other than a merger or consolidation which would result in the voting securities of the Company outstanding immediately prior to such merger or consolidation continuing to represent (either by remaining outstanding or by being converted into voting
securities of the surviving entity) more than 50% of the combined voting power of the voting securities of the surviving entity outstanding immediately after such merger or consolidation and with the power to elect at least a majority of the board
of directors or other governing body of such surviving entity; and 
 (iv) Liquidation. The approval by
the stockholders of the Company of a complete liquidation of the Company or an agreement or series of agreements for the sale or disposition by the Company of all or substantially all of the Company’s assets, or, if such approval is not
required, the decision by the Board to proceed with such a liquidation, sale, or disposition in one transaction or a series of related transactions. 
 (b) “Corporate Status” describes the status of a person who is or was a director, officer, employee, agent or fiduciary of the Company, any direct or indirect subsidiary of the Company,
or of any other corporation, limited liability company, partnership, joint venture, trust or other enterprise, including service with respect to an employee benefit plan, that such person is or was serving at the request of the Company;
provided, that any person that serves as a director, officer, employee, agent or fiduciary of another corporation, limited liability company, partnership, joint venture, trust or other enterprise, of at least 50% of whose equity interests are
owned by the Company, shall be conclusively presumed to be serving in such capacity at the request of the Company. 

  
 11 

 (c) “Disinterested Director” means a director of the
Company who is not and was not a party to the Proceeding in respect of which indemnification is sought by Indemnitee. 
 (d) “Enterprise” shall mean the Company and any other corporation, limited liability company, partnership, joint venture, trust, employee benefit plan or other enterprise that Indemnitee
is or was serving at the express written request of the Company as a director, officer, trustee, partner, managing member, employee, agent or fiduciary. 
 (e) “Exchange Act” shall mean the Securities Exchange Act of l934, as amended. 
 (f) “Expenses” shall include all reasonable documented direct and indirect costs, including attorneys’ fees, retainers, court costs, transcript costs, fees of experts and other
professionals, witness fees, travel expenses, duplicating costs, printing and binding costs, telephone charges, postage, delivery service fees, out-of-pocket expenses and other disbursements and expenses of the types customarily incurred in
connection with prosecuting, defending, preparing to prosecute or defend, investigating, participating, or being or preparing to be a witness in a Proceeding, responding to, or objecting to, a request to provide discovery in any Proceeding, or, to
the fullest extent permitted by applicable law, successfully establishing a right to indemnification under this Agreement, whether in whole or part. Expenses also shall include Expenses incurred in connection with any appeal resulting from any
Proceeding and any federal, state, local or foreign taxes imposed on Indemnitee as a result of the actual or deemed receipt of any payments under this Agreement, including without limitation the premium, security for, and other costs relating to any
cost bond, supersede as bond, or other appeal bond or its equivalent. Expenses, however, shall not include any Liabilities. 
 (g) “Independent Counsel” means a law firm, or a member of a law firm, that is experienced in matters of corporate law and neither presently is, nor in the past five (5) years has
been, retained to represent: (i) the Company or Indemnitee in any matter material to either such party (other than with respect to matters concerning Indemnitee under this Agreement, or of other indemnitees under similar indemnification
agreements), or (ii) any other party to the Proceeding giving rise to a claim for indemnification hereunder. Notwithstanding the foregoing, the term “Independent Counsel” shall not include any Person who, under the applicable
standards of professional conduct then prevailing, would have a conflict of interest in representing either the Company or Indemnitee in an action to determine Indemnitee’s rights under this Agreement. The Company agrees to pay the reasonable
fees and disbursements of the Independent Counsel referred to above and to fully indemnify such counsel against any and all expenses, claims, liabilities and damages arising out of or relating to this Agreement or its engagement pursuant hereto.

 (h) “Liabilities” shall mean damages, losses and liabilities of any type whatsoever,
including, but not limited to, any judgments, fines, excise or other taxes, penalties and amounts paid in settlement (including all interest assessments and other charges paid or payable in connection with or in respect of such judgments, fines,
excise or other taxes, penalties or amounts paid in settlement) of any Proceeding. 
 (i)
“Person” shall have the meaning as set forth in Sections 13(d) and 14(d) of the Exchange Act; provided, however, that Person shall exclude (i) the Company, (ii) any trustee or other fiduciary holding
securities under an employee benefit plan of the Company, and (iii) any corporation owned, directly or indirectly, by the stockholders of the Company in substantially the same proportions as their ownership of stock of the Company. 

  
 12 

 (j) “Proceeding” includes any actual, threatened, pending
or completed action, suit, arbitration, alternate dispute resolution mechanism, investigation, inquiry, administrative hearing or any other actual, threatened, pending or completed proceeding, and any appeal thereof, whether brought by or in the
right of the Company or otherwise and whether civil, criminal, administrative or investigative, in which Indemnitee was, is or will be involved as a party or otherwise, by reason of the Corporate Status of Indemnitee, by reason of any action taken
by Indemnitee or of any inaction on Indemnitee’s part while acting in such Corporate Status, or by reason of the fact that Indemnitee is or was serving at the request of the Company as a director, officer, employee, agent or fiduciary of
another corporation, partnership, joint venture, trust or other enterprise; in each case whether or not Indemnitee is acting or serving in any such capacity at the time any Liability or Expense is incurred for which indemnification can be provided
under this Agreement; including one pending on or before the date of this Agreement. 
 13. Severability. If any
provision of this Agreement or the application of any such provision to any Person or circumstance shall be declared by any court of competent jurisdiction to be invalid, illegal, void or unenforceable in any respect, all other provisions of this
Agreement, or the application of such provision to Persons or circumstances other than those as to which it has been held invalid, illegal, void or unenforceable, shall nevertheless remain in full force and effect and will in no way be affected,
impaired or invalidated thereby. Upon such determination that any provision, or the application of any such provision, is invalid, illegal, void or unenforceable, the parties hereto shall negotiate in good faith to modify this Agreement so as to
effect the original intent of the parties hereto as closely as possible to the fullest extent permitted by law in an acceptable manner to the end that the transactions contemplated hereby are fulfilled to the greatest extent possible. 

14. Enforcement and Binding Effect. 
 (a) The Company expressly confirms and agrees that it has entered into this Agreement and assumed the obligations imposed on it hereby in order to induce Indemnitee to serve as a director, officer or key
employee of the Company and/or Enterprise, and the Company acknowledges that Indemnitee is relying upon this Agreement in serving as a director, officer or key employee of the Company and/or Enterprise. 

(b) Without limiting any of the rights of Indemnitee under the Charter or Bylaws of the Company as they may be amended
from time to time, this Agreement constitutes the entire agreement between the parties hereto with respect to the subject matter hereof and supersedes all prior agreements and understandings, oral, written and implied, between the parties hereto
with respect to the subject matter hereof. 
 (c) The indemnification and advancement of expenses provided by, or
granted pursuant to, this Agreement shall be binding upon and be enforceable by the parties hereto and their respective successors and assigns (including any direct or indirect successor by purchase, merger, consolidation or otherwise to all or
substantially all of the business or assets of the Company), shall continue as to an Indemnitee who has ceased to be a director, officer, employee or agent of the Company or of any other Enterprise at the Company’s request, and shall inure to
the benefit of Indemnitee and Indemnitee’s spouse, assigns, heirs, devisees, executors and administrators and other legal representatives. 

  
 13 

 (d) The Company shall require and cause any successor (whether direct or
indirect by purchase, merger, consolidation or otherwise) to all or substantially all of the business and/or assets of the Company to expressly assume and agree to perform this Agreement in the same manner and to the same extent that the Company
would be required to perform if no such succession had taken place. 
 (e) The Company and Indemnitee agree
herein that a monetary remedy for breach of this Agreement, at some later date, may be inadequate, impracticable and difficult of proof, and further agree that such breach may cause Indemnitee irreparable harm. Accordingly, the parties hereto agree
that Indemnitee may enforce this Agreement by seeking injunctive relief and/or specific performance hereof or other equitable relief, without any necessity of showing actual damage or irreparable harm, and that by seeking injunctive relief and/or
specific performance or other equitable relief, Indemnitee shall not be precluded from seeking or obtaining any other relief to which Indemnitee may be entitled. The Company and Indemnitee further agree that Indemnitee shall be entitled to such
specific performance and injunctive or other equitable relief, including temporary restraining orders, preliminary injunctions and permanent injunctions, without the necessity of posting bonds or other undertaking in connection therewith. The
Company acknowledges that in the absence of a waiver, a bond or undertaking may be required of Indemnitee by the court, and the Company hereby waives any such requirement of such a bond or undertaking. 

15. Modification and Waiver. No term of this Agreement may be amended or modified without the prior written consent of each party
hereto. No provision of this Agreement may be waived except in a writing executed and delivered by the party against whom such waiver is sought to be enforced. Any amendment or waiver effected in accordance with this Section 15 shall be
binding upon the parties hereto. 
 16. Notice By Indemnitee. Indemnitee agrees promptly to notify the Company in writing
upon being served with or otherwise receiving any summons, citation, subpoena, complaint, indictment or other similar document relating to any Proceeding or matter which may be subject to indemnification covered hereunder. The failure to so notify
the Company shall not relieve the Company of any obligation which it may have to Indemnitee under this Agreement or otherwise unless and only to the extent that such failure or delay materially prejudices the Company. 

17. Notices. Unless otherwise provided, any notice or request required or permitted to be delivered under this Agreement shall be
given in writing and shall be deemed effectively given as hereinafter described (a) if given by personal delivery, upon actual delivery, (b) if given by facsimile or telecopier, upon receipt of confirmation of a completed transmittal,
(c) if given by mail, upon the earlier of (i) actual receipt of such notice by the intended recipient or (ii) three (3) business days after such notice is deposited in first class mail, postage prepaid, and (d) if by an
internationally recognized overnight air courier, one (1) business day after delivery to such carrier. All notices shall be addressed to the party to be notified at the address as follows, or at such other address as such party may designate by
ten (10) days’ advance written notice to the other party: 
 If to the Company: 

RTI Biologics, Inc. 
 11621 Research Circle 
 Alachua, FL 32615 

Attention: Board of Directors 
 Telecopy: 386-418-0342 

  
 14 

 With a copy to (which shall not constitute notice to the Company): 

Fulbright & Jaworski LLP 
 666 Fifth Avenue 
 New York, NY 10103 

Attention: Warren J. Nimetz 
 Facsimile: (212) 318-3400 
 If to Indemnitee: 

At the address set forth below Indemnitee’s signature hereto 

With a copy to (which shall not constitute notice to Indemnitee): 

Kirkland & Ellis LLP 
 300 North LaSalle 
 Chicago, IL 60654 

Attention: Ted H. Zook, P.C. 
   James S. Rowe 
   Martin A. DiLoreto, Jr.,
P.C. 
 Telecopy:  (312) 862-2200 
 or to such other address as may have been furnished to Indemnitee by the Company or to the Company by Indemnitee, as the case may be. 

18. Counterparts; Electronic Delivery. This Agreement may be executed in one or more counterparts, each of which shall be deemed
an original, but all of which together shall constitute one and the same instrument. This Agreement and any signed agreement or instrument entered into in connection with this Agreement, and any amendments hereto or thereto, to the extent delivered
by means of a telecopy machine or electronic mail (any such delivery, an “Electronic Delivery”), shall be treated in all manner and respects as an original agreement or instrument and shall be considered to have the same binding
legal effect as if it were the original signed version thereof delivered in person. At the request of any party hereto or to any such agreement or instrument, each other party hereto or thereto shall re-execute original forms thereof and deliver
them to all other parties. No party hereto or to any such agreement or instrument shall raise (a) the use of Electronic Delivery to deliver a signature or (b) the fact that any signature or agreement or instrument was transmitted or
communicated through the use of Electronic Delivery, as a defense to the formation of a contract, and each such party forever waives any such defense, except to the extent such defense related to lack of authenticity. 

19. Headings; Interpretation. All headings and subheadings used in this Agreement are used for convenience only and are not to be
considered in construing or interpreting this Agreement. The words “include,” “includes” and “including” will be deemed to be followed by the phrase “without limitation”. The meanings given to terms defined
herein will be equally applicable to both the singular and plural forms of such terms. Whenever the context may require, any pronoun includes the corresponding masculine, feminine and neuter forms. All references to “dollars” or
“$” will be deemed references to the lawful money of the United States of America. Further, the parties hereto have participated jointly in the negotiation and drafting of this Agreement. In the event an ambiguity or question of intent or
interpretation arises, this Agreement shall be construed as if drafted jointly by the parties hereto, and no presumption or burden of proof shall arise favoring or disfavoring any party hereto by virtue of the authorship of any provisions of this
Agreement. 

  
 15 

 20. Governing Law; CONSENT TO JURISDICTION. This Agreement and the legal relations
among the parties shall be governed by, and construed and enforced in accordance with, the laws of the State of Delaware, without regard to its conflict-of-laws rules. Except with respect to any arbitration commenced by Indemnitee pursuant to
Section 7 of this Agreement, the Company and Indemnitee hereby irrevocably and unconditionally (i) agree that any action or proceeding arising out of or in connection with this Agreement shall be brought only in the Chancery Court
of the State of Delaware (the “Delaware Court”), and not in any other state or federal court in the United States of America or any court in any other country, (ii) consent to submit to the exclusive jurisdiction of the
Delaware Court for purposes of any action or proceeding arising out of or in connection with this Agreement, (iii) agree that service of process in any such action or proceeding may be effected by notice given pursuant to Section 17
of this Agreement, (iv) waive any objection to the laying of venue of any such action or proceeding in the Delaware Court, and (v) waive, and agree not to plead or to make, any claim that any such action or proceeding brought in the
Delaware Court has been brought in an improper or inconvenient forum. The foregoing consent to jurisdiction shall not constitute general consent to service of process in the state for any purpose except as provided above, and shall not be deemed to
confer rights on any Person other than the parties to this Agreement. 
 [Signature page follows] 

  
 16 

 IN WITNESS WHEREOF, the parties hereto have executed this Agreement on and as of the day and
year first written above. 
  

			
	RTI BIOLOGICS, INC.
		
	By:	 	 

 
			
	Name:	 	
	Title:	 	

  

	
	INDEMNITEE
	
	  
	 Name:
  
 Address:

	
	
	 
	
	 
	 

 Signature Page to Director Indemnification Agreement 

 Exhibit F 
 Every term which is defined or given special meaning in the Investment Agreement and which is not given a different meaning in this letter has the same meaning whenever it is used in this letter as the
meaning it is given in the Investment Agreement. The Investment Agreement, the Series A Certificate of Designations, the Investor Rights Agreement, the Management Rights Agreement, the Director Indemnification Agreements and the Pioneer Merger
Agreement are collectively referred to herein as the “Transaction Documents.” 
 Subject to the assumptions,
qualifications, exclusions and other limitations which are identified in this letter, we advise you that: 
  

	1.	The Company is a corporation existing and in good standing under the General Corporation Law of the State of Delaware (the “DGCL”).

  

	2.	The Company has the corporate power and authority to enter into and perform its obligations under each of the Transaction Documents. 

 

	3.	The filing of the Certificate of Designation with the Secretary of State of the State of Delaware has been duly authorized by all necessary corporate action of the
Company. 

  

	4.	The Company’s execution, delivery and performance of the Investment Agreement have been authorized by all necessary corporate actions on the part of the Company.
The Company has duly executed and delivered the Investment Agreement. Assuming due authorization, execution and delivery by Investor, the Investment Agreement is a valid and binding obligation of the Company and is enforceable against the Company in
accordance with its terms. 

  

	5.	The Company’s execution, delivery and performance of the Investor Rights Agreement have been authorized by all necessary corporate actions on the part of the
Company. The Company has duly executed and delivered the Investor Rights Agreement. Assuming due authorization, execution and delivery by Investor, the Investor Rights Agreement is a valid and binding obligation of the Company and is enforceable
against the Company in accordance with its terms. 

  

	6.	The Company’s execution, delivery and performance of the Management Rights Agreement have been authorized by all necessary corporate actions on the part of the
Company. The Company has duly executed and delivered the Management Rights Agreement. Assuming due authorization, execution and delivery by Investor and Water Street Healthcare Partners II, L.P., the Management Rights Agreement is a valid and
binding obligation of the Company and is enforceable against the Company in accordance with its terms. 

  

	7.	The Company’s execution, delivery and performance of the Director Indemnification Agreements have been authorized by all necessary corporate actions on the part of
the Company. The Company has duly executed and delivered the Director Indemnification Agreements. Assuming due authorization, execution and delivery by each Preferred Director, the Director Indemnification Agreements are valid and binding
obligations of the Company and are enforceable against the Company in accordance with their terms. 

  

	8.	The Company’s execution, delivery and performance of the Pioneer Merger Agreement have been authorized by all necessary corporate actions on the part of the
Company. The Company has duly executed and delivered the Pioneer Merger Agreement. Assuming due authorization, execution and delivery by Pioneer and the other parties thereto, the Pioneer Merger Agreement is a valid and binding obligation of the
Company and is enforceable against the Company in accordance with its terms. 

	9.	The execution and delivery of the Transaction Documents by the Company, and the consummation of the transactions contemplated thereby (including, without limitation,
the issuance and sale of the Shares to Investor in accordance with the terms of the Investment Agreement) do not and will not conflict with or constitute or result in a breach or default under (or an event which with notice or the passage of time or
both would constitute a default under) or violation of (i) the Company’s Amended and Restated Certificate of Incorporation, Amended and Restated Bylaws or Series A Certificate of Designation, or (ii) any listing rules of NASDAQ or any
Law of the United States or the State of Delaware typically applicable to transactions that are similar to the transactions contemplated by the Investment Agreement, provided that we express no opinion in this paragraph with respect to (a) any
Law to which the Company may be subject as a result of the legal or regulatory status of Investor or the involvement of Investor in such transactions. 

  

	10.	No consent, approval, authorization or order of any court or Governmental Authority is required for the issuance and sale by the Company of the Shares to Investor or
the consummation by the Company of the transactions contemplated by the Transaction Documents, except such as may be required under the United States securities laws or securities or blue sky laws of the various states (and the rules and regulations
thereunder), as to which we express no opinion in this paragraph. 

  

	11.	The issuance of the Series A Preferred Shares to be sold on the date hereof pursuant to the Investment Agreement has been duly authorized. When appropriate certificates
representing those Shares are delivered against payment for consideration therefor in accordance with the Investment Agreement, those Shares will be validly issued, fully paid and nonassessable. The Shares are not subject to preemptive rights or
other similar rights under the terms of the DGCL, the Company’s Amended and Restated Certificate of Incorporation, Amended and Restated By-laws or Series A Certificate of Designation or, to such counsel’s knowledge, any other agreement to
which the Company is a party. To such ccounsel’s knowledge, there are no securities or instruments of the Company containing anti-dilution or similar provisions that will be triggered by the issuance of the Shares. 

 

	12.	The issuance of the Common Stock upon conversion of the Series A Preferred in accordance with the Certificate of Designation has been duly authorized. When appropriate
certificates representing the Common Stock are duly countersigned by the Company’s registrar and delivered in accordance with the Investment Agreement and Series A Certificate of Designation, the Common Stock will be validly issued, fully paid
and nonassessable. As of the date hereof, the Common Stock issuable upon conversion is not subject to preemptive rights under the terms of the DGCL or under the Company’s Amended and Restated Certificate of Incorporation, Amended and Restated
Bylaws, Series A Certificate of Designation or, to such counsel’s knowledge, any other agreement to which the Company is a party. To such counsel’s knowledge, there are no securities or instruments of the Company containing anti-dilution
or similar provisions that will be triggered by the issuance of the Common Stock upon conversion. 

  

	13.	No registration under the Securities Act is required in connection with: (i) the sale of the Shares to Investor in the manner contemplated by the Investment
Agreement; and (ii) as of the date hereof, the issuance of the Conversion Shares when issued in accordance with the Investment Agreement and Series A Certificate of Designation; in each case assuming (A) the accuracy of Investor’s
representations set forth in the Investment Agreement and (B) the compliance with the procedures set forth in the Investment Agreement and Series A Certificate of Designation by Investor, on the one hand, and the Company, on the other hand.EX-4.1

 Exhibit 4.1 

 
  

HAWK ACQUISITION SUB, INC., as Issuer 
 to be merged with and into 
 H.J. HEINZ COMPANY, 

the GUARANTORS party hereto 
 AND 
 WELLS FARGO BANK, NATIONAL ASSOCIATION, 

as Trustee and Collateral Agent 
 $3,100,000,000 4.25% Second Lien Senior Secured Notes due 2020 
  

 
 INDENTURE

 Dated as of April 1, 2013 
  

 
  

 
  

 Table of Contents 

 

							
	 	 	 	  	Page	 
	EXHIBIT H	 	 FORM OF CERTIFICATE TO BE DELIVERED IN CONNECTION WITH TRANSFERS PURSUANT TO REGULATION S
	  	 	V	  
	EXHIBIT I	 	 FORM OF CERTIFICATE TO BE DELIVERED IN CONNECTION WITH TRANSFERS TO AIS
	  	 	V	  
	
	ARTICLE I	  
	
	DEFINITIONS AND INCORPORATION BY REFERENCE	  
			
	SECTION 1.1.	 	 DEFINITIONS
	  	 	1	  
	SECTION 1.2.	 	 OTHER DEFINITIONS
	  	 	36	  
	SECTION 1.3.	 	 INCORPORATION BY REFERENCE OF TRUST INDENTURE ACT
	  	 	38	  
	SECTION 1.4.	 	 RULES OF CONSTRUCTION
	  	 	38	  
	
	ARTICLE II	  
	
	THE NOTES	  
			
	SECTION 2.1.	 	 FORM, DATING AND TERMS
	  	 	39	  
	SECTION 2.2.	 	 EXECUTION AND AUTHENTICATION
	  	 	46	  
	SECTION 2.3.	 	 REGISTRAR AND PAYING AGENT
	  	 	46	  
	SECTION 2.4.	 	 PAYING AGENT TO HOLD MONEY IN TRUST
	  	 	47	  
	SECTION 2.5.	 	 HOLDER LISTS
	  	 	47	  
	SECTION 2.6.	 	 TRANSFER AND EXCHANGE
	  	 	47	  
	SECTION 2.7.	 	 [RESERVED]
	  	 	51	  
	SECTION 2.8.	 	 [RESERVED]
	  	 	51	  
	SECTION 2.9.	 	 [RESERVED]
	  	 	51	  
	SECTION 2.10.	 	 [RESERVED]
	  	 	51	  
	SECTION 2.11.	 	 MUTILATED, DESTROYED, LOST OR STOLEN NOTES
	  	 	51	  
	SECTION 2.12.	 	 OUTSTANDING NOTES
	  	 	51	  
	SECTION 2.13.	 	 TEMPORARY NOTES
	  	 	52	  
	SECTION 2.14.	 	 CANCELLATION
	  	 	52	  
	SECTION 2.15.	 	 PAYMENT OF INTEREST; DEFAULTED INTEREST
	  	 	52	  
	SECTION 2.16.	 	 CUSIP AND ISIN NUMBERS
	  	 	53	  
	SECTION 2.17.	 	 JOINT AND SEVERAL LIABILITY
	  	 	53	  
	
	ARTICLE III	  
	
	COVENANTS	  
			
	SECTION 3.1.	 	 PAYMENT OF NOTES
	  	 	54	  
	SECTION 3.2.	 	 LIMITATION ON INDEBTEDNESS
	  	 	54	  
	SECTION 3.3.	 	 LIMITATION ON RESTRICTED PAYMENTS
	  	 	58	  
	SECTION 3.4.	 	 LIMITATION ON RESTRICTIONS ON DISTRIBUTIONS FROM RESTRICTED SUBSIDIARIES
	  	 	63	  
	SECTION 3.5.	 	 LIMITATION ON SALES OF ASSETS AND SUBSIDIARY STOCK
	  	 	65	  
	SECTION 3.6.	 	 LIMITATION ON LIENS
	  	 	68	  
	SECTION 3.7.	 	 LIMITATION ON GUARANTEES
	  	 	69	  
	SECTION 3.8.	 	 LIMITATION ON AFFILIATE TRANSACTIONS
	  	 	70	  
	SECTION 3.9.	 	 CHANGE OF CONTROL
	  	 	72	  
	SECTION 3.10.	 	 REPORTS
	  	 	74	  
	SECTION 3.11.	 	 MAINTENANCE OF OFFICE OR AGENCY
	  	 	75	  
	SECTION 3.12.	 	 CORPORATE EXISTENCE
	  	 	75	  

  
 -i-

							
	 	 	 	  	Page	 
			
	 SECTION 3.13.
	 	 PAYMENT OF TAXES
	  	 	76	  
	 SECTION 3.14.
	 	 PAYMENTS FOR CONSENT
	  	 	76	  
	 SECTION 3.15.
	 	 COMPLIANCE CERTIFICATE
	  	 	76	  
	 SECTION 3.16.
	 	 FURTHER INSTRUMENTS AND ACTS
	  	 	76	  
	 SECTION 3.17.
	 	 CONDUCT OF BUSINESS
	  	 	76	  
	 SECTION 3.18.
	 	 STATEMENT BY OFFICERS AS TO DEFAULT
	  	 	76	  
	 SECTION 3.19.
	 	 SUSPENSION OF CERTAIN COVENANTS
	  	 	76	  
	 SECTION 3.20.
	 	 DESIGNATION OF RESTRICTED AND UNRESTRICTED SUBSIDIARIES
	  	 	77	  
	 SECTION 3.21.
	 	 AMENDMENT OF COLLATERAL DOCUMENTS
	  	 	78	  
	 SECTION 3.22.
	 	 AFTER-ACQUIRED PROPERTY
	  	 	78	  
	 SECTION 3.23.
	 	 [RESERVED]
	  	 	78	  
	 SECTION 3.24.
	 	 ESCROW OF PROCEEDS; ESCROW CONDITIONS
	  	 	78	  
	 SECTION 3.25.
	 	 LIMITATIONS ON ACTIVITIES PRIOR TO THE ESCROW RELEASE
	  	 	79	  
	
	ARTICLE IV	  
	
	SUCCESSOR ISSUER; SUCCESSOR PERSON	  
			
	 SECTION 4.1.
	 	 MERGER AND CONSOLIDATION
	  	 	80	  
	
	ARTICLE V	  
	
	REDEMPTION OF SECURITIES	  
			
	 SECTION 5.1.
	 	 NOTICES TO TRUSTEE
	  	 	81	  
	 SECTION 5.2.
	 	 SELECTION OF NOTES TO BE REDEEMED OR PURCHASED
	  	 	82	  
	 SECTION 5.3.
	 	 NOTICE TO REDEMPTION
	  	 	82	  
	 SECTION 5.4.
	 	 EFFECT OF NOTICE OF REDEMPTION
	  	 	83	  
	 SECTION 5.5.
	 	 DEPOSIT OF REDEMPTION OR PURCHASE PRICE
	  	 	83	  
	 SECTION 5.6.
	 	 NOTES REDEEMED OR PURCHASED IN PART
	  	 	83	  
	 SECTION 5.7.
	 	 OPTIONAL REDEMPTION
	  	 	83	  
	 SECTION 5.8.
	 	 MANDATORY REDEMPTION
	  	 	84	  
	 SECTION 5.9.
	 	 SPECIAL MANDATORY REDEMPTION
	  	 	84	  
	
	ARTICLE VI	  
	
	DEFAULTS AND REMEDIES	  
			
	 SECTION 6.1.
	 	 EVENTS OF DEFAULT
	  	 	85	  
	 SECTION 6.2.
	 	 ACCELERATION
	  	 	87	  
	 SECTION 6.3.
	 	 OTHER REMEDIES
	  	 	87	  
	 SECTION 6.4.
	 	 WAIVER OF PAST DEFAULTS
	  	 	87	  
	 SECTION 6.5.
	 	 CONTROL BY MAJORITY
	  	 	88	  
	 SECTION 6.6.
	 	 LIMITATION ON SUITS
	  	 	88	  
	 SECTION 6.7.
	 	 RIGHTS OF HOLDERS TO RECEIVE PAYMENT
	  	 	88	  
	 SECTION 6.8.
	 	 COLLECTION SUIT BY TRUSTEE
	  	 	89	  
	 SECTION 6.9.
	 	 TRUSTEE MAY FILE PROOFS OF CLAIM
	  	 	89	  
	 SECTION 6.10.
	 	 PRIORITIES
	  	 	89	  
	 SECTION 6.11.
	 	 UNDERTAKING FOR COSTS
	  	 	89	  
	 SECTION 6.12.
	 	 REPORTING DEFAULTS
	  	 	89	  

  
 -ii-

							
	 	  	 	  	Page	 
	
	ARTICLE VII	  
	
	TRUSTEE	  
			
	 SECTION 7.1.
	  	 DUTIES OF TRUSTEE
	  	 	90	  
	 SECTION 7.2.
	  	 RIGHTS OF TRUSTEE
	  	 	91	  
	 SECTION 7.3.
	  	 INDIVIDUAL RIGHTS OF TRUSTEE
	  	 	92	  
	 SECTION 7.4.
	  	 TRUSTEE’S DISCLAIMER
	  	 	92	  
	 SECTION 7.5.
	  	 NOTICE OF DEFAULTS
	  	 	92	  
	 SECTION 7.6.
	  	 REPORTS BY TRUSTEE TO HOLDERS
	  	 	92	  
	 SECTION 7.7.
	  	 COMPENSATION AND INDEMNITY
	  	 	93	  
	 SECTION 7.8.
	  	 REPLACEMENT OF TRUSTEE
	  	 	93	  
	 SECTION 7.9.
	  	 SUCCESSOR TRUSTEE BY MERGER
	  	 	94	  
	 SECTION 7.10.
	  	 ELIGIBILITY; DISQUALIFICATION
	  	 	94	  
	 SECTION 7.11.
	  	 PREFERENTIAL COLLECTION OF CLAIMS AGAINST THE ISSUER
	  	 	94	  
	 SECTION 7.12.
	  	 TRUSTEE’S APPLICATION FOR INSTRUCTION FROM THE ISSUER
	  	 	94	  
	 SECTION 7.13.
	  	 COLLATERAL DOCUMENTS; INTERCREDITOR AGREEMENT
	  	 	94	  
	 SECTION 7.14.
	  	 ESCROW AUTHORIZATION
	  	 	95	  
	
	ARTICLE VIII	  
	
	LEGAL DEFEASANCE AND COVENANT DEFEASANCE	  
			
	 SECTION 8.1.
	  	 OPTION TO EFFECT LEGAL DEFEASANCE OR COVENANT DEFEASANCE; DEFEASANCE
	  	 	95	  
	 SECTION 8.2.
	  	 LEGAL DEFEASANCE AND DISCHARGE
	  	 	95	  
	 SECTION 8.3.
	  	 COVENANT DEFEASANCE
	  	 	96	  
	 SECTION 8.4.
	  	 CONDITIONS TO LEGAL OR COVENANT DEFEASANCE
	  	 	96	  
	 SECTION 8.5.
	  	 DEPOSITED MONEY AND U.S. GOVERNMENT OBLIGATIONS TO BE HELD IN TRUST; OTHER MISCELLANEOUS PROVISIONS
	  	 	97	  
	 SECTION 8.6.
	  	 REPAYMENT TO THE ISSUER
	  	 	97	  
	 SECTION 8.7.
	  	 REINSTATEMENT
	  	 	98	  
	
	ARTICLE IX	  
	
	AMENDMENTS	  
			
	 SECTION 9.1.
	  	 WITHOUT CONSENT OF HOLDERS
	  	 	98	  
	 SECTION 9.2.
	  	 WITH CONSENT OF HOLDERS
	  	 	99	  
	 SECTION 9.3.
	  	 COMPLIANCE WITH TRUST INDENTURE ACT
	  	 	101	  
	 SECTION 9.4.
	  	 REVOCATION AND EFFECT OF CONSENTS AND WAIVERS
	  	 	101	  
	 SECTION 9.5.
	  	 NOTATION ON OR EXCHANGE OF NOTES
	  	 	101	  
	 SECTION 9.6.
	  	 TRUSTEE TO SIGN AMENDMENTS
	  	 	101	  
	
	ARTICLE X	  
	
	GUARANTEE	  
			
	 SECTION 10.1.
	  	 GUARANTEE
	  	 	101	  
	 SECTION 10.2.
	  	 LIMITATION ON LIABILITY; TERMINATION, RELEASE AND DISCHARGE
	  	 	103	  
	 SECTION 10.3.
	  	 RIGHT OF CONTRIBUTION
	  	 	103	  
	 SECTION 10.4.
	  	 NO SUBROGATION
	  	 	104	  

  
 -iii-

							
	 	  	 	  	Page	 
	
	ARTICLE XI	  
	
	SATISFACTION AND DISCHARGE	  
			
	 SECTION 11.1.
	  	 SATISFACTION AND DISCHARGE
	  	 	104	  
	 SECTION 11.2.
	  	 APPLICATION OF TRUST MONEY
	  	 	105	  
	
	ARTICLE XII	  
	
	COLLATERAL	  
			
	 SECTION 12.1.
	  	 COLLATERAL DOCUMENTS
	  	 	105	  
	 SECTION 12.2.
	  	 RECORDINGS AND OPINIONS
	  	 	106	  
	 SECTION 12.3.
	  	 RELEASE OF COLLATERAL
	  	 	106	  
	 SECTION 12.4.
	  	 SUITS TO PROTECT THE COLLATERAL
	  	 	107	  
	 SECTION 12.5.
	  	 AUTHORIZATION OF RECEIPT OF FUNDS BY THE TRUSTEE UNDER THE COLLATERAL DOCUMENTS
	  	 	107	  
	 SECTION 12.6.
	  	 PURCHASER PROTECTED
	  	 	107	  
	 SECTION 12.7.
	  	 POWERS EXERCISABLE BY RECEIVER OR TRUSTEE
	  	 	108	  
	 SECTION 12.8.
	  	 RELEASE UPON TERMINATION OF THE ISSUER’S OBLIGATIONS
	  	 	108	  
	 SECTION 12.9.
	  	 COLLATERAL AGENT
	  	 	108	  
	 SECTION 12.10.
	  	 DESIGNATIONS
	  	 	113	  
	 SECTION 12.11.
	  	 NO IMPAIRMENT OF THE SECURITY INTERESTS
	  	 	113	  
	 SECTION 12.12.
	  	 INSURANCE
	  	 	113	  
	
	ARTICLE XIII	  
	
	MISCELLANEOUS	  
			
	 SECTION 13.1.
	  	 TRUST INDENTURE ACT CONTROLS
	  	 	114	  
	 SECTION 13.2.
	  	 NOTICES
	  	 	114	  
	 SECTION 13.3.
	  	 COMMUNICATION BY HOLDERS WITH OTHER HOLDERS
	  	 	115	  
	 SECTION 13.4.
	  	 CERTIFICATE AND OPINION AS TO CONDITIONS PRECEDENT
	  	 	115	  
	 SECTION 13.5.
	  	 STATEMENTS REQUIRED IN CERTIFICATE OR OPINION
	  	 	115	  
	 SECTION 13.6.
	  	 WHEN NOTES DISREGARDED
	  	 	116	  
	 SECTION 13.7.
	  	 RULES BY TRUSTEE, PAYING AGENT AND REGISTRAR
	  	 	116	  
	 SECTION 13.8.
	  	 LEGAL HOLIDAYS
	  	 	116	  
	 SECTION 13.9.
	  	 GOVERNING LAW
	  	 	116	  
	 SECTION 13.10.
	  	 JURISDICTION
	  	 	116	  
	 SECTION 13.11.
	  	 WAIVERS OF JURY TRIAL
	  	 	116	  
	 SECTION 13.12.
	  	 USA PATRIOT ACT
	  	 	116	  
	 SECTION 13.13.
	  	 NO RECOURSE AGAINST OTHERS
	  	 	117	  
	 SECTION 13.14.
	  	 SUCCESSORS
	  	 	117	  
	 SECTION 13.15.
	  	 MULTIPLE ORIGINALS
	  	 	117	  
	 SECTION 13.16.
	  	 QUALIFICATION OF INDENTURE
	  	 	117	  
	 SECTION 13.17.
	  	 TABLE OF CONTENTS; HEADINGS
	  	 	117	  
	 SECTION 13.18.
	  	 FORCE MAJEURE
	  	 	117	  
	 SECTION 13.19.
	  	 SEVERABILITY
	  	 	117	  
	 SECTION 13.20.
	  	 INTERCREDITOR AGREEMENT
	  	 	117	  
	 SECTION 13.21.
	  	 APPOINTMENT OF AGENT FOR SERVICE OF PROCESS
	  	 	118	  
	 SECTION 13.22.
	  	 WAIVER OF IMMUNITIES
	  	 	119	  
	 SECTION 13.23.
	  	 JUDGMENT CURRENCY
	  	 	119	  
	 FORM OF CERTIFICATE TO BE DELIVERED IN CONNECTION WITH TRANSFERS PURSUANT TO REGULATIONS
	  	 	1	  
	 FORM OF CERTIFICATE TO BE DELIVERED IN CONNECTION WITH TRANSFERS TO AIS
	  	 	1	  

  
 -iv-

					
	 	  	 	  	Page
			
	 EXHIBIT A
	  	 Form of Global Restricted Note
	  	
	 EXHIBIT B
	  	 Form of Exchange Global Note
	  	
	 EXHIBIT C
	  	 Form of Supplemental Indenture
	  	
	 EXHIBIT D
	  	 Form of Intercreditor Agreement
	  	
	 EXHIBIT E
	  	 Form of Second Lien Security Agreement
	  	
	 EXHIBIT F
	  	 Form of Certificate to be Delivered Upon Termination of Restricted Period
	  	
	 EXHIBIT G
	  	 Form of Certificate to be Delivered in Connection with Transfers to IAIs
	  	
	 EXHIBIT H
	  	 Form of Certificate to be Delivered in Connection with Transfers Pursuant to Regulation S
	  	
	 EXHIBIT I
	  	 Form of Certificate to be Delivered in Connection with Transfers to AIsCROSS-REFERENCE
	  	

 TABLE 
  

					
	 TIA Section
	  	Indenture Section
	 310
	 	 (a)(1)
	  	7.10
		 	 (a)(2)
	  	7.10
		 	 (a)(3)
	  	N.A.
		 	 (a)(4)
	  	N.A.
		 	 (a)(5)
	  	7.10
		 	 (b)
	  	7.3; 7.8; 7.10
	 311
	 	 (a)
	  	7.11
		 	 (b)
	  	7.11
	 312
	 	 (a)
	  	2.5
		 	 (b)
	  	13.3
		 	 (c)
	  	13.3
	 313
	 	 (a)
	  	7.6; 12.2
		 	 (b)(1)
	  	7.6
		 	 (b)(2)
	  	7.6
		 	 (c)
	  	7.6
		 	 (d)
	  	7.6
	 314
	 	 (a)
	  	3.10; 3.15; 13.5
		 	 (b)
	  	N.A.
		 	 (c)(1)
	  	2.2; 13.4
		 	 (c)(2)
	  	2.2; 13.4
		 	 (c)(3)
	  	N.A.
		 	 (d)
	  	N.A.
		 	 (e)
	  	13.5
	 315
	 	 (a)
	  	7.1
		 	 (b)
	  	7.5; 13.2
		 	 (c)
	  	7.1
		 	 (d)
	  	7.1
		 	 (e)
	  	6.11
	 316
	 	 (a)(last sentence)
	  	13.6
		 	 (a)(1)(A)
	  	6.5
		 	 (a)(1)(B)
	  	6.4
		 	 (a)(2)
	  	N.A.
		 	 (b)
	  	6.7
		 	 (c)
	  	N.A.
	 317
	 	 (a)(1)
	  	6.8
		 	 (a)(2)
	  	6.9
		 	 (b)
	  	2.4
	 318
	 	 (a)
	  	13.1

 N.A. means not applicable. 

  
 -v-

 Note: This Cross-Reference Table shall not, for any purpose, be deemed to be part of this Indenture.

  
 -vi-

 INDENTURE dated as of April 1, 2013, among HAWK ACQUISITION SUB, INC., a Pennsylvania
corporation (“Merger Sub”) to be merged with and into H.J. HEINZ COMPANY, a Pennsylvania corporation (“Heinz”), HAWK ACQUISITION INTERMEDIATE CORPORATION II, a Delaware corporation (“Holdings”), as
a Guarantor, the other Guarantors party hereto from time to time and WELLS FARGO BANK, NATIONAL ASSOCIATION, a national banking association, as trustee (in such capacity, the “Trustee”) and as collateral agent (in such capacity, the
“Collateral Agent”). 
 W I T N E S S E T
H: 
 WHEREAS, the Issuer (as defined herein) has duly authorized the execution and delivery of this Indenture to provide
for the issuance of (i) its $3,100,000,000 4.25% Second Lien Senior Secured Notes due 2020 (the “Initial Notes”), each as issued on the date hereof, (ii) any additional Notes (the “Additional Notes”) that
may be issued after the Issue Date and (iii) its $3,100,000,000 4.25% Second Lien Senior Secured Notes due 2020 issued pursuant to the Registration Rights Agreement (as defined herein) in exchange for any Initial Notes or Additional Notes (the
“Exchange Notes,” and together with the Initial Notes and any Additional Notes, the “Notes”); 

WHEREAS, Merger Sub and Holdings, as a Guarantor, have duly authorized the execution and delivery of this Indenture; 

WHEREAS, upon consummation of the Acquisition (as defined herein), pursuant to which Merger Sub will merge with and into Heinz, and upon
execution and delivery of the Supplemental Indenture (as defined herein) by Heinz, the Guarantors (other than Holdings), the Trustee and the Collateral Agent, the obligations of Merger Sub with respect to the due and punctual payment of the
principal of, premium, if any, and interest on all the Notes and the performance and observation of each covenant and agreement under this Indenture on the part of Merger Sub to be performed or observed will become the obligations of Heinz and will
be unconditionally and irrevocably guaranteed by the remaining Guarantors (in addition to Holdings); and 
 WHEREAS, all things
necessary (i) to make the Notes, when executed and duly issued by the Issuer and authenticated and delivered hereunder, the valid obligations of the Issuer and Holdings and (ii) to make this Indenture a valid agreement of Merger Sub and
Holdings have been done. 
 NOW, THEREFORE, in consideration of the premises and the purchase of the Notes by the Holders
thereof, it is mutually covenanted and agreed, for the equal and proportionate benefit of all Holders, as follows: 
 ARTICLE I

 DEFINITIONS AND INCORPORATION BY REFERENCE 
 SECTION 1.1. Definitions. 
 “2030 Notes Indebtedness”
means the Company’s Guarantee of the 6.25% Guaranteed Notes due February 18, 2030 of H.J. Heinz Finance Company UK Plc. 
 “Acquired Indebtedness” means Indebtedness (1) of a Person or any of its Subsidiaries existing at the time such Person becomes a Restricted Subsidiary, or (2) assumed in
connection with the acquisition of assets from such Person, in each case whether or not Incurred by such Person in connection with such Person becoming a Restricted Subsidiary of the Issuer or such acquisition or (3) of a Person at the time
such Person merges with or into or consolidates or otherwise combines with the Issuer or any Restricted Subsidiary. Acquired Indebtedness shall be deemed to have been Incurred, with respect to clause (1) of the preceding sentence, on the date
such Person becomes a Restricted Subsidiary and, with respect to clause (2) of the preceding sentence, on the date of consummation of such acquisition of assets and, with respect to clause (3) of the preceding sentence, on the date of the
relevant merger, consolidation or other combination. 
 “Acquisition” means the transactions contemplated by
the Merger Agreement. 

 “Additional Assets” means: 

(1) any property or assets (other than Capital Stock) used or to be used by the Issuer, a Restricted Subsidiary or
otherwise useful in a Similar Business (it being understood that capital expenditures on property or assets already used in a Similar Business or to replace any property or assets that are the subject of such Asset Disposition shall be deemed an
investment in Additional Assets); 
 (2) the Capital Stock of a Person that is engaged in a Similar Business and
becomes a Restricted Subsidiary as a result of the acquisition of such Capital Stock by the Issuer or a Restricted Subsidiary of the Issuer; or 
 (3) Capital Stock constituting a minority interest in any Person that at such time is a Restricted Subsidiary of the Issuer. 
 “Additional Interest” means all additional interest then owing pursuant to the Registration Rights Agreement. 
 “Additional Notes” has the meaning ascribed to it in the second introductory paragraph of this Indenture. 
 “Affiliate” of any specified Person means any other Person, directly or indirectly, controlling or controlled by or under direct or indirect common control with such specified Person. For
the purposes of this definition, “control” when used with respect to any Person means the power to direct the management and policies of such Person, directly or indirectly, whether through the ownership of voting securities, by
contract or otherwise; and the terms “controlling” and “controlled” have meanings correlative to the foregoing. 
 “AI” means an “accredited investor” as described in Rule 501(a)(4) under the Securities Act. 
 “Alternative Currency” means each of Euro, British Pounds Sterling, Australian Dollars, Brazilian Real, Canadian Dollars, Chinese Yuan, Danish Kroner, Egyptian Pound, Hong Kong Dollars,
Indian Rupee, Indonesian Rupiah, Japanese Yen, Korean Won, Mexican Pesos, New Zealand Dollars, Russian Ruble, Singapore Dollars, Swedish Kroner, Swiss Francs and each other currency (other than United States Dollars) that is a lawful currency (other
than United States Dollars) that is readily available and freely transferable and convertible into United States Dollars. 

“Applicable Premium” means the greater of (A) 1.0% of the principal amount of such Note and (B) on any
redemption date, the excess (to the extent positive) of: 
 (a) the present value at such redemption date of
(i) the redemption price of such Note at April 15, 2015 (such redemption price (expressed in percentage of principal amount) being set forth in the table in Section 5.7(e) (excluding accrued but unpaid interest)), plus
(ii) all required interest payments due on such Note to and including such date set forth in clause (i) (excluding accrued but unpaid interest), computed upon the redemption date using a discount rate equal to the Applicable Treasury Rate
at such redemption date plus 50 basis points; over 
 (b) the outstanding principal amount of such Note;

 in each case, as calculated by the Issuer or on behalf of the Issuer by such Person as the Issuer shall designate. 

“Applicable Treasury Rate” means the yield to maturity at the time of computation of United States Treasury securities
with a constant maturity (as compiled and published in the most recent Federal Reserve Statistical Release H.15 (519) which has become publicly available at least two Business Days (but not more than five Business Days) prior to the redemption
date (or, if such statistical release is not so published or available, any publicly available source of similar market data selected by the Issuer in good faith)) most nearly equal to the period from the redemption date to April 15, 2015;
provided, however, that if the period from the redemption date to April 15, 2015 is not equal to the constant maturity of a United States Treasury security for which a weekly average

  
 -2-

 
yield is given, the Applicable Treasury Rate shall be obtained by linear interpolation (calculated to the nearest one-twelfth of a year) from the weekly average yields of United States Treasury
securities for which such yields are given, except that if the period from the redemption date to such applicable date is less than one year, the weekly average yield on actually traded United States Treasury securities adjusted to a constant
maturity of one year shall be used. 
 “Asset Disposition” means: 

(a) the sale, conveyance, transfer or other disposition, whether in a single transaction or a series of related
transactions, of property or assets (including by way of a Sale and Leaseback Transaction) of the Issuer or any of its Restricted Subsidiaries (in each case other than Capital Stock of the Issuer) (each referred to in this definition as a
“disposition”); or 
 (b) the issuance or sale of Capital Stock of any Restricted Subsidiary
(other than Preferred Stock or Disqualified Stock of Restricted Subsidiaries issued in compliance with Section 3.2 hereof or directors’ qualifying shares and shares issued to foreign nationals as required under applicable law),
whether in a single transaction or a series of related transactions; 
 in each case, other than: 

(1) a disposition by a Restricted Subsidiary to the Issuer or by the Issuer or a Restricted Subsidiary to a Restricted
Subsidiary; 
 (2) a disposition of cash, Cash Equivalents or Investment Grade Securities; 

(3) a disposition of inventory or other assets in the ordinary course of business (including allowing any registrations or
any applications for registrations of any intellectual property rights to lapse or go abandoned in the ordinary course of business); 
 (4) a disposition of obsolete, surplus or worn out property, equipment or other assets or property, equipment or other assets that are no longer used or useful in the conduct of the business of the Issuer
and its Restricted Subsidiaries; 
 (5) transactions permitted under Section 4.1 hereof or a
transaction that constitutes a Change of Control; 
 (6) an issuance of Capital Stock by a Restricted Subsidiary
to the Issuer or to another Restricted Subsidiary or as part of or pursuant to an equity incentive or compensation plan approved by the Board of Directors; 
 (7) any dispositions of Capital Stock, properties or assets in a single transaction or series of related transactions with a fair market value (as determined in good faith by the Issuer) of less than
$25.0 million; 
 (8) any Restricted Payment that is permitted to be made, and is made, under
Section 3.3 and the making of any Permitted Payment or Permitted Investment or, solely for purposes of Section 3.5(a)(3) asset sales, the proceeds of which are used to make such Restricted Payments or Permitted Investments;

 (9) dispositions in connection with Permitted Liens; 

(10) dispositions of receivables in connection with the compromise, settlement or collection thereof in the ordinary
course of business or in bankruptcy or similar proceedings and exclusive of factoring or similar arrangements; 

  
 -3-

 (11) the licensing or sub-licensing of intellectual property or other
general intangibles and licenses, sub-licenses, leases or subleases of other property, in each case, in the ordinary course of business; 
 (12) foreclosure, condemnation or any similar action with respect to any property or other assets; 
 (13) the sale or discount (with or without recourse, and on customary or commercially reasonable terms and for credit management purposes) of accounts receivable or notes receivable arising in the
ordinary course of business, or the conversion or exchange of accounts receivable for notes receivable; 
 (14)
any disposition of Capital Stock, Indebtedness or other securities of an Unrestricted Subsidiary; 
 (15) any
disposition of Capital Stock of a Restricted Subsidiary pursuant to an agreement or other obligation with or to a Person (other than the Issuer or a Restricted Subsidiary) from whom such Restricted Subsidiary was acquired, or from whom such
Restricted Subsidiary acquired its business and assets (having been newly formed in connection with such acquisition), made as part of such acquisition and in each case comprising all or a portion of the consideration in respect of such sale or
acquisition; 
 (16) (i) dispositions of property to the extent that such property is exchanged for credit
against the purchase price of similar replacement property that is promptly purchased, (ii) dispositions of property to the extent that the proceeds of such disposition are promptly applied to the purchase price of such replacement property
(which replacement property is actually promptly purchased) and (iii) to the extent allowable under Section 1031 of the Code, any exchange of like property (excluding any boot thereon) for use in a Similar Business; 

(17) any disposition of Securitization Assets, or participations therein, in connection with any Qualified Securitization
Financing, or the disposition of an account receivable in connection with the collection or compromise thereof in the ordinary course of business; 
 (18) any financing transaction with respect to property constructed, acquired, replaced, repaired or improved (including any reconstruction, refurbishment, renovation and/or development of real property)
by the Issuer or any Restricted Subsidiary after the Escrow Release Date, including Sale and Leaseback Transactions and asset securitizations, permitted by this Indenture; 

(19) dispositions of Investments in joint ventures or similar entities to the extent required by, or made pursuant to
customary buy/sell arrangements between, the parties to such joint venture set forth in joint venture arrangements and similar binding arrangements; 
 (20) any surrender or waiver of contract rights or the settlement, release or surrender of contract, tort or other claims of any kind; 

(21) the unwinding of any Hedging Obligations pursuant to its terms; 

(22) the surrender or waiver of any contractual rights and the settlement or waiver of any contractual or litigation
claims in each case in the ordinary course of business; and 
 (23) any swap of assets in exchange for services
or other assets in the ordinary course of business of comparable or greater value of usefulness to the business as determined in good faith by the Issuer. 

  
 -4-

 “Associate” means (i) any Person engaged in a Similar Business of
which the Issuer or its Restricted Subsidiaries are the legal and beneficial owners of between 20% and 50% of all outstanding Voting Stock and (ii) any joint venture entered into by the Issuer or any Restricted Subsidiary of the Issuer.

 “Berkshire Hathaway” means Berkshire Hathaway, Inc. and each of its Affiliates but not including, however,
any portfolio companies of any of the foregoing. 
 “Bankruptcy Law” means Title 11 of the United States
Code or similar federal, state or foreign law for the relief of debtors. 
 “Board of Directors” means
(1) with respect to the Issuer or any corporation, the board of directors or managers, as applicable, of the corporation, or any duly authorized committee thereof; (2) with respect to any partnership, the board of directors or other
governing body of the general partner of the partnership or any duly authorized committee thereof; and (3) with respect to any other Person, the board or any duly authorized committee of such Person serving a similar function. Whenever any
provision requires any action or determination to be made by, or any approval of, a Board of Directors, such action, determination or approval shall be deemed to have been taken or made if approved by a majority of the directors on any such Board of
Directors (whether or not such action or approval is taken as part of a formal board meeting or as a formal board approval). 

“Board Resolution” means a copy of a resolution certified by the Secretary or an Assistant Secretary of a Person to have
been duly adopted by the Board of Directors of such Person and to be in full force and effect of the date of such certification, and delivered to the Trustee. 
 “Business Day” means each day that is not a Saturday, Sunday or other day on which banking institutions in New York, New York, United States or the jurisdiction of the place of payment
are authorized or required by law to close. 
 “Capital Stock” of any Person means any and all shares of,
rights to purchase, warrants, options or depositary receipts for, or other equivalents of or partnership or other interests in (however designated), equity of such Person, including any Preferred Stock, but excluding any debt securities convertible
into such equity. 
 “Capitalized Lease Obligations” means an obligation that is required to be classified and
accounted for as a capitalized lease for financial reporting purposes on the basis of GAAP. The amount of Indebtedness represented by such obligation will be the capitalized amount of such obligation at the time any determination thereof is to be
made as determined on the basis of GAAP, and the Stated Maturity thereof will be the date of the last payment of rent or any other amount due under such lease prior to the first date such lease may be terminated without penalty. 

“Cash Equivalents” means: 
 (1) (a) United States Dollars, Euro, or any national currency of any member state of the European Union or Canada; or (b) any other foreign currency held by the Issuer and the Restricted Subsidiaries
in the ordinary course of business; 
 (2) securities issued or directly and fully Guaranteed or insured by the
United States or Canadian governments, a member state of the European Union or, in each case, or any agency or instrumentality of the foregoing (provided that the full faith and credit obligation of such country or such member state is
pledged in support thereof), having maturities of not more than two years from the date of acquisition; 
 (3)
certificates of deposit, time deposits, eurodollar time deposits, overnight bank deposits or bankers’ acceptances having maturities of not more than one year from the date of acquisition thereof issued by any lender or by any bank or trust
company (a) whose commercial paper is rated at least “A-2” or the equivalent thereof by S&P or at least “P-2” or the equivalent thereof by Moody’s (or if at the time neither is issuing comparable ratings, then a
comparable rating of another Nationally Recognized Statistical Rating Organization) or (b) (in the event that the bank or trust company does not have commercial paper which is rated) having combined capital and surplus in excess of
$100.0 million; 

  
 -5-

 (4) repurchase obligations for underlying securities of the types described
in clauses (2), (3) and (7) entered into with any bank meeting the qualifications specified in clause (3) above; 
 (5) commercial paper rated at least (i) “A-1” or higher by S&P or “P-1” or higher by Moody’s (or, if at the time, neither is issuing comparable ratings, then a comparable
rating of another Nationally Recognized Statistical Rating Organization selected by the Issuer) maturing within two years after the date of creation thereof or (ii) “A-2” or higher by S&P or “P-2” or higher by
Moody’s (or, if at the time, neither is issuing comparable ratings, then a comparable rating of another Nationally Recognized Statistical Rating Organization selected by the Issuer) maturing within one year after the date of creation thereof,
or in each case, if no rating is available in respect of the commercial paper, the issuer of which has an equivalent rating in respect of its long-term debt; 
 (6) marketable short-term money market and similar securities, having a rating of at least “P-2” or “A-2” from either S&P or Moody’s, respectively, (or, if at the time,
neither is issuing comparable ratings, then a comparable rating of another Nationally Recognized Statistical Rating Organization selected by the Issuer) and in each case maturing within 24 months after the date of creation or acquisition thereof;

 (7) readily marketable direct obligations issued by any state, commonwealth or territory of the United States
of America or any political subdivision, taxing authority or public instrumentality thereof, in each case, having one of the two highest ratings categories by S&P or Moody’s (or, if at the time, neither is issuing comparable ratings, then a
comparable rating of another Nationally Recognized Statistical Rating Organization selected by the Issuer) with maturities of not more than two years from the date of acquisition; 

(8) readily marketable direct obligations issued by any foreign government or any political subdivision, taxing authority
or public instrumentality thereof, in each case, having one of the two highest ratings categories obtainable by S&P or Moody’s (or, if at the time, neither is issuing comparable ratings, then a comparable rating of another Nationally
Recognized Statistical Rating Organization selected by the Issuer) with maturities of not more than two years from the date of acquisition; 
 (9) Investments with average maturities of 12 months or less from the date of acquisition in money market funds rated within the three highest ratings categories by S&P or Moody’s (or, if at the
time, neither is issuing comparable ratings, then a comparable rating of another Nationally Recognized Statistical Rating Organization selected by the Issuer); 
 (10) with respect to any Foreign Subsidiary: (i) obligations of the national government of the country in which such Foreign Subsidiary maintains its chief executive office and principal place of
business provided such country is a member of the Organization for Economic Cooperation and Development, in each case maturing within one year after the date of investment therein, (ii) certificates of deposit of, bankers acceptance of, or time
deposits with, any commercial bank which is organized and existing under the laws of the country in which such Foreign Subsidiary maintains its chief executive office and principal place of business provided such country is a member of the
Organization for Economic Cooperation and Development, and whose short-term commercial paper rating from S&P is at least “A-1” or the equivalent thereof or from Moody’s is at least “P-1” or the equivalent thereof (any
such bank being an “Approved Foreign Bank”), and in each case with maturities of not more than 270 days from the date of acquisition and (iii) the equivalent of demand deposit accounts which are maintained with an Approved
Foreign Bank; 
 (11) Indebtedness or Preferred Stock issued by Persons with a rating of (i) “A”
or higher from S&P or “A-2” or higher from Moody’s (or, if at the time, neither is issuing comparable ratings, then a comparable rating of another Nationally Recognized Statistical Rating Organization selected by the Issuer) with
maturities of 24 months or less from the date of acquisition, or (ii) “A-” or higher from S&P or “A-3” or higher from Moody’s (or, if at the time, neither is issuing comparable ratings, then a comparable rating of
another Nationally Recognized Statistical Rating Organization selected by the Issuer) with maturities of 12 months or less from the date of acquisition; 

  
 -6-

 (12) bills of exchange issued in the United States, Canada, a member state
of the European Union or Japan eligible for rediscount at the relevant central bank and accepted by a bank (or any dematerialized equivalent); 
 (13) Cash Equivalents or instruments similar to those referred to in clauses (1) through (12) above denominated in Dollars or any Alternative Currency; 

(14) interests in any investment company, money market, enhanced high yield fund or other investment fund which invests
90% or more of its assets in instruments of the types specified in clauses (1) through (13) above; and 

(15) for purposes of clause (2) of the definition of “Asset Disposition,” any marketable securities
portfolio owned by the Issuer and its Subsidiaries on the Escrow Release Date. 
 Notwithstanding the foregoing, Cash
Equivalents shall include amounts denominated in currencies other than those set forth in clause (1) above, provided that such amounts are converted into any currency listed in clause (1) as promptly as practicable and in any event
within 10 Business Days following the receipt of such amounts. 
 “Cash Management Services” means any of the
following to the extent not constituting a line of credit (other than an overnight draft facility that is not in default): automated clearing house transfers of funds, treasury, depository, credit or debit card, purchasing card, and/or cash
management services, including controlled disbursement services, overdraft facilities, foreign exchange facilities, deposit and other accounts and merchant services. 
 “Change of Control” means: 
 (1) the Issuer
becomes aware of (by way of a report or any other filing pursuant to Section 13(d) of the Exchange Act, proxy, vote, written notice or otherwise) any “person” or “group” of related persons (as such terms are used in Sections
13(d) and 14(d) of the Exchange Act as in effect on the Issue Date), other than one or more Permitted Holders, is or becomes the “beneficial owner” (as defined in Rules 13d-3 and 13d-5 under the Exchange Act as in effect on the Issue
Date), directly or indirectly, of more than 50% of the total voting power of the Voting Stock of the Issuer; or 

(2) the sale, lease, transfer, conveyance or other disposition (other than by way of merger, consolidation or other
business combination transaction), in one or a series of related transactions, of all or substantially all of the assets of the Issuer and its Restricted Subsidiaries taken as a whole to a Person, other than a Restricted Subsidiary or one or more
Permitted Holders. 
 “Code” means the United States Internal Revenue Code of 1986, as amended. 

“Collateral” means all of the assets and properties subject or purported to be subject to Liens in favor of the
Collateral Agent for the benefit of the Trustee and the Holders. 
 “Collateral Agent” means the Trustee in its
capacity as “Collateral Agent” under this Indenture and under the Collateral Documents or any successor or assign thereto in such capacity. 
 “Collateral Documents” means, collectively, any security agreements, intellectual property security agreements, mortgages, collateral assignments, security agreement supplements, pledge
agreements or any similar agreements, guarantees and each of the other agreements, instruments or documents that creates or purports to create a lien or guarantee in favor of the Collateral Agent for its benefit and the benefit of the Trustee and
the Holders of the Notes, in all or any portion of the Collateral, as amended, extended, renewed, restated, refunded, replaced, refinanced, supplemented, modified or otherwise changed from time to time. 

  
 -7-

 “Consolidated Depreciation and Amortization Expense” means, with respect to
any Person for any period, the total amount of depreciation and amortization expense, including the amortization of deferred financing fees or costs, capitalized expenditures, customer acquisition costs and incentive payments, conversion costs and
contract acquisition costs, the amortization of original issue discount resulting from the issuance of Indebtedness at less than par and amortization of favorable or unfavorable lease assets or liabilities, of such Person and its Restricted
Subsidiaries for such period on a consolidated basis and otherwise determined in accordance with GAAP. 
 “Consolidated
EBITDA” means, with respect to any Person for any period, the Consolidated Net Income of such Person for such period: 
 (1) increased (without duplication) by: 
 (a) provision for taxes
based on income or profits or capital, including state, franchise and similar taxes and foreign withholding taxes of such Person paid or accrued during such period, including any penalties and interest relating to any tax examinations, deducted (and
not added back) in computing Consolidated Net Income; plus  
 (b) Fixed Charges of such Person for such
period (including (x) net losses or any Hedging Obligations or other derivative instruments entered into for the purpose of hedging interest rate, currency or commodities risk, (y) bank fees and (z) costs of surety bonds in connection
with financing activities, plus amounts excluded from the definition of “Consolidated Interest Expense” pursuant to clauses (t) through (z) in clause (1) thereof), to the extent the same were deducted (and not added back) in
calculating such Consolidated Net Income; plus  
 (c) Consolidated Depreciation and Amortization Expense
of such Person for such period to the extent the same were deducted (and not added back) in computing Consolidated Net Income; plus  
 (d) any expenses or charges (other than depreciation or amortization expense) related to any Equity Offering, Permitted Investment, acquisition, disposition, recapitalization or the incurrence of
Indebtedness permitted to be incurred by this Indenture (including a refinancing thereof) (whether or not successful), including (i) such fees, expenses or charges related to the offering of the Notes, the Credit Agreement, any other Credit
Facilities and any Securitization Fees, and (ii) any amendment or other modification of the Notes, the Credit Agreement, any other Credit Facilities and any Securitization Fees, in each case, deducted (and not added back) in computing
Consolidated Net Income; plus  
 (e) the amount of any restructuring charge or reserve, integration cost
or other business optimization expense or cost that is deducted (and not added back) in such period in computing Consolidated Net Income, including any one-time costs incurred in connection with acquisitions or divestitures after the Escrow Release
Date, and costs related to the closure and/or consolidation of facilities and to exiting lines of business; plus  
 (f) any other non-cash charges, write-downs, expenses, losses or items reducing Consolidated Net Income for such period including any impairment charges or the impact of purchase accounting, (excluding
any such non-cash charge, write-down or item to the extent it represents an accrual or reserve for a cash expenditure for a future period) or other items classified by the Issuer as special items less other non-cash items of income increasing
Consolidated Net Income (excluding any such non-cash item of income to the extent it represents a receipt of cash in any future period); plus 
 (g) the amount of any minority interest expense consisting of Subsidiary income attributable to minority equity interests of third parties in any non-wholly owned Subsidiary; plus 

  
 -8-

 (h) the amount of management, monitoring, advisory, consulting, refinancing,
subsequent transaction and exit fees (including termination fees) and related indemnities and expenses paid or accrued in such period to the Sponsor or Berkshire Hathaway, Inc. to the extent permitted under Section 3.8 hereof; plus
 
 (i) the amount of “run-rate” cost savings and synergies projected by the Issuer in good faith
to result from actions taken or to be taken prior to or during such period (calculated on a pro forma basis as though such cost savings had been realized on the first day of such period), net of the amount of actual benefits realized prior to or
during such period from such actions; provided that (x) such cost savings are reasonably identifiable, reasonably attributable to the actions specified and reasonably anticipated to result from such actions and (y) such actions have
been taken or are to be taken within twelve (12) months (or in connection with the Transactions, within eighteen (18) months of the Escrow Release Date); plus  

(j) any costs or expense incurred by the Issuer or a Restricted Subsidiary pursuant to any management equity plan or stock
option plan or any other management or employee benefit plan or agreement or any stock subscription or shareholder agreement, to the extent that such cost or expenses are funded with cash proceeds contributed to the capital of the Issuer or net cash
proceeds of an issuance of Capital Stock (other than Disqualified Stock) of the Issuer solely to the extent that such net cash proceeds are excluded from the calculation set forth in Section 3.3(a)(4)(iii) hereof; plus 

 (k) the amount of any loss attributable to a new plant or facility until the date that is twenty-four
(24) months after the date of commencement of construction or the date of acquisition thereof, as the case may be; provided that (x) such losses are reasonably identifiable, (y) losses attributable to such plant or facility
after twenty-four (24) months from the date of commencement of construction or the date of acquisition of such plant or facility, as the case may be, shall not be included in this clause (k) and (z) no amounts shall be added pursuant
to this clause (k) to the extent duplicative of any expenses or charges relating to such cost savings that are included in clause (i) above with respect to such period; plus 

(l) cash receipts (or any netting arrangements resulting in reduced cash expenditures) not representing Consolidated
EBITDA or Consolidated Net Income in any period to the extent non-cash gains relating to such income were deducted in the calculation of Consolidated EBITDA pursuant to clause (2) below for any previous period and not added back; plus 

 (m) any net loss included in the Consolidated Net Income attributable to non-controlling interests pursuant to
the application of Accounting Standards Codification Topic 810-10-45 (“Topic 810”); plus  
 (n) realized foreign exchange losses resulting from the impact of foreign currency changes on the valuation of assets or liabilities on the balance sheet of the Issuer and its Restricted Subsidiaries;
plus 
 (o) net realized losses from Hedging Obligations or embedded derivatives that require similar
accounting treatment and the application of Accounting Standard Codification Topic 815 and related pronouncements; plus  
 (p) the amount of loss on sale of Securitization Assets and related assets to the Securitization Subsidiary in connection with a Qualified Securitization Financing; plus 

(2) decreased (without duplication) by: (a) non-cash gains increasing Consolidated Net Income of such Person for such
period, excluding any non-cash gains to the extent they represent the reversal of an accrual or reserve for a potential cash item that reduced Consolidated EBITDA in any prior 

  
 -9-

 
period and any non-cash gains with respect to cash actually received in a prior period so long as such cash did not increase Consolidated EBITDA in such prior period; plus
(b) realized foreign exchange income or gains resulting from the impact of foreign currency changes on the valuation of assets or liabilities on the balance sheet of the Issuer and its Restricted Subsidiaries; plus (c) any net
realized income or gains from Hedging Obligations or embedded derivatives that require similar accounting treatment and the application of Accounting Standards Codification Topic 815 and related pronouncements, plus (d) any net income
included in Consolidated Net Income attributable to non-controlling interests pursuant to the application of Topic 810; and 
 (3) increased or decreased (without duplication) by, as applicable, any adjustments resulting from the application of Accounting Standards Codification Topic 460 or any comparable regulation. 

“Consolidated First Lien Secured Leverage Ratio” means, as of any date of determination, the ratio of
(x) Consolidated Total Indebtedness that is secured by a Lien (other than a lien that is pari passu with or is junior to the Liens securing the Notes) as of such date to (y) the aggregate amount of Consolidated EBITDA for the period of the
most recent four consecutive fiscal quarters ending prior to the date of such determination for which internal consolidated financial statements of the Issuer are available, in each case with such pro forma adjustments as are consistent with the pro
forma adjustments set forth in the definition of “Fixed Charge Coverage Ratio.” 
 “Consolidated Interest
Expense” means, with respect to any Person for any period, without duplication, the sum of: 
 (1)
consolidated interest expense of such Person and its Restricted Subsidiaries for such period, to the extent such expense was deducted (and not added back) in computing Consolidated Net Income (including (a) amortization of original issue
discount or premium resulting from the issuance of Indebtedness at less than par, (b) all commissions, discounts and other fees and charges owed with respect to letters of credit or bankers acceptances, (c) non-cash interest payments (but
excluding any non-cash interest expense attributable to the movement in the mark to market valuation of any Hedging Obligations or other derivative instruments pursuant to GAAP), (d) the interest component of Capitalized Lease Obligations, and
(e) net payments, if any, pursuant to interest rate Hedging Obligations with respect to Indebtedness), and excluding (t) penalties and interest relating to taxes, (u) any additional cash interest owing pursuant to any registration
rights agreement, (v) accretion or accrual of discounted liabilities other than Indebtedness, (w) any expense resulting from the discounting of any Indebtedness in connection with the application of purchase accounting in connection with
any acquisition, (x) amortization of deferred financing fees, debt issuance costs, commissions, fees and expenses, (y) any expensing of bridge, commitment and other financing fees and (z) interest with respect to Indebtedness of any
parent of such Person appearing upon the balance sheet of such Person solely by reason of push-down accounting under GAAP; plus  
 (2) consolidated capitalized interest of such Person and its Restricted Subsidiaries for such period, whether paid or accrued; less  

(3) interest income for such period. 
 For purposes of this definition, interest on a Capitalized Lease Obligation shall be deemed to accrue at an interest rate reasonably determined by such Person to be the rate of interest implicit in such
Capitalized Lease Obligation in accordance with GAAP. 
 “Consolidated Net Income” means, with respect to any
Person, for any period, the net income (loss) of such Person and its Restricted Subsidiaries for such period determined on a consolidated basis on the basis of GAAP; provided, however, that there will not be included in such
Consolidated Net Income: 
 (1) subject to the limitations contained in clause (3) below, any net income
(loss) of any Person if such Person is not a Restricted Subsidiary, except that the Issuer’s equity in the net income of any such Person for such period will be included in such Consolidated Net Income up to the aggregate amount

  
 -10-

 
of cash or Cash Equivalents actually distributed or that (as reasonably determined by an Officer of the Issuer) could have been distributed by such Person during such period to the Issuer or a
Restricted Subsidiary as a dividend or other distribution or return on investment (subject, in the case of a dividend or other distribution or return on investment to a Restricted Subsidiary, to the limitations contained in clause (2) below);

 (2) solely for the purpose of determining the amount available for Restricted Payments under
Section 3.3(a)(4)(iii)(A) hereof, any net income (loss) of any Restricted Subsidiary (other than the Guarantors) if such Subsidiary is subject to restrictions, directly or indirectly, on the payment of dividends or the making of
distributions by such Restricted Subsidiary, directly or indirectly, to the Issuer or a Guarantor by operation of the terms of such Restricted Subsidiary’s charter or any agreement, instrument, judgment, decree, order, statute or governmental
rule or regulation applicable to such Restricted Subsidiary or its shareholders (other than (a) restrictions that have been waived or otherwise released, (b) restrictions pursuant to the Credit Agreement, the Notes, or this Indenture, and
(c) restrictions specified in Section 3.4(b)(13)(i)), except that the Issuer’s equity in the net income of any such Restricted Subsidiary for such period will be included in such Consolidated Net Income up to the aggregate
amount of cash or Cash Equivalents actually distributed or that could have been distributed by such Restricted Subsidiary during such period to the Issuer or another Restricted Subsidiary as a dividend or other distribution (subject, in the case of
a dividend to another Restricted Subsidiary, to the limitation contained in this clause); 
 (3) any net gain (or
loss) realized upon the sale or other disposition of any asset (including pursuant to any Sale and Leaseback Transaction) or disposed operations of the Issuer or any Restricted Subsidiaries which is not sold or otherwise disposed of in the ordinary
course of business (as determined in good faith by an Officer or the Board of Directors of the Issuer); 
 (4)
any extraordinary, exceptional, unusual or nonrecurring gain, loss, charge or expense (including relating to the Transaction Expenses), or any charges, expenses or reserves in respect of any restructuring, redundancy or severance expense;

 (5) the cumulative effect of a change in accounting principles; 

(6) any (i) non-cash compensation charge or expense arising from any grant of stock, stock options or other equity
based awards and any non-cash deemed finance charges in respect of any pension liabilities or other provisions and (ii) income (loss) attributable to deferred compensation plans or trusts; 

(7) all deferred financing costs written off and premiums paid or other expenses incurred directly in connection with any
early extinguishment of Indebtedness and any net gain (loss) from any write-off or forgiveness of Indebtedness; 

(8) any unrealized gains or losses in respect of any Hedging Obligations or any ineffectiveness recognized in earnings
related to qualifying hedge transactions or the fair value of changes therein recognized in earnings for derivatives that do not qualify as hedge transactions, in each case, in respect of any Hedging Obligations; 

(9) any unrealized foreign currency translation or transaction gains or losses in respect of Indebtedness of any Person
denominated in a currency other than the functional currency of such Person and any unrealized foreign exchange gains or losses relating to translation of assets and liabilities denominated in foreign currencies; 

(10) any unrealized foreign currency translation or transaction gains or losses in respect of Indebtedness or other
obligations of the Issuer or any Restricted Subsidiary owing to the Issuer or any Restricted Subsidiary; 
 (11)
any purchase accounting effects including adjustments to inventory, property and equipment, software and other intangible assets and deferred revenue in component amounts required or 

  
 -11-

 
permitted by GAAP and related authoritative pronouncements (including the effects of such adjustments pushed down to the Issuer and the Restricted Subsidiaries), as a result of any consummated
acquisition, or the amortization or write-off of any amounts thereof (including any write-off of in process research and development); 
 (12) any goodwill or other intangible asset impairment charge or write-off; 
 (13) any after-tax effect of income (loss) from the early extinguishment or cancellation of Indebtedness or any Hedging Obligations or other derivative instruments; 

(14) accruals and reserves that are established within twelve (12) months after the Escrow Release Date that are so
required to be established as a result of the Transactions in accordance with GAAP; 
 (15) any net unrealized
gains and losses resulting from Hedging Obligations or embedded derivatives that require similar accounting treatment and the application of Accounting Standards Codification Topic 815 and related pronouncements; and 

(16) any deferred tax expense associated with tax deductions or net operating losses arising as a result of the
Transactions, or the release of any valuation allowances related to such item. 
 In addition, to the extent not already
included in the Consolidated Net Income of such Person and its Restricted Subsidiaries, notwithstanding anything to the contrary in the foregoing, Consolidated Net Income shall include (i) any expenses and charges that are reimbursed by
indemnification or other reimbursement provisions in connection with any investment or any sale, conveyance, transfer or other disposition of assets permitted hereunder and (ii) to the extent covered by insurance and actually reimbursed, or, so
long as the Issuer has made a determination that there exists reasonable evidence that such amount will in fact be reimbursed by the insurer and only to the extent that such amount is (A) not denied by the applicable carrier in writing within
180 days and (B) in fact reimbursed within 365 days of the date of such evidence (with a deduction for any amount so added back to the extent not so reimbursed within 365 days), expenses with respect to liability or casualty events or business
interruption. 
 “Consolidated Total Indebtedness” means, as of any date of determination, (a) the
aggregate principal amount of Indebtedness for borrowed money (other than Indebtedness with respect to Cash Management Services) of the Issuer and its Restricted Subsidiaries outstanding on such date minus (b) the aggregate amount of cash and
Cash Equivalents included in the consolidated balance sheet of the Issuer and its Restricted Subsidiaries as of the end of the most recent fiscal period for which internal financial statements of the Issuer are available with such pro forma
adjustments as are consistent with the pro forma adjustments set forth in the definition of “Fixed Charge Coverage Ratio” and as determined in good faith determined by the Issuer. 

“Consolidated Total Leverage Ratio” means, as of any date of determination, the ratio of (x) Consolidated Total
Indebtedness as of such date to (y) the aggregate amount of Consolidated EBITDA for the period of the most recent four consecutive fiscal quarters ending prior to the date of such determination for which internal consolidated financial
statements of the Issuer are available, in each case with such pro forma adjustments as are consistent with the pro forma adjustments set forth in the definition of “Fixed Charge Coverage Ratio.” 

“Consolidated Total Secured Leverage Ratio” means, as of any date of determination, the ratio of (x) Consolidated
Total Indebtedness secured by a lien as of such date to (y) the aggregate amount of Consolidated EBITDA for the period of the most recent four consecutive fiscal quarters ending prior to the date of such determination for which internal
consolidated financial statements of the Issuer are available, in each case with such pro forma adjustments as are consistent with the pro forma adjustments set forth in the definition of “Fixed Charge Coverage Ratio.” 

“Contingent Obligations” means, with respect to any Person, any obligation of such Person guaranteeing in any manner,
whether directly or indirectly, any operating lease, dividend or other obligation that does not constitute Indebtedness (“primary obligations”) of any other Person (the “primary obligor”), including any obligation
of such Person, whether or not contingent: 
 (1) to purchase any such primary obligation or any property
constituting direct or indirect security therefor; 

  
 -12-

 (2) to advance or supply funds: 

(a) for the purchase or payment of any such primary obligation; or 

(b) to maintain the working capital or equity capital of the primary obligor or otherwise to maintain the net worth or
solvency of the primary obligor; or 
 (3) to purchase property, securities or services primarily for the purpose
of assuring the owner of any such primary obligation of the ability of the primary obligor to make payment of such primary obligation against loss in respect thereof. 
 “Credit Agreement” means the Credit Agreement to be entered into on or prior to the Escrow Release Date by and among Heinz, Merger Sub, Holdings, the guarantors from time to time party
thereto, JPMorgan Chase Bank, N.A., as administrative agent and collateral agent, and each lender from time to time party thereto, together with the related documents thereto (including the revolving loans thereunder, any letters of credit and
reimbursement obligations related thereto, any Guarantees and security documents), as amended, extended, renewed, restated, refunded, replaced, refinanced, supplemented, modified or otherwise changed (in whole or in part, and without limitation as
to amount, terms, conditions, covenants and other provisions) from time to time, and any one or more agreements (and related documents) governing Indebtedness, including indentures, incurred to refinance, substitute, supplement, replace or add to
(including increasing the amount available for borrowing or adding or removing any Person as a borrower, issuer or guarantor thereunder, in whole or in part, the borrowings and commitments then outstanding or permitted to be outstanding under such
Credit Agreement or one or more successors to the Credit Agreement or one or more new credit agreements. 
 “Credit
Facility” means, with respect to the Issuer or any of its Subsidiaries, one or more debt facilities, indentures or other arrangements (including the Credit Agreement or commercial paper facilities and overdraft facilities) with banks, other
financial institutions or investors providing for revolving credit loans, term loans, notes, receivables financing (including through the sale of receivables to such institutions or to special purpose entities formed to borrow from such institutions
against such receivables), letters of credit or other Indebtedness, in each case, as amended, restated, modified, renewed, refunded, replaced, restructured, refinanced, repaid, increased or extended in whole or in part from time to time (and whether
in whole or in part and whether or not with the original administrative agent and lenders or another administrative agent or agents or other banks or institutions and whether provided under the original Credit Agreement or one or more other credit
or other agreements, indentures, financing agreements or otherwise) and in each case including all agreements, instruments and documents executed and delivered pursuant to or in connection with the foregoing (including any notes and letters of
credit issued pursuant thereto and any Guarantee and collateral agreement, patent and trademark security agreement, mortgages or letter of credit applications and other Guarantees, pledges, agreements, security agreements and collateral documents).
Without limiting the generality of the foregoing, the term “Credit Facility” shall include any agreement or instrument (1) changing the maturity of any Indebtedness Incurred thereunder or contemplated thereby, (2) adding
Subsidiaries of the Issuer as additional borrowers or guarantors thereunder, (3) increasing the amount of Indebtedness Incurred thereunder or available to be borrowed thereunder or (4) otherwise altering the terms and conditions thereof.

 “Credit Facility Documents” means the collective reference to any Credit Facility, any notes issued pursuant
thereto and the guarantees thereof, and the collateral documents relating thereto, as amended, supplemented, restated, renewed, refunded, replaced, restructured, repaid, refinanced or otherwise modified, in whole or in part, from time to time.

  
 -13-

 “Custodian” means any receiver, trustee, assignee, liquidator, custodian or
similar official under any Bankruptcy Law. 
 “Default” means any event that is, or with the passage of time or
the giving of notice or both would be, an Event of Default; provided that any Default that results solely from the taking of an action that would have been permitted but for the continuation of a previous Default will be deemed to be cured if
such previous Default is cured prior to becoming an Event of Default. 
 “Definitive Notes” means certificated
Notes. 
 “Depositary” means, with respect to the Notes issuable or issued in whole or in part in global form,
the Person specified in Section 2.3 hereof as the Depositary with respect to the Notes, and any and all successors thereto appointed as depositary hereunder and having become such pursuant to the applicable provision of this Indenture.

 “Designated Non-Cash Consideration” means the fair market value (as determined in good faith by the Issuer)
of non-cash consideration received by the Issuer or one of its Restricted Subsidiaries in connection with an Asset Disposition that is so designated as Designated Non-Cash Consideration pursuant to an Officer’s Certificate, setting forth the
basis of such valuation, less the amount of cash or Cash Equivalents received in connection with a subsequent payment, redemption, retirement, sale or other disposition of such Designated Non-Cash Consideration. A particular item of Designated
Non-Cash Consideration will no longer be considered to be outstanding when and to the extent it has been paid, redeemed or otherwise retired or sold or otherwise disposed of in compliance with Section 3.5 hereof. 

“Designated Preferred Stock” means, with respect to the Issuer, Preferred Stock (other than Disqualified Stock)
(a) that is issued for cash (other than to the Issuer or a Subsidiary of the Issuer or an employee stock ownership plan or trust established by the Issuer or any such Subsidiary for the benefit of their employees to the extent funded by the
Issuer or such Subsidiary) and (b) that is designated as “Designated Preferred Stock” pursuant to an Officer’s Certificate of the Issuer at or prior to the issuance thereof, the Net Cash Proceeds of which are excluded from the
calculation set forth in Section 3.3(a)(4)(iii)(B) hereof. 
 “Disinterested Director” means, with
respect to any Affiliate Transaction, a member of the Board of Directors of the Issuer having no material direct or indirect financial interest in or with respect to such Affiliate Transaction. A member of the Board of Directors of the Issuer shall
be deemed not to have such a financial interest by reason of such member’s holding Capital Stock of the Issuer or any options, warrants or other rights in respect of such Capital Stock. 

“Disqualified Stock” means, with respect to any Person, any Capital Stock of such Person which by its terms (or by the
terms of any security into which it is convertible or for which it is exchangeable) or upon the happening of any event: 
 (1) matures or is mandatorily redeemable for cash or in exchange for Indebtedness pursuant to a sinking fund obligation or otherwise; or 

(2) is or may become (in accordance with its terms) upon the occurrence of certain events or otherwise redeemable or
repurchasable for cash or in exchange for Indebtedness at the option of the holder of the Capital Stock in whole or in part, 
 in each case on
or prior to the earlier of (a) the Stated Maturity of the Notes or (b) the date on which there are no Notes outstanding; provided, however, that (i) only the portion of Capital Stock which so matures or is mandatorily
redeemable, is so convertible or exchangeable or is so redeemable at the option of the holder thereof prior to such date will be deemed to be Disqualified Stock and (ii) any Capital Stock that would constitute Disqualified Stock solely because
the holders thereof have the right to require the Issuer to repurchase such Capital Stock upon the occurrence of a change of control or asset sale (howsoever defined or referred to) shall not constitute Disqualified Stock if any such redemption or
repurchase obligation is subject to compliance by the relevant Person with Section 3.3 hereof; provided, however, that if such Capital Stock is issued to any plan for the benefit of employees of the

  
 -14-

 
Issuer or its Subsidiaries or by any such plan to such employees, such Capital Stock shall not constitute Disqualified Stock solely because it may be required to be repurchased by the Issuer or
its Subsidiaries in order to satisfy applicable statutory or regulatory obligations. 
 “Domestic Subsidiary”
means, with respect to any Person, any Restricted Subsidiary of such Person other than a Foreign Subsidiary. 

“DTC” means The Depository Trust Company or any successor securities clearing agency. 

“Eligible Escrow Investments” means (1) Government Securities maturing no later than the Business Day preceding the
Escrow End Date and (2) money market funds registered under the Federal Investment Company Act of 1940, whose shares are registered under the Securities Act, and rated “AAAm” or “AAAm-G” by S&P and “Aaa” if
rated by Moody’s, including any mutual fund for which the escrow agent or its affiliate serves as investment manager, administrator, shareholder servicing agent, and/or custodian, (3) U.S. dollar denominated deposit accounts with domestic
national or commercial banks, including the escrow agent or an affiliate of the escrow agent, that have short term issuer rating on the date of purchase of “A-1+” or “A-1” by S&P or “Prime-1” or better by
Moody’s and maturing no more than 360 days after the date of purchase and (4) such other short-term liquid investments in which the Escrowed Property may be invested in accordance with the Escrow Agreement. 

“Equity Offering” means (x) a sale of Capital Stock of the Issuer (other than Disqualified Stock) other than
offerings registered on Form S-8 (or any successor form) under the Securities Act or any similar offering in other jurisdictions, or (y) the sale of Capital Stock or other securities, the proceeds of which are contributed to the equity
(other than through the issuance of Disqualified Stock or Designated Preferred Stock or through an Excluded Contribution) of Heinz or any of its Restricted Subsidiaries. 
 “Escrow End Date” has the meaning ascribed to it in the Escrow Agreement. 
 “Exchange Act” means the U.S. Securities Exchange Act of 1934, as amended, and the rules and regulations of the SEC promulgated thereunder, as amended. 

“Exchange Notes” means any notes issued in exchange for the Notes pursuant to the Registration Rights Agreement or
similar agreement. 
 “Excluded Contribution” means Net Cash Proceeds or property or assets received by the
Issuer as capital contributions to the equity (other than through the issuance of Disqualified Stock or Designated Preferred Stock) of the Issuer after the Issue Date or from the issuance or sale (other than to a Restricted Subsidiary or an employee
stock ownership plan or trust established by the Issuer or any Subsidiary of the Issuer for the benefit of their employees to the extent funded by the Issuer or any Restricted Subsidiary) of Capital Stock (other than Disqualified Stock or Designated
Preferred Stock) of the Issuer, in each case, to the extent designated as an Excluded Contribution pursuant to an Officer’s Certificate of the Issuer. 
 “Existing Notes” means any of the 5.350% Notes due 2013, 2.000% Notes due 2016, 1.500% Notes due 2017, 6.049% Remarketable Securities due 2020, 3.125% Notes due 2021, 2.850% Notes due
2022 and 7.125% Guaranteed Notes due 2039, 2.11% Guaranteed Senior Notes, Series A, due 2014, 2.81% Guaranteed Senior Notes, Series B, due 2016, 2.86% Guaranteed Senior Notes, Series E, due 2016, 3.53% Guaranteed Senior Notes, Series C, due 2018,
3.55% Guaranteed Senior Notes, Series F, due 2018 and 4.23% Guaranteed Senior Notes, Series D, due 2021 and, in each case to the extent outstanding on the Escrow Release Date. 
 “Excluded Property” has the meaning given to such term in the Collateral Documents. 
 “fair market value” may be conclusively established by means of an Officer’s Certificate or resolutions of the Board of Directors of the Issuer setting out such fair market value as
determined by such Officer or such Board of Directors in good faith. 

  
 -15-

 “First Priority Obligations” means (i) any and all amounts payable
under or in respect of any Credit Facility and the other Credit Facility Documents as amended, restated, supplemented, waived, replaced, restructured, repaid, refunded, refinanced or otherwise modified from time to time (including after termination
of the Credit Agreement), including principal, premium (if any), interest (including interest accruing on or after the filing of any petition in bankruptcy or for reorganization relating to the Issuer whether or not a claim for Post-Petition
Interest is allowed in such proceedings), fees, charges, expenses, reimbursement obligations, guarantees and all other amounts payable thereunder or in respect of, in each case, to the extent secured by a Permitted Lien incurred or deemed incurred
to secure Indebtedness constituting First Priority Obligations pursuant to clause (19) and subclause (a) of the proviso to clause (31) of the definition of “Permitted Liens,” and (ii) all other Obligations of the Issuer
or any of its Restricted Subsidiaries in respect of Hedging Obligations or Obligations in respect of cash management services in each case owing to a Person that is a holder of Indebtedness described in clause (i) above or an Affiliate of such
holder at the time of entry into such Hedging Obligations or Obligations in respect of cash management services. 

“Fitch” means Fitch Ratings, Inc. or any of its successors or assigns that is a Nationally Recognized Statistical Rating
Organization. 
 “Fixed Charge Coverage Ratio” means, with respect to any Person on any determination date, the
ratio of Consolidated EBITDA of such Person for the most recent four consecutive fiscal quarters ending immediately prior to such determination date for which internal consolidated financial statements are available to the Fixed Charges of such
Person for four consecutive fiscal quarters. In the event that the Issuer or any Restricted Subsidiary Incurs, assumes, Guarantees, redeems, defeases, retires or extinguishes any Indebtedness (other than Indebtedness incurred under any revolving
credit facility unless such Indebtedness has been permanently repaid and has not been replaced) or issues or redeems Disqualified Stock or Preferred Stock subsequent to the commencement of the period for which the Fixed Charge Coverage Ratio is
being calculated but prior to or simultaneously with the event for which the calculation of the Fixed Charge Coverage Ratio is made (the “Fixed Charge Coverage Ratio Calculation Date”), then the Fixed Charge Coverage Ratio shall be
calculated giving pro forma effect to such Incurrence, assumption, Guarantee, redemption, defeasance, retirement or extinguishment of Indebtedness, or such issuance or redemption of Disqualified Stock or Preferred Stock, as if the same had occurred
at the beginning of the applicable four-quarter period; provided, however, that the pro forma calculation shall not give effect to any Indebtedness Incurred on such determination date pursuant to Section 3.2(b). 

For purposes of making the computation referred to above, any Investments, acquisitions, dispositions, mergers, consolidations and
disposed operations that have been made by the Issuer or any of its Restricted Subsidiaries, during the four-quarter reference period or subsequent to such reference period and on or prior to or simultaneously with the Fixed Charge Coverage Ratio
Calculation Date shall be calculated on a pro forma basis assuming that all such Investments, acquisitions, dispositions, mergers, consolidations and disposed or discontinued operations (and the change in any associated fixed charge obligations and
the change in Consolidated EBITDA resulting therefrom) had occurred on the first day of the four-quarter reference period. If since the beginning of such period any Person that subsequently became a Restricted Subsidiary or was merged with or into
the Issuer or any of its Restricted Subsidiaries since the beginning of such period shall have made any Investment, acquisition, disposition, merger, consolidation or disposed or discontinued operation that would have required adjustment pursuant to
this definition, then the Fixed Charge Coverage Ratio shall be calculated giving pro forma effect thereto for such period as if such Investment, acquisition, disposition, merger, consolidation or disposed operation had occurred at the beginning of
the applicable four-quarter period. 
 For purposes of this definition, whenever pro forma effect is to be given to a
transaction, the pro forma calculations shall be made in good faith by a responsible financial or chief accounting officer of the Issuer (including cost savings; provided that (x) such cost savings are reasonably identifiable, reasonably
attributable to the action specified and reasonably anticipated to result from such actions and (y) such actions have been taken or initiated and the benefits resulting therefrom are anticipated by the Issuer to be realized within twelve
(12) months). If any Indebtedness bears a floating rate of interest and is being given pro forma effect, the interest on such Indebtedness shall be calculated as if the rate in effect on the Fixed Charge Coverage Ratio Calculation Date had been
the applicable rate for the entire period (taking into account any Hedging Obligations applicable to such Indebtedness). Interest on a Capitalized Lease Obligation shall be deemed to accrue at an interest rate reasonably determined by a responsible
financial or accounting officer of the Issuer to be the rate of interest implicit in such Capitalized Lease Obligation in accordance with GAAP. For purposes of making the computation referred to above,

  
 -16-

 
interest on any Indebtedness under a revolving credit facility computed with a pro forma basis shall be computed based upon the average daily balance of such Indebtedness during the applicable
period except as set forth in the first paragraph of this definition. Interest on Indebtedness that may optionally be determined at an interest rate based upon a factor of a prime or similar rate, a eurocurrency interbank offered rate, or other
rate, shall be determined to have been based upon the rate actually chosen, or if none, then based upon such optional rate chosen as the Issuer may designate. 
 “Fixed Charges” means, with respect to any Person for any period, the sum of: 
 (1) Consolidated Interest Expense of such Person for such Period; 

(2) all cash dividends or other distributions paid (excluding items eliminated in consolidation) on any series of
Preferred Stock of any Subsidiary of such Person during such period; and 
 (3) all cash dividends or other
distributions paid (excluding items eliminated in consolidation) on any series of Disqualified Stock during this period. 

“Foreign Subsidiary” means, with respect to any Person, (i) any Subsidiary of such Person that is not organized or
existing under the laws of the United States, any state thereof or the District of Columbia, and any Subsidiary of such Subsidiary and (ii) any Subsidiary of such Person that otherwise would be a Domestic Subsidiary substantially all of whose
assets consist of Capital Stock and/or indebtedness of one or more Foreign Subsidiaries and any other assets incidental thereto. 
 “Future Second Lien Indebtedness” means any Indebtedness of the Issuer and/or the Guarantors that is secured by a lien on the Collateral ranking equally and ratably with the Notes as
permitted by this Indenture; provided that (i) the trustee, agent or other authorized representative for the holders of such Indebtedness (other than in the case of any Additional Notes) shall execute a joinder to the Collateral
Documents and/or the Intercreditor Agreement, as applicable, and (ii) the Issuer shall designate such Indebtedness as Future Second Lien Indebtedness for purposes of this Indenture. 

“GAAP” means generally accepted accounting principles in the United States of America as in effect on the date of any
calculation or determination required hereunder. Except as otherwise set forth in this Indenture, all ratios and calculations based on GAAP contained in this Indenture shall be computed in accordance with GAAP, as in effect on the Issue Date. At any
time after the Issue Date, the Issuer may elect to establish that GAAP shall mean the GAAP as in effect on or prior to the date of such election; provided that any such election, once made, shall be irrevocable. At any time after the Issue
Date, the Issuer may elect to apply IFRS accounting principles in lieu of GAAP and, upon any such election, references herein to GAAP shall thereafter be construed to mean IFRS (except as otherwise provided in this Indenture), including as to the
ability of the Issuer to make an election pursuant to the previous sentence; provided that any such election, once made, shall be irrevocable; provided, further, that any calculation or determination in this Indenture that
requires the application of GAAP for periods that include fiscal quarters ended prior to the Issuer’s election to apply IFRS shall remain as previously calculated or determined in accordance with GAAP; provided, further again,
that the Issuer may only make such election if it also elects to report any subsequent financial reports required to be made by the Issuer, including pursuant to Section 13 or Section 15(d) of the Exchange Act and Section 3.10
hereof, in IFRS. The Issuer shall give notice of any such election made in accordance with this definition to the Trustee and the Holders. 
 “Government Securities” means securities that are: 

(1) direct obligations of the United States of America for the timely payment of which its full faith and credit is
pledged; or 
 (2) obligations of a Person controlled or supervised by and acting as an agency or instrumentality
of the United States of America the timely payment of which is unconditionally guaranteed as a full faith and credit obligation by the United States of America, 

  
 -17-

 which, in either case, are not callable or redeemable at the option of the issuers thereof, and shall also
include a depository receipt issued by a bank (as defined in Section 3(a)(2) of the Securities Act), as custodian with respect to any such Government Securities or a specific payment of principal of or interest on any such Government Securities
held by such custodian for the account of the holder of such depository receipt; provided that (except as required by law) such custodian is not authorized to make any deduction from the amount payable to the holder of such depository receipt
from any amount received by the custodian in respect of the Government Securities or the specific payment of principal of or interest on the Government Securities evidenced by such depository receipt. 

“Governmental Authority” means any nation, sovereign or government, any state, province, territory or other political
subdivision thereof, any agency, authority, instrumentality, regulatory body, court, administrative tribunal, central bank, stock exchange or other entity or authority exercising executive, legislative, judicial, taxing, regulatory, self-regulatory
or administrative powers or functions of or pertaining to government. 
 “Grantors” means the Issuer and the
Guarantors. 
 “Guarantee” means any obligation, contingent or otherwise, of any Person directly or indirectly
guaranteeing any Indebtedness of any other Person, including any such obligation, direct or indirect, contingent or otherwise, of such Person: 
 (1) to purchase or pay (or advance or supply funds for the purchase or payment of) such Indebtedness of such other Person (whether arising by virtue of partnership arrangements, or by agreements to
keep-well, to purchase assets, goods, securities or services, to take-or-pay or to maintain financial statement conditions or otherwise); or 
 (2) entered into primarily for purposes of assuring in any other manner the obligee of such Indebtedness of the payment thereof or to protect such obligee against loss in respect thereof (in whole or in
part); 
 provided, however, that the term “Guarantee” will not include endorsements for collection or deposit in the
ordinary course of business. The term “Guarantee” used as a verb has a corresponding meaning. 

“Guarantor” means, prior to the Escrow Release, Holdings, and following the Escrow Release, Holdings and any Restricted
Subsidiary that Guarantees the Notes, until such Note Guarantee is released in accordance with the terms of this Indenture. 

“Hedging Obligations” means, with respect to any Person, the obligations of such Person under any interest rate swap
agreement, interest rate cap agreement, interest rate collar agreement, commodity swap agreement, commodity cap agreement, commodity collar agreement, foreign exchange contracts, currency swap agreement or similar agreement providing for the
transfer or mitigation of interest rate, commodity price or currency risks either generally or under specific contingencies. 

“Heinz” has the meaning ascribed to such term in the preamble hereto. 

“Holder” means each Person in whose name the Notes are registered on the Registrar’s books, which shall initially
be the respective nominee of DTC. 
 “Holdings” means Hawk Acquisition Intermediate Corporation II, a Delaware
corporation, or any successors or assigns thereto. 
 “IAI” means an institutional “accredited
investor” as described in Rule 501(a)(1), (2), (3) or (7) under the Securities Act. 

“IFRS” means International Financial Reporting standards, as adopted in the European Union. 

  
 -18-

 “Immaterial Subsidiary” means, at any date of determination, each
Restricted Subsidiary of the Issuer that (i) has not guaranteed any other Indebtedness of the Issuer and (ii) has Total Assets together with all other Immaterial Subsidiaries (other than Foreign Subsidiaries and Unrestricted Subsidiaries)
(as determined in accordance with GAAP) and Consolidated EBITDA of less than 2.5% of the Issuer’s Total Assets and Consolidated EBITDA (measured, in the case of Total Assets, at the end of the most recent fiscal period for which internal
financial statements are available and, in the case of Consolidated EBITDA, for the most recently ended four consecutive fiscal quarters ended for which internal consolidated financial statements are available, in each case measured on a pro forma
basis giving effect to any acquisitions or depositions of companies, division or lines of business since such balance sheet date or the start of such four quarter period, as applicable, and on or prior to the date of acquisition of such Subsidiary).

 “Incur” means issue, create, assume, enter into any Guarantee of, incur, extend or otherwise become liable
for; provided, however, that any Indebtedness or Capital Stock of a Person existing at the time such Person becomes a Restricted Subsidiary (whether by merger, consolidation, acquisition or otherwise) will be deemed to be Incurred by
such Restricted Subsidiary at the time it becomes a Restricted Subsidiary and the terms “Incurred” and “Incurrence” have meanings correlative to the foregoing and any Indebtedness pursuant to any revolving credit or similar
facility shall only be “Incurred” at the time any funds are borrowed thereunder. 
 “Indebtedness”
means, with respect to any Person on any date of determination (without duplication): 
 (1) the principal of
indebtedness of such Person for borrowed money; 
 (2) the principal of obligations of such Person evidenced by
bonds, debentures, notes or other similar instruments; 
 (3) all reimbursement obligations of such Person in
respect of letters of credit, bankers’ acceptances or other similar instruments (the amount of such obligations being equal at any time to the aggregate then undrawn and unexpired amount of such letters of credit or other instruments plus the
aggregate amount of drawings thereunder that have been reimbursed) (except to the extent such reimbursement obligations relate to trade payables and such obligations are satisfied within 30 days of Incurrence); 

(4) the principal component of all obligations of such Person to pay the deferred and unpaid purchase price of property
(except trade payables), which purchase price is due more than one year after the date of placing such property in service or taking final delivery and title thereto; 

(5) Capitalized Lease Obligations of such Person; 

(6) the principal component of all obligations, or liquidation preference, of such Person with respect to any Disqualified
Stock or, with respect to any Restricted Subsidiary, any Preferred Stock (but excluding, in each case, any accrued dividends); 
 (7) the principal component of all Indebtedness of other Persons secured by a Lien on any asset of such Person, whether or not such Indebtedness is assumed by such Person; provided, however,
that the amount of such Indebtedness will be the lesser of (a) the fair market value of such asset at such date of determination (as determined in good faith by the Issuer) and (b) the amount of such Indebtedness of such other Persons;

 (8) Guarantees by such Person of the principal component of Indebtedness of other Persons to the extent
Guaranteed by such Person; and 
 (9) to the extent not otherwise included in this definition, net obligations of
such Person under Hedging Obligations (the amount of any such obligations to be equal at any time to the net payments under such agreement or arrangement giving rise to such obligation that would be payable by such Person at the termination of such
agreement or arrangement). 

  
 -19-

 The term “Indebtedness” shall not include any lease, concession or license of
property (or Guarantee thereof) which would be considered an operating lease under GAAP as in effect on the Issue Date, any prepayments of deposits received from clients or customers in the ordinary course of business, or obligations under any
license, permit or other approval (or Guarantees given in respect of such obligations) Incurred prior to the Issue Date or in the ordinary course of business. 
 The amount of Indebtedness of any Person at any time in the case of a revolving credit or similar facility shall be the total amount of funds borrowed and then outstanding. The amount of any Indebtedness
outstanding as of any date shall be (a) the accreted value thereof in the case of any Indebtedness issued with original issue discount and (b) the principal amount of Indebtedness, or liquidation preference thereof, in the case of any
other Indebtedness. 
 Notwithstanding the above provisions, in no event shall the following constitute Indebtedness:

 (i) Contingent Obligations Incurred in the ordinary course of business; 

(ii) Cash Management Services; 
 (iii) in connection with the purchase by the Issuer or any Restricted Subsidiary of any business, any post-closing payment adjustments to which the seller may become entitled to the extent such payment is
determined by a final closing balance sheet or such payment depends on the performance of such business after the closing; provided, however, that, at the time of closing, the amount of any such payment is not determinable and, to the
extent such payment thereafter becomes fixed and determined, the amount is paid in a timely manner; or 
 (iv)
for the avoidance of doubt, any obligations in respect of workers’ compensation claims, early retirement or termination obligations, pension fund obligations or contributions or similar claims, obligations or contributions or social security or
wage Taxes. 
 “Indenture” means this Indenture as amended or supplemented from time to time. 

“Independent Financial Advisor” means an investment banking or accounting firm of international standing or any third
party appraiser of international standing; provided, however, that such firm or appraiser is not an Affiliate of the Issuer. 
 “Initial Notes” has the meaning ascribed to it in the second introductory paragraph of this Indenture. 
 “Initial Purchasers” means Wells Fargo Securities, LLC, J.P. Morgan Securities LLC, Barclays Capital Inc., Citigroup Global Markets Inc., BB Securities Limited, BNP Paribas Securities
Corp., Credit Suisse Securities (USA) LLC, HSBC Securities (USA) Inc., Itau BBA International Limited, Mitsubishi UFJ Securities (USA), Inc., PNC Capital Markets LLC, Rabo Securities USA, Inc., RBC Capital Markets, LLC, SMBC Nikko Capital Markets
Limited and UBS Securities LLC. 
 “Intercreditor Agreement” means the intercreditor agreement, dated as of the
Escrow Release Date, among JPMorgan Chase Bank, N.A., as agent under the Credit Facility Documents and the Collateral Agent, substantially in the form of Exhibit D hereto, as it may be amended from time to time in accordance with this
Indenture. 
 “Investment” means, with respect to any Person, all investments by such Person in other Persons
(including Affiliates) in the form of any direct or indirect advance, loan or other extensions of credit (other than advances or extensions of credit to customers, suppliers, directors, officers or employees of any Person in the ordinary course of
business, and excluding any debt or extension of credit represented by a bank deposit other than a time deposit) or capital contribution to (by means of any transfer of cash or other property to others or any payment for property or services for the
account or use of others), or the Incurrence of a Guarantee of any obligation of, or any purchase or acquisition of Capital Stock, Indebtedness or other similar instruments issued by, such other Persons and all other items that are or would be
classified as investments on a balance sheet prepared on the basis of GAAP; provided, 

  
 -20-

 
however, that endorsements of negotiable instruments and documents in the ordinary course of business will not be deemed to be an Investment. If the Issuer or any Restricted Subsidiary
issues, sells or otherwise disposes of any Capital Stock of a Person that is a Restricted Subsidiary such that, after giving effect thereto, such Person is no longer a Restricted Subsidiary, any Investment by the Issuer or any Restricted Subsidiary
in such Person remaining after giving effect thereto will be deemed to be a new Investment at such time. 
 For purposes of
Sections 3.3 and 3.20 hereof: 
 (1) “Investment” will include the portion
(proportionate to the Issuer’s equity interest in a Restricted Subsidiary to be designated as an Unrestricted Subsidiary) of the fair market value of the net assets of such Restricted Subsidiary of the Issuer at the time that such Restricted
Subsidiary is designated an Unrestricted Subsidiary; provided, however, that upon a redesignation of such Subsidiary as a Restricted Subsidiary, the Issuer will be deemed to continue to have a permanent “Investment” in an
Unrestricted Subsidiary in an amount (if positive) equal to (a) the Issuer’s “Investment” in such Subsidiary at the time of such redesignation less (b) the portion (proportionate to the Issuer’s equity interest in such
Subsidiary) of the fair market value of the net assets (as conclusively determined by the Board of Directors of the Issuer in good faith) of such Subsidiary at the time that such Subsidiary is so re-designated a Restricted Subsidiary; and

 (2) any property transferred to or from an Unrestricted Subsidiary will be valued at its fair market value at
the time of such transfer, in each case as determined in good faith by the Board of Directors of the Issuer. 

“Investment Grade Securities” means: 

(1) securities issued or directly and fully Guaranteed or insured by the United States or Canadian government or any
agency or instrumentality thereof (other than Cash Equivalents); 
 (2) securities issued or directly and fully
guaranteed or insured by a member of the European Union, or any agency or instrumentality thereof (other than Cash Equivalents); 
 (3) debt securities or debt instruments with a rating of “A—” or higher from S&P or “A3” or higher by Moody’s or the equivalent of such rating by such rating organization
or, if no rating of Moody’s or S&P then exists, the equivalent of such rating by any other Nationally Recognized Statistical Rating Organization, but excluding any debt securities or instruments constituting loans or advances among the
Issuer and its Subsidiaries; and 
 (4) investments in any fund that invests exclusively in investments of the
type described in clauses (1), (2) and (3) above which fund may also hold cash and Cash Equivalents pending investment or distribution. 
 “Investment Grade Status” shall occur when the Notes receive two of the following: 
 (1) a rating of “BBB-” or higher from S&P; 
 (2) a
rating of “Baa3” or higher from Moody’s; or 
 (3) a rating of “BBB-” or higher from
Fitch; 
 or the equivalent of such rating by either such rating organization or, if no rating of Moody’s or S&P then exists, the
equivalent of such rating by any other Nationally Recognized Statistical Rating Organization. 
 “Issue Date”
means April 1, 2013. 

  
 -21-

 “Issuer” means (a) prior to the consummation of the Acquisition on the
Escrow Release Date, Merger Sub and (b) from and after the consummation of the Acquisition on the Escrow Release Date, Heinz. 
 “Junior Priority Indebtedness” means other Indebtedness of the Issuer and/or the Guarantors that is secured by Liens on the Collateral ranking junior in priority to the Liens securing the
Notes as permitted by this Indenture and is designated by the Issuer as Junior Priority Indebtedness. 
 “Lien”
means any mortgage, pledge, security interest, encumbrance, lien or charge of any kind (including any conditional sale or other title retention agreement or lease in the nature thereof). 

“Management Advances” means loans or advances made to, or Guarantees with respect to loans or advances made to,
directors, officers, employees or consultants of any Parent Entity, the Issuer or any Restricted Subsidiary: 

(1) (a) in respect of travel, entertainment or moving related expenses Incurred in the ordinary course of business or
(b) for purposes of funding any such person’s purchase of Capital Stock (or similar obligations) of the Issuer, its Subsidiaries or any Parent Entity with (in the case of this sub-clause (b)) the approval of the Board of Directors;

 (2) in respect of moving related expenses Incurred in connection with any closing or consolidation of any
facility or office; or 
 (3) not exceeding $50.0 million in the aggregate outstanding at any time. 

“Management Stockholders” means the members of management of the Issuer (or its direct parent) or its Subsidiaries who
are holders of Capital Stock of the Issuer or of any Parent Entity on the Escrow Release Date or will become holders of such Capital Stock in connection with the Acquisition. 
 “Merger Agreement” means the Agreement and Plan of Merger, dated as of February 13, 2013, by and among Heinz, Merger Sub and Hawk Acquisition Holding Corporation, a Delaware
Corporation, as amended on March 4, 2013 and as subsequently amended prior to the Escrow Release Date. 
 “Merger
Sub” has the meaning assigned to such term in the preamble hereto. 
 “Moody’s” means
Moody’s Investors Service, Inc. or any of its successors or assigns that is a Nationally Recognized Statistical Rating Organization. 
 “Nationally Recognized Statistical Rating Organization” means a nationally recognized statistical rating organization within the meaning of Rule 436 under the Securities Act.

 “Net Available Cash” from an Asset Disposition means cash payments received (including any cash payments
received by way of deferred payment of principal pursuant to a note or installment receivable or otherwise and net proceeds from the sale or other disposition of any securities received as consideration, but only as and when received, but excluding
any other consideration received in the form of assumption by the acquiring person of Indebtedness or other obligations relating to the properties or assets that are the subject of such Asset Disposition or received in any other non-cash form)
therefrom, in each case net of: 
 (1) all legal, accounting, investment banking, title and recording tax
expenses, commissions and other fees and expenses Incurred, and all Taxes paid, reasonably estimated to be actually payable or accrued as a liability under GAAP (including, for the avoidance of doubt, any income, withholding and other Taxes payable
as a result of the distribution of such proceeds to the Issuer and after taking into account any available tax credits or deductions and any tax sharing agreements), as a consequence of such Asset Disposition; 

  
 -22-

 (2) all payments made on any Indebtedness which is secured by any assets
subject to such Asset Disposition, in accordance with the terms of any Lien upon such assets, or which by applicable law be repaid out of the proceeds from such Asset Disposition; 

(3) all distributions and other payments required to be made to minority interest holders (other than any Parent Entity,
the Issuer or any of its respective Subsidiaries) in Subsidiaries or joint ventures as a result of such Asset Disposition; and 
 (4) the deduction of appropriate amounts required to be provided by the seller as a reserve, on the basis of GAAP, against any liabilities associated with the assets disposed of in such Asset Disposition
and retained by the Issuer or any Restricted Subsidiary after such Asset Disposition. 
 “Net Cash Proceeds,”
with respect to any issuance or sale of Capital Stock, means the cash proceeds of such issuance or sale net of attorneys’ fees, accountants’ fees, underwriters’ or placement agents’ fees, listing fees, discounts or commissions
and brokerage, consultant and other fees and charges actually Incurred in connection with such issuance or sale and net of Taxes paid or reasonably estimated to be actually payable as a result of such issuance or sale (including, for the avoidance
of doubt, any income, withholding and other Taxes payable as a result of the distribution of such proceeds to the Issuer and after taking into account any available tax credit or deductions and any tax sharing agreements). 

“Non-Guarantor” means any Restricted Subsidiary that is not a Guarantor. 

“Non-refinanced Notes” means any of the 6.049% Remarketable Securities due 2020, 3.125% Notes due 2021, 2.850% Notes due
2022 and 4.23% Guaranteed Senior Notes, Series D, due 2021. 
 “Non-U.S. Person” means a Person who is not a
U.S. Person (as defined in Regulation S). 
 “Note Documents” means the Notes (including Additional Notes), the
Note Guarantee, the Collateral Documents, the Intercreditor Agreement and this Indenture. 
 “Notes” has the
meaning ascribed to it in the second introductory paragraph of this Indenture. 
 “Notes Custodian” means the
custodian with respect to the Global Notes (as appointed by DTC), or any successor Person thereto and shall initially be the Trustee. 
 “Obligations” means any principal, interest (including interest accruing on or after the filing of any petition in bankruptcy or for reorganization relating to the Issuer or any Guarantor
whether or not a claim for Post-Petition Interest is allowed in such proceedings), penalties, fees, indemnifications, reimbursements (including, without limitation, reimbursement obligations with respect to letters of credit and bankers’
acceptances), damages and other liabilities payable under the documentation governing any Indebtedness. 
 “Offering
Memorandum” means the final offering memorandum, dated March 22, 2013, relating to the offering by the Issuer of $3,100,000,000 aggregate principal amount of 4.25% second lien senior secured notes due 2020 and any future offering
memorandum relating to Additional Notes. 
 “Officer” means, with respect to any Person, (1) the Chairman
of the Board of Directors, the Chief Executive Officer, the President, the Chief Financial Officer, any Vice President, the Treasurer, any Managing Director, or the Secretary (a) of such Person or (b) if such Person is owned or managed by
a single entity, of such entity, or (2) any other individual designated as an “Officer” for the purposes of this Indenture by the Board of Directors of such Person. 

“Officer’s Certificate” means, with respect to any Person, a certificate signed by one Officer of such Person.

  
 -23-

 “Opinion of Counsel” means a written opinion from legal counsel reasonably
satisfactory to the Trustee. The counsel may be an employee of or counsel to the Issuer or its Subsidiaries. 
 “Parent
Entity” means any direct or indirect parent of the Issuer. 
 “Parent Entity Expenses” means:

 (1) costs (including all professional fees and expenses) Incurred by any Parent Entity in connection with
reporting obligations under or otherwise Incurred in connection with compliance with applicable laws, rules or regulations of any governmental, regulatory or self-regulatory body or stock exchange, this Indenture or any other agreement or instrument
relating to Indebtedness of the Issuer or any Restricted Subsidiary, including in respect of any reports filed with respect to the Securities Act, Exchange Act or the respective rules and regulations promulgated thereunder; 

(2) customary indemnification obligations of any Parent Entity owing to directors, officers, employees or other Persons
under its charter or by-laws or pursuant to written agreements with any such Person to the extent relating to the Issuer and its Subsidiaries; 
 (3) obligations of any Parent Entity in respect of director and officer insurance (including premiums therefor) to the extent relating to the Issuer and its Subsidiaries; 

(4) general corporate overhead expenses, including professional fees and expenses and other operational expenses of any
Parent Entity related to the ownership or operation of the business of the Issuer or any of its Restricted Subsidiaries; and 
 (5) expenses Incurred by any Parent Entity in connection with any public offering or other sale of Capital Stock or Indebtedness: 

(x) where the net proceeds of such offering or sale are intended to be received by or contributed to the Issuer or a
Restricted Subsidiary, 
 (y) in a pro-rated amount of such expenses in proportion to the amount of such net
proceeds intended to be so received or contributed, or 
 (z) otherwise on an interim basis prior to completion
of such offering so long as any Parent Entity shall cause the amount of such expenses to be repaid to the Issuer or the relevant Restricted Subsidiary out of the proceeds of such offering promptly if completed. 

“Pari Passu Indebtedness” means Indebtedness of the Issuer which ranks equally in right of payment to the Notes or of
any Guarantor if such Indebtedness ranks equally in right of payment to the Guarantees of the Notes. 
 “Paying
Agent” means any Person authorized by the Issuer to pay the principal of (and premium, if any) or interest on any Note on behalf of the Issuer. 
 “Permitted Asset Swap” means the concurrent purchase and sale or exchange of assets used or useful in a Similar Business or a combination of such assets and cash, Cash Equivalents between
the Issuer or any of its Restricted Subsidiaries and another Person; provided that any cash or Cash Equivalents received in excess of the value of any cash or Cash Equivalents sold or exchanged must be applied in accordance with
Section 3.5 hereof. 
 “Permitted Holders” means, collectively, (1) the Sponsor,
(2) Berkshire Hathaway, (3) any one or more Persons, together with such Persons’ Affiliates, whose beneficial ownership constitutes or results in a Change of Control in respect of which a Change of Control Offer is made in accordance
with the requirements of this Indenture, (4) Management Stockholders, (5) any Person who is acting solely as an underwriter in connection with a public or private offering of Capital Stock of any Parent Entity or the Issuer, acting in such
capacity, and (6) any group (within the meaning of Section 13(d)(3) or Section 14(d)(2) of the Exchange Act or any successor provision) 

  
 -24-

 
of which any of the foregoing are members; provided that, in the case of such group and without giving effect to the existence of such group or any other group, the Sponsor, Berkshire
Hathaway and the Management Stockholders, collectively, have beneficial ownership of more than 50% of the total voting power of the Voting Stock of the Issuer or any of its direct or indirect Parent Entities held by such group. 

“Permitted Investment” means (in each case, by the Issuer or any of its Restricted Subsidiaries): 

(1) Investments in (a) a Restricted Subsidiary (including the Capital Stock of a Restricted Subsidiary) or the Issuer
or (b) a Person (including the Capital Stock of any such Person) that will, upon the making of such Investment, become a Restricted Subsidiary; 
 (2) Investments in another Person if such Person is engaged in any Similar Business and as a result of such Investment such other Person is merged, consolidated or otherwise combined with or into, or
transfers or conveys all or substantially all its assets to, the Issuer or a Restricted Subsidiary; 
 (3)
Investments in cash, Cash Equivalents or Investment Grade Securities; 
 (4) Investments in receivables owing to
the Issuer or any Restricted Subsidiary created or acquired in the ordinary course of business; 
 (5)
Investments in payroll, travel and similar advances to cover matters that are expected at the time of such advances ultimately to be treated as expenses for accounting purposes and that are made in the ordinary course of business; 

(6) Management Advances; 
 (7) Investments received in settlement of debts created in the ordinary course of business and owing to the Issuer or any Restricted Subsidiary or in exchange for any other Investment or accounts
receivable held by the Issuer or any such Restricted Subsidiary, or as a result of foreclosure, perfection or enforcement of any Lien, or in satisfaction of judgments or pursuant to any plan of reorganization or similar arrangement including upon
the bankruptcy or insolvency of a debtor or otherwise with respect to any secured Investment or other transfer of title with respect to any secured Investment in default; 

(8) Investments made as a result of the receipt of non-cash consideration from a sale or other disposition of property or
assets, including an Asset Disposition; 
 (9) Investments existing or pursuant to agreements or arrangements in
effect on the Escrow Release Date and any modification, replacement, renewal or extension thereof; provided that the amount of any such Investment may not be increased except (a) as required by the terms of such Investment as in
existence on the Escrow Release Date or (b) as otherwise permitted under this Indenture; 
 (10) Hedging
Obligations, which transactions or obligations are Incurred in compliance with Section 3.2 hereof; 

(11) pledges or deposits with respect to leases or utilities provided to third parties in the ordinary course of business
or Liens otherwise described in the definition of “Permitted Liens” or made in connection with Liens permitted under Section 3.6 hereof; 
 (12) any Investment to the extent made using Capital Stock of the Issuer (other than Disqualified Stock) or Capital Stock of any Parent Entity as consideration; 

(13) any transaction to the extent constituting an Investment that is permitted and made in accordance with
Section 3.8(b) hereof (except those described in Sections 3.8(b)(1), (3), (6), (7), (8), (9), (12) and (14)); 

  
 -25-

 (14) Investments consisting of purchases and acquisitions of inventory,
supplies, materials and equipment or licenses or leases of intellectual property, in any case, in the ordinary course of business and in accordance with this Indenture; 

(15) (i) Guarantees of Indebtedness not prohibited by Section 3.2 hereof and (other than with respect to
Indebtedness) guarantees, keepwells and similar arrangements in the ordinary course of business, and (ii) performance guarantees with respect to obligations that are permitted by this Indenture; 

(16) Investments consisting of earnest money deposits required in connection with a purchase agreement, or letter of
intent, or other acquisitions to the extent not otherwise prohibited by this Indenture; 
 (17) Investments of a
Restricted Subsidiary acquired after the Issue Date or of an entity merged into the Issuer or merged into or consolidated with a Restricted Subsidiary after the Issue Date to the extent that such Investments were not made in contemplation of or in
connection with such acquisition, merger or consolidation and were in existence on the date of such acquisition, merger or consolidation; 
 (18) Investments consisting of licensing or contribution of intellectual property pursuant to joint marketing arrangements with other Persons; 

(19) contributions to a “rabbi” trust for the benefit of employees or other grantor trust subject to claims of
creditors in the case of a bankruptcy of the Issuer; 
 (20) Investments in joint ventures and similar entities
and Unrestricted Subsidiaries having an aggregate fair market value, when taken together with all other Investments made pursuant to this clause that are at the time outstanding, not to exceed the greater of $500.0 million and 1.50% of Total Assets
at the time of such Investment (with the fair market value of each Investment being measured at the time made and without giving effect to subsequent changes in value); 

(21) additional Investments having an aggregate fair market value, taken together with all other Investments made pursuant
to this clause (21) that are at that time outstanding, not to exceed the greater of $1,050.0 million and 3.25% of Total Assets (with the fair market value of each Investment being measured at the time made and without giving effect to
subsequent changes in value) plus the amount of any distributions, dividends, payments or other returns in respect of such Investments (without duplication for purposes of Section 3.3 of any amounts applied pursuant to
Section 3.3(a)(4)(iii)); provided that if such Investment is in Capital Stock of a Person that subsequently becomes a Restricted Subsidiary, such Investment shall thereafter be deemed permitted under clause (1) or
(2) above and shall not be included as having been made pursuant to this clause (21); 
 (22) (i)
Investments in a Securitization Subsidiary or any Investment by a Securitization Subsidiary in any other Person in connection with a Qualified Securitization Financing and (ii) distributions or payments of Securitization Fees and purchases of
Securitization Assets pursuant to a securitization repurchase obligation in connection with a Qualified Securitization Financing; 
 (23) Investments in connection with the Transactions; and 
 (24)
Investments by an Unrestricted Subsidiary entered into prior to the day such Unrestricted Subsidiary is redesignated as a Restricted Subsidiary as described under Section 3.20. 

“Permitted Liens” means, with respect to any Person: 

(1) Liens on assets or property of a Restricted Subsidiary that is not a Guarantor securing Indebtedness of any Restricted
Subsidiary that is not a Guarantor; 
 (2) pledges, deposits or Liens under workmen’s compensation laws,
payroll taxes, unemployment insurance laws, social security laws or similar legislation, or insurance related obligations 

  
 -26-

 
(including pledges or deposits securing liability to insurance carriers under insurance or self-insurance arrangements), or in connection with bids, tenders, completion guarantees, contracts
(other than for borrowed money) or leases, or to secure utilities, licenses, public or statutory obligations, or to secure surety, indemnity, judgment, appeal or performance bonds, guarantees of government contracts (or other similar bonds,
instruments or obligations), or as security for contested taxes or import or customs duties or for the payment of rent, or other obligations of like nature, in each case Incurred in the ordinary course of business; 

(3) Liens imposed by law, including carriers’, warehousemen’s, mechanics’, landlords’,
materialmen’s, repairmen’s, construction contractors’ or other like Liens, in each case for sums not yet overdue for a period of more than 60 days or that are bonded or being contested in good faith by appropriate proceedings;

 (4) Liens for Taxes which are not overdue for a period of more than 60 days or which are being contested in
good faith by appropriate proceedings; provided that appropriate reserves required pursuant to GAAP have been made in respect thereof; 
 (5) encumbrances, ground leases, easements (including reciprocal easement agreements), survey exceptions, or reservations of, or rights of others for, licenses, rights of way, sewers, electric lines,
telegraph and telephone lines and other similar purposes, or zoning, building codes or other restrictions (including minor defects or irregularities in title and similar encumbrances) as to the use of real properties or Liens incidental to the
conduct of the business of the Issuer and its Restricted Subsidiaries or to the ownership of their properties which do not in the aggregate materially adversely affect the value of said properties or materially impair their use in the operation of
the business of the Issuer and its Restricted Subsidiaries; 
 (6) Liens (a) on assets or property of the
Issuer or any Restricted Subsidiary securing Hedging Obligations or Cash Management Services permitted under this Indenture; (b) that are contractual rights of set-off or, in the case of clause (i) or (ii) below, other bankers’
Liens (i) relating to treasury, depository and cash management services or any automated clearing house transfers of funds in the ordinary course of business and not given in connection with the issuance of Indebtedness, (ii) relating to
pooled deposit or sweep accounts to permit satisfaction of overdraft or similar obligations incurred in the ordinary course of business of the Issuer or any Subsidiary or (iii) relating to purchase orders and other agreements entered into with
customers of the Issuer or any Restricted Subsidiary in the ordinary course of business; (c) on cash accounts securing Indebtedness incurred under Section 3.2(b)(8)(iii) with financial institutions; (d) encumbering reasonable
customary initial deposits and margin deposits and similar Liens attaching to commodity trading accounts or other brokerage accounts incurred in the ordinary course of business, consistent with past practice and not for speculative purposes; and/or
(e) (i) of a collection bank arising under Section 4-210 of the Uniform Commercial Code on items in the course of collection and (ii) in favor of a banking institution arising as a matter of law encumbering deposits (including
the right of set-off) arising in the ordinary course of business in connection with the maintenance of such accounts and (iii) arising under customary general terms of the account bank in relation to any bank account maintained with such bank
and attaching only to such account and the products and proceeds thereof, which Liens, in any event, do not to secure any Indebtedness; 
 (7) leases, licenses, subleases and sublicenses of assets (including real property and intellectual property rights), in each case entered into in the ordinary course of business; 

(8) Liens arising out of judgments, decrees, orders or awards not giving rise to an Event of Default so long as
(a) any appropriate legal proceedings which may have been duly initiated for the review of such judgment, decree, order or award have not been finally terminated, (b) the period within which such proceedings may be initiated has not
expired or (c) no more than 60 days have passed after (i) such judgment, decree, order or award has become final or (ii) such period within which such proceedings may be initiated has expired; 

  
 -27-

 (9) Liens (i) on assets or property of the Issuer or any Restricted
Subsidiary for the purpose of securing Capitalized Lease Obligations or Purchase Money Obligations, or securing the payment of all or a part of the purchase price of, or securing other Indebtedness Incurred to finance or refinance the acquisition,
improvement or construction of, assets or property acquired or constructed in the ordinary course of business; provided that (a) the aggregate principal amount of Indebtedness secured by such Liens is otherwise permitted to be Incurred
under this Indenture and (b) any such Liens may not extend to any assets or property of the Issuer or any Restricted Subsidiary other than assets or property acquired, improved, constructed or leased with the proceeds of such Indebtedness and
any improvements or accessions to such assets and property and (ii) any interest or title of a lessor under any Capitalized Lease Obligations or operating lease; 

(10) Liens arising from Uniform Commercial Code financing statement filings (or similar filings in other applicable
jurisdictions) regarding operating leases entered into by the Issuer and its Restricted Subsidiaries in the ordinary course of business; 
 (11) Liens existing on the Escrow Release Date, excluding Liens securing the Credit Agreement; 
 (12) Liens on property, other assets or shares of stock of a Person at the time such Person becomes a Restricted Subsidiary (or at the time the Issuer or a Restricted Subsidiary acquires such property,
other assets or shares of stock, including any acquisition by means of a merger, consolidation or other business combination transaction with or into the Issuer or any Restricted Subsidiary); provided, however, that such Liens are not
created, Incurred or assumed in anticipation of or in connection with such other Person becoming a Restricted Subsidiary (or such acquisition of such property, other assets or stock); provided, further, that such Liens are limited to
all or part of the same property, other assets or stock (plus improvements, accession, proceeds or dividends or distributions in connection with the original property, other assets or stock) that secured (or, under the written arrangements
under which such Liens arose, could secure) the obligations to which such Liens relate; 
 (13) Liens on assets
or property of the Issuer or any Restricted Subsidiary securing Indebtedness or other obligations of the Issuer or such Restricted Subsidiary owing to the Issuer or another Restricted Subsidiary, or Liens in favor of the Issuer or any Restricted
Subsidiary; 
 (14) Liens securing Refinancing Indebtedness Incurred to refinance Indebtedness that was
previously so secured, and permitted to be secured under this Indenture; provided that any such Lien is limited to all or part of the same property or assets (plus improvements, accessions, proceeds or dividends or distributions in respect
thereof) that secured (or, under the written arrangements under which the original Lien arose, could secure) the Indebtedness being refinanced or is in respect of property that is or could be the security for or subject to a Permitted Lien
hereunder; 
 (15) (a) mortgages, liens, security interests, restrictions, encumbrances or any other matters of
record that have been placed by any government, statutory or regulatory authority, developer, landlord or other third party on property over which the Issuer or any Restricted Subsidiary of the Issuer has easement rights or on any leased property
and subordination or similar arrangements relating thereto and (b) any condemnation or eminent domain proceedings affecting any real property; 
 (16) any encumbrance or restriction (including put and call arrangements) with respect to Capital Stock of any joint venture or similar arrangement pursuant to any joint venture or similar agreement;

 (17) Liens on property or assets under construction (and related rights) in favor of a contractor or developer
or arising from progress or partial payments by a third party relating to such property or assets; 

  
 -28-

 (18) Liens arising out of conditional sale, title retention, hire purchase,
consignment or similar arrangements for the sale of goods entered into in the ordinary course of business; 

(19) Liens securing Indebtedness permitted to be Incurred under Credit Facilities, including any letter of credit facility
relating thereto, that was permitted by the terms of this Indenture to be Incurred pursuant to Section 3.2(b)(1); provided that (A) in the case of Liens securing any Indebtedness constituting First Priority Obligations,
Future Second Lien Indebtedness or 2030 Notes Indebtedness, the holders of such Indebtedness, or their duly appointed agent, shall become party to the Intercreditor Agreement and (B) in the case of Liens securing any Junior Priority
Indebtedness, the holders of such Junior Priority Indebtedness, or their duly appointed agent, shall become a party to an Intercreditor agreement with the Trustee on terms that are customary for such financings as determined by the Issuer in good
faith reflecting the subordination of such Liens to the liens securing the Notes; 
 (20) Liens to secure
Indebtedness of any Non-Guarantor permitted by Section 3.2(b)(11) covering only the assets of such Subsidiary; 
 (21) Liens on Capital Stock or other securities or assets of any Unrestricted Subsidiary that secure Indebtedness of such Unrestricted Subsidiary; 

(22) any security granted over the marketable securities portfolio described in clause (9) of the definition of
“Cash Equivalents” in connection with the disposal thereof to a third party; 
 (23) Liens on specific
items of inventory of other goods and proceeds of any Person securing such Person’s obligations in respect of bankers’ acceptances issued or created for the account of such Person to facilitate the purchase, shipment or storage of such
inventory or other goods; 
 (24) Liens on equipment of the Issuer or any Restricted Subsidiary and located on
the premises of any client or supplier in the ordinary course of business; 
 (25) Liens on assets or securities
deemed to arise in connection with and solely as a result of the execution, delivery or performance of contracts to sell such assets or securities if such sale is otherwise permitted by this Indenture; 

(26) Liens arising by operation of law or contract on insurance policies and the proceeds thereof to secure premiums
thereunder, and Liens, pledges and deposits in the ordinary course of business securing liability for premiums or reimbursement or indemnification obligations of (including obligations in respect of letters of credit or bank guarantees for the
benefits of) insurance carriers; 
 (27) Liens solely on any cash earnest money deposits made in connection with
any letter of intent or purchase agreement permitted under this Indenture; 
 (28) Liens (i) on cash
advances in favor of the seller of any property to be acquired in an Investment permitted pursuant to Permitted Investments to be applied against the purchase price for such Investment, and (ii) consisting of an agreement to sell any property
in an asset sale permitted under Section 3.5, in each case, solely to the extent such Investment or asset sale, as the case may be, would have been permitted on the date of the creation of such Lien; 

(29) Liens securing Indebtedness and other obligations in an aggregate principal amount not to exceed $750 million at any
one time outstanding; 
 (30) Liens then existing with respect to assets of an Unrestricted Subsidiary on the day
such Unrestricted Subsidiary is redesignated as a Restricted Subsidiary as described under Section 3.20. 
 (31) Liens Incurred to secure Obligations in respect of any Indebtedness permitted to be Incurred pursuant to Section 3.2; provided that (a) in the case of Liens Incurred pursuant
to this clause (31)

  
 -29-

 
securing any Indebtedness either constituting (i) First Priority Obligations or (ii) obligations otherwise secured by a ranking prior to the lien securing the Notes (such obligations,
“Other First Priority Obligations”) in each case, at the time of Incurrence and after giving pro forma effect thereto, the Consolidated First Lien Secured Leverage Ratio would be no greater than 4.75 to 1.00 and the holders of such
Indebtedness, or their duly appointed agent, shall become a party to the Intercreditor Agreement and (b) in the case of Liens Incurred pursuant to this clause (31) securing any Future Second Lien Indebtedness, at the time of Incurrence and
after giving pro forma effect thereto, the Consolidated Total Secured Leverage Ratio would be no greater than 6.00 to 1.00 and holders of such Future Second Lien Indebtedness, or their duly appointed agent, shall become a party to the Intercreditor
Agreement; 
 (32) Liens on the Securitization Assets arising in connection with a Qualified Securitization
Financing; 
 (33) Liens securing any Obligations in respect of the Notes issued on the Issue Date, this
Indenture or the Collateral Documents, including, for the avoidance of doubt, obligations in respect of Exchange Notes and the Guarantees thereof; 
 (34) Liens on the Collateral in favor of any Collateral Agent for the benefit of the Holders relating to such Collateral Agent’s administrative expenses with respect to the Collateral; or 

(35) Liens on the Collateral in favor of the holders of the 6.25% Guaranteed Notes due February 18, 2030 guaranteed
by the Company securing the Company’s guarantee thereunder equally and ratably with the obligations of the Issuer under the Notes and the Indenture and the Guarantors under the Indenture and the Note Guarantees. 

For purposes of this definition, the term Indebtedness shall be deemed to include interest on such Indebtedness including
interest which increases the principal amount of such Indebtedness. 
 “Person” means any individual,
corporation, partnership, joint venture, association, joint-stock company, trust, unincorporated organization, limited liability company, government or any agency or political subdivision thereof or any other entity. 

“Post-Petition Interest” means any interest or entitlement to fees or expenses or other charges that accrue after the
commencement of any bankruptcy or insolvency proceeding, whether or not allowed or allowable as a claim in any such bankruptcy or insolvency proceeding. 
 “Predecessor Note” of any particular Note means every previous Note evidencing all or a portion of the same debt as that evidenced by such particular Note; and, for the purposes of this
definition, any Note authenticated and delivered under Section 2.11 in exchange for or in lieu of a mutilated, destroyed, lost or stolen Note shall be deemed to evidence the same debt as the mutilated, destroyed, lost or stolen Note.

 “Preferred Stock,” as applied to the Capital Stock of any Person, means Capital Stock of any class or
classes (however designated) which is preferred as to the payment of dividends or as to the distribution of assets upon any voluntary or involuntary liquidation or dissolution of such Person, over shares of Capital Stock of any other class of such
Person. 
 “Purchase Money Obligations” means any Indebtedness Incurred to finance or refinance the
acquisition, leasing, construction or improvement of property (real or personal) or assets (including Capital Stock), and whether acquired through the direct acquisition of such property or assets or the acquisition of the Capital Stock of any
Person owning such property or assets, or otherwise. 
 “Qualified Securitization Financing” means any
Securitization Facility of a Securitization Subsidiary that meets the following conditions: (i) the board of directors of the Issuer shall have determined in good faith that such Qualified Securitization Financing (including financing terms,
covenants, termination events and other provisions) is in the aggregate economically fair and reasonable to the Issuer and its Restricted Subsidiaries, (ii) all sales of 

  
 -30-

 
Securitization Assets and related assets by the Issuer or any Restricted Subsidiary to the Securitization Subsidiary or any other Person are made at fair market value (as determined in good faith
by the Issuer) and (iii) the financing terms, covenants, termination events and other provisions thereof shall be market terms (as determined in good faith by the Issuer) and may include Standard Securitization Undertakings. The grant of a
security interest in any Securitization Assets of the Issuer or any of its Restricted Subsidiaries (other than a Securitization Subsidiary) to secure Indebtedness under the Credit Agreement prior to engaging in any securitization financing shall not
be deemed a Qualified Securitization Financing. 
 “QIB” means any “qualified institutional buyer” as
such term is defined in Rule 144A. 
 “Refinance” means refinance, refund, replace, renew, repay, modify,
restate, defer, substitute, supplement, reissue, resell, extend or increase (including pursuant to any defeasance or discharge mechanism) and the terms “refinances,” “refinanced” and “refinancing”
as used for any purpose in this Indenture shall have a correlative meaning. 
 “Refinancing Indebtedness” means
Indebtedness that is Incurred to refund, refinance, replace, exchange, renew, repay or extend (including pursuant to any defeasance or discharge mechanism) any Indebtedness existing on the Issue Date or Incurred in compliance with this Indenture
(including Indebtedness of the Issuer that refinances Indebtedness of any Restricted Subsidiary and Indebtedness of any Restricted Subsidiary that refinances Indebtedness of the Issuer or another Restricted Subsidiary) including Indebtedness that
refinances Refinancing Indebtedness; provided, however, that: 
 (1) (a) such Refinancing
Indebtedness has a Weighted Average Life to Maturity at the time such Refinancing Indebtedness is Incurred which is not less than the remaining Weighted Average Life to Maturity of the Indebtedness, Disqualified Stock or Preferred Stock being
refunded or refinanced; and (b) to the extent such Refinancing Indebtedness refinances Subordinated Indebtedness, Disqualified Stock or Preferred Stock, such Refinancing Indebtedness is Subordinated Indebtedness, Disqualified Stock or Preferred
Stock; 
 (2) Refinancing Indebtedness shall not include: 

(i) Indebtedness, Disqualified Stock or Preferred Stock a Subsidiary of the Issuer that is not a Guarantor that refinances
Indebtedness, Disqualified Stock or Preferred Stock of the Issuer or a Guarantor; or 
 (ii) Indebtedness,
Disqualified Stock or Preferred Stock of the Issuer or a Restricted Subsidiary that refinances Indebtedness, Disqualified Stock or Preferred Stock of an Unrestricted Subsidiary; and 

(3) such Refinancing Indebtedness has an aggregate principal amount (or if Incurred with original issue discount, an
aggregate issue price) that is equal to or less than the aggregate principal amount (or if Incurred with original issue discount, the aggregate accreted value) then outstanding (plus fees and expenses, including any premium and defeasance costs)
under the Indebtedness being Refinanced. 
 Refinancing Indebtedness in respect of any Credit Facility or any other Indebtedness
may be Incurred from time to time after the termination, discharge or repayment of any such Credit Facility or other Indebtedness. 
 “Registration Rights Agreement” means (i) the Registration Rights Agreement related to the Notes dated as of the Issue Date, among Holdings, Merger Sub and the Initial Purchasers, as
amended or supplemented, and (ii) any other registration rights agreement entered into in connection with the issuance of Additional Notes in a private offering by the Issuer after the Issue Date. 

“Regulation S” means Regulation S under the Securities Act. 

“Regulation S-X” means Regulation S-X under the Securities Act. 

  
 -31-

 “Related Taxes” means: 

(1) any Taxes, including sales, use, transfer, rental, ad valorem, value added, stamp, property, consumption,
franchise, license, capital, registration, business, customs, net worth, gross receipts, excise, occupancy, intangibles or similar Taxes (other than (x) Taxes measured by income and (y) withholding imposed on payments made by any Parent
Entity), required to be paid (provided such Taxes are in fact paid) by any Parent Entity by virtue of its: 
 (a) being organized or having Capital Stock outstanding (but not by virtue of owning stock or other equity interests of any corporation or other entity other than, directly or indirectly, the Issuer or
any of the Issuer’s Subsidiaries); 
 (b) being a holding company parent, directly or indirectly, of the
Issuer or any of the Issuer’s Subsidiaries; 
 (c) receiving dividends from or other distributions in
respect of the Capital Stock of, directly or indirectly, the Issuer or any of the Issuer’s Subsidiaries; or 

(d) having made any payment in respect to any of the items for which the Issuer is permitted to make payments to any
Parent Entity pursuant to Section 3.3; or 
 (2) if and for so long as the Issuer is a member of a
group filing a consolidated or combined tax return with any Parent Entity, any Taxes measured by income for which such Parent Entity is liable up to an amount not to exceed with respect to such Taxes the amount of any such Taxes that the Issuer and
its Subsidiaries would have been required to pay on a separate company basis or on a consolidated basis if the Issuer and its Subsidiaries had paid Tax on a consolidated, combined, group, affiliated or unitary basis on behalf of an affiliated group
consisting only of the Issuer and its Subsidiaries. 
 “Restricted Investment” means any Investment other than
a Permitted Investment. 
 “Restricted Notes” means Initial Notes and Additional Notes bearing one of the
restrictive legends described in Section 2.1(d). 
 “Restricted Notes Legend” means the legend set
forth in Section 2.1(d)(1) and, in the case of the Temporary Regulation S Global Note, the legend set forth in Section 2.1(d)(2). 
 “Restricted Subsidiary” means any Subsidiary of the Issuer other than an Unrestricted Subsidiary. 
 “Rule 144A” means Rule 144A under the Securities Act. 

“S&P” means Standard & Poor’s Investors Ratings Services or any of its successors or assigns that is a
Nationally Recognized Statistical Rating Organization. 
 “Sale and Leaseback Transaction” means any
arrangement providing for the leasing by the Issuer or any of its Restricted Subsidiaries of any real or tangible personal property, which property has been or is to be sold or transferred by the Issuer or such Restricted Subsidiary to a third
Person in contemplation of such leasing. 
 “SEC” means the U.S. Securities and Exchange Commission or any
successor thereto. 
 “Second Lien Security Agreement” means the second priority security agreement dated as of
the Escrow Release Date by and among Merger Sub, Heinz, each Guarantor and the Collateral Agent, substantially in the form of Exhibit E hereto, as it may be amended from time to time in accordance with this Indenture. 

“Second Priority After-Acquired Property” means property (other than Excluded Property) that is intended to be
Collateral acquired by the Issuer or a Guarantor and is pledged to secure the First Priority Obligations 

  
 -32-

 
(including property of a Person that becomes a new Guarantor) after the date of this Indenture that is not automatically subject to a perfected security interest under the Collateral Documents,
which the Issuer or such Guarantor will provide a Second Priority Lien over such property (or, in the case of a new Guarantor, such of its property) in favor of the Collateral Agent and deliver certain certificates and opinions in respect thereof,
all as and to the extent required by this Indenture, the Intercreditor Agreement or the Collateral Documents. 
 “Second
Priority Liens” means all Liens in favor of the Collateral Agent on Collateral securing the Second Priority Obligations. 
 “Second Priority Obligations” means all Obligations of the Issuer and the Guarantors under the Notes, this Indenture and the Collateral Documents and all Obligations in respect of the
Future Second Lien Indebtedness and the 2030 Notes Indebtedness. 
 “Secured Indebtedness” means any
Indebtedness secured by a Lien other than Indebtedness with respect to Cash Management Services. 
 “Securities
Act” means the U.S. Securities Act of 1933, as amended, and the rules and regulations of the SEC promulgated thereunder, as amended. 
 “Securitization Asset” means any accounts receivable, real estate asset, mortgage receivables or related assets, in each case subject to a Securitization Facility. 

“Securitization Facility” means any of one or more securitization financing facilities as amended, supplemented,
modified, extended, renewed, restated or refunded from time to time, pursuant to which the Issuer or any of its Restricted Subsidiaries sells its Securitization Assets to either (a) Person that is not a Restricted Subsidiary or (b) a
Securitization Subsidiary that in turn sells Securitization Assets to a person that is not a Restricted Subsidiary. 

“Securitization Fees” means distributions or payments made directly or by means of discounts with respect to any
Securitization Asset or participation interest therein issued or sold in connection with, and other fees paid to a person that is not a Restricted Subsidiary in connection with, any Qualified Securitization Financing. 

“Securitization Repurchase Obligation” means any obligation of a seller of Securitization Assets in a Qualified
Securitization Financing to repurchase Securitization Assets arising as a result of a breach of a representation, warranty or covenant or otherwise, including as a result of a receivable or portion thereof becoming subject to any asserted defense,
dispute, offset or counterclaim of any kind as a result of any action taken by, any failure to take action by or any other event relating to the seller. 
 “Securitization Subsidiary” means any Subsidiary in each case formed for the purpose of and that solely engages in one or more Qualified Securitization Financings and other activities
reasonably related thereto. 
 “Significant Subsidiary” means any Restricted Subsidiary that would be a
“significant subsidiary” as defined in Article 1, Rule 1-02 of Regulation S-X, promulgated pursuant to the Securities Act, as such regulation is in effect on the Issue Date. 

“Similar Business” means (a) any businesses, services or activities engaged in by the Issuer or any of its
Subsidiaries or any Associates on the Escrow Release Date and (b) any businesses, services and activities engaged in by the Issuer or any of its Subsidiaries or any Associates that are related, complementary, incidental, ancillary or similar to
any of the foregoing or are extensions or developments of any thereof. 
 “Sponsor” means 3G Capital, Inc., and
each of its Affiliates but not including, however, any portfolio companies of any of the foregoing. 
 “Standard
Securitization Undertakings” means representations, warranties, covenants and indemnities entered into by the Issuer or any Subsidiary of the Issuer which the Issuer has determined in good faith to be

  
 -33-

 
customary in a Qualified Securitization Financing, including those relating to the servicing of the assets of a Securitization Subsidiary, it being understood that any Securitization Repurchase
Obligation shall be deemed to be a Standard Securitization Undertaking. 
 “Stated Maturity” means, with
respect to any security, the date specified in such security as the fixed date on which the payment of principal of such security is due and payable, including pursuant to any mandatory redemption provision, but shall not include any contingent
obligations to repay, redeem or repurchase any such principal prior to the date originally scheduled for the payment thereof. 

“Subordinated Indebtedness” means, with respect to any person, any Indebtedness (whether outstanding on the Issue Date
or thereafter Incurred) which is expressly subordinated in right of payment to the Notes pursuant to a written agreement. 

“Subsidiary” means, with respect to any Person: 

(1) any corporation, association, or other business entity (other than a partnership, joint venture, limited liability
company or similar entity) of which more than 50% of the total voting power of shares of Capital Stock entitled (without regard to the occurrence of any contingency) to vote in the election of directors, managers or trustees thereof is at the time
of determination owned or controlled, directly or indirectly, by such Person or one or more of the other Subsidiaries of that Person or a combination thereof; or 

(2) any partnership, joint venture, limited liability company or similar entity of which: 

(a) more than 50% of the capital accounts, distribution rights, total equity and voting interests or general or limited
partnership interests, as applicable, are owned or controlled, directly or indirectly, by such Person or one or more of the other Subsidiaries of that Person or a combination thereof whether in the form of membership, general, special or limited
partnership interests or otherwise; and 
 (b) such Person or any Subsidiary of such Person is a controlling
general partner or otherwise controls such entity. 
 “Supplemental Indenture” means the supplemental indenture
to this Indenture, dated as of the Escrow Release Date, by and among Merger Sub, Heinz, the Guarantors (other than Holdings), the Trustee and the Collateral Agent, substantially in the form of Exhibit C. 

“Taxes” means all present and future taxes, levies, imposts, deductions, charges, duties and withholdings and any
charges of a similar nature (including interest, penalties and other liabilities with respect thereto) that are imposed by any government or other taxing authority. 
 “TIA” means the Trust Indenture Act of 1939, as amended. 

“Total Assets” means, as of any date, the total consolidated assets of the Issuer and its Restricted Subsidiaries on a
consolidated basis, as shown on the most recent consolidated balance sheet of the Issuer and its Restricted Subsidiaries, determined on a pro forma basis in a manner consistent with the pro forma basis contained in the definition of Fixed Charge
Coverage Ratio. 
 “Transaction Expenses” means any fees or expenses incurred or paid by Hawk Acquisition
Holding Corporation, a Delaware Corporation, Holdings, Merger Sub or any Restricted Subsidiary in connection with the Transactions. 
 “Transactions” means the transactions contemplated by the Merger Agreement, the issuance of the Notes and borrowings under the Credit Agreement as in effect on the Escrow Release Date.

  
 -34-

 “Trust Officer” means, when used with respect to the Trustee or Collateral
Agent, as applicable, any vice president, assistant vice president, any trust officer or any other officer of the Trustee or Collateral Agent, as applicable, who customarily performs functions similar to those performed by the Persons who at the
time shall be such officers, respectively, or to whom any corporate trust matter is referred because of such person’s knowledge of and familiarity with the particular subject and who shall have direct responsibility for the administration of
this Indenture. 
 “Trustee” means the party named as such in this Indenture until a successor replaces it and,
thereafter, means the successor. 
 “Uniform Commercial Code” or “UCC” means the New York
Uniform Commercial Code as in effect from time to time. 
 “Unrestricted Subsidiary” means: 

(1) any Subsidiary (other than the Issuer or any direct or indirect parent entity of the Issuer) of the Issuer that at the
time of determination is an Unrestricted Subsidiary (as designated by the Board of Directors of the Issuer in the manner provided below); and 
 (2) any Subsidiary of an Unrestricted Subsidiary. 
 The Board of Directors of the
Issuer may designate any Subsidiary (other than the Issuer or any direct or indirect parent entity of the Issuer) of the Issuer, respectively (including any newly acquired or newly formed Subsidiary or a Person becoming a Subsidiary through merger,
consolidation or other business combination transaction, or Investment therein) to be an Unrestricted Subsidiary only if: 
 (1) such Subsidiary or any of its Subsidiaries does not own any Capital Stock or Indebtedness of, or own or hold any Lien on any property of, the Issuer or any other Subsidiary of the Issuer which is not
a Subsidiary of the Subsidiary to be so designated or otherwise an Unrestricted Subsidiary; and 
 (2) such
designation and the Investment of the Issuer in such Subsidiary complies with Section 3.3 hereof. 
 “U.S.
Government Obligations” means securities that are (1) direct obligations of the United States of America for the timely payment of which its full faith and credit is pledged or (2) obligations of a Person controlled or supervised
by and acting as an agency or instrumentality of the United States of America the timely payment of which is unconditionally Guaranteed as a full faith and credit obligation of the United States of America, which, in either case, are not callable or
redeemable at the option of the issuers thereof, and shall also include a depositary receipt issued by a bank (as defined in Section 3(a)(2) of the Securities Act), as custodian with respect to any such U.S. Government Obligations or a specific
payment of principal of or interest on any such U.S. Government Obligations held by such custodian for the account of the holder of such depositary receipt, provided that (except as required by law) such custodian is not authorized to make
any deduction from the amount payable to the holder of such depositary receipt from any amount received by the custodian in respect of the U.S. Government Obligations or the specific payment of principal of or interest on the U.S. Government
Obligations evidenced by such depositary receipt. 
 “Voting Stock” of a Person means all classes of Capital
Stock of such Person then outstanding and normally entitled to vote in the election of directors. 

  
 -35-

 “Weighted Average Life to Maturity” means, when applied to any
Indebtedness, Disqualified Stock or Preferred Stock, as the case may be, at any date, the quotient obtained by dividing: 
 (1) the sum of the products of the number of years from the date of determination to the date of each successive scheduled principal payment of such Indebtedness or redemption or similar payment with
respect to such Disqualified Stock or Preferred Stock multiplied by the amount of such payment, by 
 (2) the sum
of all such payments. 
 “Wholly Owned Domestic Subsidiary” means a Domestic Subsidiary of the Issuer, all of
the Capital Stock of which (other than directors’ qualifying shares or shares required by any applicable law or regulation to be held by a Person other than the Issuer or another Domestic Subsidiary) is owned by the Issuer or another Domestic
Subsidiary. 
 SECTION 1.2. Other Definitions. 

 

			
	 Term
	  	 Defined in

Section

	 “Accredited Investor Note”
	  	2.1(d)(1)
	 “Action”
	  	12.9(w)
	 “Additional Restricted Notes”
	  	2.1(b)
	 “Affiliate Transaction”
	  	3.8(a)
	 “Agent Members”
	  	2.1(g)(2)
	 “Asset Disposition Offer”
	  	3.5(b)
	 “Asset Sale Payment Date”
	  	3.5(g)(2)
	 “Authenticating Agent”
	  	2.2
	 “Automatic Exchange”
	  	2.6(e)
	 “Automatic Exchange Date”
	  	2.6(e)
	 “Automatic Exchange Notice”
	  	2.6(e)
	 “Automatic Exchange Notice Date”
	  	2.6(e)
	 “bankruptcy provisions”
	  	6.1(a)(5)(F)
	 “Change of Control Offer”
	  	3.9(a)
	 “Change of Control Payment”
	  	3.9(a)
	 “Change of Control Payment Date”
	  	3.9(a)
	 “Clearstream”
	  	2.1(b)
	 “Collateral Document Order”
	  	12.9(s)
	 “Covenant Defeasance”
	  	8.3
	 “cross acceleration provision”
	  	6.1(a)(4)(B)
	 “Defaulted Interest”
	  	2.15
	 “Escrow Account”
	  	3.24(a)
	 “Escrow Agent”
	  	3.24(a)
	 “Escrow Agreement”
	  	3.24(a)

  
 -36-

			
	 Term
	  	 Defined in

Section

	 “Escrowed Property”
	  	3.24(a)
	 “Escrow Release”
	  	3.24(c)
	 “Escrow Release Date”
	  	3.24(c)
	 “Euroclear”
	  	2.1(b)
	 “Event of Default”
	  	6.1
	 “Excess Proceeds”
	  	3.5(b)
	 “Exchange Global Note”
	  	2.1(b)
	 “Foreign Disposition”
	  	3.5(e)
	 “Global Notes”
	  	2.1(b)
	 “Guaranteed Obligations”
	  	10.1
	 “Increased Amount”
	  	3.6(c)
	 “Initial Agreement”
	  	3.4(b)
	 “Initial Default”
	  	6.12
	 “Initial Lien”
	  	3.6
	 “Institutional Accredited Investor Global Note”
	  	2.1(b)
	 “Institutional Accredited Investor Notes”
	  	2.1(b)
	 “Issuer Order”
	  	2.2
	 “judgment default provision”
	  	6.1(a)(7)
	 “Legal Defeasance”
	  	8.2
	 “Legal Holiday”
	  	13.8
	 “Note Guarantee”
	  	10.1
	 “Notes Register”
	  	2.3
	 “payment default”
	  	6.1(a)(4)(A)
	 “Permanent Regulation S Global Note”
	  	2.1(b)
	 “Permitted Payments”
	  	3.3(b)
	 “protected purchaser”
	  	2.11
	 “Redemption Date”
	  	5.7(a)
	 “Refunding Capital Stock”
	  	3.3(b)
	 “Registrar”
	  	2.3
	 “Regulation S Global Note”
	  	2.1(b)
	 “Regulation S Notes”
	  	2.1(b)
	 “Related Person”
	  	12.9(b)
	 “Resale Restriction Termination Date”
	  	2.6(b)
	 “Restricted Global Note”
	  	2.6(e)
	 “Restricted Payment”
	  	3.3(a)(4)

  
 -37-

			
	 Term
	  	 Defined in

Section

	“Restricted Period”	  	2.1(b)
	“Reversion Date”	  	3.19(b)
	“Rule 144A Global Note”	  	2.1(b)
	“Rule 144A Notes”	  	2.1(b)
	“Second Commitment”	  	3.5(a)(3)(ii)
	“security default provisions”	  	6.1(a)(10)
	“Special Interest Payment Date”	  	2.15(a)
	“Special Mandatory Redemption”	  	5.9
	“Special Mandatory Redemption Date”	  	5.9
	“Special Mandatory Redemption Price”	  	5.9
	“Special Record Date”	  	2.15(a)
	“Successor Company”	  	4.1(a)(1)
	“Suspended Covenants”	  	3.19(a)
	“Suspension Period”	  	3.19(b)
	“Temporary Regulation S Global Note”	  	2.1(b)
	“Unrestricted Global Note”	  	2.6(e)

 SECTION 1.3. Incorporation by Reference of Trust Indenture Act. This Indenture is subject to the
mandatory provisions of the TIA which are incorporated by reference in and made a part of this Indenture. The following TIA terms have the following meanings: 
 “Commission” means the SEC. 
 “indenture
securities” means the Notes. 
 “indenture security holder” means a Holder. 

“indenture to be qualified” means this Indenture. 

“indenture trustee” or “institutional trustee” means the Trustee. 

“obligor” on the indenture securities means the Issuer and any other obligor on the indenture securities.

 All other TIA terms used in this Indenture that are defined by the TIA, defined in the TIA by reference to another statute or
defined by SEC rule have the meanings assigned to them by such definitions. 
 SECTION 1.4. Rules of Construction. Unless
the context otherwise requires: 
 (1) a term has the meaning assigned to it; 

(2) an accounting term not otherwise defined has the meaning assigned to it in accordance with GAAP; 

  
 -38-

 (3) “or” is not exclusive; 

(4) “including” means including without limitation; 

(5) words in the singular include the plural and words in the plural include the singular; 

(6) “will” shall be interpreted to express a command; 

(7) whenever in this Indenture there is mentioned, in any context, principal, interest or any other amount payable under
or with respect to any Notes, such mention shall be deemed to include mention of the payment of Additional Interest, to the extent that, in such context, Additional Interest is, was or would be payable in respect thereof pursuant to the Notes,
provided, however, that the Trustee shall not be deemed to have knowledge of the requirement that Additional Interest is due unless the Trustee receives written notice from Issuer stating that such amounts are due and specifying the
dollar amounts thereof; 
 (8) all amounts expressed in this Indenture or in any of the Notes in terms of money
refer to the lawful currency of the United States of America; 
 (9) the words “herein,”
“hereof” and “hereunder” and other words of similar import refer to this Indenture as a whole and not to any particular Article, Section or other subdivision; 

(10) unless otherwise specifically indicated, the term “consolidated” with respect to any Person refers to such
Person consolidated with its Restricted Subsidiaries, and excludes from such consolidation any Unrestricted Subsidiary as if such Unrestricted Subsidiary were not an Affiliate of such Person; and 

ARTICLE II 

THE NOTES 

SECTION 2.1. Form, Dating and Terms. 
 (a) The aggregate principal amount of Notes that may be authenticated and delivered under this Indenture is unlimited. The Initial Notes issued on the date hereof will be in an aggregate principal amount
of $3,100,000,000. In addition, the Issuer may issue, from time to time in accordance with the provisions of this Indenture, Additional Notes (as provided herein) and Exchange Notes. Furthermore, Notes may be authenticated and delivered upon
registration of transfer, exchange or in lieu of, other Notes pursuant to Sections 2.2, 2.6, 2.11, 2.13, 5.6 or 9.5, in connection with an Asset Disposition Offer pursuant to Section 3.5 or
in connection with a Change of Control Offer pursuant to Section 3.9. 
 Notwithstanding anything to the contrary
contained herein, the Issuer may not issue any Additional Notes, unless such issuance is in compliance with Sections 3.2 and 3.6. 
 With respect to any Additional Notes, the Issuer shall set forth in (1) a Board Resolution and (2) (i) an Officer’s Certificate and (ii) one or more indentures supplemental
hereto, the following information: 
 (A) the aggregate principal amount of such Additional Notes to be
authenticated and delivered pursuant to this Indenture; 
 (B) the issue price and the issue date of such
Additional Notes, including the date from which interest shall accrue; and 
 (C) whether such Additional Notes
shall be Restricted Notes. 

  
 -39-

 In authenticating and delivering Additional Notes, the Trustee shall be entitled to receive
and shall be fully protected in relying upon, in addition to the Opinion of Counsel and Officer’s Certificate required by Section 13.4, an Opinion of Counsel as to the due authorization, execution, delivery, validity and
enforceability of such Additional Notes. 
 The Initial Notes, the Additional Notes and the Exchange Notes shall be considered
collectively as a single class for all purposes of this Indenture. Holders of the Initial Notes, the Additional Notes and the Exchange Notes will vote and consent together on all matters to which such Holders are entitled to vote or consent as one
class, and none of the Holders of the Initial Notes, the Additional Notes or the Exchange Notes shall have the right to vote or consent as a separate class on any matter to which such Holders are entitled to vote or consent. 

If any of the terms of any Additional Notes are established by action taken pursuant to a Board Resolution of the Issuer, a copy of an
appropriate record of such action shall be certified by the Secretary or any Assistant Secretary of the Issuer and delivered to the Trustee at or prior to the delivery of the Officer’s Certificate or an indenture supplemental hereto setting
forth the terms of the Additional Notes. 
 (b) The Initial Notes are being offered and sold by the Issuer pursuant to a
Purchase Agreement, dated March 22, 2013, among Merger Sub, Holdings and, following the Escrow Release Date, Heinz and the Guarantors (other than Holdings) (upon execution of a joinder agreement to the Purchase Agreement) and the Initial
Purchasers. The Initial Notes and any Additional Notes (if issued as Restricted Notes) (the “Additional Restricted Notes”) will be resold initially only to (A) QIBs in reliance on Rule 144A and (B) Non-U.S. Persons in
reliance on Regulation S. Such Initial Notes and Additional Restricted Notes may thereafter be transferred to, among others, QIBs, purchasers in reliance on Regulation S, AIs and IAIs in accordance with Rule 501 under the Securities Act,
in each case, in accordance with the procedure described herein. Additional Notes offered after the date hereof may be offered and sold by the Issuer from time to time pursuant to one or more purchase agreements in accordance with applicable law.

 Initial Notes and Additional Restricted Notes offered and sold to QIBs in the United States of America in reliance on
Rule 144A (the “Rule 144A Notes”) shall be issued in the form of a permanent global Note substantially in the form of Exhibit A, which is hereby incorporated by reference and made a part of this Indenture,
including appropriate legends as set forth in Section 2.1(d) and (e) (the “Rule 144A Global Note”), deposited with the Trustee, as custodian for DTC, duly executed by the Issuer and authenticated by the
Trustee as hereinafter provided. The Rule 144A Global Note may be represented by more than one certificate, if so required by DTC’s rules regarding the maximum principal amount to be represented by a single certificate. The aggregate
principal amount of the Rule 144A Global Note may from time to time be increased or decreased by adjustments made on the records of the Trustee, as custodian for DTC or its nominee, as hereinafter provided. 

Initial Notes and any Additional Restricted Notes offered and sold outside the United States of America (the “Regulation S
Notes”) in reliance on Regulation S shall initially be issued in the form of a temporary global Note (the “Temporary Regulation S Global Note”). Beneficial interests in the Temporary Regulation S Global Note
will be exchanged for beneficial interests in a corresponding permanent global Note substantially in the form of Exhibit A including appropriate legends as set forth in Section 2.1(d) and (e) (the
“Permanent Regulation S Global Note” and, together with the Temporary Regulation S Global Note, each a “Regulation S Global Note”) within a reasonable period after the expiration of the Restricted
Period (as defined below) upon delivery of the certification contemplated by Exhibit F. Each Regulation S Global Note will be deposited upon issuance with, or on behalf of, the Trustee as custodian for DTC in the manner described in this
Article II for credit to the respective accounts of the purchasers (or to such other accounts as they may direct), including, but not limited to, accounts at Euroclear Bank S.A./N.V. (“Euroclear”) or Clearstream Banking,
société anonyme (“Clearstream”). Prior to the 40th day after the later of the commencement of the offering of the Initial Notes and the Issue Date (such period through and including such 40th day, the
“Restricted Period”), interests in the Temporary Regulation S Global Note may only be transferred to non-U.S. persons pursuant to Regulation S, unless exchanged for interests in a Global Note in accordance with the
transfer and certification requirements described herein. 
 Investors may hold their interests in the Regulation S Global
Note through organizations other than Euroclear or Clearstream that are participants in DTC’s system or directly through Euroclear or Clearstream, if they are participants in such systems, or indirectly through organizations which are
participants in such systems. If such 

  
 -40-

 
interests are held through Euroclear or Clearstream, Euroclear and Clearstream will hold such interests in the applicable Regulation S Global Note on behalf of their participants through
customers’ securities accounts in their respective names on the books of their respective depositaries. Such depositaries, in turn, will hold such interests in the applicable Regulation S Global Note in customers’ securities accounts
in the depositaries’ names on the books of DTC. 
 The Regulation S Global Note may be represented by more than one
certificate, if so required by DTC’s rules regarding the maximum principal amount to be represented by a single certificate. The aggregate principal amount of the Regulation S Global Note may from time to time be increased or decreased by
adjustments made on the records of the Trustee, as custodian for DTC or its nominee, as hereinafter provided. 
 Initial Notes
and Additional Restricted Notes resold to IAIs (the “Institutional Accredited Investor Notes”) in the United States of America shall be issued in the form of a permanent global Note substantially in the form of Exhibit A
including appropriate legends as set forth in Section 2.1(d) and (e) (the “Institutional Accredited Investor Global Note”) deposited with the Trustee, as custodian for DTC, duly executed by the Issuer and
authenticated by the Trustee as hereinafter provided. The Institutional Accredited Investor Global Note may be represented by more than one certificate, if so required by DTC’s rules regarding the maximum principal amount to be represented by a
single certificate. The aggregate principal amount of the Institutional Accredited Investor Global Note may from time to time be increased or decreased by adjustments made on the records of the Trustee, as custodian for DTC or its nominee, as
hereinafter provided. 
 Initial Notes and Additional Restricted Notes resold to AIs in the United States of America shall be
issued in the form of a Definitive Note substantially in the form of Exhibit A including the legend as set forth in Section 2.1(f) (an “Accredited Investor Note”). 

Exchange Notes exchanged for interests in the Rule 144A Notes, the Regulation S Notes, and the Institutional Accredited
Investor Notes will be issued in the form of a permanent global Note, substantially in the form of Exhibit B, which is hereby incorporated by reference and made a part of this Indenture, deposited with the Trustee as hereinafter
provided, including the appropriate legend set forth in Section 2.1(d) and (e) (the “Exchange Global Note”). The Exchange Global Note will be deposited upon issuance with, or on behalf of, the Trustee as
custodian for DTC, duly executed by the Issuer and authenticated by the Trustee as hereinafter provided. The Exchange Global Note may be represented by more than one certificate, if so required by DTC’s rules regarding the maximum principal
amount to be represented by a single certificate. 
 The Rule 144A Global Note, the Regulation S Global Note, the
Institutional Accredited Investor Global Note and the Exchange Global Note are sometimes collectively herein referred to as the “Global Notes.” 
 The principal of (and premium, if any) and interest on the Notes shall be payable at the office or agency of Paying Agent designated by the Issuer maintained for such purpose (which shall initially be the
office of the Trustee maintained for such purpose), or at such other office or agency of the Issuer as may be maintained for such purpose pursuant to Section 2.3; provided, however, that, at the option of the Paying Agent,
each installment of interest may be paid by (i) check mailed to addresses of the Persons entitled thereto as such addresses shall appear on the Notes Register or (ii) wire transfer to an account located in the United States maintained by
the payee, subject to the last sentence of this paragraph. Payments in respect of Notes represented by a Global Note (including principal, premium, if any, and interest) will be made by wire transfer of immediately available funds to the accounts
specified by DTC. Payments in respect of Notes represented by Definitive Notes (including principal, premium, if any, and interest) held by a Holder of at least $1,000,000 aggregate principal amount of Notes represented by Definitive Notes will be
made by wire transfer to a U.S. dollar account maintained by the payee with a bank in the United States if such Holder elects payment by wire transfer by giving written notice to the Trustee or the Paying Agent to such effect designating such
account no later than 15 days immediately preceding the relevant due date for payment (or such other date as the Trustee may accept in its discretion). 
 The Notes may have notations, legends or endorsements required by law, stock exchange rule or usage, in addition to those set forth on Exhibit A and Exhibit B and in
Section 2.1(d), (e) and (f). The Issuer shall approve any notation, endorsement or legend on the Notes. Each Note shall be dated the date of its authentication. The terms of the Notes set forth in Exhibit A
and Exhibit B are part of the terms of this Indenture and, to the extent applicable, the Issuer, the Guarantors and the Trustee, by their execution and delivery of this Indenture, expressly agree to be bound by such terms. 

  
 -41-

 (c) Denominations. The Notes shall be in minimum denominations of $2,000 and integral
multiples of $1,000 in excess thereof. 
 (d) Restrictive Legends. Unless and until (i) an Initial Note or an
Additional Note issued as a Restricted Note is sold under an effective registration statement or (ii) an Initial Note or an Additional Note issued as a Restricted Note is exchanged for an Exchange Note in connection with an effective
registration statement, in each case pursuant to the Registration Rights Agreement or a similar agreement or (iii) the Trustee receives an Opinion of Counsel reasonably satisfactory to it to the effect that neither such legend nor the related
restrictions on transfer are required in order to maintain compliance with the provisions of the Securities Act: 

(1) the Rule 144A Global Note, the Regulation S Global Note, the Institutional Accredited Investor Global Note
and the Accredited Investor Global Note shall bear the following legend on the face thereof: 
 THIS SECURITY HAS NOT BEEN AND
WILL NOT BE REGISTERED UNDER THE U.S. SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”) OR THE SECURITIES LAWS OF ANY STATE OR OTHER JURISDICTION. NEITHER THIS NOTE NOR ANY INTEREST OR PARTICIPATION HEREIN MAY BE OFFERED, SOLD,
ASSIGNED, TRANSFERRED, PLEDGED, ENCUMBERED OR OTHERWISE DISPOSED OF IN THE ABSENCE OF SUCH REGISTRATION OR UNLESS SUCH TRANSACTION IS EXEMPT FROM, OR NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT. 

THE HOLDER OF THIS SECURITY BY ITS ACCEPTANCE HEREOF AGREES TO OFFER, SELL OR OTHERWISE TRANSFER SUCH NOTE, PRIOR TO THE DATE (THE
“RESALE RESTRICTION TERMINATION DATE”) THAT IS IN THE CASE OF RULE 144A NOTES: ONE YEAR, IN THE CASE OF REGULATION S NOTES: 40 DAYS, AFTER THE LATER OF THE ORIGINAL ISSUE DATE HEREOF AND THE LAST DATE ON WHICH THE ISSUER OR ANY AFFILIATE
OF THE ISSUER WAS THE OWNER OF THIS SECURITY (OR ANY PREDECESSOR OF THIS SECURITY) ONLY (A) TO THE ISSUER, THE GUARANTORS OR ANY SUBSIDIARY THEREOF, (B) PURSUANT TO A REGISTRATION STATEMENT THAT HAS BEEN DECLARED EFFECTIVE UNDER THE
SECURITIES ACT, (C) FOR SO LONG AS THE SECURITIES ARE ELIGIBLE FOR RESALE PURSUANT TO RULE 144A UNDER THE SECURITIES ACT (“RULE 144A”), TO A PERSON IT REASONABLY BELIEVES IS A “QUALIFIED INSTITUTIONAL BUYER” AS DEFINED IN
RULE 144A THAT PURCHASES FOR ITS OWN ACCOUNT OR FOR THE ACCOUNT OF A QUALIFIED INSTITUTIONAL BUYER TO WHOM NOTICE IS GIVEN THAT THE TRANSFER IS BEING MADE IN RELIANCE ON RULE 144A, (D) PURSUANT TO OFFERS AND SALES THAT OCCUR OUTSIDE THE UNITED
STATES IN COMPLIANCE WITH REGULATION S UNDER THE SECURITIES ACT OR (E) PURSUANT TO ANY OTHER AVAILABLE EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT, SUBJECT IN EACH OF THE FOREGOING CASES TO ANY REQUIREMENT OF LAW THAT THE
DISPOSITION OF ITS PROPERTY OR THE PROPERTY OF SUCH INVESTOR ACCOUNT OR ACCOUNTS BE AT ALL TIMES WITHIN ITS OR THEIR CONTROL AND TO COMPLIANCE WITH ANY APPLICABLE STATE SECURITIES LAWS, AND ANY APPLICABLE LOCAL LAWS AND REGULATIONS AND FURTHER
SUBJECT TO THE ISSUER’S AND THE TRUSTEE’S RIGHTS PURSUANT TO THE INDENTURE PRIOR TO ANY SUCH OFFER, SALE OR TRANSFER (I) PURSUANT TO CLAUSE (E) TO REQUIRE THE DELIVERY OF AN OPINION OF COUNSEL, CERTIFICATION AND/OR OTHER
INFORMATION SATISFACTORY TO EACH OF THEM, (II) IN EACH OF THE FOREGOING CASES, TO REQUIRE 

  
 -42-

 
THAT A CERTIFICATE OF TRANSFER IN THE FORM APPEARING ON THE OTHER SIDE OF THIS SECURITY IS COMPLETED AND DELIVERED BY THE TRANSFEROR TO THE TRUSTEE AND (III) AGREES THAT IT WILL GIVE TO EACH
PERSON TO WHOM THIS SECURITY IS TRANSFERRED A NOTICE SUBSTANTIALLY TO THE EFFECT OF THIS LEGEND. 
 (2) the
Temporary Regulation S Global Note shall bear the following additional legend on the face thereof: 
 THIS SECURITY IS A
TEMPORARY GLOBAL NOTE. PRIOR TO THE EXPIRATION OF THE RESTRICTED PERIOD APPLICABLE HERETO, BENEFICIAL INTERESTS HEREIN MAY NOT BE HELD BY ANY PERSON OTHER THAN (1) A NON-U.S. PERSON OR (2) A U.S. PERSON THAT PURCHASED SUCH INTEREST IN A
TRANSACTION EXEMPT FROM REGISTRATION UNDER THE SECURITIES ACT. BENEFICIAL INTERESTS HEREIN ARE NOT EXCHANGEABLE FOR PHYSICAL NOTES OTHER THAN A PERMANENT GLOBAL NOTE IN ACCORDANCE WITH THE TERMS OF THE INDENTURE. TERMS IN THIS LEGEND ARE USED AS
USED IN REGULATION S UNDER THE SECURITIES ACT. 
 (e) Global Note Legend. Each Global Note, whether or not an Initial
Note, shall bear the following legend on the face thereof: 
 UNLESS THIS CERTIFICATE IS PRESENTED BY AN AUTHORIZED
REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY, A NEW YORK CORPORATION (“DTC”), NEW YORK, NEW YORK, TO THE ISSUER OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY CERTIFICATE ISSUED IS REGISTERED IN THE NAME
OF CEDE & CO. OR IN SUCH OTHER NAME AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC (AND ANY PAYMENT IS MADE TO CEDE & CO. OR TO SUCH OTHER ENTITY AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC), ANY TRANSFER, PLEDGE
OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL INASMUCH AS THE REGISTERED OWNER HEREOF, CEDE & CO., HAS AN INTEREST HEREIN. 
 TRANSFERS OF THIS GLOBAL NOTE SHALL BE LIMITED TO TRANSFERS IN WHOLE, BUT NOT IN PART, TO DTC, TO NOMINEES OF DTC OR TO A SUCCESSOR THEREOF OR SUCH SUCCESSOR’S NOMINEE AND TRANSFERS OF PORTIONS OF
THIS GLOBAL NOTE SHALL BE LIMITED TO TRANSFERS MADE IN ACCORDANCE WITH THE RESTRICTIONS SET FORTH IN THE INDENTURE REFERRED TO ON THE REVERSE HEREOF. 
 (f) AI Note Legend. Each Accredited Investor Note shall bear the following legend on the face thereof: 
 THIS SECURITY HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD WITHIN THE UNITED STATES OR TO, OR FOR THE
ACCOUNT OR BENEFIT OF, U.S. PERSONS EXCEPT AS SET FORTH BELOW. BY ITS ACQUISITION HEREOF, THE HOLDER (1) REPRESENTS THAT (A) IT IS A “QUALIFIED INSTITUTIONAL BUYER” (AS DEFINED IN RULE 144A UNDER THE SECURITIES ACT), (B) IT
IS NOT A U.S. PERSON AND IS ACQUIRING THIS SECURITY IN AN OFFSHORE TRANSACTION IN COMPLIANCE WITH RULE 904 UNDER THE SECURITIES ACT OR (C) IT IS AN ACCREDITED INVESTOR (AS DEFINED IN RULE 501(a)(1), (2), (3), OR (7) UNDER THE SECURITIES
ACT) (AN “ACCREDITED INVESTOR”), (2) AGREES THAT IT WILL NOT WITHIN ONE YEAR AFTER THE ORIGINAL ISSUANCE OF THIS SECURITY RESELL OR OTHERWISE TRANSFER THIS SECURITY EXCEPT (A) TO THE ISSUER OR ANY SUBSIDIARY THEREOF,
(B) INSIDE THE UNITED STATES TO A QUALIFIED 

  
 -43-

 
INSTITUTIONAL BUYER IN COMPLIANCE WITH RULE 144A UNDER THE SECURITIES ACT, (C) INSIDE THE UNITED STATES TO AN ACCREDITED INVESTOR THAT, PRIOR TO SUCH TRANSFER, FURNISHES (OR HAS FURNISHED ON
ITS BEHALF BY A U.S. BROKER DEALER) TO THE TRUSTEE A SIGNED LETTER CONTAINING CERTAIN REPRESENTATIONS AND AGREEMENTS RELATING TO THE RESTRICTIONS ON TRANSFER OF THIS SECURITY (THE FORM OF WHICH LETTER CAN BE OBTAINED FROM THE TRUSTEE FOR THIS
SECURITY), (D) OUTSIDE THE UNITED STATES IN AN OFFSHORE TRANSACTION IN COMPLIANCE WITH RULE 904 UNDER THE SECURITIES ACT (IF AVAILABLE), (E) PURSUANT TO THE EXEMPTION FROM REGISTRATION PROVIDED BY RULE 144 UNDER THE SECURITIES ACT (IF
AVAILABLE), (F) IN ACCORDANCE WITH ANOTHER EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT (AND BASED UPON AN OPINION OF COUNSEL IF THE ISSUER SO REQUESTS), OR (G) PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER
THE SECURITIES ACT AND (3) AGREES THAT IT WILL GIVE TO EACH PERSON TO WHOM THIS SECURITY IS TRANSFERRED A NOTICE SUBSTANTIALLY TO THE EFFECT OF THIS LEGEND. IN CONNECTION WITH ANY TRANSFER OF THIS SECURITY WITHIN ONE YEAR AFTER THE ORIGINAL
ISSUANCE OF THIS SECURITY, IF THE PROPOSED TRANSFEREE IS AN ACCREDITED INVESTOR, THE HOLDER MUST, PRIOR TO SUCH TRANSFER, FURNISH TO THE TRUSTEE AND THE ISSUER SUCH CERTIFICATIONS, LEGAL OPINIONS OR OTHER INFORMATION AS EITHER OF THEM MAY REASONABLY
REQUIRE TO CONFIRM THAT SUCH TRANSFER IS BEING MADE PURSUANT TO AN EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT. AS USED HEREIN, THE TERMS “OFFSHORE TRANSACTION,” “UNITED
STATES” AND “U.S. PERSON” HAVE THE MEANING GIVEN TO THEM BY REGULATION S UNDER THE SECURITIES ACT. 
 (g)
Book-Entry Provisions. (i) This Section 2.1(g) shall apply only to Global Notes deposited with the Trustee, as custodian for DTC. 
 (1) Each Global Note initially shall (x) be registered in the name of DTC or the nominee of DTC, (y) be delivered to the Notes Custodian for DTC and (z) bear legends as set forth in
Section 2.1(e). Transfers of a Global Note (but not a beneficial interest therein) will be limited to transfers thereof in whole, but not in part, to the DTC, its successors or its respective nominees, except as set forth in
Section 2.1(g)(4) and 2.1(h). If a beneficial interest in a Global Note is transferred or exchanged for a beneficial interest in another Global Note, the Notes Custodian will (x) record a decrease in the principal amount of
the Global Note being transferred or exchanged equal to the principal amount of such transfer or exchange and (y) record a like increase in the principal amount of the other Global Note. Any beneficial interest in one Global Note that is
transferred to a Person who takes delivery in the form of an interest in another Global Note, or exchanged for an interest in another Global Note, will, upon transfer or exchange, cease to be an interest in such Global Note and become an interest in
the other Global Note and, accordingly, will thereafter be subject to all transfer and exchange restrictions, if any, and other procedures applicable to beneficial interests in such other Global Note for as long as it remains such an interest.

 (2) Members of, or participants in, DTC (“Agent Members”) shall have no rights under this
Indenture with respect to any Global Note held on their behalf by DTC or by the Notes Custodian as the custodian of DTC or under such Global Note, and DTC may be treated by the Issuer, the Trustee and any agent of the Issuer or the Trustee as the
absolute owner of such Global Note for all purposes whatsoever. Notwithstanding the foregoing, nothing herein shall prevent the Issuer, the Trustee or any agent of the Issuer or the Trustee from giving effect to any written certification, proxy or
other authorization furnished by DTC or impair, as between DTC and its Agent Members, the operation of customary practices of DTC governing the exercise of the rights of a holder of a beneficial interest in any Global Note. 

(3) In connection with any transfer of a portion of the beneficial interest in a Global Note pursuant to
Section 2.1(h) to beneficial owners who are required to hold Definitive Notes, the Notes Custodian shall reflect on its books and records the date and a decrease in the principal amount of such

  
 -44-

 
Global Note in an amount equal to the principal amount of the beneficial interest in the Global Note to be transferred, and the Issuer shall execute, and the Trustee shall authenticate and make
available for delivery, one or more Definitive Notes of like tenor and amount. 
 (4) In connection with the
transfer of an entire Global Note to beneficial owners pursuant to Section 2.1(h), such Global Note shall be deemed to be surrendered to the Trustee for cancellation, and the Issuer shall execute, and the Trustee shall authenticate and
make available for delivery, to each beneficial owner identified by DTC in exchange for its beneficial interest in such Global Note, an equal aggregate principal amount of Definitive Notes of authorized denominations. 

(5) The registered Holder of a Global Note may grant proxies and otherwise authorize any person, including Agent Members
and persons that may hold interests through Agent Members, to take any action which a Holder is entitled to take under this Indenture or the Notes. 
 (6) Any Holder of a Global Note shall, by acceptance of such Global Note, agree that transfers of beneficial interests in such Global Note may be effected only through a book-entry system maintained by
(i) the Holder of such Global Note (or its agent) or (ii) any holder of a beneficial interest in such Global Note, and that ownership of a beneficial interest in such Global Note shall be required to be reflected in a book entry.

 (h) Definitive Notes. Except as provided below, owners of beneficial interests in Global Notes will not be entitled to
receive Definitive Notes. Definitive Notes shall be transferred to all beneficial owners in exchange for their beneficial interests in a Global Note if (A) DTC notifies the Issuer that it is unwilling or unable to continue as Depositary for the
Global Note and the Issuer fails to appoint a successor depositary within 90 days of such notice, or (B) there shall have occurred and be continuing an Event of Default with respect to the Notes under this Indenture and DTC shall have requested
the issuance of Definitive Notes. In the event of the occurrence of any of the events specified in the second preceding sentence or in clause (A) or (B) of the preceding sentence, the Issuer shall promptly make available to the Trustee a
reasonable supply of Definitive Notes. In addition, any Note transferred to an affiliate (as defined in Rule 405 under the Securities Act) of the Issuer or evidencing a Note that has been acquired by an affiliate in a transaction or series of
transactions not involving any public offering must, until one year after the last date on which either the Issuer or any affiliate of the Issuer was an owner of the Note, be in the form of a Definitive Note and bear the legend regarding transfer
restrictions in Section 2.1(d). If required to do so pursuant to any applicable law or regulation, beneficial owners may also obtain Definitive Notes in exchange for their beneficial interests in a Global Note upon written request in
accordance with DTC’s and the Registrar’s procedures. 
 (1) Any Definitive Note delivered in exchange
for an interest in a Global Note pursuant to Section 2.1(g) shall, except as otherwise provided by Section 2.6(d), bear the applicable legend regarding transfer restrictions applicable to the Global Note set forth in
Section 2.1(d). 
 (2) If a Definitive Note is transferred or exchanged for a beneficial interest in
a Global Note, the Trustee will (x) cancel such Definitive Note, (y) record an increase in the principal amount of such Global Note equal to the principal amount of such transfer or exchange and (z) in the event that such transfer or
exchange involves less than the entire principal amount of the canceled Definitive Note, the Issuer shall execute, and the Trustee shall authenticate and make available for delivery, to the transferring Holder a new Definitive Note representing the
principal amount not so transferred. 
 (3) If a Definitive Note is transferred or exchanged for another
Definitive Note, (x) the Trustee will cancel the Definitive Note being transferred or exchanged, (y) the Issuer shall execute, and the Trustee shall authenticate and make available for delivery, one or more new Definitive Notes in
authorized denominations having an aggregate principal amount equal to the principal amount of such transfer or exchange to the transferee (in the case of a transfer) or the Holder of the canceled Definitive Note (in the case of an exchange),
registered in the name of such transferee or Holder, as applicable, and (z) if such transfer or exchange involves less than the entire principal amount of the canceled Definitive Note, the Issuer shall execute, and the Trustee shall
authenticate and make available for delivery to the Holder thereof, one or more Definitive Notes in authorized denominations having an aggregate principal amount equal to the untransferred or unexchanged portion of the canceled Definitive Notes,
registered in the name of the Holder thereof. 
 (4) Notwithstanding anything to the contrary in this Indenture,
in no event shall a Definitive Note be delivered upon exchange or transfer of a beneficial interest in the Temporary Regulation S Global Note prior to the end of the Restricted Period. 

  
 -45-

 SECTION 2.2. Execution and Authentication. One Officer shall sign the Notes for the
Issuer by manual, facsimile or PDF signature. If the Officer whose signature is on a Note no longer holds that office at the time the Trustee authenticates the Note, the Note shall be valid nevertheless. 

A Note shall not be valid until an authorized officer of the Trustee manually authenticates the Note. The signature of the Trustee on a
Note shall be conclusive evidence that such Note has been duly and validly authenticated and issued under this Indenture. A Note shall be dated the date of its authentication. 
 At any time and from time to time after the execution and delivery of this Indenture, the Trustee shall authenticate and make available for delivery: (1) Initial Notes for original issue on the Issue
Date in an aggregate principal amount of $3,100,000,000, (2) subject to the terms of this Indenture, Additional Notes for original issue in an unlimited principal amount, (3) Exchange Notes for issue only in an exchange offer pursuant to
the Registration Rights Agreement and only in exchange for Initial Notes or Additional Notes of an equal principal amount and (4) under the circumstances set forth in Section 2.6(e), Initial Notes in the form of an Unrestricted
Global Note, in each case upon a written order of the Issuer signed by one Officer (the “Issuer Order”). Such Issuer Order shall specify whether the Notes will be in the form of Definitive Notes or Global Notes, the amount of the
Notes to be authenticated, the date on which the original issue of Notes is to be authenticated, the holder of the Notes and whether the Notes are to be Initial Notes, Additional Notes or Exchange Notes. 

The Trustee may appoint an agent (the “Authenticating Agent”) reasonably acceptable to the Issuer to authenticate the
Notes. Any such appointment shall be evidenced by an instrument signed by a Trust Officer, a copy of which shall be furnished to the Issuer. Unless limited by the terms of such appointment, any such Authenticating Agent may authenticate Notes
whenever the Trustee may do so. Each reference in this Indenture to authentication by the Trustee includes authentication by the Authenticating Agent. An Authenticating Agent has the same rights as any Registrar, Paying Agent or agent for service of
notices and demands. 
 In case the Issuer or any Guarantor, pursuant to Article IV or Section 10.2, as
applicable, shall be consolidated or merged with or into any other Person or shall convey, transfer, lease or otherwise dispose of its properties and assets substantially as an entirety to any Person, and the successor Person resulting from such
consolidation, or surviving such merger, or into which the Issuer or any Guarantor shall have been merged, or the Person which shall have received a conveyance, transfer, lease or other disposition as aforesaid, shall have executed an indenture
supplemental hereto with the Trustee pursuant to Article IV, any of the Notes authenticated or delivered prior to such consolidation, merger, conveyance, transfer, lease or other disposition may (but shall not be required), from time to
time, at the request of the successor Person, be exchanged for other Notes executed in the name of the successor Person with such changes in phraseology and form as may be appropriate to reflect such successor Person, but otherwise in substance of
like tenor as the Notes surrendered for such exchange and of like principal amount; and the Trustee, upon the Issuer Order of the successor Person, shall authenticate and make available for delivery Notes as specified in such order for the purpose
of such exchange. If Notes shall at any time be authenticated and delivered in any new name of a successor Person pursuant to this Section 2.2 in exchange or substitution for or upon registration of transfer of any Notes, such successor
Person, at the option of the Holders but without expense to them, shall provide for the exchange of all Notes at the time outstanding for Notes authenticated and delivered in such new name. 

SECTION 2.3. Registrar and Paying Agent. The Issuer shall maintain an office or agency where Notes may be presented for
registration of transfer or for exchange (the “Registrar”) and an office or agency where Notes may be presented for payment. The Registrar shall keep a register of the Notes and of their transfer and exchange (the “Notes
Register”). The Issuer may have one or more co-registrars and one or more additional paying agents. The term “Paying Agent” includes any additional paying agent and the term “Registrar” includes any co-registrar.

  
 -46-

 The Issuer shall advise the Paying Agent in writing five Business Days prior to any interest
payment date of any Additional Interest payable pursuant to the Registration Rights Agreement. 
 The Issuer shall enter into an
appropriate agency agreement with any Registrar or Paying Agent not a party to this Indenture, which shall incorporate the terms of the TIA. The agreement shall implement the provisions of this Indenture that relate to such agent. The Issuer shall
notify the Trustee in writing of the name and address of each such agent. If the Issuer fails to maintain a Registrar or Paying Agent, the Trustee shall act as such and shall be entitled to appropriate compensation therefor pursuant to
Section 7.7. The Issuer or any Guarantor may act as Paying Agent, Registrar or transfer agent. 
 The Issuer
initially appoints The Depository Trust Company (“DTC”) to act as Depositary with respect to the Global Notes. The Issuer initially appoints the Trustee as the Registrar and Paying Agent for the Notes and the Issuer may remove any
Registrar or Paying Agent without prior notice to the Holders, but upon written notice to such Registrar or Paying Agent and to the Trustee; provided, however, that no such removal shall become effective until (i) acceptance of
any appointment by a successor as evidenced by an appropriate agreement entered into by the Issuer and such successor Registrar or Paying Agent, as the case may be, and delivered to the Trustee and the passage of any waiting or notice periods
required by DTC procedures or (ii) written notification to the Trustee that the Trustee shall serve as Registrar or Paying Agent until the appointment of a successor in accordance with clause (i) above. The Registrar or Paying Agent may
resign at any time upon written notice to the Issuer and the Trustee. 
 SECTION 2.4. Paying Agent to Hold Money in
Trust. Prior to 10:00 a.m. New York City time, on each due date of the principal of, premium, if any, or interest on any Note is due and payable, the Issuer shall deposit with the Paying Agent a sum sufficient in immediately available funds to
pay such principal, premium or interest when due. The Issuer shall require the Paying Agent (other than the Trustee) to agree in writing that such Paying Agent shall hold in trust for the benefit of Holders or the Trustee all money held by such
Paying Agent for the payment of principal of, premium, if any, or interest on the Notes (whether such assets have been distributed to it by the Issuer or other obligors on the Notes), shall notify the Trustee in writing of any default by the Issuer
or any Guarantor in making any such payment and shall during the continuance of any default by the Issuer (or any other obligor upon the Notes) in the making of any payment in respect of the Notes, upon the written request of the Trustee, forthwith
deliver to the Trustee all sums held in trust by such Paying Agent for payment in respect of the Notes together with a full accounting thereof. If the Issuer or a Subsidiary of the Issuer acts as Paying Agent, it shall segregate the money held by it
as Paying Agent and hold it as a separate trust fund. The Issuer at any time may require a Paying Agent (other than the Trustee) to pay all money held by it to the Trustee and to account for any funds or assets disbursed by such Paying Agent. Upon
complying with this Section 2.4, the Paying Agent (if other than the Issuer or a Subsidiary of the Issuer) shall have no further liability for the money delivered to the Trustee. Upon any bankruptcy, reorganization or similar proceeding
with respect to the Issuer, the Trustee shall serve as Paying Agent for the Notes. 
 SECTION 2.5. Holder Lists. The
Trustee shall preserve in as current a form as is reasonably practicable the most recent list available to it of the names and addresses of Holders and shall otherwise comply with TIA Section 312(a). If the Trustee is not the Registrar, or to
the extent otherwise required under the TIA, the Issuer, on its own behalf and on behalf of each of the Guarantors, shall furnish or cause the Registrar to furnish to the Trustee, in writing at least five Business Days before each interest payment
date and at such other times as the Trustee may request in writing, a list in such form and as of such date as the Trustee may reasonably require of the names and addresses of Holders and the Issuer shall otherwise comply with TIA
Section 312(a). 
 SECTION 2.6. Transfer and Exchange. 

(a) A Holder may transfer a Note (or a beneficial interest therein) to another Person or exchange a Note (or a beneficial interest
therein) for another Note or Notes of any authorized denomination by presenting to the Trustee a written request therefor stating the name of the proposed transferee or requesting such an exchange, accompanied by any certification, opinion or other
document required by this Section 2.6. The Trustee will promptly register any transfer or exchange that meets the requirements of this Section 2.6 by noting the same in the Notes Register maintained by the Trustee for the
purpose, and no transfer or exchange will be effective until it is registered in such Notes Register. The transfer or exchange of any Note (or a beneficial interest therein) may only 

  
 -47-

 
be made in accordance with this Section 2.6 and Section 2.1(g) and 2.1(h), as applicable, and, in the case of a Global Note (or a beneficial interest therein), the
applicable rules and procedures of DTC, Euroclear and Clearstream. The Trustee shall refuse to register any requested transfer or exchange that does not comply with this paragraph. 

(b) Transfers of Rule 144A Notes and Institutional Accredited Investor Notes. The following provisions shall apply with
respect to any proposed registration of transfer of a Rule 144A Note or an Institutional Accredited Investor Note prior to the date that is one year after the later of the date of its original issue and the last date on which the Issuer or any
Affiliate of the Issuer was the owner of such Notes (or any predecessor thereto) (the “Resale Restriction Termination Date”): 
 (1) a registration of transfer of a Rule 144A Note or an Institutional Accredited Investor Note or a beneficial interest therein to a QIB shall be made upon the representation of the transferee in
the form as set forth on the reverse of the Note that it is purchasing for its own account or an account with respect to which it exercises sole investment discretion and that it and any such account is a “qualified institutional buyer”
within the meaning of Rule 144A, and is aware that the sale to it is being made in reliance on Rule 144A and acknowledges that it has received such information regarding the Issuer as the undersigned has requested pursuant to
Rule 144A or has determined not to request such information and that it is aware that the transferor is relying upon its foregoing representations in order to claim the exemption from registration provided by Rule 144A; provided
that no such written representation or other written certification shall be required in connection with the transfer of a beneficial interest in the Rule 144A Global Note to a transferee in the form of a beneficial interest in that
Rule 144A Global Note in accordance with this Indenture and the applicable procedures of DTC. 
 (2) a
registration of transfer of a Rule 144A Note or an Institutional Accredited Investor Note or a beneficial interest therein to an IAI or an AI shall be made upon receipt by the Registrar or its agent of a certificate substantially in the form
set forth in Exhibit G or Exhibit I, respectively, from the proposed transferee and the delivery of an Opinion of Counsel, certification and/or other information satisfactory to it; and 

(3) a registration of transfer of a Rule 144A Note or an Institutional Accredited Investor Note or a beneficial
interest therein to a Non-U.S. Person shall be made upon receipt by the Registrar or its agent of a certificate substantially in the form set forth in Exhibit H from the proposed transferee and the delivery of an Opinion of Counsel,
certification and/or other information satisfactory to it. 
 (c) Transfers of Regulation S Notes. The following
provisions shall apply with respect to any proposed transfer of a Regulation S Note prior to the expiration of the Restricted Period: 
 (1) a transfer of a Regulation S Note or a beneficial interest therein to a QIB shall be made upon the representation of the transferee, in the form of assignment on the reverse of the certificate,
that it is purchasing the Note for its own account or an account with respect to which it exercises sole investment discretion and that it and any such account is a “qualified institutional buyer” within the meaning of Rule 144A, is
aware that the sale to it is being made in reliance on Rule 144A and acknowledges that it has received such information regarding the Issuer as the undersigned has requested pursuant to Rule 144A or has determined not to request such
information and that it is aware that the transferor is relying upon its foregoing representations in order to claim the exemption from registration provided by Rule 144A; 

(2) a transfer of a Regulation S Note or a beneficial interest therein to an IAI or an AI shall be made upon receipt
by the Registrar or its agent of a certificate substantially in the form set forth in Exhibit G or Exhibit I, respectively, from the proposed transferee and the delivery of an Opinion of Counsel, certification and/or other information
satisfactory to the Issuer; and 
 (3) a transfer of a Regulation S Note or a beneficial interest therein to
a Non-U.S. Person shall be made upon receipt by the Registrar or its agent of a certificate substantially in the form set forth in Exhibit H hereof from the proposed transferee and receipt by the Registrar or its agent of an Opinion of
Counsel, certification and/or other information satisfactory to the Issuer. 

  
 -48-

 After the expiration of the Restricted Period, interests in the Regulation S Note may
be transferred in accordance with applicable law without requiring the certification set forth in Exhibit G, Exhibit H, Exhibit I or any additional certification. 

(d) Restricted Notes Legend. Upon the transfer, exchange or replacement of Notes not bearing a Restricted Notes Legend, the
Registrar shall deliver Notes that do not bear a Restricted Notes Legend. Upon the transfer, exchange or replacement of Notes bearing a Restricted Notes Legend, the Registrar shall deliver only Notes that bear a Restricted Notes Legend unless
(1) Initial Notes are being exchanged for Exchange Notes in an exchange offer pursuant to the Registration Rights Agreement, in which case the Exchange Notes shall not bear a Restricted Notes Legend, (2) an Initial Note is being
transferred pursuant to an effective registration statement, (3) Initial Notes are being exchanged for Notes that do not bear the Restricted Notes Legend in accordance with Section 2.6(e) or (4) there is delivered to the
Registrar an Opinion of Counsel satisfactory to it stating that neither such legend nor the related restrictions on transfer are required in order to maintain compliance with the provisions of the Securities Act. Any Additional Notes sold in a
registered offering shall not be required to bear the Restricted Notes Legend. 
 (e) Automatic Exchange from Global Note
Bearing Restricted Notes Legend to Global Note Not Bearing Restricted Notes Legend. Upon the Issuer’s satisfaction that the Restricted Notes Legend shall no longer be required in order to maintain compliance with the Securities Act,
beneficial interests in a Global Note bearing the Restricted Notes Legend (a “Restricted Global Note”) may be automatically exchanged into beneficial interests in a Global Note not bearing the Restricted Notes Legend (an
“Unrestricted Global Note”) without any action required by or on behalf of the Holder (the “Automatic Exchange”) at any time on or after the date that is the 366th calendar day after (1) with respect to the
Notes issued on the Issue Date, the Issue Date or (2) with respect to Additional Notes, if any, the issue date of such Additional Notes, or, in each case, if such day is not a Business Day, on the next succeeding Business Day (the
“Automatic Exchange Date”). Upon the Issuer’s satisfaction that the Restricted Notes Legend shall no longer be required in order to maintain compliance with the Securities Act, the Issuer shall (i) provide written notice
to DTC and the Trustee at least fifteen (15) calendar days prior to the Automatic Exchange Date, instructing DTC to exchange all of the outstanding beneficial interests in a particular Restricted Global Note to the Unrestricted Global Note,
which the Issuer shall have previously otherwise made eligible for exchange with the DTC, (ii) provide prior written notice (the “Automatic Exchange Notice”) to each Holder at such Holder’s address appearing in the
register of Holders at least fifteen (15) calendar days prior to the Automatic Exchange Date (the “Automatic Exchange Notice Date”), which notice must include (w) the Automatic Exchange Date, (x) the section of this
Indenture pursuant to which the Automatic Exchange shall occur, (y) the “CUSIP” number of the Restricted Global Note from which such Holder’s beneficial interests will be transferred and (z) the “CUSIP” number of
the Unrestricted Global Note into which such Holder’s beneficial interests will be transferred, and (iii) on or prior to the Automatic Exchange Date, deliver to the Trustee for authentication one or more Unrestricted Global Notes, duly
executed by the Issuer, in an aggregate principal amount equal to the aggregate principal amount of Restricted Global Notes to be exchanged into such Unrestricted Global Notes. At the Issuer’s written request on no less than five (5)
calendar days’ notice prior to the Automatic Exchange Notice Date, the Trustee shall deliver, in the Issuer’s name and at its expense, the Automatic Exchange Notice to each Holder at such Holder’s address appearing in the register of
Holders; provided that the Issuer has delivered to the Trustee the information required to be included in such Automatic Exchange Notice. 
 Notwithstanding anything to the contrary in this Section 2.6(e), during the fifteen (15) calendar day period prior to the Automatic Exchange Date, no transfers or exchanges other than
pursuant to this Section 2.6(e) shall be permitted without the prior written consent of the Issuer. As a condition to any Automatic Exchange, the Issuer shall provide, and the Trustee shall be entitled to conclusively rely upon, an
Officer’s Certificate and Opinion of Counsel to the Issuer to the effect that the Automatic Exchange shall be effected in compliance with the Securities Act and that the restrictions on transfer contained herein and in the Restricted Notes
Legend shall no longer be required in order to maintain compliance with the Securities Act and that the aggregate principal amount of the particular Restricted Global Note is to be transferred to the particular Unrestricted Global Note by adjustment
made on the records of the Trustee, as custodian for the Depositary to reflect the Automatic Exchange. Upon such exchange of beneficial interests pursuant to this Section 2.6(e), the aggregate principal amount of the Global Notes shall
be increased or decreased by adjustments made on the records of the Trustee, as custodian for the Depositary, to reflect the relevant increase or decrease in the principal amount of such Global Note resulting from the applicable exchange. The
Restricted Global Note from which beneficial interests are transferred pursuant to an Automatic Exchange shall be cancelled following the Automatic Exchange. 

  
 -49-

 (f) Retention of Written Communications. The Registrar shall retain copies of all
letters, notices and other written communications received pursuant to Section 2.1 or this Section 2.6. The Issuer shall have the right to inspect and make copies of all such letters, notices or other written communications
at any reasonable time upon the giving of reasonable prior written notice to the Registrar. 
 (g) Obligations with Respect
to Transfers and Exchanges of Notes. To permit registrations of transfers and exchanges, the Issuer shall, subject to the other terms and conditions of this Article II, execute and the Trustee shall authenticate Definitive Notes and
Global Notes at the Issuer’s and Registrar’s written request. 
 No service charge shall be made to a Holder for any
registration of transfer or exchange, but the Issuer may require the Holder to pay a sum sufficient to cover any transfer tax assessments or similar governmental charge payable in connection therewith (other than any such transfer taxes, assessments
or similar governmental charges payable upon exchange or transfer pursuant to Sections 2.2, 2.6, 2.11, 2.13, 5.6 or 9.5). 
 The Issuer (and the Registrar) shall not be required to register the transfer of or exchange of any Note (A) for a period beginning (1) 15 calendar days before the mailing of a notice of an
offer to repurchase or redeem Notes and ending at the close of business on the day of such mailing or (2) 15 calendar days before an interest payment date and ending on such interest payment date or (B) called for redemption, except
the unredeemed portion of any Note being redeemed in part. 
 Prior to the due presentation for registration of transfer of any
Note, the Issuer, the Trustee, the Paying Agent or the Registrar may deem and treat the person in whose name a Note is registered as the owner of such Note for the purpose of receiving payment of principal of, premium, if any, and (subject to
paragraph 2 of the forms of Notes attached hereto as Exhibits A, B and C) interest on such Note and for all other purposes whatsoever, including without limitation the transfer or exchange of such Note, whether or not
such Note is overdue, and none of the Issuer, the Trustee, the Paying Agent or the Registrar shall be affected by notice to the contrary. 
 Any Definitive Note delivered in exchange for an interest in a Global Note pursuant to Section 2.1(h) shall, except as otherwise provided by Section 2.6(d), bear the applicable
legend regarding transfer restrictions applicable to the Definitive Note set forth in Section 2.1(d). 
 All Notes
issued upon any transfer or exchange pursuant to the terms of this Indenture shall evidence the same debt and shall be entitled to the same benefits under this Indenture as the Notes surrendered upon such transfer or exchange. 

(h) No Obligation of the Trustee. The Trustee shall have no responsibility or obligation to any beneficial owner of a Global Note,
a member of, or a participant in, DTC or other Person with respect to the accuracy of the records of DTC or its nominee or of any participant or member thereof, with respect to any ownership interest in the Notes or with respect to the delivery to
any participant, member, beneficial owner or other Person (other than DTC) of any notice (including any notice of redemption or purchase) or the payment of any amount or delivery of any Notes (or other security or property) under or with respect to
such Notes. All notices and communications to be given to the Holders and all payments to be made to Holders in respect of the Notes shall be given or made only to or upon the order of the registered Holders (which shall be DTC or its nominee in the
case of a Global Note). The rights of beneficial owners in any Global Note shall be exercised only through DTC subject to the applicable rules and procedures of DTC. The Trustee may rely and shall be fully protected in relying upon information
furnished by DTC with respect to its members, participants and any beneficial owners. 
 The Trustee shall have no obligation or
duty to monitor, determine or inquire as to compliance with any restrictions on transfer imposed under this Indenture or under applicable law with respect to any transfer of any interest in any Note (including any transfers between or among DTC
participants, members or beneficial owners in any Global Note) other than to require delivery of such certificates and other documentation or evidence as are 

  
 -50-

 
expressly required by, and to do so if and when expressly required by, the terms of this Indenture, and to examine the same to determine substantial compliance as to form with the express
requirements hereof. Neither the Trustee nor any of its agents shall have any responsibility for any actions taken or not taken by DTC. 
 SECTION 2.7. [Reserved] 
 SECTION 2.8. [Reserved] 

SECTION 2.9. [Reserved] 
 SECTION 2.10. [Reserved] 
 SECTION 2.11. Mutilated, Destroyed, Lost or
Stolen Notes. 
 If a mutilated Note is surrendered to the Registrar or if the Holder of a Note claims that the Note has
been lost, destroyed or wrongfully taken, the Issuer shall issue and the Trustee shall authenticate a replacement Note if the requirements of Section 8-405 of the Uniform Commercial Code are met, such that the Holder (a) satisfies the
Issuer and the Trustee that such Note has been lost, destroyed or wrongfully taken within a reasonable time after such Holder has notice of such loss, destruction or wrongful taking and the Registrar has not registered a transfer prior to receiving
such notification, (b) makes such request to the Issuer and the Trustee prior to the Note being acquired by a protected purchaser as defined in Section 8-303 of the Uniform Commercial Code (a “protected purchaser”) and
(c) satisfies any other reasonable requirements of the Trustee; provided, however, if after the delivery of such replacement Note, a protected purchaser of the Note for which such replacement Note was issued presents for payment
or registration such replaced Note, the Trustee and/or the Issuer shall be entitled to recover such replacement Note from the Person to whom it was issued and delivered or any Person taking therefrom, except a protected purchaser, and shall be
entitled to recover upon the security or indemnity provided therefor to the extent of any loss, damage, cost or expense incurred by the Issuer or the Trustee in connection therewith. Such Holder shall furnish an indemnity bond sufficient in the
judgment of the (i) Trustee to protect the Trustee and (ii) the Issuer to protect the Issuer, the Trustee, the Paying Agent and the Registrar, from any loss which any of them may suffer if a Note is replaced, and, in the absence of notice
to the Issuer, any Guarantor or the Trustee that such Note has been acquired by a protected purchaser, the Issuer shall execute, and upon receipt of an Issuer Order, the Trustee shall authenticate and make available for delivery, in exchange for any
such mutilated Note or in lieu of any such destroyed, lost or stolen Note, a new Note of like tenor and principal amount, bearing a number not contemporaneously outstanding. 
 In case any such mutilated, destroyed, lost or stolen Note has become or is about to become due and payable, the Issuer in its discretion may, instead of issuing a new Note, pay such Note. 

Upon the issuance of any new Note under this Section 2.11, the Issuer may require that such Holder pay a sum sufficient to
cover any tax or other governmental charge that may be imposed in relation thereto and any other expenses (including the fees and expenses of counsel and of the Trustee) in connection therewith. 

Subject to the proviso in the initial paragraph of this Section 2.11, every new Note issued pursuant to this
Section 2.11, in lieu of any mutilated, destroyed, lost or stolen Note shall constitute an original additional contractual obligation of the Issuer, any Guarantor (if applicable) and any other obligor upon the Notes, whether or not the
mutilated, destroyed, lost or stolen Note shall be at any time enforceable by anyone, and shall be entitled to all benefits of this Indenture equally and proportionately with any and all other Notes duly issued hereunder. 

The provisions of this Section 2.11 are exclusive and shall preclude (to the extent lawful) all other rights and remedies
with respect to the replacement or payment of mutilated, destroyed, lost or stolen Notes. 
 SECTION 2.12. Outstanding
Notes. Notes outstanding at any time are all Notes authenticated by the Trustee except for those cancelled by it, those delivered to it for cancellation, those paid pursuant to Section 2.11 and those described in this
Section 2.12 as not outstanding. A Note does not cease to be outstanding in the event the Issuer or an Affiliate of the Issuer holds the Note; provided, however, that (i) for purposes of determining which are

  
 -51-

 
outstanding for consent or voting purposes hereunder, the provisions of Section 13.6 shall apply and (ii) in determining whether the Trustee shall be protected in making a
determination whether the Holders of the requisite principal amount of outstanding Notes are present at a meeting of Holders of Notes for quorum purposes or have consented to or voted in favor of any request, demand, authorization, direction,
notice, consent, waiver, amendment or modification hereunder, or relying upon any such quorum, consent or vote, only Notes which a Trust Officer of the Trustee actually knows to be held by the Issuer or an Affiliate of the Issuer shall not be
considered outstanding. 
 If a Note is replaced pursuant to Section 2.11 (other than a mutilated Note surrendered
for replacement), it ceases to be outstanding unless the Trustee and the Issuer receive proof satisfactory to them that the replaced Note is held by a protected purchaser. A mutilated Note ceases to be outstanding upon surrender of such Note and
replacement pursuant to Section 2.11. 
 If the Paying Agent segregates and holds in trust, in accordance with this
Indenture, on a Redemption Date or maturity date, money sufficient to pay all principal, premium, if any, and accrued interest payable on that date with respect to the Notes (or portions thereof) to be redeemed or maturing, as the case may be, and
the Paying Agent is not prohibited from paying such money to the Holders on that date pursuant to the terms of this Indenture, then on and after that date such Notes (or portions thereof) cease to be outstanding and interest on them ceases to
accrue. 
 SECTION 2.13. Temporary Notes. In the event that Definitive Notes are to be issued under the terms of this
Indenture, until such Definitive Notes are ready for delivery, the Issuer may prepare and the Trustee shall authenticate temporary Notes. Temporary Notes shall be substantially in the form, and shall carry all rights, of Definitive Notes but may
have variations that the Issuer considers appropriate for temporary Notes. Without unreasonable delay, the Issuer shall prepare and the Trustee shall authenticate Definitive Notes. After the preparation of Definitive Notes, the temporary Notes shall
be exchangeable for Definitive Notes upon surrender of the temporary Notes at any office or agency maintained by the Issuer for that purpose and such exchange shall be without charge to the Holder. Upon surrender for cancellation of any one or more
temporary Notes, the Issuer shall execute, and the Trustee shall, upon receipt of an Issuer Order, authenticate and make available for delivery in exchange therefor, one or more Definitive Notes representing an equal principal amount of Notes. Until
so exchanged, the Holder of temporary Notes shall in all respects be entitled to the same benefits under this Indenture as a Holder of Definitive Notes. 
 SECTION 2.14. Cancellation. The Issuer at any time may deliver Notes to the Trustee for cancellation. The Registrar and the Paying Agent shall forward to the Trustee any Notes surrendered to them
for registration of transfer, exchange or payment. The Trustee and no one else shall cancel all Notes surrendered for registration of transfer, exchange, payment or cancellation and dispose of such Notes in accordance with its internal policies and
customary procedures (subject to the record retention requirements of the Exchange Act and the Trustee). If the Issuer or any Guarantor acquires any of the Notes, such acquisition shall not operate as a redemption or satisfaction of the Indebtedness
represented by such Notes unless and until the same are surrendered to the Trustee for cancellation pursuant to this Section 2.14. The Issuer may not issue new Notes to replace Notes it has paid or delivered to the Trustee for
cancellation for any reason other than in connection with a transfer or exchange. 
 At such time as all beneficial interests in
a Global Note have either been exchanged for Definitive Notes, transferred, redeemed, repurchased or canceled, such Global Note shall be returned by DTC to the Trustee for cancellation or retained and canceled by the Trustee. At any time prior to
such cancellation, if any beneficial interest in a Global Note is exchanged for Definitive Notes, transferred in exchange for an interest in another Global Note, redeemed, repurchased or canceled, the principal amount of Notes represented by such
Global Note shall be reduced and an adjustment shall be made on the books and records of the Trustee (if it is then the Notes Custodian for such Global Note) with respect to such Global Note, by the Trustee or the Notes Custodian, to reflect such
reduction. 
 SECTION 2.15. Payment of Interest; Defaulted Interest. Interest on any Note which is payable, and is
punctually paid or duly provided for, on any interest payment date shall be paid to the Person in whose name such Note (or one or more Predecessor Notes) is registered at the close of business on the regular record date for such payment at the
office or agency of the Issuer maintained for such purpose pursuant to Section 2.3. 

  
 -52-

 Any interest on any Note which is payable, but is not paid when the same becomes due and
payable and such nonpayment continues for a period of 30 days shall forthwith cease to be payable to the Holder on the regular record date, and such defaulted interest and (to the extent lawful) interest on such defaulted interest at the rate
borne by the Notes (such defaulted interest and interest thereon herein collectively called “Defaulted Interest”) shall be paid by the Issuer, at its election in each case, as provided in clause (a) or (b) below:

 (a) The Issuer may elect to make payment of any Defaulted Interest to the Persons in whose names the Notes (or
their respective predecessor Notes) are registered at the close of business on a Special Record Date (as defined below) for the payment of such Defaulted Interest, which shall be fixed in the following manner. The Issuer shall notify the Trustee in
writing of the amount of Defaulted Interest proposed to be paid on each Note and the date (not less than 30 days after such notice) of the proposed payment (the “Special Interest Payment Date”), and at the same time the Issuer
shall deposit with the Trustee an amount of money equal to the aggregate amount proposed to be paid in respect of such Defaulted Interest or shall make arrangements satisfactory to the Trustee for such deposit prior to the date of the proposed
payment, such money when deposited to be held in trust for the benefit of the Persons entitled to such Defaulted Interest as in this Section 2.15(a). Thereupon the Issuer shall fix a record date (the “Special Record
Date”) for the payment of such Defaulted Interest, which date shall be not more than 20 calendar days and not less than 15 calendar days prior to the Special Interest Payment Date and not less than 10 calendar days after
the receipt by the Trustee of the notice of the proposed payment. The Issuer shall promptly notify the Trustee in writing of such Special Record Date, and in the name and at the expense of the Issuer, the Trustee shall cause notice of the proposed
payment of such Defaulted Interest and the Special Record Date and Special Interest Payment Date therefor to be given in the manner provided for in Section 13.2, not less than 10 calendar days prior to such Special Record Date.
Notice of the proposed payment of such Defaulted Interest and the Special Record Date and Special Interest Payment Date therefor having been so given, such Defaulted Interest shall be paid on the Special Interest Payment Date to the Persons in whose
names the Notes (or their respective predecessor Notes) are registered at the close of business on such Special Record Date and shall no longer be payable pursuant to the provisions in Section 2.15(b). 

(b) The Issuer may make payment of any Defaulted Interest in any other lawful manner not inconsistent with the
requirements of any securities exchange on which the Notes may be listed, and upon such notice as may be required by such exchange, if, after written notice given by the Issuer to the Trustee of the proposed payment pursuant to this
Section 2.15(b), such manner of payment shall be deemed practicable by the Trustee. 
 Subject to the foregoing
provisions of this Section 2.15, each Note delivered under this Indenture upon registration of, transfer of or in exchange for or in lieu of any other Note shall carry the rights to interest accrued and unpaid, and to accrue, which were
carried by such other Note. 
 SECTION 2.16. CUSIP and ISIN Numbers. The Issuer in issuing the Notes may use
“CUSIP” and “ISIN” numbers and, if so, the Trustee shall use “CUSIP and “ISIN” numbers in notices of redemption or purchase as a convenience to Holders; provided, however, that any such notice may
state that no representation is made as to the correctness of such numbers either as printed on the Notes or as contained in any notice of a redemption or purchase and that reliance may be placed only on the other identification numbers printed on
the Notes, and any such redemption or purchase shall not be affected by any defect in or omission of such CUSIP and ISIN numbers. The Issuer shall promptly notify the Trustee in writing of any change in the CUSIP and ISIN numbers. 

SECTION 2.17. Joint and Several Liability. Except as otherwise expressly provided herein, prior to the consummation of the
Acquisition on the Escrow Release Date, Merger Sub and Holdings, and from and after the consummation of the Acquisition on the Escrow Release Date, Heinz and the Guarantors shall be jointly and severally liable for the performance of all obligations
and covenants under this Indenture, the Notes and the Collateral Documents. 

  
 -53-

 ARTICLE III 
 COVENANTS 
 SECTION 3.1. Payment of Notes. The Issuer shall promptly
pay the principal of, premium, if any, and interest (including Additional Interest) on the Notes on the dates and in the manner provided in the Notes and in this Indenture. Principal, premium, if any, and interest (including Additional Interest)
shall be considered paid on the date due if by 10:00 a.m. Eastern time on such date the Trustee or the Paying Agent holds in accordance with this Indenture money sufficient to pay all principal, premium, if any, and interest (including Additional
Interest) then due and the Trustee or the Paying Agent, as the case may be, is not prohibited from paying such money to the Holders on that date pursuant to the terms of this Indenture. 

The Issuer shall pay interest on overdue principal at the rate specified therefor in the Notes, and it shall pay interest on overdue
installments of interest (including Additional Interest) at the same rate to the extent lawful. 
 Notwithstanding anything to
the contrary contained in this Indenture, the Issuer may, to the extent it is required to do so by law, deduct or withhold income or other similar taxes imposed by the United States of America from principal or interest payments hereunder.

 SECTION 3.2. Limitation on Indebtedness. 
 (a) The Issuer shall not, and shall not permit any of its Restricted Subsidiaries to, Incur any Indebtedness (including Acquired Indebtedness); provided, however, that the Issuer and any of
its Restricted Subsidiaries may Incur Indebtedness (including Acquired Indebtedness), if on the date of such Incurrence and after giving pro forma effect thereto (including pro forma application of the proceeds thereof), the Fixed Charge Coverage
Ratio for the Issuer and its Restricted Subsidiaries is greater than 2.00 to 1.00; provided, further, that Non-Guarantors may not Incur Indebtedness if, after giving pro forma effect to such Incurrence (including a pro forma
application of the net proceeds therefrom), more than an aggregate of the greater of (a) $1,150 million and (b) 3.50% of Total Assets of Indebtedness of Non-Guarantors would be outstanding pursuant to this paragraph. 

(b) Section 3.2(a) will not prohibit the Incurrence of the following Indebtedness: 

(1) Indebtedness Incurred pursuant to any Credit Facility (including letters of credit or bankers’ acceptances issued
or created under any Credit Facility), and any Refinancing Indebtedness in respect thereof and Guarantees in respect of such Indebtedness in a maximum aggregate principal amount at any time outstanding not exceeding (i) $14,250 million, plus
(ii) in the case of any refinancing of any Indebtedness permitted under this clause or any portion thereof, the aggregate amount of fees, underwriting discounts, premiums and other costs and expenses Incurred in connection with such
refinancing; 
 (2) Guarantees by the Issuer or any Restricted Subsidiary of Indebtedness of the Issuer or any
Restricted Subsidiary so long as the Incurrence of such Indebtedness is permitted under the terms of this Indenture; 
 (3) Indebtedness of the Issuer owing to and held by any Restricted Subsidiary or Indebtedness of a Restricted Subsidiary owing to and held by the Issuer or any Restricted Subsidiary; provided,
however, that: 
 (i) any subsequent issuance or transfer of Capital Stock or any other event which
results in any such Indebtedness being beneficially held by a Person other than the Issuer or a Restricted Subsidiary of the Issuer; and 
 (ii) any sale or other transfer of any such Indebtedness to a Person other than the Issuer or a Restricted Subsidiary of the Issuer, 

  
 -54-

 shall be deemed, in each case, to constitute an Incurrence of such Indebtedness by the
Issuer or such Restricted Subsidiary, as the case may be; 
 (4) Indebtedness represented by (i) the Notes
(other than any Additional Notes), including any Guarantee thereof, (ii) any Exchange Notes issued in exchange for such Notes (including any Guarantee thereof), (iii) any Indebtedness (other than Indebtedness incurred pursuant to
Section 3.2(b)(1) and (3)) outstanding on the Escrow Release Date, including the Existing Notes and any Guarantee thereof (including any exchange notes and related exchange guarantees issued in respect of such Existing
Notes), (iv) Refinancing Indebtedness Incurred in respect of any Indebtedness described in this clause or clauses (5) or (10) of this Section 3.2(b) or Incurred pursuant to Section 3.2(a), and
(v) Management Advances; 
 (5) Indebtedness of (x) the Issuer or any Restricted Subsidiary Incurred or
issued to finance an acquisition or (y) Persons that are acquired by the Issuer or any Restricted Subsidiaries or merged into or consolidated with the Issuer or a Restricted Subsidiary in accordance with the terms of this Indenture;
provided that after giving effect to such acquisition, merger or consolidation, either 
 (i) the Issuer
would be permitted to Incur at least $1.00 of additional Indebtedness pursuant to the Fixed Charge Coverage Ratio test set forth in Section 3.2(a), or 

(ii) the Fixed Charge Coverage Ratio of the Issuer and the Restricted Subsidiaries would not be lower than immediately
prior to such acquisition, merger or consolidation; 
 (6) Hedging Obligations (excluding Hedging Obligations
entered into for speculative purposes); 
 (7) Indebtedness represented by Capitalized Lease Obligations or
Purchase Money Obligations in an aggregate outstanding principal amount which, when taken together with the principal amount of all other Indebtedness Incurred pursuant to this clause and then outstanding, does not exceed the greater of
(i) $1,050.0 million and (ii) 3.25% of Total Assets at the time of Incurrence and any Refinancing Indebtedness in respect thereof; 
 (8) Indebtedness in respect of (i) workers’ compensation claims, self-insurance obligations, performance, indemnity, surety, judgment, appeal, advance payment, customs, value added or other tax
or other guarantees or other similar bonds, instruments or obligations and completion guarantees and warranties provided by the Issuer or a Restricted Subsidiary or relating to liabilities, obligations or guarantees Incurred in the ordinary course
of business, (ii) the honoring by a bank or other financial institution of a check, draft or similar instrument drawn against insufficient funds in the ordinary course of business; provided, however, that such Indebtedness is
extinguished within five Business Days of Incurrence; (iii) customer deposits and advance payments received in the ordinary course of business from customers for goods or services purchased in the ordinary course of business; (iv) letters
of credit, bankers’ acceptances, guarantees or other similar instruments or obligations issued or relating to liabilities or obligations Incurred in the ordinary course of business and (v) any customary cash management, cash pooling or
netting or setting off arrangements in the ordinary course of business; 
 (9) Indebtedness arising from
agreements providing for guarantees, indemnification, obligations in respect of earn-outs or other adjustments of purchase price or, in each case, similar obligations, in each case, Incurred or assumed in connection with the acquisition or
disposition of any business or assets or Person or any Capital Stock of a Subsidiary (other than Guarantees of Indebtedness Incurred by any Person acquiring or disposing of such business or assets or such Subsidiary for the purpose of financing such
acquisition or disposition); provided that the maximum liability of the Issuer and its Restricted Subsidiaries in respect of all such Indebtedness in connection with a Disposition shall at no time exceed the gross proceeds, including the fair
market value of non-cash proceeds (measured at the time received and without giving effect to any subsequent changes in value), actually received by the Issuer and its Restricted Subsidiaries in connection with such disposition; 

  
 -55-

 (10) Indebtedness in an aggregate outstanding principal amount which, when
taken together with any Refinancing Indebtedness in respect thereof and the principal amount of all other Indebtedness Incurred pursuant to this clause and then outstanding, will not exceed 100% of the Net Cash Proceeds received by the Issuer from
the issuance or sale (other than to a Restricted Subsidiary) of its Capital Stock (other than Disqualified Stock, Designated Preferred Stock or an Excluded Contribution) or otherwise contributed to the equity (other than through the issuance of
Disqualified Stock, Designated Preferred Stock or an Excluded Contribution) of the Issuer, in each case, subsequent to the Issue Date; provided, however, that (i) any such Net Cash Proceeds that are so received or contributed
shall not increase the amount available for making Restricted Payments to the extent the Issuer and its Restricted Subsidiaries Incur Indebtedness in reliance thereon and (ii) any Net Cash Proceeds that are so received or contributed shall be
excluded for purposes of Incurring Indebtedness pursuant to this clause to the extent the Issuer or any of its Restricted Subsidiaries makes a Restricted Payment; 

(11) Indebtedness of Non-Guarantors in an aggregate amount not to exceed the greater of (i) $750 million and
(ii) 2.25% of Total Assets of non-Guarantors at any time outstanding and any Refinancing Indebtedness in respect thereof; 
 (12) Indebtedness consisting of promissory notes issued by the Issuer or any of its Subsidiaries to any current or former employee, director or consultant of the Issuer, any of its Subsidiaries or any
Parent Entity (or permitted transferees, assigns, estates, or heirs of such employee, director or consultant), to finance the purchase or redemption of Capital Stock of the Issuer or any Parent Entity that is permitted by Section 3.3;

 (13) Indebtedness of the Issuer or any of its Restricted Subsidiaries consisting of (i) the financing of
insurance premiums or (ii) take-or-pay obligations contained in supply arrangements, in each case Incurred in the ordinary course of business; 
 (14) Indebtedness in an aggregate outstanding principal amount which, when taken together with any Refinancing Indebtedness in respect thereof and the principal amount of all other Indebtedness Incurred
pursuant to this clause and then outstanding, will not exceed the greater of (i) $900 million and (ii) 2.75% of Total Assets; and 
 (15) Indebtedness Incurred by a Securitization Subsidiary in a Qualified Securitization Financing that is not recourse (except for Standard Securitization Undertakings) to the Issuer or any of its
Restricted Subsidiaries 
 (c) For purposes of determining compliance with, and the outstanding principal amount of any
particular Indebtedness Incurred pursuant to and in compliance with, this Section 3.2: 
 (1) subject
to Section 3.2(c), in the event that Indebtedness meets the criteria of more than one of the types of Indebtedness described in Section 3.2(a) and (b), the Issuer, in its sole discretion, will classify, and may from
time to time reclassify, such item of Indebtedness and only be required to include the amount and type of such Indebtedness in one of the clauses of Section 3.2(a) or (b); 

(2) subject to Section 3.2(c)(3), additionally, all or any portion of any item of Indebtedness may later be
classified as having been Incurred pursuant to any type of Indebtedness described in Section 3.2(a) and (b) so long as such Indebtedness is permitted to be Incurred pursuant to such provision at the time of reclassification;

 (3) all Indebtedness outstanding on the Escrow Release Date under the Credit Agreement shall be deemed to have
been incurred on the Escrow Release Date under Section 3.2(b)(1) and may not be reclassified at any time pursuant to clause (1) or (2) of this Section 3.2(c); 

(4) In the case of any refinancing of any Indebtedness permitted under clause (7), (10), (11) or (14) of the
second paragraph above or any portion thereof, such Indebtedness shall not include the aggregate amount of fees, underwriting discounts, premiums and other costs and expenses Incurred in connection with such refinancing; 

  
 -56-

 (5) Guarantees of, or obligations in respect of letters of credit,
bankers’ acceptances or other similar instruments relating to, or Liens securing, Indebtedness that is otherwise included in the determination of a particular amount of Indebtedness shall not be included; 

(6) if obligations in respect of letters of credit, bankers’ acceptances or other similar instruments are Incurred
pursuant to any Credit Facility and are being treated as Incurred pursuant to clause (1), (7), (10), (11) or (14) of Section 3.2(b) or Section 3.2(a) and the letters of credit, bankers’ acceptances or
other similar instruments relate to other Indebtedness, then such other Indebtedness shall not be included; 

(7) the principal amount of any Disqualified Stock of the Issuer or a Restricted Subsidiary, or Preferred Stock of a
Restricted Subsidiary, will be equal to the greater of the maximum mandatory redemption or repurchase price (not including, in either case, any redemption or repurchase premium) or the liquidation preference thereof; 

(8) Indebtedness permitted by this Section 3.2 need not be permitted solely by reference to one provision
permitting such Indebtedness but may be permitted in part by one such provision and in part by one or more other provisions of this Section 3.2 permitting such Indebtedness; and 

(9) the amount of any Indebtedness outstanding as of any date shall be (i) the accreted value thereof in the case of
any Indebtedness issued with original issue discount and (ii) the principal amount of Indebtedness, or liquidation preference thereof, in the case of any other Indebtedness. 

(d) Accrual of interest, accrual of dividends, the accretion of accreted value, the accretion or amortization of original issue discount,
the payment of interest in the form of additional Indebtedness, the payment of dividends in the form of additional shares of Preferred Stock or Disqualified Stock or the reclassification of commitments or obligations not treated as Indebtedness due
to a change in GAAP, will not be deemed to be an Incurrence of Indebtedness for purposes of this Section 3.2. 
 (e)
If at any time an Unrestricted Subsidiary becomes a Restricted Subsidiary, any Indebtedness of such Subsidiary shall be deemed to be Incurred by a Restricted Subsidiary of the Issuer as of such date (and, if such Indebtedness is not permitted to be
Incurred as of such date under this Section 3.2, the Issuer shall be in default of this Section 3.2). 

(f) Notwithstanding any other provision of this Section 3.2, the maximum amount of Indebtedness that the Issuer or a
Restricted Subsidiary may Incur pursuant to this Section 3.2 shall not be deemed to be exceeded solely as a result of fluctuations in the exchange rate of currencies. The principal amount of any Indebtedness Incurred to refinance other
Indebtedness, if Incurred in a different currency from the Indebtedness being refinanced, shall be calculated based on the currency exchange rate applicable to the currencies in which such Refinancing Indebtedness is denominated that is in effect on
the date of such refinancing. 
 (g) The Issuer shall not, and shall not permit any Guarantor to, directly or indirectly, Incur
any Indebtedness (including Acquired Indebtedness) that is subordinated or junior in right of payment to any Indebtedness of the Issuer or such Guarantor, as the case may be, unless such Indebtedness is expressly subordinated in right of payment to
the Notes or such Guarantor’s Note Guarantee to the extent and in the same manner as such Indebtedness is subordinated to other Indebtedness of the Issuer or such Guarantor, as the case may be. 

  
 -57-

 SECTION 3.3. Limitation on Restricted Payments. 

(a) The Issuer shall not, and shall not permit any of its Restricted Subsidiaries, directly or indirectly, to: 

(1) declare or pay any dividend or make any distribution on or in respect of the Issuer’s or any Restricted
Subsidiary’s Capital Stock (including any payment in connection with any merger or consolidation involving the Issuer or any of its Restricted Subsidiaries) except: 

(i) dividends or distributions payable in Capital Stock of the Issuer (other than Disqualified Stock) or in options,
warrants or other rights to purchase such Capital Stock of the Issuer; and 
 (ii) dividends or distributions
payable to the Issuer or a Restricted Subsidiary (and, in the case of any such Restricted Subsidiary making such dividend or distribution, to holders of its Capital Stock other than the Issuer or another Restricted Subsidiary on no more than a
pro rata basis); 
 (2) purchase, redeem, retire or otherwise acquire for value any Capital Stock of the
Issuer or any Parent Entity of the Issuer held by Persons other than the Issuer or a Restricted Subsidiary of the Issuer; 
 (3) purchase, repurchase, redeem, defease or otherwise acquire or retire for value, prior to scheduled maturity, scheduled repayment or scheduled sinking fund payment, any Subordinated Indebtedness (other
than (i) any such purchase, repurchase, redemption, defeasance or other acquisition or retirement in anticipation of satisfying a sinking fund obligation, principal installment or final maturity, in each case, due within one year of the date of
purchase, repurchase, redemption, defeasance or other acquisition or retirement and (ii) any Indebtedness Incurred pursuant to Section 3.2(b)(3)); or 

(4) make any Restricted Investment; 
 (any such dividend, distribution, purchase, redemption, repurchase, defeasance, other acquisition, retirement or Restricted Investment referred to in clauses (1) through (4) are referred to
herein as a “Restricted Payment”), if at the time the Issuer or such Restricted Subsidiary makes such Restricted Payment: 
 (i) a Default shall have occurred and be continuing (or would result immediately thereafter therefrom); 
 (ii) the Issuer is not able to Incur an additional $1.00 of Indebtedness pursuant to Section 3.2(a) after giving effect, on a pro forma basis, to such Restricted Payment; or 

(iii) the aggregate amount of such Restricted Payment and all other Restricted Payments made subsequent to the Escrow
Release Date (and not returned or rescinded) (including Permitted Payments permitted by Section 3.3(b)(1) (without duplication), (10) and (11), but excluding all other Restricted Payments permitted by
Section 3.3(b)) would exceed the sum of (without duplication): 
 (A) 50% of Consolidated Net Income
for the period (treated as one accounting period) from the first day of the first fiscal quarter commencing after the Escrow Release Date to the end of the most recent fiscal quarter ending prior to the date of such Restricted Payment for which
internal consolidated financial statements of the Issuer are available (or, in the case such Consolidated Net Income is a deficit, minus 100% of such deficit); 

  
 -58-

 (B) 100% of the aggregate Net Cash Proceeds, and the fair market value of
property or assets or marketable securities, received by the Issuer from the issue or sale of its Capital Stock (other than Disqualified Stock or Designated Preferred Stock) subsequent to the Issue Date or otherwise contributed to the equity (other
than through the issuance of Disqualified Stock or Designated Preferred Stock) of the Issuer subsequent to the Issue Date (other than (x) Net Cash Proceeds or property or assets or marketable securities received from an issuance or sale of such
Capital Stock to a Restricted Subsidiary or an employee stock ownership plan or trust established by the Issuer or any Subsidiary of the Issuer for the benefit of its employees to the extent funded by the Issuer or any Restricted Subsidiary,
(y) Net Cash Proceeds or property or assets or marketable securities to the extent that any Restricted Payment has been made from such proceeds in reliance on Section 3.3(b)(6) and (z) Excluded Contributions); 

(C) 100% of the aggregate Net Cash Proceeds, and the fair market value of property or assets or marketable securities,
received by the Issuer or any Restricted Subsidiary from the issuance or sale (other than to the Issuer or a Restricted Subsidiary of the Issuer or an employee stock ownership plan or trust established by the Issuer or any Subsidiary of the Issuer
for the benefit of their employees to the extent funded by the Issuer or any Restricted Subsidiary) by the Issuer or any Restricted Subsidiary subsequent to the Issue Date of any Indebtedness, Disqualified Stock or Designated Preferred Stock that
has been converted into or exchanged for Capital Stock of the Issuer (other than Disqualified Stock or Designated Preferred Stock) plus, without duplication, the amount of any cash, and the fair market value of property or assets or marketable
securities, received by the Issuer or any Restricted Subsidiary upon such conversion or exchange; 
 (D) 100% of
the aggregate amount received in cash and the fair market value, as determined in good faith by the Issuer, of marketable securities or other property received by means of: (i) the sale or other disposition (other than to the Issuer or a
Restricted Subsidiary) of Restricted Investments made by the Issuer or its Restricted Subsidiaries and repurchases and redemptions of such Restricted Investments from the Issuer or its Restricted Subsidiaries and repayments of loans or advances, and
releases of guarantees, which constitute Restricted Investments by the Issuer or its Restricted Subsidiaries, in each case after the Issue Date; or (ii) the sale (other than to the Issuer or a Restricted Subsidiary) of the stock of an
Unrestricted Subsidiary or a distribution from an Unrestricted Subsidiary (other than to the extent of the amount of the Investment that constituted a Permitted Investment) or a dividend from an Unrestricted Subsidiary after the Issue Date; and

 (E) in the case of the redesignation of an Unrestricted Subsidiary as a Restricted Subsidiary or the merger
or consolidation of an Unrestricted Subsidiary into the Issuer or a Restricted Subsidiary or the transfer of all or substantially all of the assets of an Unrestricted Subsidiary to the Issuer or a Restricted Subsidiary after the Issue Date, the fair
market value of the Investment in such Unrestricted Subsidiary (or the assets transferred), as determined in good faith of the Issuer at the time of the redesignation of such Unrestricted Subsidiary as a Restricted Subsidiary or at the time of such
merger or consolidation or transfer of assets (after taking into consideration any Indebtedness associated with the Unrestricted Subsidiary so designated or merged or consolidated or Indebtedness associated with the assets so transferred), other
than to the extent of the amount of the Investment that constituted a Permitted Investment. 
 (b) Section 3.3(a)
will not prohibit any of the following (collectively, “Permitted Payments”): 
 (1) the payment
of any dividend or distribution within 60 days after the date of declaration thereof, if at the date of declaration such payment would have complied with the provisions of this Indenture or the redemption, repurchase or retirement of Indebtedness
if, at the date of any irrevocable redemption notice, such payment would have complied with the provisions of this Indenture; 

  
 -59-

 (2) any purchase, repurchase, redemption, defeasance or other acquisition or
retirement of Capital Stock or Subordinated Indebtedness made by exchange (including any such exchange pursuant to the exercise of a conversion right or privilege in connection with which cash is paid in lieu of the issuance of fractional shares)
for, or out of the proceeds of the substantially concurrent sale of, Capital Stock of the Issuer (other than Disqualified Stock or Designated Preferred Stock) (“Refunding Capital Stock”) or a substantially concurrent contribution to
the equity (other than through the issuance of Disqualified Stock or Designated Preferred Stock or through an Excluded Contribution) of the Issuer; provided, however, that to the extent so applied, the Net Cash Proceeds, or fair market
value of property or assets or of marketable securities, from such sale of Capital Stock or such contribution will be excluded from Section 3.3(a)(4)(iii); 

(3) any purchase, repurchase, redemption, defeasance or other acquisition or retirement of Subordinated Indebtedness made
by exchange for, or out of the proceeds of the substantially concurrent sale of, Subordinated Indebtedness that constitutes Refinancing Indebtedness permitted to be Incurred pursuant to Section 3.2; 

(4) any purchase, repurchase, redemption, defeasance or other acquisition or retirement of Preferred Stock of the Issuer
or a Restricted Subsidiary made by exchange for or out of the proceeds of the substantially concurrent sale of Preferred Stock of the Issuer or a Restricted Subsidiary, as the case may be, that, in each case, is permitted to be Incurred pursuant to
Section 3.2; 
 (5) any purchase, repurchase, redemption, defeasance or other acquisition or
retirement of Subordinated Indebtedness or Disqualified Stock or Preferred Stock of a Restricted Subsidiary: 

(i) from Net Available Cash to the extent permitted under Section 3.5, but only if the Issuer shall have first
complied with the terms described under Section 3.5 and purchased all Notes tendered pursuant to any offer to repurchase all the Notes required thereby, prior to purchasing, repurchasing, redeeming, defeasing or otherwise acquiring or
retiring such Subordinated Indebtedness, Disqualified Stock or Preferred Stock; or 
 (ii) to the extent required
by the agreement governing such Subordinated Indebtedness, Disqualified Stock or Preferred Stock, following the occurrence of a Change of Control (or other similar event described therein as a “change of control”), but only if the Issuer
shall have first complied with the terms described under Section 3.9 and purchased all Notes tendered pursuant to the offer to repurchase all the Notes required thereby, prior to purchasing, repurchasing, redeeming, defeasing or
otherwise acquiring or retiring such Subordinated Indebtedness, Disqualified Stock or Preferred Stock; or 

(iii) consisting of Acquired Indebtedness (other than Indebtedness Incurred (A) to provide all or any portion of the
funds utilized to consummate the transaction or series of related transactions pursuant to which such Person became a Restricted Subsidiary or was otherwise acquired by the Issuer or a Restricted Subsidiary or (B) otherwise in connection with
or contemplation of such acquisition); 
 (6) a Restricted Payment to pay for the repurchase, retirement or other
acquisition or retirement for value of Capital Stock (other than Disqualified Stock) of the Issuer or of any Parent Entity held by any future, present or former employee, director or consultant of the Issuer, any of its Subsidiaries or of any Parent
Entity (or permitted transferees, assigns, estates, trusts or heirs of such employee, director or consultant) either pursuant to any management equity plan or stock option plan or any other management or employee benefit plan or agreement or upon
the termination of such employee, director or consultant’s employment or directorship; provided, however, that the aggregate Restricted Payments made under this clause (6) do not exceed $50.0 million in any calendar year
(with unused amounts in any calendar year being carried over to succeeding calendar years subject to a maximum of $50 million in any calendar year); provided further that such amount in any calendar year may be increased by an amount not to
exceed: 
 (i) the cash proceeds from the sale of Capital Stock (other than Disqualified Stock or Designated
Preferred Stock or Excluded Contributions) of the Issuer and, to the extent contributed to the capital of the Issuer (other than through the issuance of Disqualified Stock or Designated Preferred Stock or an Excluded Contribution), Capital Stock of
any Parent Entity, in each case to members of management, directors or consultants of the Issuer, any of its Subsidiaries or any Parent Entity that occurred after the Escrow Release Date, to the extent the cash proceeds from the sale of such Capital
Stock have not otherwise been applied to the payment of Restricted Payments by virtue of Section 3.3(a)(4)(iii); plus  

  
 -60-

 (ii) the cash proceeds of key man life insurance policies received by the
Issuer and its Restricted Subsidiaries after the Escrow Release Date; less  
 (iii) the amount of any
Restricted Payments made in previous calendar years pursuant to clauses (i) and (ii) of this clause (6); 
 and
provided further that cancellation of Indebtedness owing to the Issuer or any Restricted Subsidiary from members of management, directors, employees or consultants of the Issuer, or any Parent Entity or Restricted Subsidiaries in connection
with a repurchase of Capital Stock of the Issuer or any Parent Entity will not be deemed to constitute a Restricted Payment for purposes of this Section 3.3 or any other provision of this Indenture; 

(7) the declaration and payment of dividends on Disqualified Stock or Preferred Stock of a Restricted Subsidiary, Incurred
in accordance with the terms of Section 3.2; 
 (8) purchases, repurchases, redemptions, defeasances
or other acquisitions or retirements of Capital Stock deemed to occur upon the exercise of stock options, warrants or other rights in respect thereof if such Capital Stock represents a portion of the exercise price thereof; 

(9) dividends, loans, advances or distributions to any Parent Entity or other payments by the Issuer or any Restricted
Subsidiary in amounts equal to (without duplication): 
 (i) the amounts required for any Parent Entity to pay
any Parent Entity Expenses or any Related Taxes; or 
 (ii) amounts constituting or to be used for purposes of
making payments to the extent specified in Section 3.8(b)(2), (3), (5), (11) and (12); 
 (10) the declaration and payment by the Issuer of, dividends on the common stock or common equity interests of the Issuer or any Parent Entity following a public offering of such common stock or common
equity interests, in an amount not to exceed 6% of the proceeds received by or contributed to the Issuer in or from any public offering in any fiscal year; 
 (11) payments by the Issuer, or loans, advances, dividends or distributions to any Parent Entity to make payments, to holders of Capital Stock of the Issuer or any Parent Entity in lieu of the issuance of
fractional shares of such Capital Stock, provided, however, that any such payment, loan, advance, dividend or distribution shall not be for the purpose of evading any limitation of this Section 3.3 or otherwise to
facilitate any dividend or other return of capital to the holders of such Capital Stock (as determined in good faith by the Board of Directors); 
 (12) Restricted Payments that are made with Excluded Contributions; 

(13) (i) the declaration and payment of dividends on Designated Preferred Stock of the Issuer issued after the Issue Date;
and (ii) the declaration and payment of dividends on Refunding Capital Stock that is Preferred Stock; provided, however, that, in the case of clause (i), the amount of all dividends declared or paid pursuant to this clause
shall not exceed the Net Cash Proceeds received by the Issuer or the 

  
 -61-

 
aggregate amount contributed in cash to the equity (other than through the issuance of Disqualified Stock or an Excluded Contribution of the Issuer), from the issuance or sale of such Designated
Preferred Stock; provided further, in the case of clause (ii), that for the most recently ended four fiscal quarters for which internal financial statements are available immediately preceding the date of issuance of such Designated
Preferred Stock, after giving effect to such payment on a pro forma basis the Issuer would be permitted to Incur at least $1.00 of additional Indebtedness pursuant to the test set forth in Section 3.2(a); 

(14) dividends or other distributions of Capital Stock of, or Indebtedness owed to the Issuer or a Restricted Subsidiary
by, Unrestricted Subsidiaries (unless the Unrestricted Subsidiary’s principal asset is cash and Cash Equivalents); 
 (15) distributions or payments of Securitization Fees, sales contributions and other transfers of Securitization Assets and purchases of Securitization Assets pursuant to a Securitization Repurchase
Obligation, in each case in connection with a Qualified Securitization Financing; 
 (16) any Restricted Payment
made in connection with the Transactions and the fees and expenses related thereto or used to fund amounts owed to Affiliates in connection with the Transactions (including dividends to any Parent Entity of the Issuer to permit payment by such
Parent Entity of such amounts); 
 (17) so long as no Default or Event of Default has occurred and is continuing
(or would result from), Restricted Payments (including loans or advances) in an aggregate amount outstanding at the time made not to exceed $750 million; 
 (18) so long as no Default or Event of Default has occurred and is continuing (or would result therefrom), mandatory redemptions of Disqualified Stock issued as a Restricted Payment or as consideration
for a Permitted Investment; provided that the amount of such redemptions are no greater than the amount that constituted a Restricted Payment or Permitted Investment; 

(19) any Restricted Payments made in connection with paying dividends with respect to the declaration and payment by the
Issuer or any Restricted Subsidiary of cash dividends with respect to the Preferred Stock of the Issuer or any Parent Entity in existence on the Escrow Release Date and any accretions or accumulations of unpaid dividends thereon or any Preferred
Stock issued as a replacement therefor so long as the terms of such Preferred Stock are not materially adverse to the Holders of the Notes as compared to the terms of the Preferred Stock that is being replaced (as determined in good faith by the
Board of Directors); and 
 (20) following the third anniversary of the Escrow Release Date, any Restricted
Payments made in connection with the Issuer or any Restricted Subsidiary paying for the repurchase, retirement or other acquisition or retirement or other acquisition or retirement for value of all or any portion of the Preferred Stock of the Issuer
or any Parent Entity in existence on the Escrow Release Date and any accretions or accumulations of unpaid dividends thereon; provided that after giving effect to such Restricted Payment and to the Incurrence of any Indebtedness in connection
therewith on a pro forma basis the Issuer would (x) be permitted to Incur at least $1.00 of additional Indebtedness pursuant to the test set forth in Section 3.2(a) and (y) have a Consolidated Total Leverage Ratio as of the end
of the most recently completed four-quarter period for which financial statements have been provided that is not greater than 6.00 to 1.00. 
 (c) For purposes of determining compliance with this Section 3.3, in the event that a Restricted Payment meets the criteria of more than one of the categories of Permitted Payments described
in clauses (1) through (18) of Section 3.3(b), or is permitted pursuant to Section 3.3(a), the Issuer will be entitled to classify such Restricted Payment (or portion thereof) on the date of its payment or later
reclassify such Restricted Payment (or portion thereof) in any manner that complies with this Section 3.3. 

  
 -62-

 (d) The amount of all Restricted Payments (other than cash) shall be the fair market value
on the date of such Restricted Payment of the asset(s) or securities proposed to be paid, transferred or issued by the Issuer or such Restricted Subsidiary, as the case may be, pursuant to such Restricted Payment. The fair market value of any cash
Restricted Payment shall be its face amount, and the fair market value of any non-cash Restricted Payment, property or assets other than cash shall be determined conclusively by the Board of Directors of the Issuer acting in good faith. 

SECTION 3.4. Limitation on Restrictions on Distributions from Restricted Subsidiaries. 

(a) The Issuer shall not, and shall not permit any Restricted Subsidiary to, create or otherwise cause or permit to exist or become
effective any consensual encumbrance or consensual restriction on the ability of any Restricted Subsidiary to: 

(1) pay dividends or make any other distributions in cash or otherwise on its Capital Stock or pay any Indebtedness or
other obligations owed to the Issuer or any Restricted Subsidiary; 
 (2) make any loans or advances to the
Issuer or any Restricted Subsidiary; or 
 (3) sell, lease or transfer any of its property or assets to the
Issuer or any Restricted Subsidiary; 
 provided that (x) the priority of any Preferred Stock in receiving dividends or liquidating
distributions prior to dividends or liquidating distributions being paid on common stock and (y) the subordination of (including the application of any standstill requirements to) loans or advances made to the Issuer or any Restricted
Subsidiary to other Indebtedness Incurred by the Issuer or any Restricted Subsidiary shall not be deemed to constitute such an encumbrance or restriction. 
 (b) Section 3.4(a) shall not prohibit: 
 (1) any
encumbrance or restriction pursuant to (a) any Credit Facility or (b) any other agreement or instrument, in each case, in effect at or entered into on the Escrow Release Date; 

(2) this Indenture, the Notes, the Collateral Documents, the Intercreditor Agreement, the Note Guarantees, the Exchange
Notes and any Guarantees thereof; 
 (3) any encumbrance or restriction pursuant to an agreement or instrument of
a Person or relating to any Capital Stock or Indebtedness of a Person, entered into on or before the date on which such Person was acquired by or merged, consolidated or otherwise combined with or into the Issuer or any Restricted Subsidiary, or was
designated as a Restricted Subsidiary or on which such agreement or instrument is assumed by the Issuer or any Restricted Subsidiary in connection with an acquisition of assets (other than Capital Stock or Indebtedness Incurred as consideration in,
or to provide all or any portion of the funds utilized to consummate, the transaction or series of related transactions pursuant to which such Person became a Restricted Subsidiary or was acquired by the Issuer or was merged, consolidated or
otherwise combined with or into the Issuer or any Restricted Subsidiary or entered into in contemplation of or in connection with such transaction) and outstanding on such date; provided that, for the purposes of this clause, if another
Person is the Successor Company, any Subsidiary thereof or agreement or instrument of such Person or any such Subsidiary shall be deemed acquired or assumed by the Issuer or any Restricted Subsidiary when such Person becomes the Successor Company;

 (4) any encumbrance or restriction: 

(i) that restricts in a customary manner the subletting, assignment or transfer of any property or asset that is subject
to a lease, license or similar contract or agreement, or the assignment or transfer of any lease, license or other contract or agreement; 

  
 -63-

 (ii) contained in mortgages, pledges, charges or other security agreements
permitted under this Indenture and the Collateral Documents or securing Indebtedness of the Issuer or a Restricted Subsidiary permitted under this Indenture and the Collateral Documents to the extent such encumbrances or restrictions restrict the
transfer or encumbrance of the property or assets subject to such mortgages, pledges, charges or other security agreements; or 
 (iii) pursuant to customary provisions restricting dispositions of real property interests set forth in any reciprocal easement agreements of the Issuer or any Restricted Subsidiary; 

(5) any encumbrance or restriction pursuant to Purchase Money Obligations and Capitalized Lease Obligations permitted
under this Indenture and the Collateral Documents, in each case, that impose encumbrances or restrictions on the property so acquired; 
 (6) any encumbrance or restriction imposed pursuant to an agreement entered into for the direct or indirect sale or disposition to a Person of all or substantially all the Capital Stock or assets of the
Issuer or any Restricted Subsidiary (or the property or assets that are subject to such restriction) pending the closing of such sale or disposition; 
 (7) customary provisions in leases, licenses, joint venture agreements and other similar agreements and instruments; 

(8) encumbrances or restrictions arising or existing by reason of applicable law or any applicable rule, regulation or
order, or required by any regulatory authority; 
 (9) any encumbrance or restriction on cash or other deposits
or net worth imposed by customers under agreements entered into in the ordinary course of business; 
 (10) any
encumbrance or restriction pursuant to Hedging Obligations; 
 (11) other Indebtedness, Disqualified Stock or
Preferred Stock of Foreign Subsidiaries permitted to be Incurred or issued subsequent to the Escrow Release Date pursuant to Section 3.2 that impose restrictions solely on the Foreign Subsidiaries party thereto or their Subsidiaries;

 (12) restrictions created in connection with any Qualified Securitization Financing that, in the good faith
determination of the Issuer, are necessary or advisable to effect such Securitization Facility; 
 (13) any
encumbrance or restriction arising pursuant to an agreement or instrument which, if it relates to any Indebtedness, shall only be permitted if such Indebtedness is permitted to be Incurred pursuant to Section 3.2 if the encumbrances and
restrictions contained in any such agreement or instrument taken as a whole (i) are not materially less favorable to the Holders than the encumbrances and restrictions contained in the Credit Agreement, together with the security documents
associated therewith as in effect on the Escrow Release Date or (ii) either (A) the Issuer determines at the time of entry into such agreement or instrument that such encumbrances or restrictions will not adversely affect, in any material
respect, the Issuer’s ability to make principal or interest payments on the Notes or (B) such encumbrance or restriction applies only during the continuance of a default relating to such agreement or instrument; 

(14) any encumbrance or restriction existing by reason of any lien permitted under Section 3.6; or 

(15) any encumbrance or restriction pursuant to an agreement or instrument effecting a refinancing of Indebtedness
Incurred pursuant to, or that otherwise refinances, an agreement or instrument referred to in clauses (1) to (14) of this Section 3.4(b) or this clause (15) (an “Initial Agreement”) or contained in any
amendment, supplement or other modification to an agreement referred to in clauses (1) to (14) of this Section 3.4(b) or this clause (15); provided, however, that the encumbrances and restrictions

  
 -64-

 
with respect to such Restricted Subsidiary contained in any such agreement or instrument are no less favorable in any material respect to the Holders taken as a whole than the encumbrances and
restrictions contained in the Initial Agreement or Initial Agreements to which such refinancing or amendment, supplement or other modification relates (as determined in good faith by the Issuer). 

SECTION 3.5. Limitation on Sales of Assets and Subsidiary Stock. 

(a) The Issuer shall not, and shall not permit any of its Restricted Subsidiaries to, make any Asset Disposition unless: 

(1) the Issuer or such Restricted Subsidiary, as the case may be, receives consideration (including by way of relief from,
or by any other Person assuming responsibility for, any liabilities, contingent or otherwise) at least equal to the fair market value (such fair market value to be determined on the date of contractually agreeing to such Asset Disposition), as
determined in good faith by the Board of Directors of the Issuer, of the shares and assets subject to such Asset Disposition (including, for the avoidance of doubt, if such Asset Disposition is a Permitted Asset Swap); 

(2) in any such Asset Disposition, or series of related Asset Dispositions (except to the extent the Asset Disposition is
a Permitted Asset Swap) with a purchase price in excess of $50 million, at least 75% of the consideration from such Asset Disposition (including by way of relief from, or by any other Person assuming responsibility for, any liabilities, contingent
or otherwise) received by the Issuer or such Restricted Subsidiary, as the case may be, is in the form of cash or Cash Equivalents; and 
 (3) an amount equal to 100% of the Net Available Cash from such Asset Disposition is applied: 
 (i) to the extent the Issuer or any Restricted Subsidiary, as the case may be, elects (or is required by the terms of any Indebtedness), (A) to prepay, repay or purchase any Indebtedness of a
Non-Guarantor or that is secured by a Lien (in each case, other than Indebtedness owed to the Issuer or any Restricted Subsidiary) or any First Priority Obligations, including Indebtedness under the Credit Agreement (or any Refinancing Indebtedness
in respect thereof) within 450 days from the later of (1) the date of such Asset Disposition and (2) the receipt of such Net Available Cash; provided, however, that, in connection with any prepayment, repayment or
purchase of Indebtedness pursuant to this clause (i), the Issuer or such Restricted Subsidiary will retire such Indebtedness and will cause the related commitment (if any) to be reduced in an amount equal to the principal amount so prepaid,
repaid or purchased; or (B) to prepay, repay or purchase Pari Passu Indebtedness at a price of no more than 100% of the principal amount of such Pari Passu Indebtedness plus accrued and unpaid interest to the date of such prepayment, repayment
or purchase; provided further that, to the extent the Issuer redeems, repays or repurchases Pari Passu Indebtedness pursuant to this clause (B), the Issuer shall equally and ratably reduce Obligations under the Notes as provided under
Section 5.7, through open-market purchases (to the extent such purchases are at or above 100% of the principal amount thereof) or by making an offer (in accordance with the procedures set forth below for an Asset Disposition Offer) to
all Holders to purchase their Notes at 100% of the principal amount thereof, plus the amount of accrued but unpaid interest, if any, on the amount of Notes that would otherwise be prepaid; provided further, that, in addition to the foregoing,
the Net Available Cash from an Asset Disposition of Collateral may not be applied to prepay, repay or purchase any Indebtedness other than First Priority Obligations, Notes or Pari Passu Indebtedness of the Issuer or a Guarantor secured by a Lien on
such Collateral; and/or 
 (ii) to the extent the Issuer or any Restricted Subsidiary elects, to invest in or
commit to invest in Additional Assets (including by means of an investment in Additional Assets by a Restricted Subsidiary with Net Available Cash received by the Issuer or another Restricted Subsidiary) within 450 days from the later of
(A) the date of such Asset Disposition and (B) the receipt of such Net Available Cash; provided, however, that a binding agreement shall be treated as a permitted application of Net Proceeds from the date of such commitment
with the good faith 

  
 -65-

 
expectation that such Net Proceeds will be applied to satisfy such commitment within 180 days of such commitment (an “Acceptable Commitment”) and, in the event any Acceptable
Commitment is later cancelled or terminated for any reason before the Net Proceeds are applied in connection therewith, the Issuer or such Restricted Subsidiary enters into another Acceptable Commitment (a “Second Commitment”)
within 180 days of such cancellation or termination; provided further that if any Second Commitment is later cancelled or terminated for any reason before such Net Proceeds are applied, then such Net Proceeds shall constitute Excess Proceeds;
and 
 (4) if such Asset Disposition involves the disposition of Collateral, the Issuer or such Subsidiary has
complied with the provisions of this Indenture and the Collateral Documents; 
 provided that, pending the final application of any such
Net Available Cash in accordance with clause (i) or clause (ii) in Section 3.5(a)(3), the Issuer and its Restricted Subsidiaries may temporarily reduce Indebtedness or otherwise use such Net Available Cash in any manner not
prohibited by this Indenture. 
 (b) Any Net Available Cash from Asset Dispositions that is not applied or invested or committed
to be applied or invested as provided in the preceding paragraph will be deemed to constitute “Excess Proceeds” under this Indenture. On the 451st day after an Asset Disposition or the receipt of such Net Available Cash, if the
aggregate amount of Excess Proceeds under this Indenture exceeds (i) $100.0 million, in the case of a single transaction or a series of related transactions, or (ii) $200.0 million aggregate amount in any fiscal year, the Issuer will
within 10 Business Days be required to make an offer (“Asset Disposition Offer”) to all Holders of Notes issued under this Indenture and, to the extent the Issuer elects, to all holders of other outstanding Pari Passu Indebtedness,
to purchase the maximum principal amount of Notes and any such Pari Passu Indebtedness to which the Asset Disposition Offer applies that may be purchased out of the Excess Proceeds, at an offer price in respect of the Notes in an amount equal to
100% of the principal amount of the Notes and Pari Passu Indebtedness, in each case, plus accrued and unpaid interest, if any, to, but not including, the date of purchase, in accordance with the procedures set forth in this Indenture or the
agreements governing the Pari Passu Indebtedness, as applicable, and, with respect to the Notes, in minimum denominations of $2,000 and in integral multiples of $1,000 in excess thereof. The Issuer will deliver notice of such Asset Disposition Offer
electronically or by first-class mail, with a copy to the Trustee, to each Holder of Notes at the address of such Holder appearing in the security register or otherwise in accordance with the procedures of DTC, describing the transaction or
transactions that constitute the Asset Disposition and offering to repurchase the Notes for the specified purchase price on the date specified in the notice, which date will be no earlier than 30 days and no later than 60 days from the date such
notice is delivered, pursuant to the procedures required by this Indenture and described in such notice. 
 (c) To the extent
that the aggregate amount of Notes and Pari Passu Indebtedness so validly tendered and not properly withdrawn pursuant to an Asset Disposition Offer is less than the Excess Proceeds, the Issuer may use any remaining Excess Proceeds for any purpose
not prohibited by this Indenture. If the aggregate principal amount of the Notes surrendered in any Asset Disposition Offer by Holders and other Pari Passu Indebtedness surrendered by holders or lenders, collectively, exceeds the amount of Excess
Proceeds, the Excess Proceeds shall be allocated among the Notes and Pari Passu Indebtedness to be purchased on a pro rata basis on the basis of the aggregate principal amount of tendered Notes and Pari Passu Indebtedness provided that no Notes or
other Pari Passu Indebtedness will be selected and purchased in an unauthorized denomination. Upon completion of any Asset Disposition Offer, the amount of Excess Proceeds shall be reset at zero. 

(d) To the extent that any portion of Net Available Cash payable in respect of the Notes is denominated in a currency other than U.S.
dollars, the amount thereof payable in respect of the Notes shall not exceed the net amount of funds in U.S. dollars that is actually received by the Issuer upon converting such portion into U.S. dollars. 

(e) Notwithstanding any other provisions of this Section 3.5, (i) to the extent that any or all the Net Available Cash
of any Asset Disposition by a Foreign Subsidiary (a “Foreign Disposition”) is prohibited or delayed by applicable local law from being repatriated to the United States, the portion of such Net Available Cash so affected will not be
required to be applied in compliance with this Section 3.5, and such amounts may be retained by the applicable Foreign Subsidiary so long, but only so long, as the applicable local law will not permit repatriation to the United States
(the Issuer hereby agreeing to cause the applicable Foreign Subsidiary to promptly take all 

  
 -66-

 
commercially reasonable actions available under the applicable local law to permit such repatriation), and once such repatriation of any of such affected Net Available Cash is permitted under the
applicable local law, such repatriation will be promptly effected and such repatriated Net Available Cash will be promptly (and in any event not later than three (3) Business Days after such repatriation) applied (net of additional Taxes
payable or reserved against as a result thereof) in compliance with this Section 3.5 and (ii) to the extent that the Issuer has determined in good faith that repatriation of any of or all the Net Available Cash of any Foreign
Disposition would have a material adverse Tax consequence (taking into account any foreign tax credit or benefit received in connection with such repatriation) with respect to such Net Available Cash, the Net Available Cash so affected may be
retained by the applicable Foreign Subsidiary. 
 (f) For the purposes of Section 3.5(a)(2) hereof, the following
will be deemed to be cash: 
 (i) the assumption by the transferee of Indebtedness or other liabilities
contingent or otherwise of the Issuer or a Restricted Subsidiary (other than Subordinated Indebtedness of the Issuer or a Guarantor) and the release of the Issuer or such Restricted Subsidiary from all liability on such Indebtedness or other
liability in connection with such Asset Disposition; 
 (ii) securities, notes or other obligations received by
the Issuer or any Restricted Subsidiary of the Issuer from the transferee that are converted by the Issuer or such Restricted Subsidiary into cash or Cash Equivalents within 180 days following the closing of such Asset Disposition; 

(iii) Indebtedness of any Restricted Subsidiary that is no longer a Restricted Subsidiary as a result of such Asset
Disposition, to the extent that the Issuer and each other Restricted Subsidiary are released from any Guarantee of payment of such Indebtedness in connection with such Asset Disposition; 

(iv) consideration consisting of Indebtedness of the Issuer (other than Subordinated Indebtedness) received after the
Issue Date from Persons who are not the Issuer or any Restricted Subsidiary; and 
 (v) any Designated Non-Cash
Consideration received by the Issuer or any Restricted Subsidiary in such Asset Dispositions having an aggregate fair market value, taken together with all other Designated Non-Cash Consideration received pursuant to this Section 3.5
that is at that time outstanding, not to exceed the greater of $750.0 million and 2.25% of Total Assets (with the fair market value of each item of Designated Non-Cash Consideration being measured at the time received and without giving effect to
subsequent changes in value). 
 (g) Upon the commencement of an Asset Disposition Offer, the Issuer shall send, or cause to be
sent, by first class mail, a notice to the Trustee and to each Holder at its registered address. The notice shall contain all instructions and materials necessary to enable such Holder to tender Notes pursuant to the Asset Disposition Offer. Any
Asset Disposition Offer shall be made to all Holders. The notice, which shall govern the terms of the Asset Disposition Offer, shall state: 
 (1) that the Asset Disposition Offer is being made pursuant to this Section 3.5 and that, to the extent lawful, all Notes tendered and not withdrawn shall be accepted for payment (unless
prorated); 
 (2) the Asset Disposition payment amount, the Asset Disposition offered price, and the date on
which Notes tendered and accepted for payment shall be purchased, which date shall be at least 30 days and not later than 60 days from the date such notices is mailed (the “Asset Sale Payment Date”); 

(3) that any Notes not tendered or accepted for payment shall continue to accrue interest in accordance with the terms
thereof; 
 (4) that, unless the Issuer defaults in making such payment, any Notes accepted for payment pursuant
to the Asset Disposition Offer shall cease to accrue interest on and after the Asset Sale Payment Date; 

  
 -67-

 (5) that Holders electing to have any Notes purchased pursuant to any Asset
Disposition Offer shall be required to surrender the Notes, with the form entitled “Option of Holder to Elect Purchase” on the reverse of the Note completed, to the Paying Agent at the address specified in the notice at least three
Business Days before the Asset sale Payment Date; 
 (6) that Holders shall be entitled to withdraw their
election if the Paying Agent receives, not later than two Business Days prior to the Asset Sale Payment Date, a notice setting forth the name of the Holder, the principal amount of the Note the Holder delivered for purchase and a statement that such
Holder is withdrawing its election to have such Note purchased; 
 (7) that if the aggregate principal amount of
Notes surrendered by Holders exceeds the Asset Disposition payment amount, the Issuer shall select the Notes to be purchased on a pro rata basis (with such adjustments as may be deemed appropriate by the Issuer so that only Notes in
denominations of $2,000 or integral multiples of $1,000 in excess thereof shall be purchased); and 
 (8) that
Holders whose Notes were purchased only in part shall be issued new Notes equal in principal amount to the unpurchased portion of the Notes surrendered (or transferred by book-entry). 

(h) If the Asset Sale Payment Date is on or after a record date and on or before the related interest payment date, any accrued and
unpaid interest shall be paid to the Person in whose name a Note is registered at the close of business on such record date, and no additional interest shall be payable to Holders who tender Notes pursuant to the Asset Disposition Offer. 

(i) On the Asset Sale Payment Date, the Issuer will, to the extent permitted by law, 

(1) accept for payment all Notes issued by it or portions thereof properly tendered pursuant to the Asset Disposition
Offer, 
 (2) deposit with the Paying Agent an amount equal to the aggregate Asset Disposition payment in respect
of all Notes or portions thereof so tendered, and 
 (3) deliver, or cause to be delivered, to the Trustee for
cancellation the Notes so accepted together with an Officer’s Certificate to the Trustee stating that such Notes or portions thereof have been tendered to and purchased by the Issuer. 

(j) The Issuer will comply, to the extent applicable, with the requirements of Rule 14e-1 under the Exchange Act and any other
securities laws and regulations thereunder to the extent such laws or regulations are applicable in connection with the repurchase of Notes pursuant to this Section 3.5. To the extent that the provisions of any securities laws or
regulations conflict with the provisions of this Indenture, the Issuer will comply with the applicable securities laws and regulations and shall not be deemed to have breached its obligations under this Indenture by virtue thereof. 

SECTION 3.6. Limitation on Liens. 
 (a) The Issuer shall not, and shall not permit any Subsidiary Guarantor to, directly or indirectly, create, Incur or permit to exist any Lien (except Permitted Liens) (each an “Initial
Lien”) that secures obligations under any Indebtedness or any related guarantee, on any asset or property of the Issuer or any Subsidiary Guarantor, unless: 

(1) In the case of Liens securing Subordinated Indebtedness, the Notes and related Guarantees are secured by a Lien on
such property, assets or proceeds that is senior in priority to such Liens; or 
 (2) In all other cases, the
Notes or the Guarantees are equally and ratably secured, except that the foregoing shall not apply to Liens securing the Notes and the related Guarantees. 

  
 -68-

 (b) Any Lien created for the benefit of the Holders of the Notes pursuant to
Section 3.6(a)(1) shall provide by its terms that such Lien shall be automatically and unconditionally released and discharged upon the release and discharge of the Initial Lien. 

(c) With respect to any Lien securing Indebtedness that was permitted to secure such Indebtedness at the time of the Incurrence of such
Indebtedness, such Lien shall also be permitted to secure any Increased Amount of such Indebtedness. The “Increased Amount” of any Indebtedness shall mean any increase in the amount of such Indebtedness in connection with any
accrual of interest, the accretion of accreted value, the amortization of original issue discount, the payment of interest in the form of additional Indebtedness with the same terms, accretion of original issue discount or liquidation preference and
increases in the amount of Indebtedness outstanding solely as a result of fluctuations in the exchange rate of currencies or increases in the value of property securing Indebtedness. 

SECTION 3.7. Limitation on Guarantees. 
 (a) The Issuer (a) will not permit any of its Wholly Owned Domestic Subsidiaries that are Restricted Subsidiaries (and non-Wholly Owned Domestic Subsidiaries if such non-Wholly Owned Domestic
Subsidiaries guarantee, or are a co-issuer of, other capital markets debt securities of the Issuer or any Restricted Subsidiary or guarantee all or a portion of, or are a co-borrower under, the Credit Agreement), other than a Guarantor, to
(i) Guarantee the payment of any Indebtedness of the Issuer or any Guarantor or (ii) incur any Indebtedness under the Credit Agreement and (b) will not permit any other Restricted Subsidiary to Guarantee the payment of any
Indebtedness under the Credit Agreement, in each case, unless: 
 (1) such Restricted Subsidiary within 30 days
(i) executes and delivers a supplemental indenture to this Indenture and joinder or supplement to the Registration Rights Agreement providing for a senior Guarantee by such Restricted Subsidiary, except that with respect to a guarantee of
Indebtedness of the Issuer or any Guarantor, if such Indebtedness is by its express terms subordinated in right of payment to the Notes or such Guarantor’s Note Guarantee, any such guarantee by such Restricted Subsidiary with respect to such
Indebtedness shall be subordinated in right of payment to such Guarantee substantially to the same extent as such Indebtedness is subordinated to the Notes or such Guarantor’s Note Guarantee and (ii) executes and delivers a supplement or
joinder to the Collateral Documents or new Collateral Documents and takes all actions required thereunder to perfect the Liens created thereunder; provided that if such Indebtedness is by its express terms subordinated in right of payment to
the Notes or such Guarantor’s Note Guarantee, any such Guarantee by such Restricted Subsidiary with respect to such Indebtedness shall be subordinated in right of payment to such Note Guarantee with respect to the Notes substantially to the
same extent as such Indebtedness is subordinated to the Notes or such Guarantor’s Guarantee of the Notes; and 
 (2) such Restricted Subsidiary waives and will not in any manner whatsoever claim or take the benefit or advantage of, any rights of reimbursement, indemnity or subrogation or any other rights against the
Issuer or any other Restricted Subsidiary as a result of any payment by such Restricted Subsidiary under its Guarantee until payment in full of Obligations under this Indenture; and 

(3) such Restricted Subsidiary shall deliver to the Trustee an Opinion of Counsel stating that: 

(i) such Guarantee has been duly executed and authorized; and 

(ii) such Guarantee constitutes a valid, binding and enforceable obligation of such Restricted Subsidiary, except insofar
as enforcement thereof may be limited by bankruptcy, insolvency or similar laws (including all laws relating to fraudulent transfers) and except insofar as enforcement thereof is subject to general principals of equity; 

provided that this Section 3.7 shall not be applicable (i) to any guarantee of any Restricted Subsidiary that existed at the time
such Person became a Restricted Subsidiary and was not incurred in connection with, or in contemplation of, such Person becoming a Restricted Subsidiary, or (ii) in the event that the Guarantee of the Issuer’s obligations under the Notes
or this Indenture by such Subsidiary would not be permitted under applicable law. 

  
 -69-

 (b) The Issuer may elect, in its sole discretion, to cause any Subsidiary that is not
otherwise required to be a Guarantor to become a Guarantor, in which case, such Subsidiary shall only be required to comply with the 30-day period described in this Section 3.7. 

(c) If any Guarantor becomes an Immaterial Subsidiary, the Issuer shall have the right, by execution and delivery of a supplemental
indenture to the Trustee, to cause such Immaterial Subsidiary to cease to be a Guarantor, subject to the requirements described in Section 3.7(a) that such Subsidiary shall be required to become a Guarantor if it ceases to be an
Immaterial Subsidiary (except that if such Subsidiary has been properly designated as an Unrestricted Subsidiary it shall not be so required to become a Guarantor or execute a supplemental indenture); provided, that such Immaterial Subsidiary
shall not be permitted to Guarantee the Credit Agreement or other Indebtedness of the Issuer or the other Guarantors, unless it again becomes a Guarantor. 
 SECTION 3.8. Limitation on Affiliate Transactions. 
 (a) The Issuer shall
not, and shall not permit any of its Restricted Subsidiaries to, directly or indirectly, enter into or conduct any transaction (including the purchase, sale, lease or exchange of any property or the rendering of any service) with any Affiliate of
the Issuer (an “Affiliate Transaction”) involving aggregate value in excess of $25.0 million unless: 
 (1) the terms of such Affiliate Transaction taken as a whole are not materially less favorable to the Issuer or such Restricted Subsidiary, as the case may be, than those that could be obtained in a
comparable transaction at the time of such transaction or the execution of the agreement providing for such transaction in arm’s length dealings with a Person who is not such an Affiliate; and 

(2) in the event such Affiliate Transaction involves an aggregate value in excess of $50 million, the terms of such
transaction have been approved by a majority of the members of the Board of Directors. 
 Any Affiliate Transaction shall be
deemed to have satisfied the requirements set forth in Section 3.8(a)(2) if such Affiliate Transaction is approved by a majority of the Disinterested Directors, if any. 

(b) Section 3.8(a) shall not apply to: 

(1) any Restricted Payment permitted to be made pursuant to Section 3.3, or any Permitted Investment;

 (2) any issuance or sale of Capital Stock, options, other equity-related interests or other securities, or
other payments, awards or grants in cash, securities or otherwise pursuant to, or the funding of, or entering into, or maintenance of, any employment, consulting, collective bargaining or benefit plan, program, agreement or arrangement, related
trust or other similar agreement and other compensation arrangements, options, warrants or other rights to purchase Capital Stock of the Issuer, any Restricted Subsidiary or any Parent Entity, restricted stock plans, long-term incentive plans, stock
appreciation rights plans, participation plans or similar employee benefits or consultants’ plans (including valuation, health, insurance, deferred compensation, severance, retirement, savings or similar plans, programs or arrangements) or
indemnities provided on behalf of officers, employees, directors or consultants approved by the Board of Directors of the Issuer, in each case in the ordinary course of business; 

(3) any Management Advances and any waiver or transaction with respect thereto; 

(4) any transaction between or among the Issuer and any Restricted Subsidiary (or entity that becomes a Restricted
Subsidiary as a result of such transaction), or between or among Restricted Subsidiaries; 
 (5) the payment of
compensation, reasonable fees and reimbursement of expenses to, and customary indemnities (including under customary insurance policies) and employee benefit and pension 

  
 -70-

 
expenses provided on behalf of, directors, officers, consultants or employees of the Issuer or any Restricted Subsidiary of the Issuer (whether directly or indirectly and including through any
Person owned or controlled by any of such directors, officers or employees); 
 (6) the entry into and
performance of obligations of the Issuer or any of its Restricted Subsidiaries under the terms of any transaction arising out of, and any payments pursuant to or for purposes of funding, any agreement or instrument in effect as of or on the Escrow
Release Date, as these agreements and instruments may be amended, modified, supplemented, extended, renewed or refinanced from time to time in accordance with the other terms of this Section 3.8 or to the extent not more disadvantageous
to the Holders in any material respect; 
 (7) any customary transaction with a Securitization Subsidiary
effected as part of a Qualified Securitization Financing and any disposition of Securitization Assets or related assets in connection with any Qualified Securitization Financing and any repurchase of Securitization Assets pursuant to a
Securitization Repurchase Obligation; 
 (8) transactions with customers, clients, suppliers or purchasers or
sellers of goods or services, in each case in the ordinary course of business, which are fair to the Issuer or the relevant Restricted Subsidiary in the reasonable determination of the Board of Directors or the senior management of the Issuer or the
relevant Restricted Subsidiary, or are on terms no less favorable than those that could reasonably have been obtained at such time from an unaffiliated party; 
 (9) any transaction between or among the Issuer or any Restricted Subsidiary and any Affiliate of the Issuer or an Associate or similar entity that would constitute an Affiliate Transaction solely because
the Issuer or a Restricted Subsidiary owns an equity interest in or otherwise controls such Affiliate, Associate or similar entity; 
 (10) issuances or sales of Capital Stock (other than Disqualified Stock or Designated Preferred Stock) of the Issuer or options, warrants or other rights to acquire such Capital Stock and the granting of
registration and other customary rights in connection therewith or any contribution to capital of the Issuer or any Restricted Subsidiary; 
 (11) (i) payments by the Issuer or any Restricted Subsidiary to any Permitted Holder (whether directly or indirectly) of annual customary management, consulting, monitoring, refinancing, subsequent
transaction exit fees, advisory fees and related expenses and (ii) customary payments by the Issuer or any Restricted Subsidiary to any Permitted Holder (whether directly or indirectly, including through any Parent Entity) for financial
advisory, financing, underwriting or placement services or in respect of other investment banking activities, including in connection with acquisitions or divestitures, which payments are approved by a majority of the Board of Directors of the
Issuer in good faith; 
 (12) payment to any Permitted Holder of all reasonable out of pocket expenses Incurred
by such Permitted Holder in connection with its direct or indirect investment in the Issuer and its Subsidiaries; 
 (13) the Transactions and the payment of all fees and expenses related to the Transactions; 
 (14) transactions in which the Issuer or any Restricted Subsidiary, as the case may be, delivers to the Trustee a letter from an Independent Financial Advisor stating that such transaction is fair to the
Issuer or such Restricted Subsidiary from a financial point of view or meets the requirements of Section 3.8(a)(1); 
 (15) the existence of, or the performance by the Issuer or any Restricted Subsidiaries of its obligations under the terms of, any equityholders agreement (including any registration rights agreement or
purchase agreements related thereto) to which it is party as of the Escrow Release Date and any similar agreement that it may enter into thereafter; provided, however, that the existence of, or the performance by the Issuer or any
Restricted Subsidiary of its obligations under any future amendment to the equityholders’ 

  
 -71-

 
agreement or under any similar agreement entered into after the Escrow Release Date will only be permitted under this clause to the extent that the terms of any such amendment or new agreement
are not otherwise disadvantageous to the Holders in any material respects; 
 (16) any purchases by the
Issuer’s Affiliates of Indebtedness or Disqualified Stock of the Issuer or any of its Restricted Subsidiaries the majority of which Indebtedness or Disqualified Stock is purchased by Persons who are not the Issuer’s Affiliates;
provided that such purchases by the Issuer’s Affiliates are on the same terms as such purchases by such Persons who are not the Issuer’s Affiliates; 

(17) payments by the Issuer (and any Parent Entity) and its Restricted Subsidiaries pursuant to any tax sharing agreements
in respect of “Related Taxes” among the Issuer (and any such Parent Entity) and its Restricted Subsidiaries on customary terms to the extent attributable to the ownership or operation of the Issuer and its Subsidiaries; and 

(18) transactions entered into by an Unrestricted Subsidiary with an Affiliate prior to the day such Unrestricted
Subsidiary is redesignated as a Restricted Subsidiary under Section 3.20. 
 SECTION 3.9. Change of Control.

 (a) If a Change of Control occurs, unless the Issuer has previously or concurrently delivered a redemption notice with
respect to all the outstanding Notes under Section 5.7, the Issuer shall make an offer to purchase all of the Notes pursuant to the offer described below (the “Change of Control Offer”) at a price in cash (the
“Change of Control Payment”) equal to 101% of the aggregate principal amount thereof plus accrued and unpaid interest, if any, to but excluding the date of repurchase, subject to the right of Holders of the Notes of record on the
relevant record date to receive interest due on the relevant interest payment date. Within 30 days following any Change of Control, the Issuer will deliver notice of such Change of Control Offer electronically or by first-class mail, with a copy to
the Trustee, to each Holder of Notes at the address of such Holder appearing in the security register or otherwise in accordance with the procedures of DTC, describing the transaction or transactions that constitute the Change of Control and with
the following information: 
 (1) that a Change of Control Offer is being made pursuant to this
Section 3.9, and that all Notes properly tendered pursuant to such Change of Control Offer will be accepted for payment by the Issuer; 
 (2) the purchase price and the purchase date, which will be no earlier than 30 days nor later than 60 days from the date such notice is delivered (the “Change of Control Payment
Date”); 
 (3) that any Note not properly tendered will remain outstanding and continue to accrue
interest; 
 (4) that unless the Issuer defaults in the payment of the Change of Control Payment, all Notes
accepted for payment pursuant to the Change of Control Offer will cease to accrue interest, on the Change of Control Payment Date; 
 (5) that Holders electing to have any Notes purchased pursuant to a Change of Control Offer will be required to surrender such Notes, with the form entitled “Option of Holder to Elect Purchase”
on the reverse of such Notes completed, to the Paying Agent specified in the notice at the address specified in the notice prior to the close of business on the third Business Day preceding the Change of Control Payment Date; 

(6) that Holders will be entitled to withdraw their tendered Notes and their election to require the Issuer to purchase
such Notes; provided that the Paying Agent receives, not later than the close of business on the second Business Day prior to the expiration date of the Change of Control Offer, a telegram, facsimile transmission or letter setting forth the
name of the Holder of the Notes, the principal amount of Notes tendered for purchase, and a statement that such Holder is withdrawing its tendered Notes and its election to have such Notes purchased; 

  
 -72-

 (7) that Holders whose Notes are being purchased only in part will be issued
new Notes and such new Notes will be equal in principal amount to the unpurchased portion of the Notes surrendered. The unpurchased portion of the Notes must be equal to at least $2,000 or any integral multiple of $1,000 in excess of $2,000;

 (8) if such notice is delivered prior to the occurrence of a Change of Control, stating that the Change of
Control Offer is conditional on the occurrence of such Change of Control; and 
 (9) the other instructions, as
determined by the Issuer, consistent with this Section 3.9, that a Holder must follow. 
 The Paying Agent will
promptly deliver to each Holder of the Notes tendered the Change of Control Payment for such Notes, and the Trustee will promptly authenticate and mail (or cause to be transferred by book-entry) to each Holder a new Note equal in principal amount to
any unpurchased portion of the Notes surrendered, if any; provided that each such new Note will be in a principal amount of $2,000 or an integral multiple of $1,000 in excess thereof. The Issuer will publicly announce the results of the
Change of Control Offer on or as soon as practicable after the Change of Control Payment Date. 
 If the Change of Control
Payment Date is on or after an interest record date and on or before the related interest payment date, any accrued and unpaid interest and Additional Interest, if any, will be paid on the relevant interest payment date to the Person in whose name a
Note is registered at the close of business on such record date. 
 (b) On the Change of Control Payment Date, the Issuer will,
to the extent permitted by law, 
 (1) accept for payment all Notes issued by it or portions thereof properly
tendered pursuant to the Change of Control Offer, 
 (2) deposit with the Paying Agent an amount equal to the
aggregate Change of Control Payment in respect of all Notes or portions thereof so tendered, and 
 (3) deliver,
or cause to be delivered, to the Trustee for cancellation the Notes so accepted together with an Officer’s Certificate to the Trustee stating that such Notes or portions thereof have been tendered to and purchased by the Issuer. 

(c) The Issuer will not be required to make a Change of Control Offer following a Change of Control if (1) a third party makes the
Change of Control Offer in the manner, at the times and otherwise in compliance with the requirements set forth in this Indenture applicable to a Change of Control Offer made by the Issuer and purchases all Notes validly tendered and not withdrawn
under such Change of Control Offer or (2) a notice of redemption of all outstanding Notes has been given pursuant to this Indenture as described under Section 5.7, unless and until there is a default in the payment of the redemption
price on the applicable Redemption Date or the redemption is not consummated due to the failure of a condition precedent contained in the applicable redemption notice to be satisfied. Notwithstanding anything to the contrary in this
Section 3.9, a Change of Control Offer may be made in advance of a Change of Control, conditional upon such Change of Control, if a definitive agreement is in place for the Change of Control at the time of making of the Change of Control
Offer. 
 (d) If Holders of not less than 90% in aggregate principal amount of the outstanding Notes validly tender and do not
withdraw such Notes in a Change of Control Offer and the Issuer, or any third party making a Change of Control Offer in lieu of the Issuer as described in this Section 3.9, purchases all of the Notes validly tendered and not withdrawn by
such Holders, the Issuer or such third party will have the right, upon not less than 30 nor more than 60 days’ prior notice, given not more than 30 days following such purchase pursuant to the Change of Control Offer, to redeem all Notes that
remain outstanding following such purchase at a price in cash equal to 101% of the principal amount thereof plus accrued and unpaid interest to but excluding the date of redemption. 

  
 -73-

 (e) The Issuer will comply, to the extent applicable, with the requirements of
Rule 14e-1 under the Exchange Act and any other securities laws and regulations thereunder to the extent such laws or regulations are applicable in connection with the repurchase of Notes pursuant to a Change of Control Offer. To the extent
that the provisions of any securities laws or regulations conflict with the provisions of this Indenture, the Issuer will comply with the applicable securities laws and regulations and shall not be deemed to have breached its obligations described
in this Indenture by virtue thereof. 
 SECTION 3.10. Reports. 

(a) Whether or not required by the SEC, so long as any Notes are outstanding, if not filed electronically with the SEC through the
SEC’s Electronic Data Gathering, Analysis and Retrieval System (or any successor system), from and after the Escrow Release Date, the Issuer will furnish to the Trustee, within 15 days after the time periods specified below: 

(1) within 90 days (135 days in the case of the fiscal year containing the Escrow Release Date) after the end of each
fiscal year, all financial information that would be required to be contained in an annual report on Form 10-K, or any successor or comparable form, filed with the SEC, including a “Management’s discussion and analysis of financial
condition and results of operations” and a report on the annual financial statements by the Issuer’s independent registered public accounting firm; 
 (2) within 45 days (75 days in the case of the first fiscal quarter after the Escrow Release Date) after the end of each of the first three fiscal quarters of each fiscal year, all financial information
that would be required to be contained in a quarterly report on Form 10-Q, or any successor or comparable form, file with the SEC; and 
 (3) within the time periods specified for filing current reports on Form 8-K, all current reports that would be required to be filed with the SEC on Form 8-K if the Issuer were required to file such
reports; provided that no such current report will be required to be furnished if the Issuer determines in its good faith judgment that such event is not material to noteholders or the business, assets, operations, financial positions or
prospects of the Issuer and its Restricted Subsidiaries, taken as a whole; 
 in each case, in a manner that complies in all material respects
with the requirements specified in such form. Notwithstanding the foregoing, the Issuer shall not be so obligated to file such reports with the SEC (i) if the SEC does not permit such filing or (ii) prior to the consummation of an exchange
offer or the effectiveness of a shelf registration statement as required by the Registration Rights Agreement, so long as if clause (i) or (ii) is applicable the Issuer makes available such information to prospective purchasers of Notes,
in addition to providing such information to the Trustee and the Holders of the Notes, in each case, at the Issuer’s expense and by the applicable date the Issuer would be required to file such information pursuant to the immediately preceding
sentence. To the extent any such information is not so filed or furnished, as applicable, within the time periods specified above and such information is subsequently filed or furnished, as applicable, the Issuer will be deemed to have satisfied its
obligations with respect thereto at such time and any Default with respect thereto shall be deemed to have been cured; provided that such cure shall not otherwise affect the rights of the Holders under Section 6.1 if Holders of at
least 30% in principal amount of the then total outstanding Notes have declared the principal, premium, if any, interest and any other monetary obligations on all the then outstanding Notes to be due and payable immediately and such declaration
shall not have been rescinded or cancelled prior to such cure. In addition, to the extent not satisfied by the foregoing, the Issuer will agree that, for so long as any Notes are outstanding, it will furnish to Holders and to securities analysts and
prospective investors, upon their request, the information required to be delivered pursuant to Rule 144A(d)(4) under the Securities Act. The Issuer will deliver the financial statements and information of the type required to be delivered pursuant
to Section 3.10(a)(2) with respect to the fiscal year ended April 28, 2013 and any fiscal quarter ended prior to the Escrow Release Date or in which the Escrow Release Date occurs, which, notwithstanding the foregoing, shall not be
required to contain financial statement footnote disclosure and shall not be required to contain consolidating financial data with respect to the Issuer and the Guarantors on the one hand and Non-Guarantors on the other of the type contemplated by
Rule 3-10 of Regulation S-X promulgated under the Securities Act or otherwise. 

  
 -74-

 (b) Substantially concurrently with the furnishing or making such information available to
the Trustee pursuant to Section 3.10(a), the Issuer shall also post copies of such information required by Section 3.10(a) on a website (which may be nonpublic and may be maintained by the Issuer or a third party) to which
access will be given to Holders, prospective investors in the Notes (which prospective investors shall be limited to “qualified institutional buyers” within the meaning of Rule 144A of the Securities Act or non-U.S. persons (as
defined in Regulation S under the Securities Act) that certify their status as such to the reasonable satisfaction of the Issuer), and securities analysts and market making financial institutions that are reasonably satisfactory to the Issuer.

 (c) The Issuer will also hold quarterly conference calls for the Holders of the Notes to discuss financial information for
the previous quarter (it being understood that such quarterly conference call may be the same conference call as with the Issuer’s equity investors and analysts). The conference call will be following the last day of each fiscal quarter of the
Issuer and not later than 10 Business Days from the time that the Issuer distributes the financial information as set forth in Section 3.10(b). No fewer than two days prior to the conference call, the Issuer will issue a press release
announcing the time and date of such conference call and providing instructions for Holders, securities analysts and prospective investors to obtain access to such call. 
 (d) In the event that any Parent Entity of the Issuer becomes a guarantor of the Notes, this Indenture will permit the Issuer to satisfy its obligations in this Section 3.10 with respect to
financial information relating to the Issuer by furnishing financial information relating to such Parent Entity; provided that, to the extent required by Rule 3-10 of Regulation S-X promulgated by the SEC, the same is accompanied by
consolidating information that explains in reasonable detail the differences between the information relating to such Parent Entity, on the one hand, and the information relating to the Issuer and its Restricted Subsidiaries on a standalone basis,
on the other hand. 
 (e) Notwithstanding anything to the contrary set forth in this Section 3.10, if the Issuer or
any Parent Entity of the Issuer has furnished to the Holders of Notes and filed with the SEC the reports described in the preceding paragraphs with respect to the Issuer or any Parent Entity (including any consolidated financial information required
by Regulation S-X relating to the Issuer), the Issuer shall be deemed to be in compliance with the provisions of this Section 3.10. 
 (f) Delivery under this Section 3.10 of reports, information and documents to the Trustee is for informational purposes only and the Trustee’s receipt of such shall not constitute
constructive notice of any information contained therein or determinable from information contained therein, including the Company’s compliance with any of its covenants hereunder (as to which the Trustee is entitled to rely exclusively on
Officer’s Certificates). 
 SECTION 3.11. Maintenance of Office or Agency. 

The Issuer will maintain an office or agency where the Notes will be payable at the office or agency of the Issuer
maintained for such purpose and where, if applicable, the Notes may be surrendered for registration of transfer or exchange and where notices and demands to or upon the Issuer in respect of the Notes and this Indenture may be served. The corporate
trust office of the Trustee, which initially shall be located at Wells Fargo Bank, National Association, 150 East
42nd Street, 40th Floor, New York, NY 10017, Attention: Yana Kislenko, shall be such
office or agency of the Issuer unless the Issuer shall designate and maintain some other office or agency for one or more of such purposes. The Issuer will give prompt written notice to the Trustee of any change in the location of any such office or
agency. If at any time the Issuer shall fail to maintain any such required office or agency or shall fail to furnish the Trustee with the address thereof, such presentations and surrenders may be made or served at the corporate trust office of the
Trustee, and the Issuer hereby appoints the Trustee as its agent to receive all such presentations and surrenders. 
 The Issuer
may also from time to time designate one or more other offices or agencies where the Notes may be presented or surrendered for any or all such purposes and may from time to time rescind any such designation. The Issuer will give prompt written
notice to the Trustee of any such designation or rescission and any change in the location of any such other office or agency. 

SECTION 3.12. Corporate Existence. Except as otherwise provided in this Article III, Article IV and
Section 10.2(b), the Issuer will do or cause to be done all things necessary to preserve and keep in full force and 

  
 -75-

 
effect its corporate existence and the corporate, partnership, limited liability company or other existence of each Restricted Subsidiary and the rights (charter and statutory), licenses and
franchises of the Issuer and each Restricted Subsidiary; provided, however, that the Issuer shall not be required to preserve any such right, license or franchise or the corporate, partnership, limited liability company or other
existence of any Restricted Subsidiary if the respective Board of Directors or, with respect to a Restricted Subsidiary that is not a Significant Subsidiary (or group of Restricted Subsidiaries that taken together would not be a Significant
Subsidiary), senior management of the Issuer determines that the preservation thereof is no longer desirable in the conduct of the business of the Issuer and each of its Restricted Subsidiaries, taken as a whole, and that the loss thereof is not,
and will not be, disadvantageous in any material respect to the Holders. 
 SECTION 3.13. Payment of Taxes. The Issuer
shall pay or discharge or cause to be paid or discharged, before the same shall become delinquent, all material taxes, assessments and governmental charges levied or imposed upon the Issuer or any Subsidiary; provided, however, that
the Issuer shall not be required to pay or discharge or cause to be paid or discharged any such tax, assessment, charge or claim the amount, applicability or validity of which is being contested in good faith by appropriate proceedings and for which
appropriate reserves, if necessary (in the good faith judgment of management of the Issuer), are being maintained in accordance with GAAP or where the failure to effect such payment will not be disadvantageous in any material respect to the Holders.

 SECTION 3.14. Payments for Consent. The Issuer will not, and will not permit any of its Subsidiaries to, directly or
indirectly, pay or cause to be paid any consideration to or for the benefit of any holder of Notes for or as an inducement to any consent, waiver or amendment of any of the terms or provisions of this Indenture, the Registration Rights Agreement,
the Notes or the Note Guarantees unless such consideration is offered to be paid and is paid to all holders of the Notes that consent, waive or agree to amend in the time frame set forth in the solicitation documents relating to such consent, waiver
or agreement. 
 SECTION 3.15. Compliance Certificate. The Issuer shall deliver to the Trustee within 120 days after
the end of each fiscal year of the Issuer an Officer’s Certificate, one of the signers of which shall be the Chief Executive Officer, Chief Financial Officer or the Treasurer of the Issuer, stating that in the course of the performance by the
signer of his or her duties as an Officer of the Issuer he or she would normally have knowledge of any Default or Event of Default and whether or not the signer knows of any Default or Event of Default that occurred during the previous fiscal year;
provided that no such Officer’s Certificate shall be required for any fiscal year ended prior to the Issue Date. If such Officer does have such knowledge, the certificate shall describe the Default or Event of Default, its status and the
action the Issuer is taking or proposes to take with respect thereto. The Issuer also shall comply with TIA Section 314(a)(4). 
 SECTION 3.16. Further Instruments and Acts. Upon request of the Trustee or as necessary to comply with future developments or requirements, the Issuer will execute and deliver such further
instruments and do such further acts as may be reasonably necessary or proper to carry out more effectively the purpose of this Indenture. 
 SECTION 3.17. Conduct of Business. The Issuer will not, and will not permit any of its Restricted Subsidiaries to, engage in any businesses other than any business conducted or proposed to be
conducted by the Issuer and its Restricted Subsidiaries on the Issue Date or any business that is similar, reasonably related, incidental or ancillary thereto or any reasonable extension thereof. 

SECTION 3.18. Statement by Officers as to Default. The Issuer shall deliver to the Trustee, as soon as possible and in any event
within 30 days after the Issuer becomes aware of the occurrence of any Default or Event of Default, an Officer’s Certificate setting forth the details of such Event of Default or Default, its status and the actions which the Issuer is
taking or proposes to take with respect thereto. 
 SECTION 3.19. Suspension of Certain Covenants. 

(a) Following the first day: (1) the Notes have achieved Investment Grade Status; and (2) no Default or Event of Default has
occurred and is continuing under this Indenture, then, beginning on that day and continuing until the Reversion Date (as defined below), the Issuer and its Restricted Subsidiaries will not be subject to Sections 3.2, 3.3, 3.4,
3.5, 3.7, 3.8 and 4.1(a)(3) (collectively, the “Suspended Covenants”). 

  
 -76-

 (b) If at any time the Notes cease to have such Investment Grade Status or if a Default or
Event of Default occurs and is continuing, then the Suspended Covenants will thereafter be reinstated as if such covenants had never been suspended (the “Reversion Date”) and be applicable pursuant to the terms of this Indenture
(including in connection with performing any calculation or assessment to determine compliance with the terms of this Indenture), unless and until the Notes subsequently attain Investment Grade Status and no Default or Event of Default is in
existence (in which event the Suspended Covenants shall no longer be in effect for such time that the Notes maintain an Investment Grade Status and no Default or Event of Default is in existence); provided, however, that no Default,
Event of Default or breach of any kind shall be deemed to exist under this Indenture, the Registration Rights Agreement, the Notes or the Note Guarantees with respect to the Suspended Covenants based on, and none of the Issuer or any of its
Subsidiaries shall bear any liability for, any actions taken or events occurring during the Suspension Period (as defined below), or any actions taken at any time pursuant to any contractual obligation arising prior to the Reversion Date, regardless
of whether such actions or events would have been permitted if the applicable Suspended Covenants remained in effect during such period. The period of time between the date of suspension of the covenants and the Reversion Date is referred to as the
“Suspension Period.” 
 (c) On the Reversion Date, all Indebtedness Incurred during the Suspension Period will
be classified to have been Incurred pursuant to Section 3.2(a) or one of the clauses set forth in Section 3.2(b) (to the extent such Indebtedness would be permitted to be Incurred thereunder as of the Reversion Date and after
giving effect to the Indebtedness Incurred prior to the Suspension Period and outstanding on the Reversion Date). To the extent such Indebtedness would not be so permitted to be Incurred pursuant to Section 3.2(a) or (b), such
Indebtedness will be deemed to have been outstanding on the Issue Date, so that it is classified as permitted under Section 3.2(b)(4)(iii). Calculations made after the Reversion Date of the amount available to be made as Restricted
Payments under Section 3.3 will be made as though Section 3.3 had been in effect since the Issue Date and throughout the Suspension Period; provided, that, no Subsidiaries may be designated as Unrestricted Subsidiaries
during the Suspension Period, unless such designation would have complied with Section 3.3 as if such Section would have been in effect during such period. Accordingly, Restricted Payments made during the Suspension Period will reduce
the amount available to be made as Restricted Payments under Section 3.3(a). During the Suspension Period, any future obligation to grant further Note Guarantees shall be suspended. All such further obligation to grant Note Guarantees
shall be reinstated upon the Reversion Date. 
 SECTION 3.20. Designation of Restricted and Unrestricted Subsidiaries.

 (a) The Board of Directors of the Issuer may designate any Restricted Subsidiary to be an Unrestricted Subsidiary if that
designation would not cause a Default. If a Restricted Subsidiary is designated as an Unrestricted Subsidiary, the aggregate fair market value of all outstanding Investments owned by the Issuer and its Restricted Subsidiaries in the Subsidiary
designated as an Unrestricted Subsidiary will be deemed to be an Investment made as of the time of the designation and will reduce the amount available for Restricted Payments under Section 3.3 or under one or more clauses of the
definition of Permitted Investments, as determined by the Issuer. That designation will only be permitted if the Investment would be permitted at that time and if the Restricted Subsidiary otherwise meets the definition of an Unrestricted
Subsidiary. The Board of Directors of the Issuer may redesignate any Unrestricted Subsidiary to be a Restricted Subsidiary if that redesignation would not cause a Default. 
 (b) Any designation of a Subsidiary of the Issuer as an Unrestricted Subsidiary will be evidenced to the Trustee by filing with the Trustee a Board Resolution of the Issuer giving effect to such
designation and an Officer’s Certificate certifying that such designation complies with the preceding conditions and was permitted by Section 3.3. If, at any time, any Unrestricted Subsidiary would fail to meet the preceding
requirements as an Unrestricted Subsidiary, it will thereafter cease to be an Unrestricted Subsidiary for purposes of this Indenture and any Indebtedness of such Subsidiary will be deemed to be incurred by a Restricted Subsidiary of the Issuer as of
such date and, if such Indebtedness is not permitted to be incurred as of such date under Section 3.2, the Issuer will be in default of Section 3.2. 
 (c) The Board of Directors of the Issuer may at any time designate any Unrestricted Subsidiary to be a Restricted Subsidiary of the Issuer; provided that such designation will be deemed to be an
incurrence of Indebtedness by a Restricted Subsidiary of the Issuer of any outstanding Indebtedness of such Unrestricted Subsidiary, and such designation will only be permitted if (1) such Indebtedness is permitted under Section 3.2
 

  
 -77-

 
calculated on a pro forma basis as if such designation had occurred at the beginning of the applicable reference period; and (2) no Default or Event of Default would be in existence
following such designation. Any such designation by the Board of Directors of the Issuer shall be evidenced to the Trustee by filing with the Trustee a certified copy of a resolution of the Board of Directors of the Issuer giving effect to such
designation and an Officer’s Certificate certifying that such designation complies with the preceding conditions. 

SECTION 3.21. Amendment of Collateral Documents. The Issuer shall not amend, modify or supplement, or permit or consent to any
amendment, modification or supplement of, the Collateral Documents in any way that would be adverse to the Holders of the Notes in any material respect, except under Articles IX and XII. 

SECTION 3.22. After-Acquired Property. From and after the Issue Date, upon the acquisition by the Issuer or any Guarantor of any
Second Priority After-Acquired Property, the Issuer or such Guarantor shall execute and deliver such mortgages, deeds of trust, security instruments, financing statements, certificates and opinions of counsel as shall be necessary to vest in the
Collateral Agent a perfected security interest, subject only to Permitted Liens, in such Second Priority After-Acquired Property and to have such Second Priority After-Acquired Property (but subject to certain limitations, if applicable, including
under Article XII) added to the Collateral, and thereupon all provisions of this Indenture relating to the Collateral shall be deemed to relate to such Second Priority After-Acquired Property to the same extent and with the same force and
effect; provided, however, that if granting such second priority security interest in such Second Priority After-Acquired Property requires the consent of a third party, the Issuer shall use commercially reasonable efforts to obtain
such consent with respect to the second priority interest for the benefit of the Trustee and the Collateral Agent on behalf of the Holders of the Notes; provided further, however, that if such third party does not consent to the
granting of such second priority security interest after the use of such commercially reasonable efforts, the Issuer or such Guarantor, as the case may be, shall not be required to provide such security interest. 

SECTION 3.23. [Reserved]. 
 SECTION 3.24. Escrow of Proceeds; Escrow Conditions. 
 (a) Merger Sub will
enter into an escrow agreement (as amended, supplemented or modified from time to time, the “Escrow Agreement”) with the Trustee and Wells Fargo Bank, National Association, as escrow agent (in such capacity, together with its
successors, the “Escrow Agent”). On the Issue Date, Merger Sub will deposit the gross proceeds of the offering of the Notes sold on the Issue Date into an escrow account (the “Escrow Account”) and Merger Sub
will also deposit (or caused to be deposited) to the Escrow Account additional cash and Eligible Escrow Investments, in an amount sufficient (as reasonably determined by Merger Sub taking into account investment income therefrom and proceeds
thereof) that, when taken together with the proceeds of the offering of the Notes deposited into the Escrow Account, will be sufficient to fund a Special Mandatory Redemption of the Notes on July 1, 2013, if a Special Mandatory Redemption were
to occur on such date, plus an amount equal to three days of interest accrued on the Notes (collectively, and together with any other property from time to time held by the Escrow Agent in the Escrow Account, the “Escrowed
Property”). In addition, pursuant to the Escrow Agreement, on the date that is five Business Days prior to the last day of each month beginning on June 30, 2013, and ending on February 28, 2014 (in each case, unless the Escrow End
Date has occurred), Merger Sub will deposit (or cause to be deposited) to the Escrow Account an amount of cash equal to one month of interest accrued on the Notes (or with respect to the deposit five Business Days prior to February 28, 2014,
equal to interest from March 1, 2014 to the Escrow Release Date) (in each case, as calculated in accordance with the terms of this Indenture). The Escrowed Property will be held in the Escrow Account until the earliest of (i) the date on
which Merger Sub delivers to the Escrow Agent the Officer’s Certificate referred to in the Escrow Agreement, (ii) the Escrow End Date, (iii) the date on which Merger Sub delivers notice to the Escrow Agent to the effect set forth in
Section 5.9(b) and (iv) the date that is three Business Days after Merger Sub fails to timely deposit (or cause to be timely deposited) any amounts required by this Section 3.24 on any applicable deposit date. Merger Sub
will grant the Trustee, for its benefit and the benefit of the Holders of the Notes, subject to certain liens of the Escrow Agent, a first-priority security interest in the Escrow Account and all deposits and investment property therein to secure
the payment of the Special Mandatory Redemption Price (as defined below); provided, however, that such lien and security interest shall automatically be released and terminate at such time as the Escrowed Property is released from the
escrow on the Escrow Release Date. The Escrow Agent will invest the Escrowed Property in such Eligible Escrow Investments as Merger Sub may from time to time direct in writing. 

  
 -78-

 (b) Merger Sub will be entitled to direct the Escrow Agent to release a portion of the
Escrowed Property in an amount equal to the amount of accrued and unpaid interest from the Issue Date or the most recent interest payment date, as applicable, prior to the Escrow Release in order to satisfy the interest payment obligations in
respect of the Notes under this Indenture. 
 (c) Merger Sub will only be entitled to direct the Escrow Agent to release
Escrowed Property in accordance with the Escrow Agreement (in which case the Escrowed Property will be paid to or as directed by Merger Sub) (the “Escrow Release” upon delivery to the Escrow Agent with a copy to the Trustee, on or
prior to the Escrow End Date, of an Officer’s Certificate certifying that the following conditions have been or, substantially concurrently with the release of the Escrowed Property, will be satisfied (the date of delivery of such certificate
to the Escrow Agent is hereinafter called the “Escrow Release Date”): 
 (1) (A) all conditions
precedent to the consummation of the Acquisition will have been satisfied or waived in accordance with the terms of the Merger Agreement (other than those conditions that by their terms are to be satisfied substantially concurrently with the
consummation of the Acquisition) and (B) the Escrowed Property will have been used to consummate the Acquisition; provided that the terms of the Merger Agreement shall not have been amended, modified, consented to or waived and the
Merger Agreement shall not have been terminated on or prior to the Escrow Release Date except for such amendments, consents or waivers that are not materially adverse to Merger Sub or any of its subsidiaries (after giving effect to the consummation
of the Transactions), taken as a whole, or to the Holders of the Notes (it being understood that any reduction in the purchase price of, or consideration for, the Acquisition is not materially adverse to the interests of the Holders of the Notes,
but shall (x) first reduce the common equity portion of the equity contribution on a dollar-for-dollar basis until the equity contribution has been reduced to 45% of the total pro forma debt and equity capitalization of Merger Sub and its
subsidiaries on the Escrow Release Date after giving effect to the Transactions and (y) thereafter reduce the equity contribution and each of the Credit Facilities under the Credit Agreement on a pro rata basis and (b) any amendment to the
definition of “Company Material Adverse Effect” is materially adverse to the interests of the Holders of the Notes; 
 (2) all conditions precedent to the effectiveness of, and borrowings under, the Credit Agreement (other than the release of the Escrowed Property) have been satisfied or waived, and prior to or
substantially concurrently with the release of the funds from the Escrow Account, the borrowings under the Credit Agreement to be drawn in connection with the Acquisition shall be available to Merger Sub on the Escrow Release Date; and 

(3) Heinz and the Guarantors (other than Holdings) shall have, by supplemental indenture or joinder, as applicable,
effective upon the Escrow Release Date, become, or substantially concurrently with the release of the Escrowed Property shall become, parties to this Indenture and the other transaction documents (including, without limitation, the Collateral
Documents and the Intercreditor Agreement, but in each case only to the extent such Subsidiary has become a guarantor under, and pledged its assets to secure, the Credit Agreement) and the Issuer shall have merged, or substantially concurrently with
the Escrow Release will merge, with and into Heinz, with Heinz being the surviving corporation. 
 (d) If (A) Merger Sub
has not delivered an Officer’s Certificate described under clause (b) above or (B) a Special Mandatory Redemption Event has not occurred, in each case, prior to 5:00 p.m. (New York City time) on October 14, 2013, the Escrow
Agent shall by no later than 10:00 a.m. (New York City time) on October 15, 2013, without any action of Merger Sub, transfer to the Trustee, in immediately available funds, Escrowed Property in an amount in cash equal to the interest
payment due on Notes on such date. 
 SECTION 3.25. Limitations on Activities Prior to the Escrow Release. 

(a) Prior to the Escrow Release Date, Merger Sub’s primary activities will be restricted to issuing the Notes, issuing capital stock
to, and receiving capital contributions from Holdings, performing its obligations in respect of the Notes under this Indenture and the Escrow Agreement, performing its obligations under the Merger Agreement, consummating the Acquisition and the
Escrow Release, redeeming the Notes pursuant to Section 5.9, if applicable, and conducting such other activities as are necessary or appropriate to carry out the activities described above. Prior to the Escrow Release Date, Merger Sub
will not own, hold or otherwise have any interest in any assets other than the Escrow Account, cash and Cash Equivalents and its rights under the Merger Agreement. 
 (b) Prior to the Escrow Release Date, Heinz and its Subsidiaries shall not be subject to any of the covenants set forth in this Indenture. Pursuant to the Merger Agreement, Merger Sub and its Subsidiaries
are generally required to operate in the ordinary course of business. 

  
 -79-

 ARTICLE IV 
 SUCCESSOR ISSUER; SUCCESSOR PERSON 
 SECTION 4.1. Merger and
Consolidation. 
 (a) the Issuer will not consolidate with or merge with or into, or convey, transfer or lease all or
substantially all its assets to, any Person, unless: 
 (1) the resulting, surviving or transferee Person (the
“Successor Company”) will be a Person organized and existing under the laws of the United States of America, any State of the United States or the District of Columbia and the Successor Company (if not the Issuer) will expressly
assume, by supplemental indenture, executed and delivered to the Trustee and the Collateral Agent, in form satisfactory to the Trustee and the Collateral Agent, all the obligations of the Issuer under the Notes and this Indenture and the Collateral
Documents and if such Successor Company is not a corporation, a co-obligor of the Notes is a corporation organized or existing under such laws; 
 (2) immediately after giving effect to such transaction (and treating any Indebtedness that becomes an obligation of the applicable Successor Company or any Subsidiary of the applicable Successor Company
as a result of such transaction as having been Incurred by the applicable Successor Company or such Subsidiary at the time of such transaction), no Default or Event of Default shall have occurred and be continuing; 

(3) immediately after giving effect to such transaction, either (i) the applicable Successor Company would be able to
Incur at least an additional $1.00 of Indebtedness pursuant to Section 3.2(a) or (ii) the Fixed Charge Coverage Ratio would not be lower than it was immediately prior to giving effect to such transaction; and 

(4) the Issuer shall have delivered to the Trustee and the Collateral Agent an Officer’s Certificate and an Opinion
of Counsel, each stating that such consolidation, merger or transfer and such supplemental indenture (if any) comply with this Indenture and an Opinion of Counsel stating that such supplemental indenture (if any) has been duly authorized, executed
and delivered and is a legal, valid and binding agreement enforceable against the applicable Successor Company (in each case, in form satisfactory to the Trustee and the Collateral Agent), provided that in giving an Opinion of Counsel,
counsel may rely on an Officer’s Certificate as to any matters of fact, including as to satisfaction of Section 4.1(a)(2) and (3). 
 (b) For purposes of this Section 4.1, the sale, lease, conveyance, assignment, transfer, or other disposition of all or substantially all of the properties and assets of one or more
Subsidiaries of the Issuer, which properties and assets, if held by the Issuer instead of such Subsidiaries, would constitute all or substantially all of the properties and assets of the Issuer on a consolidated basis, shall be deemed to be the
transfer of all or substantially all of the properties and assets of the Issuer. 
 (c) The Successor Company will succeed to,
and be substituted for, and may exercise every right and power of, the Issuer under the Notes, this Indenture and the Collateral Documents but in the case of a lease of all or substantially all its assets, the predecessor company will not be
released from its obligations under such Notes, this Indenture or the Collateral Documents. 

  
 -80-

 (d) [Reserved] 
 (e) Notwithstanding Section 4.1(a)(2), (a)(3) and (a)(4) (which do not apply to transactions referred to in this sentence), (i) any Restricted Subsidiary of the Issuer may
consolidate or otherwise combine with, merge into or transfer all or part of its properties and assets to the Issuer and (ii) any Restricted Subsidiary may consolidate or otherwise combine with, merge into or transfer all or part of its
properties and assets to any other Restricted Subsidiary. Notwithstanding Section 4.1(a)(2) and (a)(3) (which do not apply to the transactions referred to in this sentence), the Issuer may consolidate or otherwise combine with or
merge into an Affiliate incorporated or organized for the purpose of changing the legal domicile of the Issuer, reincorporating the Issuer in another jurisdiction, or changing the legal form of the Issuer. 

(f) The foregoing provisions (other than the requirements of Section 4.1(a)(2)) shall not apply to the creation of a new
Subsidiary as a Restricted Subsidiary of the Issuer. 
 (g) No Guarantor may 

(1) consolidate with or merge with or into any Person, or 

(2) sell, convey, transfer or dispose of, all or substantially all its assets, in one transaction or a series of related
transactions, to any Person, or 
 (3) permit any Person to merge with or into the Guarantor, 

(i) the other Person is the Issuer or any Restricted Subsidiary that is Guarantor or becomes a Guarantor concurrently with
the transaction; or 
 (ii) (A) either (x) a Guarantor is the continuing Person or (y) the resulting,
surviving or transferee Person expressly assumes all of the obligations of the Guarantor under its Guarantee of the Notes, this Indenture and the Collateral Documents; and 

(B) immediately after giving effect to the transaction, no Default has occurred and is continuing; or 

(iii) the transaction constitutes a sale or other disposition (including by way of consolidation or merger) of the
Guarantor or the sale or disposition of all or substantially all the assets of the Guarantor (in each case other than to the Issuer or a Restricted Subsidiary) otherwise permitted by this Indenture. 

ARTICLE V 

REDEMPTION OF SECURITIES 
 SECTION 5.1. Notices to Trustee. If the Issuer elects to redeem Notes pursuant to the optional redemption provisions of Section 5.7 hereof, it must furnish to the Trustee, at least
30 days but not more than 60 days before a redemption date, an Officer’s Certificate setting forth: 

(1) the clause of this Indenture pursuant to which the redemption shall occur; 

(2) the redemption date; 
 (3) the principal amount of Notes to be redeemed; and 
 (4) the
redemption price. 

  
 -81-

 Any optional redemption referenced in such Officer’s Certificate may be cancelled by
the Issuer at any time prior to notice of redemption being sent to any Holder and thereafter shall be null and void. 
 SECTION
5.2. Selection of Notes to Be Redeemed or Purchased. If less than all of the Notes are to be redeemed at any time, the Trustee will select the Notes for redemption in compliance with the requirements of the principal securities exchange, if
any, on which such Notes are listed, as certified to the Trustee by the Issuer, and in compliance with the requirements of DTC, or if Notes are not so listed or such exchange prescribes no method of selection and such Notes are not held through DTC
or DTC prescribes no method of selection, on a pro rata basis, subject to adjustments so that no Note in an unauthorized denomination is redeemed in part and further; provided, however, that no Note of $2,000 in aggregate principal
amount or less shall be redeemed in part. 
 SECTION 5.3. Notice to Redemption. 

(a) At least 30 days but not more than 60 days before a redemption date, the Issuer will send or cause to be sent, by
electronic delivery or by first class mail postage prepaid, a notice of redemption to each Holder whose Notes are to be redeemed at the address of such Holder appearing in the security register or otherwise in accordance with the procedures of the
DTC, except that redemption notices may be delivered electronically or mailed more than 60 days prior to a redemption date if the notice is issued in connection with a defeasance of the Notes or a satisfaction and discharge of this Indenture
pursuant to Articles VIII or XI hereof. 
 The notice will identify the Notes (including the CUSIP or ISIN number)
to be redeemed and will state: 
 (1) the redemption date; 

(2) the redemption price; 
 (3) if any Note is being redeemed in part, the portion of the principal amount of such Note to be redeemed and that, after the redemption date upon surrender of such Note, a new Note or Notes in principal
amount equal to the unredeemed portion will be issued upon cancellation of the original Note; 
 (4) the name and
address of the Paying Agent; 
 (5) that Notes called for redemption must be surrendered to the Paying Agent to
collect the redemption price; 
 (6) that, unless the Issuer defaults in making such redemption payment, interest
and Additional Interest, if any, on Notes called for redemption ceases to accrue on and after the redemption date; 
 (7) the paragraph of the Notes and/or Section of this Indenture pursuant to which the Notes called for redemption are being redeemed; and 

(8) that no representation is made as to the correctness or accuracy of the CUSIP or ISIN number, if any, listed in such
notice or printed on the Notes. 
 (b) If any Note is to be redeemed in part only, the notice of redemption that relates to that
Note shall state the portion of the principal amount thereof to be redeemed, in which case a portion of the original Note will be issued in the name of the Holder thereof upon cancellation of the original Note. In the case of a global note, an
appropriate notation will be made on such Note to decrease the principal amount thereof to an amount equal to the unredeemed portion thereof. Subject to the terms of the applicable redemption notice (including any conditions contained therein),
Notes called for redemption become due on the date fixed for redemption. On and after the redemption date, unless the Issuer defaults in the payment of the redemption price, interest ceases to accrue on Notes or portions of them called for
redemption. 

  
 -82-

 SECTION 5.4. Effect of Notice of Redemption. Once notice of redemption is sent in
accordance with Section 5.3 hereof, Notes called for redemption become irrevocably due and payable on the redemption date at the redemption price. Notice of redemption may, at the Issuer’s option and discretion, be subject to one or
more conditions precedent, including, but not limited to, completion of an Equity Offering (in the case of redemption pursuant to Section 5.7(b) hereof) or Change of Control (in the case of purchase pursuant to Section 3.9
hereof), as the case may be. 
 SECTION 5.5. Deposit of Redemption or Purchase Price. Prior to 10:00 a.m. Eastern
Time on the redemption or purchase date, the Issuer will deposit with the Trustee or with the Paying Agent money sufficient to pay the redemption or purchase price of and accrued interest and Additional Interest, if any, on, all Notes to be redeemed
or purchased on that date. The Trustee or the Paying Agent will promptly return to the Issuer any money deposited with the Trustee or the Paying Agent by the Issuer in excess of the amounts necessary to pay the redemption or purchase price of, and
accrued interest and Additional Interest, if any, on, all Notes to be redeemed or purchased. 
 If the Issuer complies with the
provisions of the preceding paragraph, on and after the redemption or purchase date, interest and Additional Interest, if any, will cease to accrue on the Notes or the portions of Notes called for redemption or purchase. If a Note is redeemed or
purchased on or after an interest record date but on or prior to the related interest payment date, then any accrued and unpaid interest shall be paid to the Person in whose name such Note was registered at the close of business on such record date.
If any Note called for redemption or purchase is not so paid upon surrender for redemption or purchase because of the failure of the Issuer to comply with the preceding paragraph, interest shall be paid on the unpaid principal, from the redemption
or purchase date until such principal is paid, and to the extent lawful on any interest not paid on such unpaid principal, in each case at the rate provided in the Notes and in Section 3.1 hereof. 

SECTION 5.6. Notes Redeemed or Purchased in Part. Upon surrender of a Note that is redeemed or purchased in part, the Issuer will
issue and, upon receipt of an Issuer Order, the Trustee will authenticate for the Holder at the expense of the Issuer a new Note equal in principal amount to the unredeemed or unpurchased portion of the Note surrendered; provided, that each
such new Note will be in a principal amount of $2,000 or integral multiple of $1,000 in excess thereof. 
 SECTION 5.7.
Optional Redemption. 
 (a) At any time prior to April 15, 2015, the Issuer may redeem the Notes in whole or in
part, at their option, upon not less than 30 nor more than 60 days’ prior notice by electronic delivery or by first class mail, postage prepaid, with a copy to the Trustee, to each Holder of Notes to the address of such Holder appearing in
the Notes Register, at a redemption price equal to 100% of the principal amount of such Notes redeemed plus the Applicable Premium as of, and accrued and unpaid interest and Additional Interest, if any, to but excluding the date of redemption (the
“Redemption Date”), subject to the rights of holders of the Notes on the relevant record date to receive interest due on the relevant interest payment date. 
 (b) At any time and from time to time prior to April 15, 2015, the Issuer may redeem Notes with the net cash proceeds received by the Issuer from any Equity Offering at a redemption price equal to
104.250% plus accrued and unpaid interest to the Redemption Date, in an aggregate principal amount for all such redemptions not to exceed 40% of the original aggregate principal amount of the Notes (including Additional Notes); provided that
(1) in each case the redemption takes place not later than 180 days after the closing of the related Equity Offering, and (2) not less than 50% of the original aggregate principal amount of the Notes issued under this Indenture
remains outstanding immediately thereafter (excluding Notes held by the Issuer or any of its Restricted Subsidiaries). The Trustee shall select the Notes to be purchased in the manner described under Sections 5.1 through 5.6.

 (c) On or within ninety (90) days of the Escrow Release Date, the Issuer may redeem an amount of the Notes equal to the
aggregate principal amount of the Non-refinanced Notes that remain outstanding on the Escrow Release Date less the aggregate principal amount of any reduction to the commitments of the Credit Facilities under the Credit Agreement as a result of any
Non-refinanced Notes that remain outstanding on the Escrow Release Date pursuant to the terms of the debt financing commitments, upon not less than thirty (30) nor 

  
 -83-

 
more than sixty (60) days’ prior notice at a redemption price equal to 100% of the initial issue price of the Notes, plus accrued and unpaid interest from the Issue Date of the Notes up
to, but not including, the date of such redemption. 
 (d) Except pursuant to clauses (a), (b) and (c) of this
Section 5.7, the Notes will not be redeemable at the Issuer’s option prior to April 15, 2015. 
 (e) At
any time and from time to time on or after April 15, 2015, the Issuer may redeem the Notes in whole or in part, upon not less than 30 nor more than 60 days’ notice by electronic delivery or by first class mail, postage prepaid, with a copy
to the Trustee, to each Holder of Notes to the address of such Holder appearing in the Notes Register at a redemption price equal to the percentage of principal amount set forth below plus accrued and unpaid interest, if any, on the Notes redeemed,
to the applicable Redemption Date, if redeemed during the twelve-month period beginning on April 15 of the year indicated below: 
  

					
	Year	  	Percentage	 
	 2015
	  	 	102.1250	% 
	 2016
	  	 	101.0625	% 
	 2017 and thereafter
	  	 	100.0000	% 

 (f) Unless the Issuer defaults in the payment of the redemption price, interest will cease to accrue on
the Notes or portions thereof called for redemption on the applicable Redemption Date. 
 (g) Any redemption pursuant to this
Section 5.7 shall be made pursuant to the provisions of Sections 5.1 through 5.6. 
 SECTION 5.8.
Mandatory Redemption. The Issuer is not required to make mandatory redemption or sinking fund payments with respect to the Notes, other than a Special Mandatory Redemption; provided however, that under certain circumstances, the Issuer
may be required to offer to purchase Notes under Section 3.5 and Section 3.9. The Issuer may at any time and from time to time purchase Notes in the open market or otherwise. 

SECTION 5.9. Special Mandatory Redemption. If (a) the Escrow Agent has not received the Officer’s Certificate pursuant
to Section 3.24 on or prior to the Escrow End Date, (b) the Issuer notifies the Escrow Agent in writing that the Issuer will not pursue the consummation of the Acquisition or otherwise announces that the Merger Agreement has been
terminated or that it will not pursue the consummation of the Acquisition, or (c) the Issuer fails to timely deposit (or cause to be timely deposited) any amounts required by Section 3.24, within three (3) Business Days of the
applicable deposit date, then the Escrow Agent shall, without the requirement of notice to or action by the Issuer, the Trustee or any other Person, release the Escrowed Property (including investment earnings thereon and proceeds thereof) to the
Trustee and the Trustee shall apply (or cause a paying agent to apply) such proceeds to redeem the Notes (the “Special Mandatory Redemption”) on the third Business Day following the date of the release of the Escrowed Property to
the Trustee (the “Special Mandatory Redemption Date”) or as otherwise required by the applicable procedures of DTC, at a redemption price (the “Special Mandatory Redemption Price”), equal to 100% of the issue price
of the Notes, plus accrued and unpaid interest from the Issue Date, or the most recent date to which interest has been paid or duly provided for on the Notes, as the case may be, to, but excluding the Special Mandatory Redemption Date. On the
Special Mandatory Redemption Date, the Trustee will pay to the Issuer any Escrowed Property in excess of the amount necessary to effect the Special Mandatory Redemption. 

  
 -84-

 ARTICLE VI 
 DEFAULTS AND REMEDIES 
 SECTION 6.1. Events of Default. 

(a) Each of the following is an “Event of Default”: 

(1) default in any payment of interest or Additional Interest, if any, on any Note when due and payable, continued for
30 days; 
 (2) default in the payment of the principal amount of or premium, if any, on any Note issued
under this Indenture when due at its Stated Maturity, upon optional redemption, upon required repurchase, upon declaration or otherwise; 
 (3) failure to comply for 60 days after written notice by the Trustee on behalf of the Holders or by the Holders of 30% in principal amount of the outstanding Notes with any agreement or obligation
contained in this Indenture or the Collateral Documents; 
 (4) default under any mortgage, indenture or
instrument under which there may be issued or by which there may be secured or evidenced any Indebtedness for money borrowed by the Issuer or any of its Restricted Subsidiaries (or the payment of which is Guaranteed by the Issuer any of its
Restricted Subsidiaries) other than Indebtedness owed to the Issuer or a Restricted Subsidiary whether such Indebtedness or Guarantee now exists, or is created after the date hereof, which default: 

(A) is caused by a failure to pay principal of such Indebtedness, at its stated final maturity (after giving effect to any
applicable grace periods) provided in such Indebtedness (“payment default”); or 
 (B) results
in the acceleration of such Indebtedness prior to its stated final maturity (the “cross acceleration provision”); 
 and, in each case, the principal amount of any such Indebtedness, together with the principal amount of any other such Indebtedness under which there has been a payment default or the maturity of which
has been so accelerated, aggregates $150.0 million or more; 
 (5) Holdings, the Issuer or a Significant
Subsidiary or group of Restricted Subsidiaries that together (as of the latest audited consolidated financial statements for the Issuer and its Restricted Subsidiaries), would constitute a Significant Subsidiary; 

(A) commences a voluntary case or proceeding; 

(B) consents to the entry of an order for relief against it in an involuntary case or proceeding; 

(C) consents to the appointment of a Custodian of it or for substantially all of its property; 

(D) makes a general assignment for the benefit of its creditors; 

(E) consents to or acquiesces in the institution of a bankruptcy or an insolvency proceeding against it; or 

(F) takes any comparable action under any foreign laws relating to insolvency (collectively, the “bankruptcy
provisions”); 

  
 -85-

 (6) a court of competent jurisdiction enters an order or decree under any
Bankruptcy Law that: 
 (A) is for relief against Holdings, the Issuer or a Significant Subsidiary or group of
Restricted Subsidiaries that together (as of the latest audited consolidated financial statements for the Issuer and its Restricted Subsidiaries), would constitute a Significant Subsidiary, in an involuntary case; 

(B) appoints a Custodian of Holdings, the Issuer or a Significant Subsidiary or group of Restricted Subsidiaries that
together (as of the latest audited consolidated financial statements for the Issuer and its Restricted Subsidiaries), would constitute a Significant Subsidiary, for substantially all of its property; 

(C) orders the winding up or liquidation of Holdings, the Issuer or a Significant Subsidiary or group of Restricted
Subsidiaries that together (as of the latest audited consolidated financial statements for the Issuer and its Restricted Subsidiaries), would constitute a Significant Subsidiary; or 

(D) or any similar relief is granted under any foreign laws and the order, decree or relief remains unstayed and in effect
for 60 consecutive days; 
 (7) failure by the Issuer or any Significant Subsidiary (or group of Restricted
Subsidiaries that together (as of the latest audited consolidated financial statements for the Issuer and its Restricted Subsidiaries) would constitute a Significant Subsidiary), to pay final judgments aggregating in excess of $150.0 million other
than any judgments covered by indemnities provided by, or insurance policies issued by, reputable and creditworthy companies, which final judgments remain unpaid, undischarged and unstayed for a period of more than 60 days after such judgment
becomes final, and in the event such judgment is covered by insurance, an enforcement proceeding has been commenced by any creditor upon such judgment or decree which is not promptly stayed (the “judgment default provision”);

 (8) any Guarantee of the Notes ceases to be in full force and effect, other than (A) in accordance with
the terms of this Indenture, (B) a Guarantor denies or disaffirms its obligations under its Guarantee of the Notes, other than in accordance with the terms thereof or upon release of such Note Guarantee in accordance with this Indenture or
(C) in connection with the bankruptcy of a Guarantor, so long as the aggregate assets of such Guarantor and any other Guarantor whose Note Guarantee ceased or ceases to be in full force as a result of a bankruptcy are less than $150.0 million;

 (9) unless such Liens have been released in accordance with the provisions of the Collateral Documents, Second
Priority Liens with respect to all or substantially all of the Collateral cease to be valid or enforceable, or the Issuer shall assert or any Guarantor shall assert, in any pleading in any court of competent jurisdiction, that any such security
interest is invalid or unenforceable and, in the case of any such Guarantor, the Issuer fails to cause such Guarantor to rescind such assertions within 30 days after the Issuer has actual knowledge of such assertions; or 

(10) the failure by the Issuer or any Guarantor to comply for 60 days after notice with its other agreements contained in
the Collateral Documents except for a failure that would not be material to the Holders of the Notes and would not materially affect the value of the Collateral taken as a whole (together with the defaults described in clauses (9) and
(10) the “security default provisions”). 
 (b) Notwithstanding the foregoing, a default under
Section 6.1(a)(3), (4), (7) or (10) will not constitute an Event of Default until the Trustee or the Holders of 30% in principal amount of the outstanding Notes notify the Issuer of the default and, with
respect to Section 6.1(a)(3), (7) and (10) the Issuer does not cure such default within the time specified in Section 6.1(a)(3), (7) and (10), as applicable, after receipt of such
notice. 

  
 -86-

 SECTION 6.2. Acceleration. 

(a) If an Event of Default (other than an Event of Default described in Section 6.1(a)(5) and (a)(6) with respect to
Holdings or the Issuer) occurs and is continuing, the Trustee by notice to the Issuer or the Holders of at least 30% in principal amount of the outstanding Notes by written notice to the Issuer and the Trustee, may declare the principal of, premium,
if any, and accrued and unpaid interest, including Additional Interest, if any, on all the Notes to be immediately due and payable. Upon such a declaration, such principal, premium and accrued and unpaid interest, including Additional Interest, if
any, will be due and payable immediately. 
 In the event of any Event of Default specified in Section 6.1(a)(4),
such Event of Default and all consequences thereof shall be annulled, waived and rescinded, automatically and without any action by the Trustee or the Holders, if within 30 days after such Event of Default arose: 

(1) (x) the Indebtedness that gave rise to such Event of Default shall have been discharged in full; or 

(y) the holders thereof have rescinded or waived the acceleration, notice or action (as the case may be) giving rise to
such Event of Default; or 
 (z) if the default that is the basis for such Event of Default has been cured; and

 (2) (a) the annulment of the acceleration of the Notes would not conflict with any judgment or decree of a
court of competent jurisdiction; and 
 (b) all existing Events of Default, except nonpayment of principal,
premium or interest, including Additional Interest, if any, on the Notes that became due solely because of the acceleration of the Notes, have been cured or waived. 
 (b) If an Event of Default described in Section 6.1(a)(5) and (a)(6) with respect to Holdings or the Issuer occurs and is continuing, the principal of, premium, if any, and accrued and
unpaid interest, including Additional Interest, if any, on all the Notes will become and be immediately due and payable without any declaration or other act on the part of the Trustee or any Holders. 

(c) (i) if a Default for a failure to report or failure to deliver a required certificate in connection with another Default (the
“Initial Default”) occurs, then at the time such Initial Default is cured, such Default for failure to report or failure to deliver a required certificate in connection with another Default that resulted solely because of that
Initial Default shall also be cured and (ii) any Default or Event of Default for the failure to comply with the time periods prescribed under Section 3.10, or otherwise to deliver any notice or certificate pursuant to any other
provision of this Indenture shall be deemed to be cured upon the delivery of any such report required by said provision or such notice or certificate, as applicable, even though such delivery is not within the prescribed period specified herein.

 SECTION 6.3. Other Remedies. If an Event of Default occurs and is continuing, the Trustee may pursue any available
remedy by proceeding at law or in equity to collect the payment of principal of, or premium, if any, or interest, including Additional Interest, if any, on the Notes or to enforce the performance of any provision of the Notes or this Indenture.

 The Trustee may maintain a proceeding even if it does not possess any of the Notes or does not produce any of them in the
proceeding. A delay or omission by the Trustee or any Holder in exercising any right or remedy accruing upon an Event of Default shall not impair the right or remedy or constitute a waiver of or acquiescence in the Event of Default. No remedy is
exclusive of any other remedy. All available remedies are cumulative. 
 SECTION 6.4. Waiver of Past Defaults. The
Holders of a majority in aggregate principal amount of the then outstanding Notes by written notice to the Trustee may, on behalf of all of the Holders, (a) waive, by their consent (including, without limitation, consents obtained in connection
with a purchase of, or tender offer or 

  
 -87-

 
exchange offer for, Notes), an existing Default or Event of Default and its consequences under this Indenture except (i) a Default or Event of Default in the payment of the principal of, or
premium, if any, or interest, including Additional Interest, if any, on a Note or (ii) a Default or Event of Default in respect of a provision that under Section 9.2 cannot be amended without the consent of each Holder affected and
(b) rescind any acceleration with respect to the Notes and its consequences if (1) such rescission would not conflict with any judgment or decree of a court of competent jurisdiction, (2) all existing Events of Default have been cured
or waived except nonpayment of principal, premium, if any, interest or Additional Interest, if any, that has become due solely because of the acceleration, (3) to the extent the payment of such interest is lawful, interest on overdue
installments of interest, Additional Interest if any, premium, if any, and overdue principal, which has become due otherwise than by such declaration of acceleration, has been paid, (4) the Issuer has paid the Trustee its compensation and
reimbursed the Trustee for its reasonable expenses, disbursements and advances and (5) in the event of the cure or waiver of an Event of Default of the type described in clause (4) of Section 6.1, the Trustee shall have
received an Officer’s Certificate and an Opinion of Counsel stating that such Event of Default has been cured or waived. No such rescission shall affect any subsequent Default or impair any right consequent thereto. When a Default or Event of
Default is waived, it is deemed cured, but no such waiver shall extend to any subsequent or other Default or Event of Default or impair any consequent right. 
 SECTION 6.5. Control by Majority. Subject to the terms of the Collateral Documents, the Holders of a majority in principal amount of the outstanding Notes may direct the time, method and place of
conducting any proceeding for any remedy available to the Trustee or the Collateral Agent or of exercising any trust or power conferred on the Trustee or the Collateral Agent. However, the Trustee may refuse to follow any direction that conflicts
with law or this Indenture or the Notes or, subject to Sections 7.1 and 7.2, that the Trustee determines is unduly prejudicial to the rights of other Holders (it being understood that the Trustee does not have an affirmative duty
to ascertain whether or not any actions are unduly prejudicial to such Holders) or would involve the Trustee in personal liability; provided, however, that the Trustee may take any other action deemed proper by the Trustee that is not
inconsistent with such direction. Prior to taking any such action hereunder, the Trustee shall be entitled to indemnification satisfactory to it against all fees, losses and expenses (including attorney’s fees and expenses) that may be caused
by taking or not taking such action. 
 SECTION 6.6. Limitation on Suits. Subject to Section 6.7, no Holder
may pursue any remedy with respect to this Indenture or the Notes unless: 
 (1) such Holder has previously given
the Trustee written notice that an Event of Default is continuing; 
 (2) Holders of at least 30% in principal
amount of the outstanding Notes have requested in writing the Trustee to pursue the remedy; 
 (3) such Holders
have offered in writing the Trustee security or indemnity satisfactory to the Trustee against any loss, liability or expense; 
 (4) the Trustee has not complied with such request within 60 days after the receipt of the written request and the offer of security or indemnity; and 

(5) the Holders of a majority in principal amount of the outstanding Notes have not given the Trustee a written direction
that, in the opinion of the Trustee, is inconsistent with such request within such 60-day period. 
 A Holder may not use this
Indenture to prejudice the rights of another Holder or to obtain a preference or priority over another Holder (it being understood that the Trustee does not have an affirmative duty to ascertain whether or not such actions or forbearances are unduly
prejudicial to such Holders). 
 SECTION 6.7. Rights of Holders to Receive Payment. Notwithstanding any other provision
of this Indenture (including, without limitation, Section 6.6), the right of any Holder to receive payment of principal of, premium, if any, or interest, including Additional Interest, if any, on the Notes held by such Holder, on or
after the respective due dates expressed or provided for in the Notes, or to bring suit for the enforcement of any such payment on or after such respective dates, shall not be impaired or affected without the consent of such Holder. 

  
 -88-

 SECTION 6.8. Collection Suit by Trustee. If an Event of Default specified in
Section 6.1(a)(1) or (2) occurs and is continuing, the Trustee may recover judgment in its own name and as trustee of an express trust against the Issuer for the whole amount then due and owing (together with interest on any
unpaid interest and Additional Interest, if any, to the extent lawful) and the amounts provided for in Section 7.7. 

SECTION 6.9. Trustee May File Proofs of Claim. The Trustee may file such proofs of claim and other papers or documents as may be
necessary or advisable in order to have the claims of the Trustee (including any claim for the reasonable compensation, expenses, disbursements and advances of the Trustee, its agents and counsel) and the Holders allowed in any judicial proceedings
relative to the Issuer, its Subsidiaries or its or their respective creditors or properties and, unless prohibited by law or applicable regulations, may be entitled and empowered to participate as a member of any official committee of creditors
appointed in such matter and may vote on behalf of the Holders in any election of a trustee in bankruptcy or other Person performing similar functions, and any Custodian in any such judicial proceeding is hereby authorized by each Holder to make
payments to the Trustee and, in the event that the Trustee shall consent to the making of such payments directly to the Holders, to pay to the Trustee any amount due it for the compensation, expenses, disbursements and advances of the Trustee, its
agents and its counsel, and any other amounts due the Trustee under Section 7.7. 
 No provision of this Indenture
shall be deemed to authorize the Trustee to authorize or consent to or accept or adopt on behalf of any Holder any plan of reorganization, arrangement, adjustment or composition affecting the Notes or the rights of any Holder thereof or to authorize
the Trustee to vote in respect of the claim of any Holder in any such proceeding. 
 SECTION 6.10. Priorities.

 (a) Subject to the provisions of the Intercreditor Agreement and the Collateral Documents, if the Trustee collects any money
or property pursuant to this Article VI it shall pay out the money or property in the following order: 
 FIRST: to the Trustee for amounts due to it under Section 7.7; 
 SECOND: to Holders for amounts due and unpaid on the Notes for principal of, or premium, if any, and interest and Additional Interest, if any, ratably, without preference or priority of any kind,
according to the amounts due and payable on the Notes for principal of, or premium, if any, and interest (including Additional Interest), respectively; and 
 THIRD: to the Issuer, or to the extent the Trustee collects any amount for any Guarantor, to such Guarantor. 
 (b) The Trustee may fix a record date and payment date for any payment to Holders pursuant to this Section 6.10. At least 15 days before such record date, the Issuer shall send or cause
to be sent to each Holder and the Trustee a notice that states the record date, the payment date and amount to be paid. 

SECTION 6.11. Undertaking for Costs. In any suit for the enforcement of any right or remedy under this Indenture or in any suit
against the Trustee for any action taken or omitted by it as Trustee, a court in its discretion may require the filing by any party litigant in the suit of an undertaking to pay the costs of the suit, and the court in its discretion may assess
reasonable costs, including reasonable attorneys’ fees and expenses, against any party litigant in the suit, having due regard to the merits and good faith of the claims or defenses made by the party litigant. This Section 6.11 does
not apply to a suit by the Trustee, a suit by the Issuer, a suit by a Holder pursuant to Section 6.7 or a suit by Holders of more than 10% in outstanding principal amount of the Notes. 

SECTION 6.12. Reporting Defaults. Notwithstanding any other provision of this Indenture, the sole remedy for an Event of Default
relating to the failure to comply with the reporting obligations under Section 3.10, 

  
 -89-

 
will for the 365 days after the occurrence of such Event of Default consist exclusively of the right to receive additional interest on the principal amount of the Notes at a rate equal to
0.50% per annum. This additional interest will be payable in the same manner and subject to the same terms as other interest payable under this Indenture. This additional interest will accrue on all outstanding Notes from and including the date
on which an Event of Default relating to a failure to comply with the reporting obligations under Section 3.10 first occurs to, but excluding, the 365th day thereafter (or such earlier date on which the Event of Default relating to such
reporting obligations is cured or waived). If the Event of Default resulting from such failure to comply with the reporting obligations is continuing on such 365th day, such additional interest will cease to accrue and the Notes will be subject to
the other remedies provided under this Article VI. 
 ARTICLE VII 

TRUSTEE 

SECTION 7.1. Duties of Trustee. 
 (a) If an Event of Default has occurred and is continuing, the Trustee shall exercise the rights and powers vested in it by this Indenture and use the same degree of care and skill in its exercise as a
prudent Person would exercise or use under the circumstances in the conduct of such person’s own affairs. 
 (b) Except
during the continuance of an Event of Default: 
 (1) the Trustee undertakes to perform such duties and only such
duties as are specifically set forth as duties of the Trustee in this Indenture, the Notes, the Collateral Documents or the Intercreditor Agreement and no implied covenants or obligations shall be read into this Indenture against the Trustee; and

 (2) in the absence of bad faith on its part, the Trustee may conclusively rely, as to the truth of the
statements and the correctness of the opinions expressed therein, upon certificates, opinions or orders furnished to the Trustee and conforming to the requirements of this Indenture or the Notes, as the case may be. However, in the case of any such
certificates or opinions which by any provisions hereof are specifically required to be furnished to the Trustee, the Trustee shall examine such certificates and opinions to determine whether or not they conform to the requirements of this Indenture
or the Notes, as the case may be (but need not confirm or investigate the accuracy of mathematical calculations or other facts stated therein). 
 (c) The Trustee may not be relieved from liability for its own grossly negligent action, its own grossly negligent failure to act or its own willful misconduct, except that: 

(1) this paragraph does not limit the effect of paragraph (b) of this Section 7.1; 

(2) the Trustee shall not be liable for any error of judgment made in good faith by a Trust Officer unless it is proved
that the Trustee was grossly negligent in ascertaining the pertinent facts; 
 (3) the Trustee shall not be
liable with respect to any action it takes or omits to take in good faith in accordance with a direction received by it pursuant to Section 6.5; and 
 (4) No provision of this Indenture or the Notes shall require the Trustee to expend or risk its own funds or otherwise incur financial liability in the performance of any of its duties hereunder or
thereunder or in the exercise of any of its rights or powers, if it shall have reasonable grounds to believe that repayment of such funds or adequate indemnity against such risk or liability is not reasonably assured to it. 

(d) Every provision of this Indenture that in any way relates to the Trustee is subject to paragraphs (a), (b) and (c) of
this Section 7.1. 

  
 -90-

 (e) The Trustee shall not be liable for interest on any money received by it except as the
Trustee may agree in writing with the Issuer. 
 (f) Money held in trust by the Trustee need not be segregated from other funds
except to the extent required by law. 
 (g) Every provision of this Indenture relating to the conduct or affecting the
liability of or affording protection to the Trustee shall be subject to the provisions of this Section 7.1 and to the provisions of the TIA. 
 SECTION 7.2. Rights of Trustee. Subject to Section 7.1: 
 (a) The Trustee may conclusively rely on and shall be fully protected in acting or refraining from acting upon any resolution, certificate, statement, instrument, opinion, report, notice, request,
direction, consent, order or other paper or document (whether in its original or facsimile form) reasonably believed by it to be genuine and to have been signed or presented by the proper Person. The Trustee need not investigate any fact or matter
stated in the document. The Trustee shall receive and retain financial reports and statements of the Issuer as provided herein, but shall have no duty to review or analyze such reports or statements to determine compliance with covenants or other
obligations of the Issuer. 
 (b) Before the Trustee acts or refrains from acting, it may require an
Officer’s Certificate and/or an Opinion of Counsel. The Trustee shall not be liable for any action it takes or omits to take in good faith in reliance on an Officer’s Certificate or Opinion of Counsel. 

(c) The Trustee may execute any of the trusts and powers hereunder or perform any duties hereunder either directly or by
or through its attorneys and agents and shall not be responsible for the misconduct or negligence of any agent or attorney appointed with due care by it hereunder. 

(d) The Trustee shall not be liable for any action it takes or omits to take in good faith which it believes to be
authorized or within its rights or powers conferred upon it by this Indenture. 
 (e) The Trustee may consult
with counsel of its selection, and the advice or opinion of counsel relating to this Indenture or the Notes shall be full and complete authorization and protection from liability in respect of any action taken, omitted or suffered by it hereunder or
under the Notes in good faith and in reliance on the advice or opinion of such counsel. 
 (f) The Trustee shall
not be deemed to have notice of any Default or Event of Default or whether any entity or group of entities constitutes a Significant Subsidiary unless a Trust Officer of the Trustee has actual knowledge thereof or unless written notice of any event
which is in fact such a Default or of any such Significant Subsidiary is received by the Trustee at the corporate trust office of the Trustee specified in Section 3.11, and such notice references the Notes and this Indenture. 

(g) The rights, privileges, protections, immunities and benefits given to the Trustee, including, without limitation, its
right to be indemnified, are extended to, and shall be enforceable by, the Trustee in each of its capacities hereunder, and to each agent, custodian and other Person employed to act hereunder, including the Collateral Agent. 

(h) The Trustee shall be under no obligation to exercise any of the rights or powers vested in it by this Indenture or the
Notes at the request, order or direction of any of the Holders pursuant to the provisions of this Indenture, unless such Holders shall have offered to the Trustee security or indemnity satisfactory to it against the costs, expenses and liabilities
which may be incurred therein or thereby. 
 (i) The Trustee shall not be deemed to have knowledge of any fact or
matter unless such fact or matter is actually known to a Trust Officer of the Trustee. 

  
 -91-

 (j) Whenever in the administration of this Indenture or the Notes the
Trustee shall deem it desirable that a matter be proved or established prior to taking, suffering or omitting any action hereunder or thereunder, the Trustee (unless other evidence be herein specifically prescribed) may, in the absence of bad faith
or willful misconduct on its part, conclusively rely upon an Officer’s Certificate. 
 (k) The Trustee shall
not be bound to make any investigation into the facts or matters stated in any resolution, certificate, statement, instrument, report, notice, request, direction, consent, order, bond, debenture, coupon or other paper or document, but the Trustee,
in its discretion, may make such further inquiry or investigation into such facts or matters as it may see fit, and, if the Trustee shall determine to make such further inquiry or investigation, it shall be entitled to examine, during business hours
and upon reasonable notice, the books, records and premises of the Issuer and the Restricted Subsidiaries, personally or by agent or attorney at the sole cost of the Issuer and shall incur no liability or additional liability of any kind by reason
of such inquiry or investigation. 
 (l) The Trustee shall not be required to give any bond or surety in respect
of the performance of its powers and duties hereunder. 
 (m) The Trustee may request that the Issuer deliver an
Officer’s Certificate setting forth the names of individuals and/or titles of officers authorized at such time to take specified actions pursuant to this Indenture or the Notes. 

(n) In no event shall the Trustee be liable to any Person for special, punitive, indirect, consequential or incidental
loss or damage of any kind whatsoever (including, but not limited to, lost profits), even if the Trustee has been advised of the likelihood of such loss or damage. 

(o) Unless otherwise specifically provided in this Indenture, any demand, request, direction or notice from the Issuer
shall be sufficient if signed by one Officer of the Issuer 
 SECTION 7.3. Individual Rights of Trustee. The Trustee in
its individual or any other capacity may become the owner or pledgee of Notes and may otherwise deal with the Issuer, Guarantors or their Affiliates with the same rights it would have if it were not Trustee. Any Paying Agent, Registrar, co-registrar
or co-paying agent may do the same with like rights. However, the Trustee must comply with Sections 7.10 and 7.11. In addition, the Trustee shall be permitted to engage in transactions with the Issuer; provided,
however, that if the Trustee acquires any conflicting interest under the TIA, the Trustee must (i) eliminate such conflict within 90 days of acquiring such conflicting interest, (ii) apply to the SEC for permission to continue
acting as Trustee or (iii) resign. 
 SECTION 7.4. Trustee’s Disclaimer. The Trustee shall not be responsible
for and makes no representation as to the validity or adequacy of this Indenture or the Notes, shall not be accountable for the Issuer’s use of the proceeds from the sale of the Notes, shall not be responsible for the use or application of any
money received by any Paying Agent other than the Trustee or any money paid to the Issuer pursuant to the terms of this Indenture and shall not be responsible for any statement of the Issuer in this Indenture or in any document issued in connection
with the sale of the Notes or in the Notes other than the Trustee’s certificate of authentication. 
 SECTION 7.5.
Notice of Defaults. If a Default or Event of Default occurs and is continuing and if a Trust Officer has actual knowledge thereof, the Trustee shall send electronically or by first class mail to each Holder at the address set forth in the
Notes Register notice of the Default or Event of Default within 60 days after it is actually known to a Trust Officer. Except in the case of a Default or Event of Default in payment of principal of, or premium, if any, interest or Additional
Interest, if any, on any Note (including payments pursuant to the optional redemption or required repurchase provisions of such Note), the Trustee may withhold the notice if and so long as it in good faith determines that withholding the notice is
in the interests of Holders. 
 SECTION 7.6. Reports by Trustee to Holders. Within 60 days after each March 31
beginning March 31, 2014, the Trustee shall mail to each Holder a brief report dated as of such March 31 that complies with TIA Section 313(a) if and to the extent required thereby. The Trustee also shall comply with TIA
Section 313(c). 

  
 -92-

 A copy of each report at the time of its mailing to Holders shall be filed with the SEC and
each stock exchange (if any) on which the Notes are listed. The Issuer agrees to notify the Trustee promptly in writing whenever the Notes become listed on any stock exchange and of any delisting thereof and the Trustee shall comply with TIA
Section 313(d). 
 SECTION 7.7. Compensation and Indemnity. The Issuer shall pay to the Trustee from time to time
compensation for its services hereunder and under the Notes as the Issuer and the Trustee shall from time to time agree in writing. The Trustee’s compensation shall not be limited by any law on compensation of a trustee of an express trust. The
Issuer shall reimburse the Trustee upon request for all reasonable out-of-pocket expenses incurred or made by it, including, but not limited to, costs of collection, costs of preparing reports, certificates and other documents, costs of preparation
and mailing of notices to Holders. Such expenses shall include the reasonable compensation and expenses, disbursements and advances of the agents, counsel, accountants and experts of the Trustee. The Issuer shall indemnify the Trustee against any
and all fees, loss, liability, damages, claims or expense, including taxes (other than taxes based upon the income of the Trustee) (including reasonable attorneys’ and agents’ fees and expenses) incurred by it without willful misconduct or
gross negligence, as determined by a court of competent jurisdiction, on its part in connection with the administration of this trust and the performance of its duties hereunder and under the Notes, including the fees, costs and expenses of
enforcing this Indenture (including this Section 7.7) and the Notes and of defending itself against any claims (whether asserted by any Holder, the Issuer or otherwise). The Trustee shall notify the Issuer promptly of any claim for which
it may seek indemnity of which it has received written notice. Failure by the Trustee to so notify the Issuer shall not relieve the Issuer of its obligations hereunder. The Issuer shall defend the claim and the Trustee shall provide reasonable
cooperation at the Issuer’s expense in the defense. The Trustee may have separate counsel and the Issuer shall pay the fees and expenses of such counsel; provided that the Issuer shall not be required to pay the fees and expenses of such
separate counsel if it assumes the Trustee’s defense, and, in the reasonable judgment of outside counsel to the Trustee, there is no conflict of interest between the Issuer and the Trustee in connection with such defense. 

To secure the Issuer’s payment obligations in this Section 7.7, the Trustee shall have a lien prior to the Notes on all
money or property held or collected by the Trustee. Such lien shall survive the satisfaction and discharge of this Indenture. The Trustee’s respective right to receive payment of any amounts due under this Section 7.7 shall not be
subordinate to any other liability or Indebtedness of the Issuer. 
 The Issuer’s payment obligations pursuant to this
Section 7.7 shall survive the discharge of this Indenture and the resignation or removal of the Trustee. Without prejudice to any other rights available to the Trustee under applicable law, when the Trustee incurs fees, expenses or
renders services after the occurrence of a Default specified in Section 6.1(a)(5) or (a)(6), the fees and expenses (including the reasonable fees and expenses of its counsel) are intended to constitute expenses of administration
under any Bankruptcy Law. 
 SECTION 7.8. Replacement of Trustee. The Trustee may resign at any time by so notifying the
Issuer in writing not less than 30 days prior to the effective date of such resignation. The Holders of a majority in principal amount of the Notes may remove the Trustee by so notifying the removed Trustee in writing not less than 30 days
prior to the effective date of such removal and may appoint a successor Trustee with the Issuer’s written consent, which consent will not be unreasonably withheld. The Issuer shall remove the Trustee if: 

(1) the Trustee fails to comply with Section 7.10 hereof; 

(2) the Trustee is adjudged bankrupt or insolvent; 

(3) a receiver or other public officer takes charge of the Trustee or its property; or 

(4) the Trustee otherwise becomes incapable of acting. 

If the Trustee resigns or is removed by the Issuer or by the Holders of a majority in principal amount of the Notes and such Holders do
not reasonably promptly appoint a successor Trustee as described in the preceding paragraph, or if a vacancy exists in the office of the Trustee for any reason (the Trustee in such event being referred to herein as the retiring Trustee), the Issuer
shall promptly appoint a successor Trustee. 

  
 -93-

 A successor Trustee shall deliver a written acceptance of its appointment to the retiring
Trustee and to the Issuer. Thereupon the resignation or removal of the retiring Trustee shall become effective, and the successor Trustee shall have all the rights, powers and duties of the Trustee under this Indenture. The successor Trustee shall
mail a notice of its succession to Holders. The retiring Trustee shall, at the expense of the Issuer, promptly transfer all property held by it as Trustee to the successor Trustee, subject to the lien provided for in Section 7.7.

 If a successor Trustee does not take office within 60 days after the retiring Trustee resigns or is removed, the
retiring Trustee or the Holders of at least 10% in principal amount of the Notes may petition, at the Issuer’s expense, any court of competent jurisdiction for the appointment of a successor Trustee. 

If the Trustee fails to comply with Section 7.10, unless the Trustee’s duty to resign is stayed as provided in TIA
Section 310(b), any Holder, who has been a bona fide holder of a Note for at least six months, may petition any court of competent jurisdiction for the removal of the Trustee and the appointment of a successor Trustee. 

Notwithstanding the replacement of the Trustee pursuant to this Section 7.8, the Issuer’s obligations under
Section 7.7 shall continue for the benefit of the retiring Trustee. The predecessor Trustee shall have no liability for any action or inaction of any successor Trustee. 

SECTION 7.9. Successor Trustee by Merger. If the Trustee consolidates with, merges or converts into, or transfers all or
substantially all its corporate trust business or assets to, another corporation or banking association, the resulting, surviving or transferee corporation without any further act shall be the successor Trustee. 

In case at the time such successor or successors by merger, conversion or consolidation to the Trustee shall succeed to the trusts
created by this Indenture, any of the Notes shall have been authenticated but not delivered, any such successor to the Trustee may adopt the certificate of authentication of any predecessor trustee, and deliver such Notes so authenticated; and in
case at that time any of the Notes shall not have been authenticated, any successor to the Trustee may authenticate such Notes either in the name of any predecessor hereunder or in the name of the successor to the Trustee; provided that the
right to adopt the certificate of authentication of any predecessor Trustee or authenticate Notes in the name of any predecessor Trustee shall only apply to its successor or successors by merger, consolidation or conversion. 

SECTION 7.10. Eligibility; Disqualification. This Indenture shall always have a Trustee that satisfies the requirements of TIA
Section 310(a)(1), (2) and (5) in every respect. The Trustee shall have a combined capital and surplus of at least $100 million as set forth in its most recent published annual report of condition. The Trustee shall comply with
TIA Section 310(b); provided, however, that there shall be excluded from the operation of TIA Section 310(b)(1) any indenture or indentures under which other securities or certificates of interest or participation in other
securities of the Issuer are outstanding if the requirements for such exclusion set forth in TIA Section 310(b)(1) are met. 
 SECTION 7.11. Preferential Collection of Claims Against the Issuer. The Trustee shall comply with TIA Section 311(a), excluding any creditor relationship listed in TIA Section 311(b). A
Trustee who has resigned or been removed shall be subject to TIA Section 311(a) to the extent indicated. 
 SECTION 7.12.
Trustee’s Application for Instruction from the Issuer. Any application by the Trustee for written instructions from the Issuer may, at the option of the Trustee, set forth in writing any action proposed to be taken or omitted by the
Trustee under this Indenture and the date on and/or after which such action shall be taken or such omission shall be effective. The Trustee shall not be liable for any action taken by, or omission of, the Trustee in accordance with a proposal
included in such application on or after the date specified in such application (which date shall not be less than three Business Days after the date any Officer of the Issuer actually receives such application, unless any such Officer shall have
consented in writing to any earlier date) unless prior to taking any such action (or the effective date in the case of an omission), the Trustee shall have received written instructions in response to such application specifying the action to be
taken or omitted. 
 SECTION 7.13. Collateral Documents; Intercreditor Agreement. By their acceptance of the Notes, the
Holders hereby authorize and direct the Trustee and Collateral Agent, as the case may be, to execute and deliver the 

  
 -94-

 
Intercreditor Agreement and any other Collateral Documents in which the Trustee or the Collateral Agent, as applicable, is named as a party, including any Collateral Documents executed after the
Issue Date. It is hereby expressly acknowledged and agreed that, in doing so, the Trustee and the Collateral Agent are (a) expressly authorized to make the representations attributed to Holders in any such agreements and (b) not
responsible for the terms or contents of such agreements, or for the validity or enforceability thereof, or the sufficiency thereof for any purpose. Whether or not so expressly stated therein, in entering into, or taking (or forbearing from) any
action under, the Intercreditor Agreement or any other Collateral Documents, the Trustee and the Collateral Agent each shall have all of the rights, immunities, indemnities and other protections granted to it under this Indenture (in addition to
those that may be granted to it under the terms of such other agreement or agreements). 
 SECTION 7.14. Escrow
Authorization. Each Holder, by its acceptance of a Note, (i) consents and agrees to the terms of the Escrow Agreement, including documents related thereto, as the same may be in effect or may be amended from time to time in writing by the
parties thereto (provided that no amendment that would materially adversely affect the rights of the Holders may be effected without the consent of the Holders of a majority of the aggregate principal amount of the Notes then outstanding),
and (ii) authorizes and directs the Trustee to enter into the Escrow Agreement and to perform its obligations and exercise its rights thereunder in accordance therewith. Merger Sub shall do or cause to be done all such acts and things as
may be necessary or proper, or as may be required by the provisions of the Escrow Agreement, to assure and confirm to the Trustee the security interest contemplated by the Escrow Agreement or any part thereof, as from time to time constituted, so as
to render the same available for the security and benefit of this Indenture and of the Notes secured hereby, according to the intent and purpose herein expressed. Merger Sub shall take, or shall cause to be taken, any and all actions reasonably
required to cause the Escrow Agreement to create and maintain, as security for the obligations of Merger Sub under this Indenture and the Notes as provided in the Escrow Agreement, valid and enforceable first priority perfected Liens in and on all
of the Escrowed Property, in favor of the Trustee for its benefit and for the benefit of the Holders, superior to and prior to the rights of third Persons and subject to no other Liens. 

ARTICLE VIII 

LEGAL DEFEASANCE AND COVENANT DEFEASANCE 
 SECTION 8.1. Option to Effect Legal Defeasance or Covenant Defeasance; Defeasance. The Issuer may, at its option and at any time, elect to have either Section 8.2 or 8.3 hereof
be applied to all outstanding Notes upon compliance with the conditions set forth in this Article VIII. 
 SECTION
8.2. Legal Defeasance and Discharge. Upon the Issuer’s exercise under Section 8.1 hereof of the option applicable to this Section 8.2, the Issuer and each of the Guarantors will, subject to the satisfaction of the
conditions set forth in Section 8.4 hereof, be deemed to have been discharged from their obligations with respect to all outstanding Notes (including the Note Guarantees) on the date the conditions set forth in Section 8.4
are satisfied (hereinafter, “Legal Defeasance”). For this purpose, Legal Defeasance means that the Issuer and the Guarantors will be deemed to have paid and discharged the entire Indebtedness represented by the outstanding Notes
(including the Note Guarantees), which will thereafter be deemed to be “outstanding” only for the purposes of Section 8.5 hereof and the other Sections of this Indenture referred to in clauses (1) and (2) below, and
to have satisfied all of their other obligations under such Notes, the Note Guarantees, this Indenture and the Collateral Documents (and the Trustee, on written demand of and at the expense of the Issuer, shall execute proper instruments
acknowledging the same) and to have cured all then existing Events of Default, except for the following provisions which will survive until otherwise terminated or discharged hereunder: 

(1) the rights of Holders of Notes issued under this Indenture to receive payments in respect of the principal of,
premium, if any, and interest and Additional Interest, if any, on the Notes when such payments are due solely out of the trust referred to in Section 8.4 hereof; 

(2) the Issuer’s obligations with respect to the Notes under Article II concerning issuing temporary
Notes, registration of such Notes, mutilated, destroyed, lost or stolen Notes and Section 3.11 hereof concerning the maintenance of an office or agency for payment and money for security payments held in trust; 

  
 -95-

 (3) the rights, powers, trusts, duties and immunities of the Trustee and the
Issuer’s or Guarantors’ obligations in connection therewith; and 
 (4) this Article VIII
with respect to provisions relating to Legal Defeasance. 
 Subject to compliance with this Section 8.2, the Issuer
may exercise its option under this Section 8.2 notwithstanding the prior exercise of its option under Section 8.3 hereof. 
 SECTION 8.3. Covenant Defeasance. Upon the Issuer’s exercise under Section 8.1 hereof of the option applicable to this Section 8.3, the Issuer and each of the
Guarantors will, subject to the satisfaction of the conditions set forth in Section 8.4 hereof, be released from each of their obligations under the covenants contained in Section 3.2, 3.3, 3.4, 3.5,
3.6, 3.7, 3.8, 3.9, 3.10, 3.19, 3.20, 3.21, 3.22 and Section 4.1 (except Section 4.1(a)(1) and (a)(2)) hereof with respect to the outstanding Notes on and
after the date of the conditions set forth in Section 8.4 hereof are satisfied (hereinafter, “Covenant Defeasance”), and the Notes will thereafter be deemed not “outstanding” for the purposes of any direction,
waiver, consent or declaration or act of Holders (and the consequences of any thereof) in connection with such covenants, but will continue to be deemed “outstanding” for all other purposes hereunder. For this purpose, Covenant Defeasance
means that, with respect to the outstanding Notes and Note Guarantees, the Issuer and the Guarantors may omit to comply with and shall have no liability in respect of any term, condition or limitation set forth in any such covenant, whether directly
or indirectly, by reason of any reference elsewhere herein to any such covenant or by reason of any reference in any such covenant to any other provision herein or in any other document and such omission to comply shall not constitute a Default or
an Event of Default under Section 6.1 hereof, but, except as specified in this Section 8.3, the remainder of this Indenture and such Notes and Note Guarantees will be unaffected thereby. In addition, upon the Issuer’s
exercise under Section 8.1 hereof of the option applicable to this Section 8.3, subject to the satisfaction of the conditions set forth in Section 8.4 hereof, Sections 6.1(a)(3) (solely with respect to
the defeased covenants listed above), 6.1(a)(4), 6.1(a)(5) (with respect only to a Guarantor that is a Significant Subsidiary or any group of Guarantors that taken together would constitute a Significant Subsidiary), 6.1(a)(6)
(with respect only to a Guarantor that is a Significant Subsidiary or any group of Guarantors that taken together would constitute a Significant Subsidiary), 6.1(a)(7), 6.1(a)(8) and 6.1(a)(10) hereof shall not constitute Events
of Default. 
 SECTION 8.4. Conditions to Legal or Covenant Defeasance. In order to exercise either Legal Defeasance or
Covenant Defeasance under either Section 8.2 or 8.3 hereof: 
 (1) the Issuer must irrevocably
deposit with the Trustee, in trust (the “Defeasance Trust”), for the benefit of the Holders, cash in dollars or U.S. Government Obligations or a combination thereof in such amounts as will be sufficient, in the opinion of a
nationally recognized firm of independent public accountants, to pay the principal of and premium, if any, interest and Additional Interest, if any, due on the Notes issued under this Indenture on the stated maturity date or on the applicable
redemption date, as the case may be, and the Issuer must specify whether such Notes are being defeased to maturity or to a particular redemption date; 
 (2) in the case of Legal Defeasance, the Issuer shall have delivered to the Trustee an Opinion of Counsel in the United States confirming that, subject to customary assumptions and exclusions; 

(A) the Issuer has received from, or there has been published by, the United States Internal Revenue Service a ruling; or

 (B) since the issuance of such Notes, there has been a change in the applicable U.S. federal income tax law;

 in either case stating that, and based thereon such Opinion of Counsel in the United States shall confirm that, subject to
customary assumptions and exclusions, the Holders will not recognize income, gain or loss for U.S. federal income tax purposes as a result of such Legal Defeasance and will be subject to U.S. federal income tax on the same amounts, in the same
manner and at the same times as would have been the case if such Legal Defeasance had not occurred; 

  
 -96-

 (3) in the case of Covenant Defeasance, the Issuer shall have delivered to
the Trustee an Opinion of Counsel in the United States stating that, subject to customary assumptions and exclusions, the Holders will not recognize income, gain or loss for U.S. federal income tax purposes as a result of such Covenant Defeasance
and will be subject to U.S. federal income tax on the same amounts, in the same manner and at the same times as would have been the case if such Covenant Defeasance had not occurred; 

(4) no Default or Event of Default (other than that resulting from borrowing funds to be applied to make such deposit and
the granting of Liens in connection therewith) shall have occurred and be continuing on the date of such deposit; 
 (5) such Legal Defeasance or Covenant Defeasance shall not result in a breach or violation of, or constitute a default under the Credit Facilities or any other material agreement or instrument (other than
this Indenture) to which, the Issuer or any Guarantor is a party or by which the Issuer or any Guarantor is bound; 
 (6) the Issuer shall have delivered to the Trustee an Opinion of Counsel stating that, as of the date of such opinion and subject to customary assumptions and exclusions following the deposit, the trust
funds will not be subject to the effect of Sections 546 and 547 of Title 11 of the United States Code, as amended, or any applicable bankruptcy, insolvency, reorganization or similar laws affecting creditors’ rights generally under
any applicable U.S. federal or state law; 
 (7) the Issuer shall have delivered to the Trustee an Officer’s
Certificate stating that the deposit was not made by the Issuer with the intent of defeating, hindering, delaying, defrauding or preferring any creditors of the Issuer; and 

(8) the Issuer shall have delivered to the Trustee an Officer’s Certificate and an Opinion of Counsel (which Opinion
of Counsel may be subject to customary assumptions and exclusions), each stating that all conditions precedent provided for or relating to Legal Defeasance or Covenant Defeasance, as the case may be, have been complied with. 

SECTION 8.5. Deposited Money and U.S. Government Obligations to be Held in Trust; Other Miscellaneous Provisions. Subject to
Section 8.6 hereof, all money and U.S. Government Obligations (including the proceeds thereof) deposited with the Trustee (or other qualifying trustee, collectively for purposes of this Section 8.5, the
“Trustee”) pursuant to Section 8.4 hereof in respect of the outstanding Notes will be held in trust and applied by the Trustee, in accordance with the provisions of such Notes and this Indenture, to the payment, either
directly or through any Paying Agent (including the Issuer acting as Paying Agent) as the Trustee may determine, to the Holders of such Notes of all sums due and to become due thereon in respect of principal, premium and Additional Interest, if any,
and interest, but such money need not be segregated from other funds except to the extent required by law. 
 The Issuer will
pay and indemnify the Trustee against any tax, fee or other charge imposed on or assessed against the cash or U.S. Government Obligations deposited pursuant to Section 8.4 hereof or the principal and interest received in respect thereof
other than any such tax, fee or other charge which by law is for the account of the Holders of the outstanding Notes. 

Notwithstanding anything in this Article VIII to the contrary, the Trustee will deliver or pay to the Issuer from time to
time upon the request of the Issuer any money or U.S. Government Obligations held by it as provided in Section 8.4 hereof which, in the opinion of a nationally recognized firm of independent public accountants expressed in a written
certification thereof delivered to the Trustee (which may be the opinion delivered under Section 8.4(1) hereof), are in excess of the amount thereof that would then be required to be deposited to effect an equivalent Legal Defeasance or
Covenant Defeasance. 
 SECTION 8.6. Repayment to the Issuer. Any money deposited with the Trustee or any Paying Agent,
or then held by the Issuer, in trust for the payment of the principal of, premium or Additional Interest, if any, or interest on, any Note and remaining unclaimed for two years after such principal, premium or Additional Interest, if 

  
 -97-

 
any, or interest has become due and payable shall be paid to the Issuer on its written request unless an abandoned property law designates another Person or (if then held by the Issuer) will be
discharged from such trust; and the Holder of such Note will thereafter be permitted to look only to the Issuer for payment thereof unless an abandoned property law designates another Person, and all liability of the Trustee or such Paying Agent
with respect to such trust money, and all liability of the Issuer as trustee thereof, will thereupon cease; provided, however, that the Trustee or such Paying Agent, before being required to make any such repayment, shall at the
expense of the Issuer cause to be published once, in The New York Times and The Wall Street Journal (national edition), notice that such money remains unclaimed and that, after a date specified therein, which will not be less than 30 days from the
date of such notification or publication, any unclaimed balance of such money then remaining will be repaid to the Issuer. 

SECTION 8.7. Reinstatement. If the Trustee or Paying Agent is unable to apply any money or U.S. dollars or U.S. Government
Obligations in accordance with Section 8.2 or 8.3 hereof, as the case may be, by reason of any order or judgment of any court or Governmental Authority enjoining, restraining or otherwise prohibiting such application, then the
Issuer’s and the Guarantors’ obligations under this Indenture and the Notes and the Note Guarantees will be revived and reinstated as though no deposit had occurred pursuant to Section 8.2 or 8.3 hereof until such time
as the Trustee or Paying Agent is permitted to apply all such money in accordance with Section 8.2 or 8.3 hereof, as the case may be; provided, however, that, if the Issuer makes any payment of principal of, premium
or Additional Interest, if any, or interest on, any Note following the reinstatement of its obligations, the Issuer will be subrogated to the rights of the Holders of such Notes to receive such payment from the money or U.S. Government Obligations
held by the Trustee or Paying Agent. 
 ARTICLE IX 
 AMENDMENTS 
 SECTION 9.1. Without Consent of Holders.
Notwithstanding Section 9.2 of this Indenture, the Issuer, any Guarantor (with respect to its Note Guarantee or this Indenture), the Trustee and Collateral Agent may amend, supplement or modify this Indenture, any Note Guarantee, the
Notes and the Collateral Documents without the consent of any Holder: 
 (1) cure any ambiguity, omission,
mistake, defect, error or inconsistency, conform any provision to any provision under the heading “Description of Second Lien Notes,” in the Offering Memorandum or reduce the minimum denomination of the Notes; 

(2) provide for the assumption by a successor Person of the obligations of the Issuer under any Note Document; 

(3) provide for uncertificated Notes in addition to or in place of certificated Notes; 

(4) add to the covenants or provide for a Note Guarantee for the benefit of the Holders or surrender any right or power
conferred upon the Issuer or any Restricted Subsidiary; 
 (5) make any change that does not adversely affect the
rights of any Holder in any material respect; 
 (6) at the Issuer’s election, comply with any requirement
of the SEC in connection with the qualification of this Indenture under the Trust Indenture Act, if such qualification is required; 
 (7) make such provisions as necessary (as determined in good faith by the Issuer) for the issuance of Exchange Notes and Additional Notes; 

(8) to provide for any Restricted Subsidiary to provide a Note Guarantee in accordance with Section 3.2, to
add Guarantees with respect to the Notes, to add security to or for the benefit of the Notes, or to confirm and evidence the release, termination, discharge or retaking of any Guarantee or Lien with respect to or securing the Notes when such
release, termination, discharge or retaking is provided for under this Indenture, the Collateral Documents or the Intercreditor Agreement, as applicable; 

  
 -98-

 (9) evidence and provide for the acceptance and appointment under this
Indenture of a successor Trustee pursuant to the requirements hereof or to provide for the accession by the Trustee to any Note Document; 
 (10) make any amendment to the provisions of this Indenture relating to the transfer and legending of Notes as permitted by this Indenture, including to facilitate the issuance and administration of Notes
and the Exchange Notes; provided, however, that (i) compliance with this Indenture as so amended would not result in Notes being transferred in violation of the Securities Act or any applicable securities law and (ii) such
amendment does not adversely affect the rights of Holders to transfer Notes in any material respect; 
 (11)
mortgage, pledge, hypothecate or grant any other Lien in favor of the Collateral Agent for its benefit and the benefit of the Trustee, the Holders of the Notes and the holders of any Future Second Lien Indebtedness, as additional security for the
payment and performance of all or any portion of the Second Priority Obligations, in any property or assets, including any which are required to be mortgaged, pledged or hypothecated, or in which a Lien is required to be granted to or for the
benefit of the Trustee or the Collateral Agent pursuant to this Indenture, any of the Intercreditor Agreement, the Collateral Documents or otherwise; 
 (12) provide for the release of Collateral from the Lien pursuant to this Indenture, the Collateral Documents and the Intercreditor Agreement when permitted or required by the Collateral Documents, this
Indenture or the Intercreditor Agreement; or 
 (13) secure any Future Second Lien Indebtedness or First Priority
Obligations to the extent permitted under this Indenture, the Collateral Documents and the Intercreditor Agreement. 
 Subject
to Section 9.2, upon the request of the Issuer accompanied by a Board Resolution authorizing the execution of any such amended or supplemental indenture, and upon receipt by the Trustee of the documents described in
Sections 9.6 and 13.4 hereof, the Trustee will join with the Issuer and the Guarantors in the execution of such amended or supplemental indenture unless such amended or supplemental indenture directly affects the Trustee’s
own rights, duties or immunities under this Indenture or otherwise, in which case the Trustee may in its discretion, but will not be obligated to, enter into such amended or supplemental Indenture. 

After an amendment or supplement under this Section 9.1 becomes effective, the Issuer shall mail to Holders a notice briefly
describing such amendment or supplement. The failure to give such notice to all Holders, or any defect therein, shall not impair or affect the validity of an amendment or supplement under this Section 9.1. 

SECTION 9.2. With Consent of Holders. 
 (a) Except as provided in this Section 9.2, the Issuer, the Guarantors, the Trustee and the Collateral Agent may amend or supplement the Note Documents, the Collateral Documents and the
Intercreditor Agreement with the consent of the Holders of at least a majority in aggregate principal amount of the Notes then outstanding and issued under this Indenture, including, without limitation, consents obtained in connection with a
purchase of, or tender offer or exchange offer for, Notes, and, subject to Sections 6.4 and 6.7 hereof, any existing Default or Event of Default (other than a Default or Event of Default in the payment of the principal of,
premium, if any, and Additional Interest, if any, or interest on the Notes, except a payment default resulting from an acceleration that has been rescinded) or compliance with any provision of the Note Documents, the Collateral Documents and the
Intercreditor Agreement may be waived with the consent of the Holders of a majority in aggregate principal amount of the then outstanding Notes issued under this Indenture (including consents obtained in connection with a purchase of or tender offer
or exchange offer for Notes). Section 2.12 hereof and Section 13.6 hereof shall determine which Notes are considered to be “outstanding” for the purposes of this Section 9.2. 

  
 -99-

 Upon the request of the Issuer accompanied by a resolution of its Board of Directors
authorizing the execution of any such amended or supplemental indenture, and upon the filing with the Trustee of evidence of the consent of the Holders of Notes as aforesaid, and upon receipt by the Trustee of the documents described in
Sections 9.6 and 13.4 hereof, the Trustee will join with the Issuer and the Guarantors in the execution of such amended or supplemental indenture unless such amended or supplemental indenture directly affects the Trustee’s
own rights, duties or immunities under this Indenture or otherwise, in which case the Trustee may in its discretion, but will not be obligated to, enter into such amended or supplemental Indenture. 

(b) Without the consent of each Holder of Notes affected, an amendment, supplement or waiver may not, with respect to any Notes issued
thereunder and held by a nonconsenting Holder: 
 (1) reduce the principal amount of such Notes whose Holders
must consent to an amendment; 
 (2) reduce the stated rate of or extend the stated time for payment of interest
on any such Note (other than provisions relating to Sections 3.5 and 3.9); 
 (3) reduce the
principal of or extend the Stated Maturity of any such Note; 
 (4) reduce the premium payable upon the
redemption of any such Note or change the time at which any such Note may be redeemed, in each case as set forth in Section 5.7; 
 (5) make any such Note payable in currency other than that stated in such Note; 
 (6) impair the right of any Holder to receive payment of principal of and interest on such Holder’s Notes on or after the due dates therefor or to institute suit for the enforcement of any such
payment on or with respect to such Holder’s Notes; 
 (7) waive a Default or Event of Default with respect
to the nonpayment of principal, premium or interest (except pursuant to a rescission of acceleration of the Notes by the Holders of at least a majority in aggregate principal amount of such Notes and a waiver of the payment default that resulted
from such acceleration); 
 (8) make any change in the provisions in the Intercreditor Agreement or this
Indenture dealing with the application of proceeds of Collateral that would adversely affect the Holders of the Notes in any material respect; or 
 (9) make any change in the amendment or waiver provisions which require the Holders’ consent described in this Section 9.2. 

In addition, without the consent of the Holders of at least two-thirds in aggregate principal amount of the Notes then outstanding, no
amendment or waiver may release all or substantially all of the Collateral from the Lien of this Indenture and the Collateral Documents with respect to the Notes. 
 It shall not be necessary for the consent of the Holders under this Indenture to approve the particular form of any proposed amendment, supplement or waiver, but it shall be sufficient if such consent
approves the substance thereof. A consent to any amendment, supplement or waiver under this Indenture by any Holder of the Notes given in connection with a tender or exchange of such Holder’s Notes will not be rendered invalid by such tender or
exchange. 
 After an amendment or supplement under this Section 9.2 becomes effective, the Issuer shall mail to
Holders a notice briefly describing such amendment or supplement. The failure to give such notice to all Holders, or any defect therein, shall not impair or affect the validity of an amendment or supplement. 

  
 -100-

 SECTION 9.3. Compliance with Trust Indenture Act. Every amendment or supplement to
this Indenture, any Note Guarantee and the Notes will be set forth in an amended or supplemental indenture that complies with the TIA as then in effect. 
 SECTION 9.4. Revocation and Effect of Consents and Waivers. Until an amendment, supplement or waiver becomes effective, a consent to it by a Holder of a Note is a continuing consent by the Holder
of a Note and every subsequent Holder of a Note or portion of a Note that evidences the same debt as the consenting Holder’s Note, even if notation of the consent or waiver is not made on any Note. However, any such Holder of a Note or
subsequent Holder of a Note may revoke the consent or waiver as to such Holder’s Note or portion of its Note if the Trustee receives written notice of revocation before the date the amendment, supplement or waiver becomes effective. An
amendment, supplement or waiver becomes effective in accordance with its terms and thereafter binds every Holder. 
 The Issuer
may, but shall not be obligated to, fix a record date for the purpose of determining the Holders entitled to give their consent or take any other action described in this Section 9.4 or required or permitted to be taken pursuant to this
Indenture. If a record date is fixed, then notwithstanding the immediately preceding paragraph, those Persons who were Holders at such record date (or their duly designated proxies), and only those Persons, shall be entitled to give such consent or
to revoke any consent previously given or to take any such action, whether or not such Persons continue to be Holders after such record date. No such consent shall be valid or effective for more than 120 days after such record date. 

SECTION 9.5. Notation on or Exchange of Notes. The Trustee may place an appropriate notation about an amendment, supplement or
waiver on any Note thereafter authenticated. The Issuer in exchange for all Notes may issue and the Trustee shall, upon receipt of an Issuer Order, authenticate new Notes that reflect the amendment, supplement or waiver. Failure to make the
appropriate notation or issue a new Note will not affect the validity and effect of such amendment, supplement or waiver. 

SECTION 9.6. Trustee to Sign Amendments. The Trustee and Collateral Agent shall sign any amended or supplemental indenture
authorized pursuant to this Article IX if the amendment or supplement does not adversely affect the rights, duties, liabilities or immunities of the Trustee and Collateral Agent. The Issuer may not sign an amended or supplemental
indenture until the Board of Directors of the Issuer approves it. In executing any amended or supplemental indenture, the Trustee shall receive and (subject to Sections 7.1 and 7.2 hereof) shall be fully protected in conclusively
relying upon, in addition to the documents required by Section 13.4 hereof, an Officer’s Certificate and an Opinion of Counsel stating that the execution of such amended or supplemental indenture is authorized or permitted by this
Indenture and is valid, binding and enforceable against the Issuer or any Guarantor, as the case may be, in accordance with its terms. 
 ARTICLE X 
 GUARANTEE 

SECTION 10.1. Guarantee. Prior to the Escrow Release, the Notes will be guaranteed by Holdings (the “Escrow
Guarantee”). From and after the Escrow Release, the Notes will be guaranteed by Holdings and the other Guarantors (the “Release Guarantees” and together with the Escrow Guarantee, the “Note Guarantees”).
Subject to the provisions of this Article X, each Guarantor hereby fully, unconditionally and irrevocably guarantees, as primary obligor and not merely as surety, jointly and severally with each other Guarantor, to each Holder of the
Notes, the Trustee and the Collateral Agent the full and punctual payment when due, whether at maturity, by acceleration, by redemption or otherwise, of the principal of, premium, if any, and interest (including Additional Interest) on the Notes and
all other obligations and liabilities of the Issuer under this Indenture (including without limitation interest (including Additional Interest) accruing after the filing of any petition in bankruptcy, or the commencement of any insolvency,
reorganization or like proceeding, relating to the Issuer or any Guarantor whether or not a claim for post-filing or post-petition interest is allowed in such proceeding and the obligations under Section 7.7), and the Registration Rights
Agreement (all the foregoing being hereinafter collectively called the “Guaranteed Obligations”). Each Guarantor agrees that the Guaranteed Obligations will rank equally in right of payment with other Indebtedness of such Guarantor,
except to the extent such other Indebtedness is subordinate to the Guaranteed Obligations, in which case the obligations of the Guarantors under the Note Guarantees will rank senior in right of payment to such other Indebtedness. 

  
 -101-

 To evidence its Note Guarantee set forth in this Section 10.1, each Guarantor
hereby agrees that this Indenture shall be executed on behalf of such Guarantor by an Officer of such Guarantor. 
 Each
Guarantor hereby agrees that its Note Guarantee set forth in this Section 10.1 hereof shall remain in full force and effect notwithstanding the absence of the endorsement of any notation of such Guarantee on the Notes. 

If an Officer whose signature is on this Indenture no longer holds that office at the time the Trustee authenticates the Note, the Note
Guarantee shall be valid nevertheless. 
 Each Guarantor further agrees (to the extent permitted by law) that the Guaranteed
Obligations may be extended or renewed, in whole or in part, without notice or further assent from it, and that it will remain bound under this Article X notwithstanding any extension or renewal of any Guaranteed Obligation. 

Each Guarantor waives presentation to, demand of payment from and protest to the Issuer of any of the Guaranteed Obligations and also
waives notice of protest for nonpayment. Each Guarantor waives notice of any default under the Notes or the Guaranteed Obligations. 
 Each Guarantor further agrees that its Note Guarantee herein constitutes a Guarantee of payment when due (and not a Guarantee of collection) and waives any right to require that any resort be had by any
Holder to any security held for payment of the Guaranteed Obligations. 
 Except as set forth in Section 10.2, the
obligations of each Guarantor hereunder shall not be subject to any reduction, limitation, impairment or termination for any reason (other than payment of the Guaranteed Obligations in full), including any claim of waiver, release, surrender,
alteration or compromise, and shall not be subject to any defense of setoff, counterclaim, recoupment or termination whatsoever or by reason of the invalidity, illegality or unenforceability of the Guaranteed Obligations or otherwise. Without
limiting the generality of the foregoing, the Guaranteed Obligations of each Guarantor herein shall not be discharged or impaired or otherwise affected by (a) the failure of any Holder to assert any claim or demand or to enforce any right or
remedy against the Issuer or any other person under this Indenture, the Notes or any other agreement or otherwise; (b) any extension or renewal of any thereof; (c) any rescission, waiver, amendment or modification of any of the terms or
provisions of this Indenture, the Notes or any other agreement; (d) the release of any security held by any Holder for the Guaranteed Obligations; (e) the failure of any Holder to exercise any right or remedy against any other Guarantor;
(f) any change in the ownership of the Issuer; (g) any default, failure or delay, willful or otherwise, in the performance of the Guaranteed Obligations; or (h) any other act or thing or omission or delay to do any other act or thing
which may or might in any manner or to any extent vary the risk of any Guarantor or would otherwise operate as a discharge of such Guarantor as a matter of law or equity. 
 Each Guarantor agrees that its Note Guarantee herein shall remain in full force and effect until payment in full of all the Guaranteed Obligations or such Guarantor is released from its Note Guarantee in
compliance with Section 10.2, Article VIII or Article XI. Each Guarantor further agrees that its Note Guarantee herein shall continue to be effective or be reinstated, as the case may be, if at any time payment,
or any part thereof, of principal of, premium, if any, interest or Additional Interest, if any, on any of the Guaranteed Obligations is rescinded or must otherwise be restored by any Holder upon the bankruptcy or reorganization of the Issuer or
otherwise. 
 In furtherance of the foregoing and not in limitation of any other right which any Holder has at law or in equity
against any Guarantor by virtue hereof, upon the failure of the Issuer to pay any of the Guaranteed Obligations when and as the same shall become due, whether at maturity, by acceleration, by redemption or otherwise, each Guarantor hereby promises
to and will, upon receipt of written demand by the Trustee, forthwith pay, or cause to be paid, in cash, to the Holders or the Trustee on behalf of the Holders an amount equal to the sum of (i) the unpaid amount of such Guaranteed Obligations
then due and owing and (ii) accrued and unpaid interest (including Additional Interest) on such Guaranteed Obligations then due and owing (but only to the extent not prohibited by law) (including interest accruing after the filing of any
petition in bankruptcy or the commencement of any insolvency, reorganization or like proceeding relating to the Issuer or any Guarantor whether or not a claim for post-filing or post-petition interest is allowed in such proceeding). 

  
 -102-

 Each Guarantor further agrees that, as between such Guarantor, on the one hand, and the
Holders, on the other hand, (x) the maturity of the Guaranteed Obligations guaranteed hereby may be accelerated as provided in this Indenture for the purposes of its Note Guarantee herein, notwithstanding any stay, injunction or other
prohibition preventing such acceleration in respect of the Guaranteed Obligations guaranteed hereby and (y) in the event of any such declaration of acceleration of such Guaranteed Obligations, such Guaranteed Obligations (whether or not due and
payable) shall forthwith become due and payable by the Guarantor for the purposes of this Note Guarantee. 
 Each Guarantor also
agrees to pay any and all fees, costs and expenses (including attorneys’ fees and expenses) incurred by the Collateral Agent, Trustee or the Holders in enforcing any rights under this Section 10.1. 

SECTION 10.2. Limitation on Liability; Termination, Release and Discharge. 

(a) Any term or provision of this Indenture to the contrary notwithstanding, the obligations of each Guarantor hereunder will be limited
to the maximum amount as will, after giving effect to all other contingent and fixed liabilities of such Guarantor and after giving effect to any collections from or payments made by or on behalf of any other Guarantor in respect of the obligations
of such other Guarantor under its Note Guarantee or pursuant to its contribution obligations under this Indenture, result in the obligations of such Guarantor under its Note Guarantee not constituting a fraudulent conveyance or fraudulent transfer
under federal, foreign or state law and not otherwise being void or voidable under any similar laws affecting the rights of creditors generally. 
 (b) Any Note Guarantee of a Guarantor shall be automatically and unconditionally released and discharged upon: 
 (1) other than in the case of Holdings or any other direct or indirect parent of the Issuer that provides a Guarantee, a sale or other disposition (including by way of consolidation or merger) of the
Capital Stock of such Guarantor or the sale or disposition of all or substantially all the assets of the Guarantor to any Person other than to the Issuer or a Restricted Subsidiary) and as otherwise permitted by this Indenture; 

(2) the designation in accordance with this Indenture of the Guarantor as an Unrestricted Subsidiary or the occurrence of
any event after which the Guarantor is no longer a Restricted Subsidiary; 
 (3) defeasance or discharge of the
Notes, as provided in Articles VIII or XI; 
 (4) to the extent that such Guarantor is not an
Immaterial Subsidiary solely due to the operation of clause (i) of the definition of “Immaterial Subsidiary,” upon the release of the guarantee referred to in such clause; 

(5) such Guarantor being released from all of (i) its obligations under all of its Guarantees of payment by the
Issuer of any Indebtedness of the Issuer under the Credit Agreement or (ii) in the case of a Note Guarantee made by a Guarantor (each, an “Other Guarantee”) as a result of its guarantee of other Indebtedness of the Issuer or a
Guarantor pursuant to Section 3.7, the relevant Indebtedness, except in the case of (i) or (ii), a release as a result of the repayment in full of the Indebtedness specified in clause (i) or (ii) (it being understood that
a release subject to a contingent reinstatement is still considered a release, and if any such Indebtedness of such Guarantor under the Credit Agreement or any Other Guarantee is so reinstated, such Note Guarantee shall also be reinstated); or

 (6) upon the achievement of Investment Grade Status by the Notes; provided that such Note Guarantee
shall be reinstated upon the Reversion Date. 
 SECTION 10.3. Right of Contribution. Each Guarantor hereby agrees that to
the extent that any Guarantor shall have paid more than its proportionate share of any payment made on the obligations under the Note 

  
 -103-

 
Guarantees, such Guarantor shall be entitled to seek and receive contribution from and against the Issuer or any other Guarantor who has not paid its proportionate share of such payment. The
provisions of this Section 10.3 shall in no respect limit the obligations and liabilities of each Guarantor to the Trustee and the Holders and each Guarantor shall remain liable to the Trustee and the Holders for the full amount
guaranteed by such Guarantor hereunder. 
 SECTION 10.4. No Subrogation. Notwithstanding any payment or payments made by
each Guarantor hereunder, no Guarantor shall be entitled to be subrogated to any of the rights of the Trustee or any Holder against the Issuer or any other Guarantor or any collateral security or guarantee or right of offset held by the Trustee or
any Holder for the payment of the Guaranteed Obligations, nor shall any Guarantor seek or be entitled to seek any contribution or reimbursement from the Issuer or any other Guarantor in respect of payments made by such Guarantor hereunder, until all
amounts owing to the Trustee and the Holders by the Issuer on account of the Guaranteed Obligations are paid in full. If any amount shall be paid to any Guarantor on account of such subrogation rights at any time when all of the Guaranteed
Obligations shall not have been paid in full, such amount shall be held by such Guarantor in trust for the Trustee and the Holders, segregated from other funds of such Guarantor, and shall, forthwith upon receipt by such Guarantor, be turned over to
the Trustee in the exact form received by such Guarantor (duly indorsed by such Guarantor to the Trustee, if required), to be applied against the Guaranteed Obligations. 
 ARTICLE XI 
 SATISFACTION AND DISCHARGE 

SECTION 11.1. Satisfaction and Discharge. This Indenture will be discharged and will cease to be of further effect as to all Notes
issued hereunder, when: 
 (a) either: 

(1) all Notes that have been authenticated and delivered except lost, stolen or destroyed Notes that have been replaced or
paid and Notes for whose payment money has theretofore been deposited in trust, have been delivered to the Trustee for cancellation; or 
 (2) all such Notes not theretofore delivered to the Trustee for cancellation (i) have become due and payable by reason of the making of a notice of redemption or otherwise or (ii) will become
due and payable within one year at their Stated Maturity or (iii) are to be called for redemption within one year under arrangements satisfactory to the Trustee for the giving of notice of redemption by the Trustee in the name, and at the
expense, of the Issuer; 
 (b) the Issuer has deposited or caused to be deposited with the Trustee as trust funds
in trust solely for the benefit of the Holders, cash in dollars or U.S. Government Obligations, or a combination thereof, in an amount sufficient to pay and discharge the entire indebtedness on the Notes not previously delivered to the Trustee for
cancellation, for principal, premium, if any, and interest to the date of deposit (in the case of Notes that have become due and payable), or to the Stated Maturity or redemption date, as the case may be; 

(c) no Default or Event of Default (other than that resulting from borrowing funds to be applied to make such deposit and
the granting of Liens in connection therewith) with respect to this Indenture or the Notes issued hereunder shall have occurred and be continuing on the date of such deposit or shall occur as a result of such deposit and such deposit will not result
in a breach or violation of, or constitute a default under the Credit Facilities or any other material agreement or instrument (other than this Indenture) to which an Issuer or any Guarantor is a party or by which an Issuer or any Guarantor is
bound; 
 (d) the Issuer has paid or caused to be paid all other sums payable under this Indenture; 

  
 -104-

 (e) the Issuer has delivered irrevocable instructions to the Trustee to
apply the deposited money toward the payment of such notes issued hereunder at maturity or the Redemption Date, as the case may be; and 
 (f) the Issuer has delivered to the Trustee an Officer’s Certificate and an Opinion of Counsel each stating that all conditions precedent under Article XI relating to the satisfaction and
discharge of this Indenture have been complied with; provided that any such counsel may rely on any Officer’s Certificate as to matters of fact (including as to compliance with clauses (a), (b) and (c)). 

Notwithstanding the satisfaction and discharge of this Indenture, if money has been deposited with the Trustee pursuant to
clause (b) of this Section 11.1, the provisions of Sections 11.2 and 8.6 hereof will survive. 
 SECTION 11.2. Application of Trust Money. Subject to the provisions of Section 8.6 hereof, all money deposited with the Trustee pursuant to Section 11.1 hereof shall be held
in trust and applied by it, in accordance with the provisions of the Notes and this Indenture, to the payment, either directly or through any Paying Agent (including the Issuer acting as its own Paying Agent) as the Trustee may determine, to the
Persons entitled thereto, of the principal (and premium and Additional Interest, if any) and interest for whose payment such money has been deposited with the Trustee; but such money need not be segregated from other funds except to the extent
required by law. 
 If the Trustee or Paying Agent is unable to apply any money or U.S. Government Obligations in accordance
with Section 11.1 hereof by reason of any legal proceeding or by reason of any order or judgment of any court or Governmental Authority enjoining, restraining or otherwise prohibiting such application, the Issuer’s and any
Guarantor’s obligations under this Indenture and the Notes shall be revived and reinstated as though no deposit had occurred pursuant to Section 11.1 hereof; provided that if the Issuer has made any payment of principal of,
premium or Additional Interest, if any, or interest on, any Notes because of the reinstatement of its obligations, the Issuer shall be subrogated to the rights of the Holders of such Notes to receive such payment from the money or U.S. Government
Obligations held by the Trustee or Paying Agent. 
 ARTICLE XII 

COLLATERAL 
 SECTION 12.1. Collateral Documents. The due and punctual payment of the principal of, premium and interest on the Notes when and as the same shall be due and payable, whether on an interest payment
date, at maturity, by acceleration, repurchase, redemption or otherwise, and interest on the overdue principal of, premium and interest on the Notes and performance of all other Obligations of the Issuer and the Guarantors to the Holders or the
Trustee under this Indenture, the Notes, the Note Guarantees, the Intercreditor Agreement and the Collateral Documents, according to the terms hereunder or thereunder, shall be secured as provided in the Collateral Documents, which define the terms
of the Liens that secure the Obligations, subject to the terms of the Intercreditor Agreement. The Trustee and the Issuer hereby acknowledge and agree that the Collateral Agent holds the Collateral in trust for the benefit of the Holders and the
Trustee and pursuant to the terms of the Collateral Documents and the Intercreditor Agreement. Each Holder, by accepting a Note, consents and agrees to the terms of the Collateral Documents (including the provisions providing for the possession,
use, release and foreclosure of Collateral) and the Intercreditor Agreement as the same may be in effect or may be amended from time to time in accordance with their terms and this Indenture and the Intercreditor Agreement, and authorizes and
directs the Collateral Agent to enter into the Collateral Documents and the Intercreditor Agreement and to perform its obligations and exercise its rights thereunder in accordance therewith; provided, however, that if any of the
provisions of the Collateral Documents limit, qualify or conflict with the duties imposed by the provisions of the TIA, the TIA shall control. The Issuer shall deliver to the Collateral Agent copies of all documents required to be filed pursuant to
the Collateral Documents, and will do or cause to be done all such acts and things as may be reasonably required by the next sentence of this Section 12.1, to assure and confirm to the Collateral Agent the security interest in the
Collateral contemplated hereby, by the Collateral Documents or any part thereof, as from time to time constituted, so as to render the same available for the security and benefit of this Indenture and of the Notes secured hereby, according to the
intent and purposes herein expressed. The Issuer shall, and shall cause the Subsidiaries of the Issuer to, take any and all actions and make all filings (including the filing of UCC financing statements, continuation statements and 

  
 -105-

 
amendments thereto) required to cause the Collateral Documents to create and maintain, as security for the Obligations of the Issuer and the Guarantors to the Secured Parties under this
Indenture, the Notes, the Note Guarantees, the Intercreditor Agreement and the Collateral Documents, a valid and enforceable perfected Lien and security interest in and on all of the Collateral (subject to the terms of the Intercreditor Agreement
and the Collateral Documents), in favor of the Collateral Agent for the benefit of the Holders and the Trustee subject to no Liens other than Permitted Liens. 
 SECTION 12.2. Recordings and Opinions. 
 (a) To the extent required under
the TIA, the Issuer will comply with Section 313(b) of the TIA, relating to reports, and, following qualification of this Indenture under the TIA (if required), Section 314(d) of the TIA, relating to the release of property and to the
substitution therefor of any property to be pledged as Collateral for the Notes. Any certificate or opinion required by Section 314(d) of the TIA may be made by an officer of the Issuer except in cases where Section 314(d) requires that
such certificate or opinion be made by an independent engineer, appraiser or other expert, who shall be reasonably satisfactory to the Trustee. 
 (b) Any release of Collateral permitted by Section 12.3 hereof will be deemed not to impair the Liens under this Indenture and the other Collateral Documents in contravention thereof.

 SECTION 12.3. Release of Collateral. 
 (a) Subject to Sections 12.3(b) and (c) hereof, the Issuer and the Guarantors will be entitled to a release of property and other assets included in the Collateral from the Liens
securing the Notes, and the Trustee (subject to its receipt of an Officer’s Certificate and Opinion of Counsel as provided below) shall release, or instruct the Collateral Agent to release, as applicable, the same from such Liens at the
Issuer’s sole cost and expense, under one or more of the following circumstances: 
 (i) in whole upon:

 (A) payment in full of the principal of, together with accrued and unpaid interest on, the Notes and all other
Obligations under this Indenture, the Note Guarantees and the Collateral Documents that are due and payable at or prior to the time such principal, together with accrued and unpaid interest, are paid; 

(B) satisfaction and discharge of this Indenture as set forth under Article XI; or 

(C) a Legal Defeasance or Covenant Defeasance of this Indenture as set forth under Article VIII; 

(ii) in part, as to any property: 
 (A) that is sold, transferred or otherwise disposed of by the Issuer or any Guarantor to any Person that is not the Issuer or a Guarantor in a transaction not prohibited by this Indenture at the time of
such transfer or disposition, including, without limitation, as a result of a transaction of the type permitted under Section 3.5, 
 (B) if all other Liens on that asset securing the First Priority Obligations then secured by that asset (including all commitments thereunder) are released, 

(C) that is owned or at any time acquired by a Guarantor that has been released from its Note Guarantee, concurrently with
the release of such Note Guarantee, or 
 (D) in which a security interest is granted to another Person by the
Issuer or any Guarantor pursuant to clause (9) or (12) of the definition of “Permitted Liens”; provided that, at the request of the Issuer or such Guarantor, the security interest of the Collateral Agent shall be
subordinated to such security interest granted to such Person pursuant to such documents as such the Issuer or such Guarantor may reasonably request; 

  
 -106-

 (iii) with the consent of Holders of the Notes in accordance with Article
IX of this Indenture; 
 (iv) in part, in accordance with the applicable provisions of the Collateral
Documents and the Intercreditor Agreement, but subject to any restrictions thereon set forth in this Indenture or the Intercreditor Agreement; or 
 (v) that becomes Excluded Property. 
 (b) With respect to any release of
Collateral, upon receipt of an Officer’s Certificate and an Opinion of Counsel each stating that all conditions precedent under this Indenture and the Collateral Documents and the Intercreditor Agreement, as applicable, to such release have
been met and that it is proper for the Trustee or Collateral Agent to execute and deliver the documents requested by the Issuer in connection with such release, and any necessary or proper instruments of termination, satisfaction or release prepared
by the Issuer, the Trustee shall, or shall cause the Collateral Agent to, execute, deliver or acknowledge (at the Issuer’s expense) such instruments or releases to evidence the release of any Collateral permitted to be released pursuant to this
Indenture or the Collateral Documents or the Intercreditor Agreement. Neither the Trustee nor the Collateral Agent shall be liable for any such release undertaken in reliance upon any such Officer’s Certificate or Opinion of Counsel, and
notwithstanding any term hereof or in any Collateral Document or in the Intercreditor Agreement to the contrary, the Trustee and the Collateral Agent shall not be under any obligation to release any such Lien and security interest, or execute and
deliver any such instrument of release, satisfaction or termination, unless and until it receives such Officer’s Certificate and Opinion of Counsel. 
 (c) At any time when a Default or Event of Default has occurred and is continuing and the maturity of the Notes has been accelerated (whether by declaration or otherwise) and the Trustee has delivered
notice of acceleration to the Collateral Agent, no release of Collateral pursuant to the provisions of this Indenture or the Collateral Documents shall be effective as against the Holders, except as otherwise provided in the Intercreditor Agreement.

 SECTION 12.4. Suits to Protect the Collateral. Subject to the provisions of Article VII hereof and the
Collateral Documents and the Intercreditor Agreement, the Trustee, without the consent of the Holders, on behalf of the Holders, may or may direct the Collateral Agent to take all actions it determines in order to: 

(a) enforce any of the terms of the Collateral Documents; and 

(b) collect and receive any and all amounts payable in respect of the Obligations hereunder. 

Subject to the provisions of the Collateral Documents and the Intercreditor Agreement, the Trustee and the Collateral Agent shall have power to institute
and to maintain such suits and proceedings as the Trustee may determine to prevent any impairment of the Collateral by any acts which may be unlawful or in violation of any of the Collateral Documents or this Indenture, and such suits and
proceedings as the Trustee may determine to preserve or protect its interests and the interests of the Holders in the Collateral. Nothing in this Section 12.4 shall be considered to impose any such duty or obligation to act on the part
of the Trustee or the Collateral Agent. 
 SECTION 12.5. Authorization of Receipt of Funds by the Trustee Under the
Collateral Documents. Subject to the provisions of the Intercreditor Agreement, the Trustee is authorized to receive any funds for the benefit of the Holders distributed under the Collateral Documents, and to make further distributions of such
funds to the Holders according to the provisions of this Indenture. 
 SECTION 12.6. Purchaser Protected. In no event
shall any purchaser in good faith of any property purported to be released hereunder be bound to ascertain the authority of the Collateral Agent or the Trustee to execute the release or to inquire as to the satisfaction of any conditions required by
the provisions hereof for the exercise of such authority or to see to the application of any consideration given by such purchaser or other 

  
 -107-

 
transferee; nor shall any purchaser or other transferee of any property or rights permitted by this Article XII to be sold be under any obligation to ascertain or inquire into the
authority of the Issuer or the applicable Guarantor to make any such sale or other transfer. 
 SECTION 12.7. Powers
Exercisable by Receiver or Trustee. In case the Collateral shall be in the possession of a receiver or trustee, lawfully appointed, the powers conferred in this Article XII upon the Issuer or a Guarantor with respect to the release, sale
or other disposition of such property may be exercised by such receiver or trustee, and an instrument signed by such receiver or trustee shall be deemed the equivalent of any similar instrument of the Issuer or a Guarantor or of any Officer or
Officers thereof required by the provisions of this Article XII; and if the Trustee shall be in the possession of the Collateral under any provision of this Indenture, then such powers may be exercised by the Trustee. 

SECTION 12.8. Release Upon Termination of the Issuer’s Obligations. In the event that the Issuer delivers to the Trustee an
Officer’s Certificate certifying that (i) payment in full of the principal of, together with accrued and unpaid interest on, the Notes and all other Obligations under this Indenture, the Notes, the Note Guarantees and the Collateral
Documents that are due and payable at or prior to the time such principal, together with accrued and unpaid interest, are paid or (ii) the Issuer shall have exercised its Legal Defeasance option or its Covenant Defeasance option, in each case
in compliance with the provisions of Article VIII, and an Opinion of Counsel stating that all conditions precedent to the execution and delivery of such notice by the Trustee have been satisfied, the Trustee shall deliver to the Issuer and
the Collateral Agent a notice, in form and substance reasonably satisfactory to the Collateral Agent, stating that the Trustee, on behalf of the Holders, disclaims and gives up any and all rights it has in or to the Collateral (other than with
respect to funds held by the Trustee pursuant to Article VIII), and any rights it has under the Collateral Documents, and upon receipt by the Collateral Agent of such notice, the Collateral Agent shall be deemed not to hold a Lien in the
Collateral on behalf of the Trustee and shall do or cause to be done (at the expense of the Issuer) all acts reasonably necessary to release such Lien as soon as is reasonably practicable. 

SECTION 12.9. Collateral Agent. 
 (a) The Issuer and each of the Holders by acceptance of the Notes hereby designates and appoints the Collateral Agent as its agent under this Indenture, the Collateral Documents and the Intercreditor
Agreement and the Trustee and each of the Holders by acceptance of the Notes hereby irrevocably authorizes the Collateral Agent to take such action on its behalf under the provisions of this Indenture, the Collateral Documents and the Intercreditor
Agreement and to exercise such powers and perform such duties as are expressly delegated to the Collateral Agent by the terms of this Indenture, the Collateral Documents and the Intercreditor Agreement, and consents and agrees to the terms of the
Intercreditor Agreement and each Collateral Document, as the same may be in effect or may be amended, restated, supplemented or otherwise modified from time to time in accordance with their respective terms. The Collateral Agent agrees to act as
such on the express conditions contained in this Section 12.9. The provisions of this Section 12.9 are solely for the benefit of the Collateral Agent and none of the Trustee, any of the Holders nor any of the Grantors shall
have any rights as a third party beneficiary of any of the provisions contained herein other than as expressly provided in Section 12.4. Each Holder agrees that any action taken by the Collateral Agent in accordance with the provision of
this Indenture, the Intercreditor Agreement and the Collateral Documents, and the exercise by the Collateral Agent of any rights or remedies set forth herein and therein shall be authorized and binding upon all Holders. Notwithstanding any provision
to the contrary contained elsewhere in this Indenture, the Collateral Documents and the Intercreditor Agreement, the duties of the Collateral Agent shall be ministerial and administrative in nature, and the Collateral Agent shall not have any duties
or responsibilities, except those expressly set forth herein and in the other Note Documents to which the Collateral Agent is a party, nor shall the Collateral Agent have or be deemed to have any trust or other fiduciary relationship with the
Trustee, any Holder or any Grantor, and no implied covenants, functions, responsibilities, duties, obligations or liabilities shall be read into this Indenture, the Collateral Documents and the Intercreditor Agreement or otherwise exist against the
Collateral Agent. Without limiting the generality of the foregoing sentence, the use of the term “agent” in this Indenture with reference to the Collateral Agent is not intended to connote any fiduciary or other implied (or express)
obligations arising under agency doctrine of any applicable law. Instead, such term is used merely as a matter of market custom, and is intended to create or reflect only an administrative relationship between independent contracting parties.

  
 -108-

 (b) The Collateral Agent may perform any of its duties under this Indenture, the Collateral
Documents or the Intercreditor Agreement by or through receivers, agents, employees, attorneys-in-fact or with respect to any specified Person, such Person’s Affiliates, and the respective officers, directors, employees, agents, advisors and
attorneys-in-fact of such Person and its Affiliates, (a “Related Person”) and shall be entitled to advice of counsel concerning all matters pertaining to such duties, and shall be entitled to act upon, and shall be fully protected
in taking action in reliance upon any advice or opinion given by legal counsel. The Collateral Agent shall not be responsible for the negligence or willful misconduct of any receiver, agent, employee, attorney-in-fact or Related Person that it
selects as long as such selection was made in good faith. 
 (c) None of the Collateral Agent or any of its respective Related
Persons shall (i) be liable for any action taken or omitted to be taken by any of them under or in connection with this Indenture or the transactions contemplated hereby (except for its own gross negligence or willful misconduct) or under or in
connection with any Collateral Document or the Intercreditor Agreement or the transactions contemplated thereby (except for its own gross negligence or willful misconduct), or (ii) be responsible in any manner to any of the Trustee or any
Holder for any recital, statement, representation, warranty, covenant or agreement made by the Issuer or any other Grantor or Affiliate of any Grantor, or any Officer or Related Person thereof, contained in this Indenture, or any other Note
Documents, or in any certificate, report, statement or other document referred to or provided for in, or received by the Collateral Agent under or in connection with, this Indenture, the Collateral Documents or the Intercreditor Agreement, or the
validity, effectiveness, genuineness, enforceability or sufficiency of this Indenture, the Collateral Documents or the Intercreditor Agreement, or for any failure of any Grantor or any other party to this Indenture, the Collateral Documents or the
Intercreditor Agreement to perform its obligations hereunder or thereunder. None of the Collateral Agent or any of its respective Related Persons shall be under any obligation to the Trustee or any Holder to ascertain or to inquire as to the
observance or performance of any of the agreements contained in, or conditions of, this Indenture, the Collateral Documents or the Intercreditor Agreement or to inspect the properties, books, or records of any Grantor or any Grantor’s
Affiliates. 
 (d) The Collateral Agent shall be entitled to rely, and shall be fully protected in relying, upon any writing,
resolution, notice, consent, certificate, affidavit, letter, telegram, facsimile, certification, telephone message, statement, or other communication, document or conversation (including those by telephone or e-mail) believed by it to be genuine and
correct and to have been signed, sent, or made by the proper Person or Persons, and upon advice and statements of legal counsel (including, without limitation, counsel to the Issuer or any other Grantor), independent accountants and other experts
and advisors selected by the Collateral Agent. The Collateral Agent shall not be bound to make any investigation into the facts or matters stated in any resolution, certificate, statement, instrument, opinion, report, notice, request, direction,
consent, order, bond, debenture, or other paper or document. The Collateral Agent shall be fully justified in failing or refusing to take any action under this Indenture, the Collateral Documents or the Intercreditor Agreement unless it shall first
receive such advice or concurrence of the Trustee or the Holders of a majority in aggregate principal amount of the Notes as it determines and, if it so requests, it shall first be indemnified to its satisfaction by the Holders against any and all
liability and expense which may be incurred by it by reason of taking or continuing to take any such action. The Collateral Agent shall in all cases be fully protected in acting, or in refraining from acting, under this Indenture, the Collateral
Documents or the Intercreditor Agreement in accordance with a request, direction, instruction or consent of the Trustee or the Holders of a majority in aggregate principal amount of the then outstanding Notes and such request and any action taken or
failure to act pursuant thereto shall be binding upon all of the Holders. 
 (e) The Collateral Agent shall not be deemed to
have knowledge or notice of the occurrence of any Default or Event of Default, unless a Trust Officer of the Collateral Agent shall have received written notice from the Trustee or the Issuer referring to this Indenture, describing such Default or
Event of Default and stating that such notice is a “notice of default.” The Collateral Agent shall take such action with respect to such Default or Event of Default as may be requested by the Trustee in accordance with Article VI or
the Holders of a majority in aggregate principal amount of the Notes (subject to this Section 12.9). 
 (f) The
Collateral Agent may resign at any time by notice to the Trustee and the Issuer, such resignation to be effective upon the acceptance of a successor agent to its appointment as Collateral Agent. If the Collateral Agent resigns under this Indenture,
the Issuer shall appoint a successor collateral agent. If no successor collateral agent is appointed prior to the intended effective date of the resignation of the Collateral Agent (as stated in the notice of resignation), the Collateral Agent may
appoint, after consulting with the Trustee, subject to the 

  
 -109-

 
consent of the Issuer (which shall not be unreasonably withheld and which shall not be required during a continuing Event of Default), a successor collateral agent. If no successor collateral
agent is appointed and consented to by the Issuer pursuant to the preceding sentence within thirty (30) days after the intended effective date of resignation (as stated in the notice of resignation) the Collateral Agent shall be entitled to
petition a court of competent jurisdiction to appoint a successor. Upon the acceptance of its appointment as successor collateral agent hereunder, such successor collateral agent shall succeed to all the rights, powers and duties of the retiring
Collateral Agent, and the term “Collateral Agent” shall mean such successor collateral agent, and the retiring Collateral Agent’s appointment, powers and duties as the Collateral Agent shall be terminated. After the retiring
Collateral Agent’s resignation hereunder, the provisions of this Section 12.9 (and Section 7.7) shall continue to inure to its benefit and the retiring Collateral Agent shall not by reason of such resignation be deemed
to be released from liability as to any actions taken or omitted to be taken by it while it was the Collateral Agent under this Indenture. 
 (g) The Trustee shall initially act as Collateral Agent and shall be authorized to appoint co-Collateral Agents as necessary in its sole discretion. Except as otherwise explicitly provided herein or in
the Collateral Documents or the Intercreditor Agreement, neither the Collateral Agent nor any of its respective officers, directors, employees or agents or other Related Persons shall be liable for failure to demand, collect or realize upon any of
the Collateral or for any delay in doing so or shall be under any obligation to sell or otherwise dispose of any Collateral upon the request of any other Person or to take any other action whatsoever with regard to the Collateral or any part
thereof. The Collateral Agent shall be accountable only for amounts that it actually receives as a result of the exercise of such powers, and neither the Collateral Agent nor any of its officers, directors, employees or agents shall be responsible
for any act or failure to act hereunder, except for its own gross negligence or willful misconduct. 
 (h) The Collateral Agent
is authorized and directed to (i) enter into the Collateral Documents to which it is party, whether executed on or after the Issue Date, (ii) enter into the Intercreditor Agreement, (iii) make the representations of the Holders set
forth in the Collateral Documents and Intercreditor Agreement, (iv) bind the Holders on the terms as set forth in the Collateral Documents and the Intercreditor Agreement and (v) perform and observe its obligations under the Collateral
Documents and the Intercreditor Agreement. 
 (i) If at any time or times the Trustee shall receive (i) by payment,
foreclosure, set-off or otherwise, any proceeds of Collateral or any payments with respect to the Obligations arising under, or relating to, this Indenture, except for any such proceeds or payments received by the Trustee from the Collateral Agent
pursuant to the terms of this Indenture, or (ii) payments from the Collateral Agent in excess of the amount required to be paid to the Trustee pursuant to Article VI, the Trustee shall promptly turn the same over to the Collateral Agent,
in kind, and with such endorsements as may be required to negotiate the same to the Collateral Agent such proceeds to be applied by the Collateral Agent pursuant to the terms of this Indenture, the Collateral Documents and the Intercreditor
Agreement. 
 (j) The Collateral Agent is each Holder’s agent for the purpose of perfecting the Holders’ security
interest in assets which, in accordance with Article 9 of the Uniform Commercial Code can be perfected only by possession. Should the Trustee obtain possession of any such Collateral, upon request from the Issuer, the Trustee shall notify the
Collateral Agent thereof and promptly shall deliver such Collateral to the Collateral Agent or otherwise deal with such Collateral in accordance with the Collateral Agent’s instructions. 

(k) The Collateral Agent shall have no obligation whatsoever to the Trustee or any of the Holders to assure that the Collateral exists or
is owned by any Grantor or is cared for, protected, or insured or has been encumbered, or that the Collateral Agent’s Liens have been properly or sufficiently or lawfully created, perfected, protected, maintained or enforced or are entitled to
any particular priority, or to determine whether all or the Grantor’s property constituting collateral intended to be subject to the Lien and security interest of the Collateral Documents has been properly and completely listed or delivered, as
the case may be, or the genuineness, validity, marketability or sufficiency thereof or title thereto, or to exercise at all or in any particular manner or under any duty of care, disclosure, or fidelity, or to continue exercising, any of the rights,
authorities, and powers granted or available to the Collateral Agent pursuant to this Indenture, any Collateral Document or the Intercreditor Agreement other than pursuant to the instructions of the Trustee or the Holders of a majority in aggregate
principal amount of the Notes or as otherwise provided in the Collateral Documents, it being understood and agreed that in respect of the Collateral, or any act, omission, or event related thereto, the Collateral Agent shall have no other duty or
liability whatsoever to the Trustee or any Holder as to any of the foregoing. 

  
 -110-

 (l) If the Issuer or any Guarantor (i) incurs any obligations in respect of First
Priority Obligations at any time when no intercreditor agreement is in effect or at any time when Indebtedness constituting First Priority Obligations entitled to the benefit of an existing Intercreditor Agreement is concurrently retired, and
(ii) delivers to the Collateral Agent an Officer’s Certificate so stating and requesting the Collateral Agent to enter into an intercreditor agreement (on substantially the same terms as the Intercreditor Agreement) in favor of a
designated agent or representative for the holders of the First Priority Obligations so incurred, the Collateral Agent shall (and is hereby authorized and directed to) enter into such intercreditor agreement (at the sole expense and cost of the
Issuer, including legal fees and expenses of the Collateral Agent), bind the Holders on the terms set forth therein and perform and observe its obligations thereunder. 
 (m) If the Issuer or any Guarantor incurs any obligations in respect of Junior Priority Indebtedness and delivers to the Collateral Agent an Officer’s Certificate so stating and requesting the
Collateral Agent to enter into an intercreditor agreement (on terms that are customary for such financings as determined by the Issuer in good faith reflecting the subordination of such Liens to the Liens secured by Notes and Note Guarantees) in
favor of a designated agent or representative for the holders of the Junior Priority Indebtedness so incurred, the Collateral Agent shall (and is hereby authorized and directed to) enter into such intercreditor agreement (at the sole expense and
cost of the Issuer, including legal fees and expenses of the Collateral Agent), bind the Holders on the terms set forth therein and perform and observe its obligations thereunder. 

(n) No provision of this Indenture, the Intercreditor Agreement or any Collateral Document shall require the Collateral Agent (or the
Trustee) to expend or risk its own funds or otherwise incur any financial liability in the performance of any of its duties hereunder or thereunder or to take or omit to take any action hereunder or thereunder or take any action at the request or
direction of Holders (or the Trustee in the case of the Collateral Agent) if it shall have received indemnity satisfactory to the Collateral Agent against potential costs and liabilities incurred by the Collateral Agent relating thereto.
Notwithstanding anything to the contrary contained in this Indenture, the Intercreditor Agreement or the Collateral Documents, in the event the Collateral Agent is entitled or required to commence an action to foreclose or otherwise exercise its
remedies to acquire control or possession of the Collateral, the Collateral Agent shall not be required to commence any such action or exercise any remedy or to inspect or conduct any studies of any property under the mortgages or take any such
other action if the Collateral Agent has determined that the Collateral Agent may incur personal liability as a result of the presence at, or release on or from, the Collateral or such property, of any hazardous substances unless the Collateral
Agent has received security or indemnity from the Holders in an amount and in a form all satisfactory to the Collateral Agent in its sole discretion, protecting the Collateral Agent from all such liability. The Collateral Agent shall at any time be
entitled to cease taking any action described in this clause if it no longer reasonably deems any indemnity, security or undertaking from the Issuer or the Holders to be sufficient. 

(o) The Collateral Agent (i) shall not be liable for any action taken or omitted to be taken by it in connection with this
Indenture, the Intercreditor Agreement and the Collateral Documents or instrument referred to herein or therein, except to the extent that any of the foregoing are found by a final, non-appealable judgment of a court of competent jurisdiction to
have resulted from its own gross negligence or willful misconduct, (ii) shall not be liable for interest on any money received by it except as the Collateral Agent may agree in writing with the Issuer (and money held in trust by the Collateral
Agent need not be segregated from other funds except to the extent required by law) and (iii) may consult with counsel of its selection and the advice or opinion of such counsel as to matters of law shall be full and complete authorization and
protection from liability in respect of any action taken, omitted or suffered by it in good faith and in accordance with the advice or opinion of such counsel. The grant of permissive rights or powers to the Collateral Agent shall not be construed
to impose duties to act. 
 (p) Neither the Collateral Agent nor the Trustee shall be liable for delays or failures in
performance resulting from acts beyond its control. Such acts shall include but not be limited to acts of God, strikes, lockouts, riots, acts of war, epidemics, governmental regulations superimposed after the fact, fire, communication line failures,
computer viruses, power failures, earthquakes or other disasters. Neither the Collateral Agent nor the Trustee shall be liable for any indirect, special, punitive, incidental or consequential damages (included but not limited to lost profits)
whatsoever, even if it has been informed of the likelihood thereof and regardless of the form of action. 

  
 -111-

 (q) The Collateral Agent does not assume any responsibility for any failure or delay in
performance or any breach by the Issuer or any other Grantor under this Indenture, the Intercreditor Agreement and the Collateral Documents. The Collateral Agent shall not be responsible to the Holders or any other Person for any recitals,
statements, information, representations or warranties contained in any Note Documents or in any certificate, report, statement, or other document referred to or provided for in, or received by the Collateral Agent under or in connection with, this
Indenture, the Intercreditor Agreement or any Collateral Document; the execution, validity, genuineness, effectiveness or enforceability of the Intercreditor Agreement and any Collateral Documents of any other party thereto; the genuineness,
enforceability, collectability, value, sufficiency, location or existence of any Collateral, or the validity, effectiveness, enforceability, sufficiency, extent, perfection or priority of any Lien therein; the validity, enforceability or
collectability of any Obligations; the assets, liabilities, financial condition, results of operations, business, creditworthiness or legal status of any obligor; or for any failure of any obligor to perform its Obligations under this Indenture, the
Intercreditor Agreement and the Collateral Documents. The Collateral Agent shall have no obligation to any Holder or any other Person to ascertain or inquire into the existence of any Default or Event of Default, the observance or performance by any
obligor of any terms of this Indenture, the Intercreditor Agreement and the Collateral Documents, or the satisfaction of any conditions precedent contained in this Indenture, the Intercreditor Agreement and any Collateral Documents. The Collateral
Agent shall not be required to initiate or conduct any litigation or collection or other proceeding under this Indenture, the Intercreditor Agreement and the Collateral Documents unless expressly set forth hereunder or thereunder. The Collateral
Agent shall have the right at any time to seek instructions from the Holders with respect to the administration of the Note Documents. 
 (r) The parties hereto and the Holders hereby agree and acknowledge that the Collateral Agent shall not assume, be responsible for or otherwise be obligated for any liabilities, claims, causes of action,
suits, losses, allegations, requests, demands, penalties, fines, settlements, damages (including foreseeable and unforeseeable), judgments, expenses and costs (including but not limited to, any remediation, corrective action, response, removal or
remedial action, or investigation, operations and maintenance or monitoring costs, for personal injury or property damages, real or personal) of any kind whatsoever, pursuant to any environmental law as a result of this Indenture, the Intercreditor
Agreement, the Collateral Documents or any actions taken pursuant hereto or thereto. Further, the parties hereto and the Holders hereby agree and acknowledge that in the exercise of its rights under this Indenture, the Intercreditor Agreement and
the Collateral Documents, the Collateral Agent may hold or obtain indicia of ownership primarily to protect the security interest of the Collateral Agent in the Collateral and that any such actions taken by the Collateral Agent shall not be
construed as or otherwise constitute any participation in the management of such Collateral. 
 (s) Upon the receipt by the
Collateral Agent of a written request of the Issuer signed by two Officers (a “Collateral Document Order”), the Collateral Agent is hereby authorized to execute and enter into, and shall execute and enter into, without the further
consent of any Holder or the Trustee, any Collateral Document to be executed after the Issue Date. Such Collateral Document Order shall (i) state that it is being delivered to the Collateral Agent pursuant to, and is a Collateral Document Order
referred to in, this Section 12.9(s), and (ii) instruct the Collateral Agent to execute and enter into such Collateral Document. Any such execution of a Collateral Document shall be at the direction and expense of the Issuer, upon
delivery to the Collateral Agent of an Officer’s Certificate and Opinion of Counsel stating that all conditions precedent to the execution and delivery of the Collateral Document have been satisfied. The Holders, by their acceptance of the
Notes, hereby authorize and direct the Collateral Agent to execute such Collateral Documents. 
 (t) Subject to the provisions
of the applicable Collateral Documents and the Intercreditor Agreement, each Holder, by acceptance of the Notes, agrees that the Collateral Agent shall execute and deliver the Intercreditor Agreement and the Collateral Documents to which it is a
party and all agreements, documents and instruments incidental thereto, and act in accordance with the terms thereof. For the avoidance of doubt, the Collateral Agent shall have no discretion under this Indenture, the Intercreditor Agreement or the
Collateral Documents and shall not be required to make or give any determination, consent, approval, request or direction without the written direction of the Holders of a majority in aggregate principal amount of the then outstanding Notes or the
Trustee, as applicable. 
 (u) After the occurrence of an Event of Default, the Trustee may direct the Collateral Agent in
connection with any action required or permitted by this Indenture, the Collateral Documents or the Intercreditor Agreement. 

  
 -112-

 (v) The Collateral Agent is authorized to receive any funds for the benefit of itself, the
Trustee and the Holders distributed under the Collateral Documents or the Intercreditor Agreement and to the extent not prohibited under the Intercreditor Agreement, for turnover to the Trustee to make further distributions of such funds to itself,
the Trustee and the Holders in accordance with the provisions of Section 6.10 hereof and the other provisions of this Indenture. 
 (w) In each case that the Collateral Agent may or is required hereunder or under any other Notes Document to take any action (an “Action”), including without limitation to make any
determination, to give consents, to exercise rights, powers or remedies, to release or sell Collateral or otherwise to act hereunder or under any other Notes Document, the Collateral Agent may seek direction from the Holders of a majority in
aggregate principal amount of the then outstanding Notes. The Collateral Agent shall not be liable with respect to any Action taken or omitted to be taken by it in accordance with the direction from the Holders of a majority in aggregate principal
amount of the then outstanding Notes. If the Collateral Agent shall request direction from the Holders of a majority in aggregate principal amount of the then outstanding Notes with respect to any Action, the Collateral Agent shall be entitled to
refrain from such Action unless and until the Collateral Agent shall have received direction from the Holders of a majority in aggregate principal amount of the then outstanding Notes, and the Collateral Agent shall not incur liability to any Person
by reason of so refraining. 
 (x) Notwithstanding anything to the contrary in this Indenture or any other Notes Document, in no
event shall the Collateral Agent or the Trustee be responsible for, or have any duty or obligation with respect to, the recording, filing, registering, perfection, protection or maintenance of the security interests or Liens intended to be created
by this Indenture or the other Note Documents (including without limitation the filing or continuation of any UCC financing or continuation statements or similar documents or instruments), nor shall the Collateral Agent or the Trustee be responsible
for, and neither the Collateral Agent nor the Trustee makes any representation regarding, the validity, effectiveness or priority of any of the Collateral Documents or the security interests or Liens intended to be created thereby. 

(y) Before the Collateral Agent acts or refrains from acting in each case at the request or direction of the Issuer or the Guarantors, it
may require an Officer’s Certificate and an Opinion of Counsel, which shall conform to the provisions of Section 13.5. The Collateral Agent shall not be liable for any action it takes or omits to take in good faith in reliance on
such certificate or opinion. 
 (z) Notwithstanding anything to the contrary contained herein, the Collateral Agent shall act
pursuant to the instructions of the Holders and the Trustee solely with respect to the Collateral Documents and the Collateral. 

SECTION 12.10. Designations. Except as provided in the next sentence, for purposes of the provisions hereof and the Intercreditor
Agreement requiring the Issuer to designate Indebtedness for the purposes of the term “First Priority Obligations,” “Future Second Lien Indebtedness,” “Junior Priority Indebtedness” or any other such designations
hereunder or under the Intercreditor Agreement, any such designation shall be sufficient if the relevant designation is set forth in writing, signed on behalf of the Issuer by an Officer and delivered to the Trustee, the Collateral Agent and the
Bank Collateral Agent. For all purposes hereof and the Intercreditor Agreement, the Issuer hereby designates the Obligations pursuant to the Credit Agreement as “First Priority Obligations.” 

SECTION 12.11. No Impairment of the Security Interests. Except as otherwise permitted under this Indenture, the Intercreditor
Agreement and the Collateral Documents, neither the Issuer nor any of the Guarantors will be permitted to take any action, or knowingly omit to take any action, which action or omission would have the result of materially impairing the security
interest with respect to the Collateral for the benefit of the Trustee, the Collateral Agent and the Holders of the Notes. 

SECTION 12.12. Insurance. The Issuer shall maintain insurance, and cause each of its Restricted Subsidiaries to maintain
insurance, with financially sound and reputable insurers (naming the Collateral Agent as an additional insured), with respect to such of its properties, against such risks, casualties and contingencies and in such types and amounts as are consistent
with sound business practice, it being understood that this Section 12.12 shall not prevent the use of deductible or excess loss insurance and shall not prevent (i) the Issuer or any of its Subsidiaries from acting as a self-insurer
or maintaining insurance with another Subsidiary or Subsidiaries of Issuer so long as such action is consistent with sound business practice or (ii) the Issuer from obtaining and owning insurance policies covering activities of its
Subsidiaries. 

  
 -113-

 ARTICLE XIII 
 MISCELLANEOUS 
 SECTION 13.1. Trust Indenture Act Controls. If and
to the extent that any provision of this Indenture limits, qualifies or conflicts with another provision which is required to be included in this Indenture by the TIA, the provision required by the TIA shall control. Each Guarantor in addition to
performing its obligations under its Note Guarantee shall perform such other obligations as may be imposed upon it with respect to this Indenture under the TIA. 
 SECTION 13.2. Notices. Any notice, request, direction, consent or communication made pursuant to the provisions of this Indenture or the Notes shall be in writing and delivered in person, sent by
facsimile, sent by electronic mail in pdf format, delivered by commercial courier service or mailed by first-class mail, postage prepaid, addressed as follows: 
 if to the Issuer or to Holdings, prior to the Escrow Release Date: 
  

			
	Hawk Acquisition Sub, Inc.
	c/o 3G Capital Partners Ltd.
	600 Third Avenue, 37th Floor
	New York, New York 10016
	Fax: (212) 893-6728
	Attention:	 	Alexandre Behring
		 	Paulo Basilio
		 	Bradley Brown

 if to the Issuer or to any Guarantor, following the Escrow Release Date: 

H.J. Heinz Company 
 1 PPG Place, Suite 3100 
 Pittsburgh, Pennsylvania 15222 

Fax: (212) 893-6728 
 Attention: Corporate Affairs Department 
 in each case, with a copy to: 

 

			
	Kirkland & Ellis LLP
	601 Lexington Avenue
	New York, New York 10022
	Attention:	 	Joshua N. Korff
		
		 	Michael Kim
	Facsimile:	 	(212) 446-4900

 if to the Trustee or the Collateral Agent, at its corporate trust office, which corporate trust office for
purposes of this Indenture is at the date hereof located at: 
 Wells Fargo Bank, National Association 

150 East 42nd Street, 40th Floor 
 New York, NY 10017 
 Attention: Corporate Trust Services – H.J. Heinz Company

 Facsimile: 917-260-1593 

  
 -114-

 The Issuer, the Trustee or the Collateral Agent by written notice to each other may
designate additional or different addresses for subsequent notices or communications. 
 Any notice or communication to the
Issuer or the Guarantors shall be deemed to have been given or made as of the date so delivered if personally delivered or if delivered electronically, in pdf format; when receipt is acknowledged, if telecopied; and seven calendar days after mailing
if sent by registered or certified mail, postage prepaid (except that a notice of change of address shall not be deemed to have been given until actually received by the addressee). Any notice or communication to the Trustee or the Collateral Agent
shall be deemed delivered upon receipt. 
 Any notice or communication sent to a Holder shall be mailed to the Holder at the
Holder’s address as it appears in the Notes Register and shall be sufficiently given if so sent within the time prescribed. 
 Failure to mail a notice or communication to a Holder or any defect in it shall not affect its sufficiency with respect to other Holders. If a notice or communication is sent in the manner provided above,
it is duly given, whether or not the addressee receives it, except that notices to the Trustee or the Collateral Agent shall be effective only upon receipt. 
 Notwithstanding any other provision of this Indenture or any Note, where this Indenture or any Note provides for notice of any event (including any notice of redemption or purchase) to a Holder of a
Global Note (whether by mail or otherwise), such notice shall be sufficiently given if given to DTC (or its designee) pursuant to the standing instructions from DTC or its designee. 

SECTION 13.3. Communication by Holders with other Holders. Holders may communicate pursuant to TIA Section 312(b) with other
Holders with respect to their rights under this Indenture or the Notes. The Issuer, the Trustee, the Registrar and anyone else shall have the protection of TIA Section 312(c). 

SECTION 13.4. Certificate and Opinion as to Conditions Precedent. Upon any request or application by the Issuer or any of the
Guarantors to the Trustee to take or refrain from taking any action under this Indenture, the Notes or the Collateral Documents, the Issuer or such Guarantor, as the case may be, shall furnish to the Trustee: 

(1) an Officer’s Certificate in form satisfactory to the Trustee (which shall include the statements set forth in
Section 13.5 hereof) stating that, in the opinion of the signers, all conditions precedent, if any, provided for in this Indenture, the Notes or the Collateral Documents relating to the proposed action have been satisfied; and

 (2) an Opinion of Counsel in form satisfactory to the Trustee (which shall include the statements set forth in
Section 13.5 hereof) stating that, in the opinion of such counsel, all such conditions precedent have been satisfied and all covenants have been complied with. 
 SECTION 13.5. Statements Required in Certificate or Opinion. Each certificate or opinion with respect to compliance with a covenant or condition provided for in this Indenture, the Notes or
Collateral Documents (other than a Certificate provided pursuant to TIA Section 314(a)(4)) shall comply with the provisions of TIA Section 314(e) and shall include: 

(1) a statement that the individual making such certificate or opinion has read such covenant or condition; 

(2) a brief statement as to the nature and scope of the examination or investigation upon which the statements or opinions
contained in such certificate or opinion are based; 
 (3) a statement that, in the opinion of such individual,
he has made such examination or investigation as is necessary to enable him to express an informed opinion as to whether or not such covenant or condition has been complied with; and 

(4) a statement as to whether or not, in the opinion of such individual, such covenant or condition has been complied
with. 

  
 -115-

 In giving such Opinion of Counsel, counsel may rely as to factual matters on an
Officer’s Certificate or on certificates of public officials. 
 SECTION 13.6. When Notes Disregarded. In
determining whether the Holders of the required aggregate principal amount of Notes have concurred in any direction, waiver or consent, Notes owned by the Issuer, any Guarantor or any Affiliate of them shall be disregarded and deemed not to be
outstanding, except that, for the purpose of determining whether the Trustee shall be protected in relying on any such direction, waiver or consent, only Notes which a Trust Officer of the Trustee actually knows are so owned shall be so disregarded.
Also, subject to the foregoing, only Notes outstanding at the time shall be considered in any such determination. 
 SECTION
13.7. Rules by Trustee, Paying Agent and Registrar. The Trustee may make reasonable rules for action by, or at meetings of, Holders. The Registrar and the Paying Agent may make reasonable rules for their functions. 

SECTION 13.8. Legal Holidays. A “Legal Holiday” is a Saturday, a Sunday or other day on which commercial banking
institutions are authorized or required to be closed in New York, New York or the state of the place of payment. If a payment date is a Legal Holiday, payment shall be made on the next succeeding day that is not a Legal Holiday, and no interest
shall accrue for the intervening period. If a regular record date is a Legal Holiday, the record date shall not be affected. 

SECTION 13.9. Governing Law. THIS INDENTURE, THE NOTES AND THE NOTE GUARANTEES SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE
WITH, THE LAWS OF THE STATE OF NEW YORK. 
 SECTION 13.10. Jurisdiction. The Issuer and the Guarantors agree that any
suit, action or proceeding against the Issuer or any Guarantor brought by any Holder or the Trustee arising out of or based upon this Indenture, the Note Guarantee or the Notes may be instituted in any state or Federal court in the Borough of
Manhattan, New York, New York, and any appellate court from any thereof, and each of them irrevocably submits to the non-exclusive jurisdiction of such courts in any suit, action or proceeding. The Issuer and the Guarantors irrevocably waive, to the
fullest extent permitted by law, any objection to any suit, action, or proceeding that may be brought in connection with this Indenture, the Note Guarantee or the Notes, including such actions, suits or proceedings relating to securities laws of the
United States of America or any state thereof, in such courts whether on the grounds of venue, residence or domicile or on the ground that any such suit, action or proceeding has been brought in an inconvenient forum. The Issuer and the Guarantors
agree that final judgment in any such suit, action or proceeding brought in such court shall be conclusive and binding upon the Issuer or the Guarantors, as the case may be, and may be enforced in any court to the jurisdiction of which the Issuer or
the Guarantors, as the case may be, are subject by a suit upon such judgment. 
 SECTION 13.11. Waivers of Jury
Trial. EACH OF THE ISSUER, THE GUARANTORS AND THE TRUSTEE HEREBY IRREVOCABLY AND UNCONDITIONALLY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY LEGAL ACTION OR PROCEEDING ARISING OUT OF OR
RELATING TO THIS INDENTURE, THE NOTES OR THE NOTE GUARANTEES AND FOR ANY COUNTERCLAIM THEREIN. 
 SECTION 13.12. USA
PATRIOT Act. The parties hereto acknowledge that in accordance with Section 326 of the USA PATRIOT Act, the Trustee and the Collateral Agent, like all financial institutions and in order to help fight the funding of terrorism and money
laundering, is required to obtain, verify, and record information that identifies each person or legal entity that establishes a relationship or opens an account. The parties to this Indenture agree that they will provide the Trustee and the
Collateral Agent with such information as each may request in order to satisfy the requirements of the USA PATRIOT Act. 

  
 -116-

 SECTION 13.13. No Recourse Against Others. No director, officer, employee,
incorporator or shareholder of the Issuer or any of its Subsidiaries or Affiliates, or such (other than the Issuer and the Guarantors), shall have any liability for any obligations of the Issuer or the Guarantors under the Notes, the Note Guarantees
or this Indenture or for any claim based on, in respect of, or by reason of such obligations or their creation. Each Holder by accepting a Note waives and releases all such liability. The waiver and release are part of the consideration for issuance
of the Notes. Such waiver may not be effective to waive liabilities under the federal securities laws and it is the view of the SEC that such a waiver is against public policy. 

SECTION 13.14. Successors. All agreements of the Issuer and each Guarantor in this Indenture and the Notes shall bind their
respective successors. All agreements of the Trustee in this Indenture shall bind its successors. 
 SECTION 13.15. Multiple
Originals. The parties may sign any number of copies of this Indenture. Each signed copy shall be an original, but all of them together represent the same agreement. The exchange of copies of this Indenture and of signature pages by
facsimile or PDF transmission shall constitute effective execution and delivery of this Indenture as to the parties hereto and may be used in lieu of the original Indenture for all purposes. Signatures of the parties hereto transmitted by facsimile
or PDF shall be deemed to be their original signatures for all purposes. 
 SECTION 13.16. Qualification of Indenture.
The Issuer has agreed to qualify this Indenture under the TIA in accordance with the terms and conditions of the Registration Rights Agreement and to pay all reasonable costs and expenses (including attorneys’ fees and expenses for the Issuer,
the Trustee and the Holders) incurred in connection therewith, including, but not limited to, costs and expenses of qualification of this Indenture and the Notes and printing this Indenture and the Notes. The Trustee shall be entitled to receive
from the Issuer any such Officer’s Certificates, Opinions of Counsel or other documentation as it may reasonably request in connection with any such qualification of this Indenture under the TIA. 

SECTION 13.17. Table of Contents; Headings. The table of contents, cross-reference table and headings of the Articles and Sections
of this Indenture have been inserted for convenience of reference only, are not intended to be considered a part hereof and shall not modify or restrict any of the terms or provisions hereof. 

SECTION 13.18. Force Majeure. In no event shall the Trustee be responsible or liable for any failure or delay in the performance
of its obligations hereunder arising out of or caused by, directly or indirectly, forces beyond its control, including, without limitation, strikes, work stoppages, accidents, acts of war or terrorism, civil or military disturbances, nuclear or
natural catastrophes or acts of God, and interruptions, loss or malfunctions of utilities, communications or computer (software and hardware) services, it being understood that the Trustee shall use reasonable best efforts which are consistent with
accepted practices in the banking industry to resume performance as soon as practicable under the circumstances. 
 SECTION
13.19. Severability. In case any provision in this Indenture or in the Notes shall be invalid, illegal or unenforceable, the validity, legality and enforceability of the remaining provisions shall not in any way be affected or impaired
thereby. 
 SECTION 13.20. Intercreditor Agreement. Reference is made to the Intercreditor Agreement. Each Holder, by its
acceptance of a Note, (a) consents to the subordination of Liens provided for in the Intercreditor Agreement, (b) agrees that it will be bound by and will take no actions contrary to the provisions of the Intercreditor Agreement and
(c) authorizes and instructs the Trustee and the Collateral Agent to enter into the Intercreditor Agreement as Trustee and the Collateral Agent, as the case may be, and on behalf of such Holder, including without limitation, making the
representations of the Holders contained therein. The foregoing provisions are intended as an inducement to the lenders under the Credit Agreement to extend credit and such lenders are intended third party beneficiaries of such provisions and the
provisions of the Intercreditor Agreement. 

  
 -117-

 SECTION 13.21. Appointment of Agent for Service of Process. 

(a) The Issuer and each Guarantor hereby irrevocably consents and agrees to the service of any and all legal process, summons, notices
and documents in any such action, suit or proceeding brought against it by the Trustee or the Holders with respect to its obligations, liabilities or any other matter arising out of or in connection with this Indenture, the Notes or the Note
Guarantees, by serving a copy thereof upon any employee of Issuer or any Guarantor (in such capacity, the “Process Agent”) at any business location that Issuer or any Guarantor may maintain from time to time in the United States
including, without limitation, at the offices of Hawk Acquisition Sub, Inc. c/o 3G Capital Partners Ltd., 600 Third Avenue, 37th Floor, New York, New York 10016. 
 (b) If at any time the Issuer or any Guarantor has or maintains a business location in the State of New York (such Person, the “New York Presence Obligor”), then the Issuer or any
Guarantor shall, within 30 days after such location is opened, is acquired or otherwise exists, irrevocably designate, appoint and empower the New York Presence Obligor as their designee, appointee and agent to receive, accept and acknowledge for
and on their behalf service of any and all legal process, summons, notices and documents that may be served in any action, suit or proceeding brought against them by the Trustee or the Holders in any United States or state court located in the
County of New York with respect to their obligations, liabilities or any other matter arising out of or in connection with this Indenture, the Notes or the Note Guarantees and that may be made on such designee, appointee and agent in accordance with
legal procedures prescribed for such courts (the “New York Process Agent”). 
 (c) If at any time either
(i) the Issuer or any Guarantor maintains a bona fide business location in the State of New York or (ii) a New York Presence Obligor exists but the Issuer or any Guarantor fails to satisfy its obligations under the foregoing
paragraph (b), then Issuer or any Guarantor shall promptly (and in any event within 10 days) irrevocably designate, appoint and empower CT Corporation System, with offices currently at 111 Eighth Avenue, New York, New York 10011 (or such other third
party corporate service provider of national standing as may be reasonably acceptable to the Representatives), as their designee, appointee and agent to receive, accept and acknowledge for and on their behalf service of any and all legal process,
summons, notices and documents that may be served in any action, suit or proceeding brought against them by the Trustee or the Holders in any such United States or state court located in the County of New York with respect to their obligations,
liabilities or any other matter arising out of or in connection with this Indenture, the Notes or the Note Guarantees and that may be made on such designee, appointee and agent in accordance with legal procedures prescribed for such courts (the
“Third Party Process Agent”) and pay all fees and expenses required by the Third Party Process Agent in connection therewith. If for any reason such Third Party Process Agent hereunder shall cease to be available to act as such, the
Issuer and each Guarantor agrees to designate a new Third Party Process Agent in the County of New York on the terms and for the purposes of this Section 13.21 satisfactory to the Trustee and the Holders. 

(d) The Issuer and each Guarantor further hereby irrevocably consents and agrees to the service of any and all legal process, summons,
notices and documents in any such action, suit or proceeding against them by (i) serving a copy thereof upon any of the relevant Process Agents specified in clauses (a) through (c) above, or (ii) or by mailing copies thereof by
registered or certified air mail, postage prepaid, to the Issuer or such Guarantor, at its address specified in or designated pursuant to this Indenture. The Issuer and each Guarantor agrees that the failure of any Process Agent specified in clauses
(a) through (c) above, to give any notice of such service to it shall not impair or affect in any way the validity of such service or any judgment rendered in any action or proceeding based thereon. 

(e) Nothing herein shall in any way be deemed to limit the ability of the Trustee or any Holder to serve any such legal process, summons,
notices and documents in any other manner permitted by applicable law or to obtain jurisdiction over the Issuer or any Guarantor or bring actions, suits or proceedings against them in such other jurisdictions, and in such manner, as may be permitted
by applicable law. 
 (f) The Issuer and each Guarantor hereby irrevocably and unconditionally waives, to the fullest extent
permitted by law, any objection that it may now or hereafter have to the laying of venue of any of the aforesaid actions, suits or proceedings arising out of or in connection with this Indenture, the Notes or the Note Guarantees brought in the
United States federal courts located in the County of New York or the courts of the State of New York located in the County of New York and hereby further irrevocably and unconditionally waives and agrees not to plead or claim in any such court that
any such action, suit or proceeding brought in any such court has been brought in an inconvenient forum. 
 (g) The provisions
of this Section 13.21 shall survive any termination of this Indenture, in whole or in part, and shall survive delivery and payment for the Notes. 

  
 -118-

 SECTION 13.22. Waiver of Immunities. To the extent that Issuer or any Guarantor or
any of its properties, assets or revenues may have or may hereafter become entitled to, or have attributed to them, any right of immunity, on the grounds of sovereignty, from any legal action, suit or proceeding, from set-off or counterclaim, from
the jurisdiction of any court, from service of process, from attachment upon or prior to judgment, or from attachment in aid of execution of judgment, or from execution of judgment, or other legal process or proceeding for the giving of any relief
or for the enforcement of any judgment, in any jurisdiction in which proceedings may at any time be commenced, with respect to their obligations, liabilities or any other matter under or arising out of or in connection with this Indenture, the Notes
or the Note Guarantees, the Issuer and each Guarantor hereby irrevocably and unconditionally, to the extent permitted by applicable law, waives and agrees not to plead or claim any such immunity and consents to such relief and enforcement.

 SECTION 13.23. Judgment Currency. The Issuer and each Guarantor agrees to indemnify the recipient against any loss
incurred by such recipient as a result of any judgment or order being given or made against the Issuer or any Guarantor for any amount due hereunder and such judgment or order being expressed and paid in a currency (the “Judgment
Currency”) other than United States dollars and as a result of any variation as between (i) the rate of exchange at which the United States dollar amount is converted into the Judgment Currency for the purpose of such judgment or
order, and (ii) the rate of exchange in The City of New York at which such party on the date of payment of such judgment or order is able to purchase United States dollars with the amount of the Judgment Currency actually received by such party
if such party had utilized such amount of Judgment Currency to purchase United States dollars as promptly as practicable upon such party’s receipt thereof. The foregoing indemnity shall constitute a separate and independent obligation of the
Issuer and each Guarantor and shall continue in full force and effect notwithstanding any such judgment or order as aforesaid. The term “rate of exchange” shall include any premiums and costs of exchange payable in connection with the
purchase of, or conversion into, the relevant currency. 
 [Signature on following pages] 

  
 -119-

 IN WITNESS WHEREOF, the parties have caused this Indenture to be duly executed all as of the
date and year first written above. 
  

			
	HAWK ACQUISITION SUB, INC.
		
	By:	 	 /s/ Paulo Basilio

		 	Name: Paulo Basilio
		 	Title: Vice President and Secretary
	
	HAWK ACQUISITION INTERMEDIATE CORPORATION II, as a Guarantor
		
	By:	 	 /s/ Paulo Basilio

		 	Name: Paulo Basilio
		 	Title: Vice President and Secretary

 [Signature Page to the Indenture] 

 
			
	WELLS FARGO BANK, NATIONAL ASSOCIATION,
	as Trustee and Collateral Agent
		
	By:	 	 /s/ Yana Kislenko

		 	Name: Yana Kislenko
		 	Title: Vice President

 [Signature Page to the Indenture] 

 EXHIBIT A 
 [FORM OF FACE OF GLOBAL RESTRICTED NOTE] 
 [Applicable Restricted Notes Legend]

 [Depository Legend, if applicable] 
 [Temporary Regulation S Legend, if applicable] 
  

					
	No. [    ]	  	Principal Amount $[            ] [as revised by the Schedule of Increases and Decreases in Global Note
attached hereto]1
		  	CUSIP NO.	 	  

 HAWK ACQUISITION SUB, INC. 
 to be merged with and into 
 H.J. HEINZ CORPORATION 

4.25% Second Lien Senior Secured Notes due 2020 
 Hawk Acquisition Sub., Inc., a Pennsylvania corporation, promises to pay to [Cede & Co.], or its registered assigns, the principal sum of
                     Dollars, [as revised by the Schedule of Increases and Decreases in Global Note attached hereto], on October 15, 2020.

 Interest Payment Dates: April 15 and October 15, commencing on October 15, 20132 

Record Dates: April 1 and October 1 
 Additional provisions of this Note are set forth on the other side of this Note. 

 

	1 	Insert in Global Notes only. 

	2 	In the case of Notes issued on the Issue Date. 

  
 A-1

 IN WITNESS WHEREOF, the Issuer has caused this instrument to be duly executed. 

 

			
	HAWK ACQUISITION SUB, INC.
		
	By:	 	  

		 	Name:
		 	Title:

 TRUSTEE CERTIFICATE OF AUTHENTICATION 

This Note is one of the Notes referred to in the within-mentioned Indenture. 

 

			
	WELLS FARGO BANK, NATIONAL ASSOCIATION, as Trustee
		
	By:	 	  

		 	Name:
		 	Title:

  

			
	Dated:	 	  

  
 A-2

 [FORM OF REVERSE SIDE OF NOTE] 

HAWK ACQUISITION SUB, INC. 
 to be merged with and into 
 H.J. HEINZ COMPANY 

4.25% Second Lien Senior Secured Notes due 2020 
 Capitalized terms used herein and not defined herein have the meanings ascribed thereto in the Indenture. 
  

	1.	Interest 

 Hawk
Acquisition Sub, Inc., a Pennsylvania corporation, promises to pay interest on the principal amount of this Note at 4.25% per annum from April 1, 20133 until maturity and shall pay Additional Interest, if any, payable pursuant to the Registration Rights Agreement
referred to below. The Issuer will pay interest semi-annually in arrears every April 15 and October 15 of each year, or if any such day is not a Business Day, on the next succeeding Business Day (each, an “Interest Payment
Date”). Interest on the Notes shall accrue from the most recent date to which interest has been paid or, if no interest has been paid, from the date of issuance; provided, that the first Interest Payment Date shall be
October 15, 2013.4 The Issuer shall pay interest on
overdue principal at the rate specified herein, and it shall pay interest (including post-petition interest in any proceeding under any Bankruptcy Law) on overdue installments of interest (including Additional Interest) (without regard to any
applicable grace period) at the same rate to the extent lawful. Interest on the Notes will be computed on the basis of a 360-day year comprised of twelve 30-day months. 
 In addition to the rights provided to Holders of the Notes under the Indenture, Holders of Registrable Securities (as defined in the Registration Rights Agreement) shall have all rights set forth in the
Registration Rights Agreement, dated as of April 1, 2013, among the Issuer, the Guarantor named therein and the other parties named on the signature pages thereto (as amended, supplemented or otherwise modified from time to time, the
“Registration Rights Agreement”), including the right to receive Additional Interest in certain circumstances. If applicable, Additional Interest shall be paid to the same Persons, in the same manner and at the same times as regular
interest. 
  

	2.	Method of Payment 

 By no
later than 10:00 a.m. (New York City time) on the date on which any principal of, premium, if any, interest or Additional Interest, if any, on any Note is due and payable, the Issuer shall deposit with the Paying Agent a sum sufficient in
immediately available funds to pay such principal, premium, interest and Additional Interest when due. Interest on any Note which is payable, and is timely paid or duly provided for, on any Interest Payment Date shall be paid to the Person in whose
name such Note (or one or more Predecessor Notes) is registered at the close of business on the preceding April 1 and October 1 at the office or agency of the Issuer maintained for such purpose pursuant to Section 2.3 of the
Indenture. The principal of (and premium, if any) and interest (and Additional Interest, if any) on the Notes shall be payable at the office or agency of Paying Agent or Registrar designated by the Issuer maintained for such purpose (which shall
initially be the office of the Trustee maintained for such purpose), or at such other office or agency of the Issuer as may be maintained for such purpose pursuant to Section 2.3 of the Indenture; provided, however, that,
at the option of the Paying Agent, each installment of interest may be paid by (i) check mailed to addresses of the Persons entitled thereto as such addresses shall appear on the Notes Register or (ii) wire transfer to an account located
in the United States maintained by the payee, subject to the last sentence of this paragraph. Payments in respect of Notes represented by a Global Note (including principal, premium, if any, interest and Additional Interest, if any) will be made by
wire transfer of immediately available funds to the accounts specified by The Depository Trust Company or any successor depository. Payments in respect of Notes represented by Definitive Notes (including principal, premium, if any, interest and
Additional Interest, if any) held by a Holder of at least $1,000,000 aggregate principal amount of Notes represented by Definitive Notes will be made by wire transfer to a U.S. dollar account maintained by the payee with a bank in the United States
if such Holder elects payment by wire transfer by giving written notice to the Trustee or the Paying Agent to such 
  

	3 	In the case of Notes issued on the Issue Date. 

	4 	 In the case of Notes issued on the Issue Date. 

  
 A-3

 
effect designating such account no later than 15 days immediately preceding the relevant due date for payment (or such other date as the Trustee may accept in its discretion). If an Interest
Payment Date is a Legal Holiday, payment shall be made on the next succeeding day that is not a Legal Holiday, and no interest shall accrue for the intervening period. If a regular record date is a Legal Holiday, the record date shall not be
affected. 
  

	3.	Paying Agent and Registrar 

The Issuer initially appoints Wells Fargo Bank, National Association (the “Trustee”) as Registrar and Paying Agent for
the Notes. The Issuer may change any Registrar or Paying Agent without prior notice to the Holders. The Issuer or any Guarantor may act as Paying Agent, Registrar or transfer agent. 

 

	4.	Indenture 

 The Issuer
issued the Notes under an Indenture dated as of April 1, 2013 (as it may be amended or supplemented from time to time in accordance with the terms thereof, the “Indenture”), among the Issuer, the Guarantors party thereto and
the Trustee and Collateral Agent. The terms of the Notes include those stated in the Indenture and those made part of the Indenture by reference to the Trust Indenture Act of 1939 (15 U.S.C. Sections 77aaa-77bbbb) as in effect on the date of
the Indenture (the “Act”). The Notes are subject to all terms and provisions of the Indenture, and Holders are referred to the Indenture and the Act for a statement of those terms. 

 

	5.	Guarantees 

 To guarantee
the due and punctual payment of the principal, premium, if any, interest and Additional Interest, if any (including post-filing or post-petition interest) on the Notes and all other amounts payable by the Issuer under the Indenture and the Notes
when and as the same shall be due and payable, whether at maturity, by acceleration or otherwise, according to the terms of the Notes and the Indenture, the Guarantors will unconditionally guarantee (and future guarantors, jointly and severally with
the Guarantors, will fully and unconditionally Guarantee) such obligations on a senior basis pursuant to the terms of the Indenture. 
  

	6.	Optional Redemption 

 (a)
At any time prior to April 15, 2015, the Issuer may redeem the Notes in whole or in part, at their option, upon not less than 30 nor more than 60 days’ prior notice by electronic delivery or by first class mail, postage prepaid, with
a copy to the Trustee, to each Holder of Notes to the address of such Holder appearing in the Notes Register, at a redemption price equal to 100% of the principal amount of such Notes redeemed plus the Applicable Premium as of, and accrued and
unpaid interest and Additional Interest, if any, to but excluding the date of redemption (the “Redemption Date”), subject to the rights of holders of the Notes on the relevant record date to receive interest due on the relevant
interest payment date. 
 (b) At any time and from time to time prior to April 15, 2015, the Issuer may redeem Notes with
the net cash proceeds received by the Issuer from any Equity Offering at a redemption price equal to 104.250% plus accrued and unpaid interest to the Redemption Date, in an aggregate principal amount for all such redemptions not to exceed 40% of the
original aggregate principal amount of the Notes (including Additional Notes); provided that (1) in each case the redemption takes place not later than 180 days after the closing of the related Equity Offering, and (2) not less
than 50% of the original aggregate principal amount of the Notes issued under the Indenture remains outstanding immediately thereafter (excluding Notes held by the Issuer or any of its Restricted Subsidiaries). The Trustee shall select the Notes to
be purchased in the manner described under Sections 5.1 through 5.6 of the Indenture. 
 (c) In addition, on
or within ninety (90) days of the Escrow Release Date, the Issuer may redeem an amount of the Notes equal to the aggregate principal amount of the Non-refinanced Notes that remain outstanding on the Escrow Release Date less the aggregate
principal amount of any reduction to the commitments of the Credit Facilities under the Credit Agreement as a result of any Non-refinanced Notes that remain outstanding on the Escrow Release Date pursuant to the terms of the debt financing
commitments, upon not less than thirty (30) nor more than sixty (60) days’ prior notice at a redemption price equal to 100% of the initial issue price of the Notes, plus accrued and unpaid interest from the Issue Date of the Notes up
to, but not including, the date of such redemption. 

  
 A-4

 (d) Except pursuant to clauses (a), (b) and (c) of this paragraph 6, the
Notes will not be redeemable at the Issuer’s option prior to April 15, 2015. 
 (e) At any time and from time to time
on or after April 15, 2015, the Issuer may redeem the Notes in whole or in part, upon not less than 30 nor more than 60 days’ notice by electronic delivery or by first class mail, postage prepaid, with a copy to the Trustee, to each Holder
of Notes to the address of such Holder appearing in the Notes Register at a redemption price equal to the percentage of principal amount set forth below plus accrued and unpaid interest, if any, on the Notes redeemed, to the applicable Redemption
Date, if redeemed during the twelve-month period beginning on April 15 of the year indicated below: 
  

					
	Year	  	Percentage	 
	 2015
	  	 	102.1250	% 
	 2016
	  	 	101.0625	% 
	 2017 and thereafter
	  	 	100.0000	% 

 (f) Unless the Issuer defaults in the payment of the redemption price, interest will cease to accrue on
the Notes or portions thereof called for redemption on the applicable Redemption Date. 
 (g) Any redemption pursuant to this
paragraph 6 shall be made pursuant to the provisions of Sections 5.1 through 5.6 of the Indenture. 
 The
Issuer is not required to make mandatory redemption or sinking fund payments with respect to the Notes; provided, however, that under certain circumstances, the Issuer may be required to offer to purchase Notes under
Section 3.5 and Section 3.9 of the Indenture. The Issuer may at any time and from time to time purchase Notes in the open market or otherwise. 
  

	7.	Special Mandatory Redemption 

 If (a) the Escrow Agent has not received the Officer’s Certificate pursuant to Section 3.24 of the Indenture on or prior to the Escrow End Date, (b) the Issuer notifies the
Escrow Agent in writing that the Issuer will not pursue the consummation of the Acquisition or otherwise announces that the Merger Agreement has been terminated or that it will not pursue the consummation of the Acquisition, or (c) the Issuer
fails to timely deposit (or cause to be timely deposited) any amounts required by Section 3.24 of the Indenture, within three (3) Business Days of the applicable deposit date, then the Escrow Agent shall, without the requirement of
notice to or action by the Issuer, the Trustee or any other Person, release the Escrowed Property (including investment earnings thereon and proceeds thereof) to the Trustee and the Trustee shall apply (or cause a paying agent to apply) such
proceeds to redeem the Notes (the “Special Mandatory Redemption”) on the third Business Day following the date of the release of the Escrowed Property to the Trustee (the “Special Mandatory Redemption Date”) or as
otherwise required by the applicable procedures of DTC, at a redemption price (the “Special Mandatory Redemption Price”), equal to 100% of the issue price of the Notes, plus accrued and unpaid interest from the Issue Date, or the
most recent date to which interest has been paid or duly provided for on the Notes, as the case may be, to, but excluding the Special Mandatory Redemption Date. On the Special Mandatory Redemption Date, the Trustee will pay to the Issuer any
Escrowed Property in excess of the amount necessary to effect the Special Mandatory Redemption. 
  

	8.	Repurchase Provisions 

 If
a Change of Control occurs, unless the Issuer has previously or concurrently delivered a redemption notice with respect to all outstanding Notes pursuant to Section 5.7 of the Indenture, each Holder will have the right to require the
Issuer to repurchase from each Holder all or any part (equal to $2,000 or an integral multiple of $1,000 in excess thereof) of such Holder’s Notes at a purchase price in cash equal to 101% of the aggregate principal amount thereof plus
accrued and unpaid interest and Additional Interest, if any, to but excluding the date of purchase, subject to the right of Holders of record on the relevant record date to receive interest due on the relevant interest payment date as provided in,
and subject to the terms of, the Indenture. 

  
 A-5

 Upon certain Asset Sales, the Issuer may be required to use the Excess Proceeds from such
Asset Sales to offer to purchase the maximum aggregate principal amount of Notes (that is $2,000 or an integral multiple of $1,000 in excess thereof) and, at the Issuer’s option, Pari Passu Indebtedness that may be purchased out of the Excess
Proceeds at an offer price in cash in an amount equal to 100% of the principal amount thereof, plus accrued and unpaid interest and Additional Interest, if any, to the date fixed for the closing of such offer, in accordance with the procedures set
forth in Section 3.5 and in Article V of the Indenture. 
  

	9.	Denominations; Transfer; Exchange 

 The Notes shall be issuable only in fully registered form in denominations of principal amount of $2,000 and any integral multiple of $1,000 in excess thereof. A Holder may transfer or exchange Notes in
accordance with the Indenture. The Registrar may require a Holder, among other things, to furnish appropriate endorsements or transfer documents and to pay a sum sufficient to cover any tax and fees required by law or permitted by the Indenture. The
Registrar need not register the transfer of or exchange of any Note (A) for a period beginning (1) 15 days before the mailing of a notice of an offer to repurchase or redeem Notes and ending at the close of business on the day of such
mailing or (2) 15 days before an Interest Payment Date and ending on such Interest Payment Date or (B) called for redemption, except the unredeemed portion of any Note being redeemed in part. 

 

	10.	Persons Deemed Owners 

The registered Holder of this Note may be treated as the owner of it for all purposes. 

 

	11.	Discharge and Defeasance 

Subject to certain exceptions and conditions set forth in the Indenture, the Issuer at any time may terminate some or all of its
obligations under the Notes and the Indenture if the Issuer deposits with the Trustee money or U.S. Government Obligations for the payment of principal, premium, if any, interest and Additional Interest, if any on the Notes to redemption or
maturity, as the case may be. 
  

	12.	Amendment, Supplement, Waiver 

 Subject to certain exceptions contained in the Indenture, the Indenture, the Notes, the Collateral Documents or the Intercreditor Agreement may be amended, or a Default thereunder may be waived, with the
consent of the Holders of a majority in aggregate principal amount of the outstanding Notes. Without notice to or the consent of any Holder, the Issuer, the Guarantors and the Trustee may amend or supplement the Indenture, the Notes, the Collateral
Documents or the Intercreditor Agreement as provided in the Indenture. 
  

	13.	Defaults and Remedies 

 If
an Event of Default (other than an Event of Default relating to certain events of bankruptcy, insolvency or reorganization of the Issuer or certain Guarantors) occurs and is continuing, the Trustee by notice to the Issuer, or the Holders of at least
30% in principal amount of the outstanding Notes by notice to the Issuer and the Trustee, may, and the Trustee at the request of such Holders shall, declare the principal of, premium, if any, and accrued and unpaid interest (including Additional
Interest, if any), and any other monetary obligations on all the Notes to be due and payable immediately. Upon the effectiveness of such declaration, such principal, premium, interest, Additional Interest, if any, and other monetary obligations will
be due and payable immediately. If a bankruptcy, insolvency or reorganization of the Issuer or certain Guarantors occurs and is continuing, the principal of, premium, if any, and accrued and unpaid interest (including Additional Interest) and any
other monetary obligations on all the Notes will become and be immediately due and payable without any declaration or other act on the part of the Trustee or any Holders. Under certain circumstances, the Holders of a majority in principal amount of
the outstanding Notes may rescind any such acceleration with respect to the Notes and its consequences. 

  
 A-6

	14.	Trustee Dealings with the Issuer 

 Subject to certain limitations set forth in the Indenture, the Trustee in its individual or any other capacity may become the owner or pledgee of Notes and may otherwise deal with the Issuer, Guarantors
or their Affiliates with the same rights it would have if it were not Trustee. In addition, the Trustee shall be permitted to engage in transactions with the Issuer; provided, however, that if the Trustee acquires any conflicting
interest under the TIA, the Trustee must (i) eliminate such conflict within 90 days of acquiring such conflicting interest, (ii) apply to the Commission for permission to continue acting as Trustee or (iii) resign. 

 

	15.	No Recourse Against Others 

No director, officer, employee, incorporator or shareholder of the Issuer or any of its Subsidiaries or Affiliates, as such (other than
the Issuer and the Guarantors), shall have any liability for any obligations of the Issuer or the Guarantors under the Notes, the Note Guarantees, the Collateral Documents, the Intercreditor Agreement or the Indenture or for any claim based on, in
respect of, or by reason of such obligations or their creation. Each Holder by accepting a note waives and releases all such liability. The waiver and release are part of the consideration for issuance of the Notes. Such waiver may not be effective
to waive liabilities under the federal securities laws and it is the view of the SEC that such a waiver is against public policy. 
  

	16.	Authentication 

 This Note
shall not be valid until an authorized signatory of the Trustee (or an authenticating agent acting on its behalf) manually signs the certificate of authentication on the other side of this Note. 

 

	17.	Abbreviations 

 Customary
abbreviations may be used in the name of a Holder or an assignee, such as TEN COM (= tenants in common), TEN ENT (= tenants by the entirety), JT TEN (= joint tenants with rights of survivorship and not as tenants in common),
CUST (= custodian) and U/G/M/A (= Uniform Gift to Minors Act). 
  

	18.	CUSIP and ISIN Numbers 

The Issuer has caused CUSIP and ISIN numbers, if applicable, to be printed on the Notes and has directed the Trustee to use CUSIP and ISIN
numbers, if applicable, in notices of redemption or purchase as a convenience to Holders. No representation is made as to the accuracy of such numbers either as printed on the Notes or as contained in any notice of redemption or purchase and
reliance may be placed only on the other identification numbers placed thereon. 
  

	19.	Governing Law 

 This Note
shall be governed by, and construed in accordance with, the laws of the State of New York. 
 The Issuer will furnish to any
Holder upon written request and without charge to the Holder a copy of the Indenture and the Registration Rights Agreement. Requests may be made to: 
  

			
	Hawk Acquisition Sub, Inc.
	c/o 3G Capital Partners Ltd.
	600 Third Avenue, 37th Floor
	New York, New York 10016
	Fax: (212) 893-6728
	Attention:	 	Alexandre Behring
		 	Paulo Basilio
		 	Bradley Brown

  
 A-7

	20.	Security 

 The Note will
be secured by the Collateral on the terms and subject to the conditions set forth in the Indenture and the Collateral Documents. The Trustee and the Collateral Agent, as the case may be, hold the Collateral in trust for the benefit of the Holders of
the Notes, in each case pursuant to the Collateral Documents and the Intercreditor Agreement. Each Holder, by accepting this Note, consents and agrees to the terms of the Collateral Documents (including the provisions providing for the foreclosure
and release of Collateral) and the Intercreditor Agreement as the same may be in effect or may be amended from time to time in accordance with their terms and the Indenture and authorizes and directs the Collateral Agent to enter into the Collateral
Documents and the Intercreditor Agreement, and to perform its obligations and exercise its rights thereunder in accordance therewith. 

  
 A-8

 ASSIGNMENT FORM 
 To assign this Note, fill in the form below: 
 I or we assign and transfer this
Note to: 
  
  

 
 (Print or type assignee’s name,
address and zip code) 
  
  

 
 (Insert assignee’s social
security or tax I.D. No.) 
 and irrevocably appoint
                     agent to transfer this Note on the books of the Issuer. The agent may substitute another to act for him. 

 

					
	Date:	  	Your Signature:	 	  

  

			
	Signature Guarantee:	 	  

	(Signature must be guaranteed)

  
  

 
 Sign exactly as your name appears on the other side
of this Note. 
 The signature(s) should be guaranteed by an eligible guarantor institution (banks, stockbrokers, savings and loan associations
and credit unions with membership in an approved signature guarantee medallion program), pursuant to Exchange Act Rule 17Ad-15. 
 The
undersigned hereby certifies that it  ̈ is /  ̈ is not an Affiliate of the Issuer and that, to its knowledge, the proposed transferee  ̈ is /  ̈ is not an Affiliate of the Issuer. 
 In connection with any transfer or exchange of any of the Notes evidenced by this certificate occurring prior to the date that is one year after the later of the date of original issuance of such Notes
and the last date, if any, on which such Notes were owned by the Issuer or any Affiliate of the Issuer, the undersigned confirms that such Notes are being: 
 CHECK ONE BOX BELOW: 
  

					
	 (1)
	 	  ̈
	  	acquired for the undersigned’s own account, without transfer; or
			
	 (2)
	 	  ̈
	  	transferred to the Issuer; or
			
	 (3)
	 	  ̈
	  	transferred pursuant to and in compliance with Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”); or
			
	 (4)
	 	  ̈
	  	transferred pursuant to an effective registration statement under the Securities Act; or
			
	 (5)
	 	  ̈
	  	transferred pursuant to and in compliance with Regulation S under the Securities Act; or
			
	 (6)
	 	  ̈
	  	transferred to an institutional “accredited investor” (as defined in Rule 501(a)(1), (2), (3) or (7) under the Securities Act) or an “accredited
investor” (as defined in Rule 501(a)(4) under the Securities Act), that has furnished to the Trustee a signed letter containing certain representations and agreements (the form of which letter appears as Exhibit G or I of the Indenture,
respectively); or
			
	(7)	 	 ̈	  	transferred pursuant to another available exemption from the registration requirements of the Securities Act of 1933, as amended.

  
 A-9

 Unless one of the boxes is checked, the Trustee will refuse to register any of the Notes evidenced by this
certificate in the name of any person other than the registered Holder thereof; provided, however, that if box (5), (6) or (7) is checked, the Issuer may require, prior to registering any such transfer of the Notes, in its
sole discretion, such legal opinions, certifications and other information as the Issuer may reasonably request to confirm that such transfer is being made pursuant to an exemption from, or in a transaction not subject to, the registration
requirements of the Securities Act of 1933, as amended, such as the exemption provided by Rule 144 under such Act. 
  

					
		 		 	  

		 		 	Signature
			
	Signature Guarantee:	 		 	
			
	  
	 		 	  

	(Signature must be guaranteed)	 		 	Signature

 The signature(s) should be guaranteed by an eligible guarantor institution (banks, stockbrokers, savings and loan
associations and credit unions with membership in an approved signature guarantee medallion program), pursuant to Exchange Act Rule 17Ad-15. 
 TO BE COMPLETED BY PURCHASER IF BOX 
 (1) OR (3) ABOVE IS CHECKED. 

The undersigned represents and warrants that it is purchasing this Note for its own account or an account with respect to which it
exercises sole investment discretion and that it and any such account is a “qualified institutional buyer” within the meaning of Rule 144A under the Securities Act of 1933, as amended, and is aware that the sale to it is being made in
reliance on Rule 144A and acknowledges that it has received such information regarding the Issuer as the undersigned has requested pursuant to Rule 144A or has determined not to request such information and that it is aware that the
transferor is relying upon the undersigned’s foregoing representations in order to claim the exemption from registration provided by Rule 144A. 

 

	
	  

	Dated:

  
 A-10

 [TO BE ATTACHED TO GLOBAL NOTES] 

SCHEDULE OF INCREASES OR DECREASES IN GLOBAL NOTES 
 The following increases or decreases in this Global Note have been made: 
  

									
	 Date of Exchange
	  	Amount of decrease
in Principal 
Amount
of this Global Note	  	Amount of increase
in Principal 
Amount
of this Global Note	  	Principal Amount of
this Global Note
following such
decrease or increase	  	Signature of
authorized signatory
of Trustee or Notes
Custodian
		  		  		  		  	
		  		  		  		  	
		  		  		  		  	

  
 A-11

 OPTION OF HOLDER TO ELECT PURCHASE 

If you elect to have this Note purchased by the Issuer pursuant to Section 3.5 or 3.9 of the Indenture, check either box:

  

			
	Section 3.5  ̈    Section 3.9
 ̈

 If you want to elect to have only part of this Note purchased by the Issuer pursuant to Section 3.5
or 3.9 of the Indenture, state the amount in principal amount (must be in denominations of $2,000 or an integral multiple of $1,000 in excess thereof): $             and specify the
denomination or denominations (which shall not be less than the minimum authorized denomination) of the Notes to be issued to the Holder for the portion of the within Note not being repurchased (in the absence of any such specification, one such
Note will be issued for the portion not being repurchased):             . 
  

							
	Date:	  	  
	  	Your Signature	 	  

		  		  		 	(Sign exactly as your name appears on the other side of the Note)

  

			
	Signature Guarantee:	 	  

		 	(Signature must be guaranteed)

 The signature(s) should be guaranteed by an eligible guarantor institution (banks, stockbrokers, savings and loan
associations and credit unions with membership in an approved signature guarantee medallion program), pursuant to Exchange Act Rule 17Ad-15. 

  
 A-12

 EXHIBIT B 
 [FORM OF FACE OF EXCHANGE GLOBAL NOTE] 
 [Depository Legend, if applicable]

  

					
	No. [    ]	 	Principal Amount $[                ] [as revised by the Schedule of Increases and
Decreases in Global Note attached
hereto]1
		 	CUSIP NO.	  	  

 HAWK ACQUISITION SUB, INC. 
 to be merged with and into 
 H.J. HEINZ COMPANY 

4.250% Second Lien Senior Secured Notes due 2020 
 Hawk Acquisition Sub., Inc., a Pennsylvania corporation, promises to pay to [Cede & Co.], or its registered assigns, the principal sum of
                 Dollars, [as revised by the Schedule of Increases and Decreases in Global Note attached hereto], on October 15, 2020. 

Interest Payment Dates: April 15 and October 15, commencing on October 15, 20132 

Record Dates: April 1 and October 1 
 Additional provisions of this Note are set forth on the other side of this Note. 

 

	1 	Insert in Global Notes only. 

	2 	In the case of Notes issued on the Issue Date. 

  
 B-1

 IN WITNESS WHEREOF, the Issuer has caused this instrument to be duly executed. 

 

			
	HAWK ACQUISITION SUB, INC.
		
	By:	 	  

		 	Name:
		 	Title:

 TRUSTEE CERTIFICATE OF AUTHENTICATION 

This Note is one of the Notes referred to in the within-mentioned Indenture. 

 

			
	WELLS FARGO BANK, NATIONAL ASSOCIATION, as Trustee
		
	By:	 	  

		 	Name:
		 	Title:

  

			
	Dated:	 	  

  
 B-2

 [FORM OF REVERSE SIDE OF NOTE] 

HAWK ACQUISITION SUB, INC. 
 to be merged with and into 
 H.J. HEINZ COMPANY 

4.25% Second Lien Senior Secured Notes due 2020 
 Capitalized terms used herein and not defined herein have the meanings ascribed thereto in the Indenture. 
  

	1.	Interest 

 Hawk
Acquisitions Sub., Inc. a Pennsylvania corporation, jointly and severally, promise to pay interest on the principal amount of this Note at 4.25% per annum from April 1, 20133 until maturity. The Issuer will pay interest semi-annually in arrears every April 15 and October 15 of each
year, or if any such day is not a Business Day, on the next succeeding Business Day (each, an “Interest Payment Date”). Interest on the Notes shall accrue from the most recent date to which interest has been paid or, if no interest
has been paid, from the date of issuance; provided, that the first Interest Payment Date shall be October 15, 2013.4 The Issuer shall pay interest on overdue principal at the rate specified herein, and it shall pay interest (including
post-petition interest in any proceeding under any Bankruptcy Law) on overdue installments of interest (without regard to any applicable grace period) at the same rate to the extent lawful. Interest on the Notes will be computed on the basis of a
360-day year comprised of twelve 30-day months. 
  

	2.	Method of Payment 

 By no
later than 10:00 a.m. (New York City time) on the date on which any principal of, premium, if any, or interest on any Note is due and payable, the Issuer shall deposit with the Paying Agent a sum sufficient in immediately available funds to pay
such principal, premium, and interest when due. Interest on any Note which is payable, and is timely paid or duly provided for, on any Interest Payment Date shall be paid to the Person in whose name such Note (or one or more Predecessor Notes) is
registered at the close of business on the preceding April 1 and October 1 at the office or agency of the Issuer maintained for such purpose pursuant to Section 2.3 of the Indenture. The principal of (and premium, if any) and
interest on the Notes shall be payable at the office or agency of Paying Agent or Registrar designated by the Issuer maintained for such purpose (which shall initially be the office of the Trustee maintained for such purpose), or at such other
office or agency of the Issuer as may be maintained for such purpose pursuant to Section 2.3 of the Indenture; provided, however, that, at the option of the Paying Agent, each installment of interest may be paid by
(i) check mailed to addresses of the Persons entitled thereto as such addresses shall appear on the Notes Register or (ii) wire transfer to an account located in the United States maintained by the payee, subject to the last sentence of
this paragraph. Payments in respect of Notes represented by a Global Note (including principal, premium, if any, and interest) will be made by wire transfer of immediately available funds to the accounts specified by The Depository Trust Company or
any successor depository. Payments in respect of Notes represented by Definitive Notes (including principal, premium, if any, and interest) held by a Holder of at least $1,000,000 aggregate principal amount of Notes represented by Definitive Notes
will be made by wire transfer to a U.S. dollar account maintained by the payee with a bank in the United States if such Holder elects payment by wire transfer by giving written notice to the Trustee or the Paying Agent to such effect designating
such account no later than 15 days immediately preceding the relevant due date for payment (or such other date as the Trustee may accept in its discretion). If an Interest Payment Date is a Legal Holiday, payment shall be made on the next
succeeding day that is not a Legal Holiday, and no interest shall accrue for the intervening period. If a regular record date is a Legal Holiday, the record date shall not be affected. 

 

	3 	In the case of Notes issued on the Issue Date. 

	4 	In the case of Notes issued on the Issue Date. 

  
 B-3

	3.	Paying Agent and Registrar 

The Issuer initially appoints Wells Fargo Bank, National Association (the “Trustee”) as Registrar and Paying Agent for
the Notes. The Issuer may change any Registrar or Paying Agent without prior notice to the Holders. The Issuer or any Guarantor may act as Paying Agent, Registrar or transfer agent. 

 

	4.	Indenture 

 The Issuer
issued the Notes under an Indenture dated as of April 1, 2013 (as it may be amended or supplemented from time to time in accordance with the terms thereof, the “Indenture”), among the Issuer, the Guarantors party thereto and
the Trustee and Collateral Agent. The terms of the Notes include those stated in the Indenture and those made part of the Indenture by reference to the Trust Indenture Act of 1939 (15 U.S.C. Sections 77aaa-77bbbb) as in effect on the date of
the Indenture (the “Act”). The Notes are subject to all terms and provisions of the Indenture, and Holders are referred to the Indenture and the Act for a statement of those terms. 

 

	5.	Guarantees 

 To guarantee
the due and punctual payment of the principal, premium, if any, and interest (including post-filing or post-petition interest) on the Notes and all other amounts payable by the Issuer under the Indenture and the Notes when and as the same shall be
due and payable, whether at maturity, by acceleration or otherwise, according to the terms of the Notes and the Indenture, the Guarantors will unconditionally guarantee (and future guarantors, jointly and severally with the Guarantors, will fully
and unconditionally Guarantee) such obligations on a senior basis pursuant to the terms of the Indenture. 
  

	6.	Optional Redemption 

 (a)
At any time prior to April 15, 2015, the Issuer may redeem the Notes in whole or in part, at their option, upon not less than 30 nor more than 60 days’ prior notice by electronic delivery or by first class mail, postage prepaid, with
a copy to the Trustee, to each Holder of Notes to the address of such Holder appearing in the Notes Register, at a redemption price equal to 100% of the principal amount of such Notes redeemed plus the Applicable Premium as of, and accrued and
unpaid interest and Additional Interest, if any, to but excluding the date of redemption (the “Redemption Date”), subject to the rights of holders of the Notes on the relevant record date to receive interest due on the relevant
interest payment date. 
 (b) At any time and from time to time prior to April 15, 2015, the Issuer may redeem Notes with
the net cash proceeds received by the Issuer from any Equity Offering at a redemption price equal to 104.250% plus accrued and unpaid interest to the Redemption Date, in an aggregate principal amount for all such redemptions not to exceed 40% of the
original aggregate principal amount of the Notes (including Additional Notes); provided that (1) in each case the redemption takes place not later than 180 days after the closing of the related Equity Offering, and (2) not less
than 50% of the original aggregate principal amount of the Notes issued under the Indenture remains outstanding immediately thereafter (excluding Notes held by the Issuer or any of its Restricted Subsidiaries). The Trustee shall select the Notes to
be purchased in the manner described under Sections 5.1 through 5.6 of the Indenture. 
 (c) In addition, on
or within ninety (90) days of the Escrow Release Date, the Issuer may redeem an amount of the Notes equal to the aggregate principal amount of the Non-refinanced Notes that remain outstanding on the Escrow Release Date less the aggregate
principal amount of any reduction to the commitments under the Credit Agreement as a result of any Non-refinanced Notes that remain outstanding on the Escrow Release Date pursuant to the terms of the debt financing commitments, upon not less than
thirty (30) nor more than sixty (60) days’ prior notice at a redemption price equal to 100% of the initial issue price of the Notes, plus accrued and unpaid interest from the Issue Date of the Notes up to, but not including, the date
of such redemption. 
 (d) Except pursuant to clauses (a), (b) and (c) of this paragraph 6, the Notes will not be
redeemable at the Issuer’s option prior to April 15, 2015. 

  
 B-4

 (e) At any time and from time to time on or after April 15, 2015, the Issuer may redeem
the Notes in whole or in part, upon not less than 30 nor more than 60 days’ notice by electronic delivery or by first class mail, postage prepaid, with a copy to the Trustee, to each Holder of Notes to the address of such Holder appearing in
the Notes Register at a redemption price equal to the percentage of principal amount set forth below plus accrued and unpaid interest, if any, on the Notes redeemed, to the applicable Redemption Date, if redeemed during the twelve-month period
beginning on April 15 of the year indicated below: 
  

					
	Year	  	Percentage	 
	 2015
	  	 	102.1250	% 
	 2016
	  	 	101.0625	% 
	 2017 and thereafter
	  	 	100.0000	% 

 (f) Unless the Issuer defaults in the payment of the redemption price, interest will cease to accrue on
the Notes or portions thereof called for redemption on the applicable Redemption Date. 
 (g) Any redemption pursuant to this
paragraph 6 shall be made pursuant to the provisions of Sections 5.1 through 5.6 of the Indenture. 
 The
Issuer is not required to make mandatory redemption or sinking fund payments with respect to the Notes; provided however, that under certain circumstances, the Issuer may be required to offer to purchase Notes under Section 3.5
and Section 3.9 of the Indenture. The Issuer may at any time and from time to time purchase Notes in the open market or otherwise. 
  

	7.	Special Mandatory Redemption 

 If (a) the Escrow Agent has not received the Officer’s Certificate pursuant to Section 3.24 of the Indenture on or prior to the Escrow End Date, (b) the Issuer notifies the
Escrow Agent in writing that the Issuer will not pursue the consummation of the Acquisition or otherwise announces that the Merger Agreement has been terminated or that it will not pursue the consummation of the Acquisition, or (c) the Issuer
fails to timely deposit (or cause to be timely deposited) any amounts required by Section 3.24 of the Indenture, within three (3) Business Days of the applicable deposit date, then the Escrow Agent shall, without the requirement of
notice to or action by the Issuer, the Trustee or any other Person, release the Escrowed Property (including investment earnings thereon and proceeds thereof) to the Trustee and the Trustee shall apply (or cause a paying agent to apply) such
proceeds to redeem the Notes (the “Special Mandatory Redemption”) on the third Business Day following the date of the release of the Escrowed Property to the Trustee (the “Special Mandatory Redemption Date”) or as
otherwise required by the applicable procedures of DTC, at a redemption price (the “Special Mandatory Redemption Price”), equal to 100% of the issue price of the Notes, plus accrued and unpaid interest from the Issue Date, or the
most recent date to which interest has been paid or duly provided for on the Notes, as the case may be, to, but excluding the Special Mandatory Redemption Date. On the Special Mandatory Redemption Date, the Trustee will pay to the Issuer any
Escrowed Property in excess of the amount necessary to effect the Special Mandatory Redemption. 
  

	8.	Repurchase Provisions 

 If
a Change of Control occurs, unless the Issuer has previously or concurrently delivered a redemption notice with respect to all outstanding Notes pursuant to Section 5.7 of the Indenture, each Holder will have the right to require the
Issuer to repurchase from each Holder all or any part (equal to $2,000 or an integral multiple of $1,000 in excess thereof) of such Holder’s Notes at a purchase price in cash equal to 101% of the aggregate principal amount thereof plus accrued
and unpaid interest to but excluding the date of purchase, subject to the right of Holders of record on the relevant record date to receive interest due on the relevant Interest Payment Date as provided in, and subject to the terms of, the
Indenture. 
 Upon certain Asset Sales, the Issuer may be required to use the Excess Proceeds from such Asset Sales to offer to
purchase the maximum aggregate principal amount of Notes (that is $2,000 or an integral multiple of $1,000 in excess thereof) and, at the Issuer’s option, Pari Passu Indebtedness that may be purchased out of the Excess Proceeds at an offer
price in cash in an amount equal to 100% of the principal amount thereof, plus accrued and unpaid interest to the date fixed for the closing of such offer, in accordance with the procedures set forth in Section 3.5 and in
Article V of the Indenture. 

  
 B-5

	9.	Denominations; Transfer; Exchange 

 The Notes shall be issuable only in fully registered form in denominations of principal amount of $2,000 and any integral multiple of $1,000 in excess thereof. A Holder may transfer or exchange Notes in
accordance with the Indenture. The Registrar may require a Holder, among other things, to furnish appropriate endorsements or transfer documents and to pay a sum sufficient to cover any tax and fees required by law or permitted by the Indenture. The
Registrar need not register the transfer of or exchange of any Note (A) for a period beginning (1) 15 days before the mailing of a notice of an offer to repurchase or redeem Notes and ending at the close of business on the day of such
mailing or (2) 15 days before an Interest Payment Date and ending on such Interest Payment Date or (B) called for redemption, except the unredeemed portion of any Note being redeemed in part. 

 

	10.	Persons Deemed Owners 

The registered Holder of this Note may be treated as the owner of it for all purposes. 

 

	11.	Discharge and Defeasance 

Subject to certain exceptions and conditions set forth in the Indenture, the Issuer at any time may terminate some or all of its
obligations under the Notes and the Indenture if the Issuer deposits with the Trustee money or U.S. Government Obligations for the payment of principal, premium, if any, and interest on the Notes to redemption or maturity, as the case may be.

  

	12.	Amendment, Supplement, Waiver 

 Subject to certain exceptions contained in the Indenture, the Indenture, the Notes, the Collateral Documents or the Intercreditor Agreement may be amended, or a Default thereunder may be waived, with the
consent of the Holders of a majority in aggregate principal amount of the outstanding Notes. Without notice to or the consent of any Holder, the Issuer, the Guarantors and the Trustee may amend or supplement the Indenture, the Notes, the Collateral
Documents or the Intercreditor Agreement as provided in the Indenture. 
  

	13.	Defaults and Remedies 

 If
an Event of Default (other than an Event of Default relating to certain events of bankruptcy, insolvency or reorganization of the Issuer or certain Guarantors) occurs and is continuing, the Trustee by notice to the Issuer, or the Holders of at least
30% in principal amount of the outstanding Notes by notice to the Issuer and the Trustee, may, and the Trustee at the request of such Holders shall, declare the principal of, premium, if any, and accrued and unpaid interest, and any other monetary
obligations on all the Notes to be due and payable immediately. Upon the effectiveness of such declaration, such principal, premium, interest, Additional Interest, if any, and other monetary obligations will be due and payable immediately. If a
bankruptcy, insolvency or reorganization of the Issuer or certain Guarantors occurs and is continuing, the principal of, premium, if any, and accrued and unpaid interest and any other monetary obligations on all the Notes will become and be
immediately due and payable without any declaration or other act on the part of the Trustee or any Holders. Under certain circumstances, the Holders of a majority in principal amount of the outstanding Notes may rescind any such acceleration with
respect to the Notes and its consequences. 
  

	14.	Trustee Dealings with the Issuer 

 Subject to certain limitations set forth in the Indenture, the Trustee in its individual or any other capacity may become the owner or pledgee of Notes and may otherwise deal with the Issuer, Guarantors
or their Affiliates with the same rights it would have if it were not Trustee. In addition, the Trustee shall be permitted to engage in transactions with the Issuer; provided, however, that if the Trustee acquires any conflicting
interest under the TIA, the Trustee must (i) eliminate such conflict within 90 days of acquiring such conflicting interest, (ii) apply to the Commission for permission to continue acting as Trustee or (iii) resign. 

  
 B-6

	15.	No Recourse Against Others 

No director, officer, employee, incorporator or shareholder of the Issuer or any of its Subsidiaries or Affiliates, as such (other than
the Issuer and the Guarantors), shall have any liability for any obligations of the Issuer or the Guarantors under the Notes, the Note Guarantees, the Collateral Documents, the Intercreditor Agreement or the Indenture or for any claim based on, in
respect of, or by reason of such obligations or their creation. Each Holder by accepting a note waives and releases all such liability. The waiver and release are part of the consideration for issuance of the Notes. Such waiver may not be effective
to waive liabilities under the federal securities laws and it is the view of the SEC that such a waiver is against public policy. 
  

	16.	Authentication 

 This Note
shall not be valid until an authorized signatory of the Trustee (or an authenticating agent acting on its behalf) manually signs the certificate of authentication on the other side of this Note. 

 

	17.	Abbreviations 

 Customary
abbreviations may be used in the name of a Holder or an assignee, such as TEN COM (= tenants in common), TEN ENT (= tenants by the entirety), JT TEN (= joint tenants with rights of survivorship and not as tenants in common),
CUST (= custodian) and U/G/M/A (= Uniform Gift to Minors Act). 
  

	18.	CUSIP and ISIN Numbers 

The Issuer has caused CUSIP and ISIN numbers, if applicable, to be printed on the Notes and has directed the Trustee to use CUSIP and ISIN
numbers, if applicable, in notices of redemption or purchase as a convenience to Holders. No representation is made as to the accuracy of such numbers either as printed on the Notes or as contained in any notice of redemption or purchase and
reliance may be placed only on the other identification numbers placed thereon. 
  

	19.	Governing Law 

 This Note
shall be governed by, and construed in accordance with, the laws of the State of New York. 
 The Issuer will furnish to any
Holder upon written request and without charge to the Holder a copy of the Indenture and the Registration Rights Agreement. Requests may be made to: 
  

			
	Hawk Acquisition Sub, Inc.
	c/o 3G Capital Partners Ltd.
	600 Third Avenue, 37th Floor
	New York, New York 10016
	Fax: (212) 893-6728
	Attention:	 	Alexandre Behring,
		 	Paulo Basilio
		 	Bradley Brown

  

	20.	Security 

 The Note will
be secured by the Collateral on the terms and subject to the conditions set forth in the Indenture and the Collateral Documents. The Trustee and the Collateral Agent, as the case may be, hold the Collateral in trust for the benefit of the Holders of
the Notes, in each case pursuant to the Collateral Documents and the Intercreditor Agreement. Each Holder, by accepting this Note, consents and agrees to the terms of the Collateral Documents (including the provisions providing for the foreclosure
and release of Collateral) and the Intercreditor Agreement as the same may be in effect or may be amended from time to time in accordance with their terms and the Indenture and authorizes and directs the Collateral Agent to enter into the Collateral
Documents and the Intercreditor Agreement, and to perform its obligations and exercise its rights thereunder in accordance therewith. 

  
 B-7

 ASSIGNMENT FORM 
 To assign this Note, fill in the form below: 
 I or we assign and transfer this
Note to: 
  
  

 
 (Print or type assignee’s
name, address and zip code) 
  
  

 
 (Insert assignee’s social
security or tax I.D. No.) 
 and irrevocably appoint
                     agent to transfer this Note on the books of the Issuer. The agent may substitute another to act for him. 

 

					
	Date:	  	Your Signature:	 	  

 

			
	Signature Guarantee:	 	  

	(Signature must be guaranteed)

  
  

 
 Sign exactly as your name appears on the other
side of this Note. 
 The signature(s) should be guaranteed by an eligible guarantor institution (banks, stockbrokers, savings and loan
associations and credit unions with membership in an approved signature guarantee medallion program), pursuant to Exchange Act Rule 17Ad-15. 

  
 B-8

 [TO BE ATTACHED TO GLOBAL NOTES] 

SCHEDULE OF INCREASES OR DECREASES IN GLOBAL NOTES 
 The following increases or decreases in this Global Note have been made: 
  

									
	 Date of Exchange
	  	Amount of decrease
in Principal Amount
of this Global Note	  	Amount of increase
in Principal Amount
of this Global Note	  	Principal Amount of
this Global Note
following such
decrease or increase	  	Signature of
authorized signatory
of Trustee or Notes
Custodian
		  		  		  		  	
		  		  		  		  	
		  		  		  		  	

  
 B-9

 OPTION OF HOLDER TO ELECT PURCHASE 

If you elect to have this Note purchased by the Issuer pursuant to Section 3.5 or 3.9 of the Indenture, check either box:

  

	
	Section 3.5  ̈    Section 3.9
 ̈

 If you want to elect to have only part of this Note purchased by the Issuer pursuant to Section 3.5
or 3.9 of the Indenture, state the amount in principal amount (must be in denominations of $2,000 or an integral multiple of $1,000 in excess thereof):
$                     and specify the denomination or denominations (which shall not be less than the minimum authorized denomination) of the Notes
to be issued to the Holder for the portion of the within Note not being repurchased (in the absence of any such specification, one such Note will be issued for the portion not being repurchased):
                . 
  

							
	Date:	 	  
	 	Your Signature	 	  

		 		 		 	(Sign exactly as your name appears on the other side of the Note)

  

			
	Signature Guarantee:	 	  

	(Signature must be guaranteed)

 The signature(s) should be guaranteed by an eligible guarantor institution (banks, stockbrokers, savings and loan
associations and credit unions with membership in an approved signature guarantee medallion program), pursuant to Exchange Act Rule 17Ad-15. 

  
 B-10

 EXHIBIT C 
 Form of Supplemental Indenture 
 SUPPLEMENTAL INDENTURE, (this
“Supplemental Indenture”) dated as of [                    ], 201[    ], by and among H.J. Heinz Company, a
Pennsylvania Corporation (“Heinz”) the parties that are signatories hereto as Guarantors (each a “Guaranteeing Subsidiary”) and Wells Fargo Bank, National Association, as Trustee and Collateral Agent under the
Indenture referred to below. 
 W I T N E S S E T H:

 WHEREAS, each of Hawk Acquisition Sub, Inc., a Pennsylvania corporation (“Merger Sub”), Hawk Acquisition
Intermediate Corporation II, a Delaware corporation (“Holdings”), the Trustee and the Collateral Agent have heretofore executed and delivered an indenture dated as of April 1, 2013 (as amended, supplemented, waived or otherwise
modified, the “Indenture”), providing for the issuance of an aggregate principal amount of $3,100,000,000 of 4.25% Second Lien Senior Secured Notes due 2020 (the “Notes”) of the Issuer (as defined in the Indenture);

 WHEREAS, the Indenture provides that Heinz and the Guaranteeing Subsidiaries shall execute and deliver to the Trustee and the
Collateral Agent a supplemental indenture pursuant to which Heinz shall unconditionally assume Merger Sub’s Obligations under the Notes and the Indenture and the Guaranteeing Subsidiaries shall unconditionally guarantee, on a joint and several
basis with the other Guarantors, all of the Issuer’s Obligations under the Notes and the Indenture on the terms and conditions set forth herein and under the Indenture (the “Note Guarantee”), each on the terms and conditions
set forth herein; and 
 WHEREAS, pursuant to Section 9.1 of the Indenture, the Issuer, any Guarantor and the
Trustee are authorized to execute and deliver this Supplemental Indenture to amend or supplement the Indenture, without the consent of any Holder; 
 NOW, THEREFORE, in consideration of the foregoing and for other good and valuable consideration, the receipt of which is hereby acknowledged, Heinz, the Guaranteeing Subsidiaries and the Trustee mutually
covenant and agree for the benefit of the Trustee, the Collateral Agent and the Holders of the Notes as follows: 
 ARTICLE I

 DEFINITIONS 
 SECTION 1.1. Defined Terms. As used in this Supplemental Indenture, terms defined in the Indenture or in the preamble or recitals hereto are used herein as therein defined. The words
“herein,” “hereof” and “hereby” and other words of similar import used in this Supplemental Indenture refer to this Supplemental Indenture as a whole and not to any particular section hereof. 

ARTICLE II 

AGREEMENT TO BE BOUND; GUARANTEE 
 SECTION 2.1. Agreement to Assume Obligations. Effective upon the Escrow Release Date, Heinz hereby agrees to unconditionally assume Merger Sub’s Obligations under the Notes and the Indenture
on the terms and subject to the conditions set forth in the Indenture and to be bound by all other applicable provisions of the Indenture and the Notes and to perform all of the obligations and agreements of the Issuer under the Indenture.

 SECTION 2.2. Agreement to be Bound. Each of the Guaranteeing Subsidiaries hereby becomes a party to the Indenture as a
Guarantor and as such will have all of the rights and be subject to all of the obligations and agreements of a Guarantor under the Indenture. 

  
 C-1

 SECTION 2.3. Guarantee. Each of the Guaranteeing Subsidiaries agrees, on a joint and
several basis with all the existing Guarantors, to fully, unconditionally and irrevocably Guarantee to each Holder of the Notes and the Trustee the Guaranteed Obligations pursuant to Article X of the Indenture on a senior basis.

 ARTICLE III 
 MISCELLANEOUS 
 SECTION 3.1. Notices. All notices and other communications
to each of Heinz and the Guarantors shall be given as provided in the Indenture. 
 SECTION 3.2. Merger and
Consolidation. (i) Heinz shall not sell or otherwise dispose of all or substantially all of its assets to, or consolidate with or merge with or into, another Person except in accordance with Section 4.1(a) of the Indenture and
(ii) each Guaranteeing Subsidiary shall not sell or otherwise dispose of all or substantially all of its assets to, or consolidate with or merge with or into, another Person (other than the Issuer or any Restricted Subsidiary that is a
Guarantor or becomes a Guarantor concurrently with the transaction) except in accordance with Section 4.1(g) of the Indenture. 
 SECTION 3.3. Release of Guarantee. The Note Guarantees hereunder may be released in accordance with Section 10.2 of the Indenture. 

SECTION 3.4. Parties. Nothing expressed or mentioned herein is intended or shall be construed to give any Person, firm or
corporation, other than the Holders and the Trustee, any legal or equitable right, remedy or claim under or in respect of this Supplemental Indenture or the Indenture or any provision herein or therein contained. 

SECTION 3.5. Governing Law. This Supplemental Indenture shall be governed by, and construed in accordance with, the laws of the
State of New York. 
 SECTION 3.6. Severability. In case any provision in this Supplemental Indenture shall be invalid,
illegal or unenforceable, the validity, legality and enforceability of the remaining provisions shall not in any way be affected or impaired thereby and such provision shall be ineffective only to the extent of such invalidity, illegality or
unenforceability. 
 SECTION 3.7. Benefits Acknowledged. Each Guaranteeing Subsidiary’s Note Guarantee is subject to
the terms and conditions set forth in the Indenture. Each Guaranteeing Subsidiary acknowledges that it will receive direct and indirect benefits from the financing arrangements contemplated by the Indenture and this Supplemental Indenture and that
the guarantee and waivers made by it pursuant to its Note Guarantee are knowingly made in contemplation of such benefits. 

SECTION 3.8. Ratification of Indenture; Supplemental Indentures Part of Indenture. Except as expressly amended hereby, the
Indenture is in all respects ratified and confirmed and all the terms, conditions and provisions thereof shall remain in full force and effect. This Supplemental Indenture shall form a part of the Indenture for all purposes, and every Holder of
Notes heretofore or hereafter authenticated and delivered shall be bound hereby. 
 SECTION 3.9. The Trustee and the
Collateral Agent. Neither the Trustee nor the Collateral Agent make any representation or warranty as to the validity or sufficiency of this Supplemental Indenture or with respect to the recitals contained herein, all of which recitals are made
solely by the other parties hereto. 
 SECTION 3.10. Counterparts. The parties hereto may sign any number of copies of
this Supplemental Indenture. Each signed copy shall be an original, but all of them together represent the same agreement. The exchange of copies of this Supplemental Indenture and of signature pages by facsimile or PDF transmission shall
constitute effective execution and delivery of this Supplemental Indenture as to the parties hereto and may be used in lieu of the original Supplemental Indenture for all purposes. Signatures of the parties hereto transmitted by facsimile or PDF
shall be deemed to be their original signatures for all purposes. 

  
 C-2

 SECTION 3.11. Execution and Delivery. Each Guaranteeing Subsidiary agrees that its
Note Guarantee shall remain in full force and effect notwithstanding any failure to endorse on each Note a notation of any such Note Guarantee. 
 SECTION 3.12. Headings. The headings of the Articles and the Sections in this Supplemental Indenture are for convenience of reference only and shall not be deemed to alter or affect the meaning or
interpretation of any provisions hereof. 

  
 C-3

 IN WITNESS WHEREOF, the parties hereto have caused this Supplemental Indenture to be duly
executed as of the date first above written. 
  

			
	Acknowledged by:
	
	[H.J. HEINZ COMPANY]
		
	By:	 	  

		 	Name:
		 	Title:
	
	 [SUBSIDIARY GUARANTORS],
 as a Guarantor

		
	By:	 	  

		 	Name:
		 	Title:

  

			
	Acknowledged by:
	
	[MERGER SUB]
		
	By:	 	  

		 	Name:
		 	Title:

  
 C-4

 
			
	WELLS FARGO BANK, NATIONAL ASSOCIATION,
	as Trustee and Collateral Agent
		
	By:	 	  

		 	Name:
		 	Title:

  
 C-5

 EXHIBIT D 
 Form of Intercreditor Agreement 
 See attached. 

  
 D-1

 EXHIBIT E 
 Form of Second Lien Security Agreement 
 See attached. 

  
 E-1

 EXHIBIT F 
 Form of Certificate to be Delivered Upon Termination of Restricted Period 

[Date] 
  

			
	Hawk Acquisition Sub, Inc.
	c/o 3G Capital Partners Ltd.
	600 Third Avenue, 37th Floor
	 New York, New York 10016
 Fax: (212) 893-6728

	Attention:	 	Alexandre Behring
		 	Paulo Basilio
		 	Bradley Brown

 Wells Fargo Bank, National Association, 
 as Trustee and Registrar – DAPS Reorg 
 MAC N9303-121 

608 2nd Avenue South 
 Minneapolis, MN 55479

 Telephone No.: (877) 872-4605 
 Fax No.: (866) 969-1290 
 Email: DAPSReorg@wellsfargo.com 

with a copy to: 
  

			
	Kirkland & Ellis LLP
	 601 Lexington Avenue
 New York, New York 10022

	Attention:	 	Joshua N. Korff
		 	Michael Kim
	Facsimile:	 	(212) 446-4900

  

			
	Re:	  	Hawk Acquisition Sub, Inc. (to be merged with and into H.J. Heinz Company) (the “Issuer”).

 4.25% Second Lien Senior Secured Notes due 2020 (the “Notes”) 

Ladies and Gentlemen: 
 This
letter relates to Notes represented by a temporary global Note (the “Temporary Regulation S Global Note”). Pursuant to Section 2.1 of the Indenture dated as of April 1, 2013 relating to the Notes (the
“Indenture”), we hereby certify that the persons who are the beneficial owners of $[            ] principal amount of Notes represented by the Temporary Regulation S
Global Note are persons outside the United States to whom beneficial interests in such Notes could be transferred in accordance with Rule 904 of Regulation S promulgated under the Securities Act of 1933, as amended. Accordingly, you are
hereby requested to issue a Permanent Regulation S Global Note representing the undersigned’s interest in the principal amount of Notes represented by the Temporary Regulation S Global Note, all in the manner provided by the
Indenture. We certify that we [are][are not] an Affiliate of the Issuer. 
 The Trustee and the Issuer are entitled to
conclusively rely upon this letter and are irrevocably authorized to produce this letter or a copy hereof to any interested party in any administrative or legal proceedings or official inquiry with respect to the matters covered hereby. Terms used
in this letter have the meanings set forth in Regulation S. 

  
 F-1

 
			
	Very truly yours,
	
	[Name of Transferor]
		
	By:	 	  

		 	Authorized Signature

  
 F-2

 EXHIBIT G 
 Form of Certificate to be Delivered in Connection with Transfers to IAIs 

[Date] 
  

			
	Hawk Acquisition Sub, Inc.
	 c/o 3G Capital Partners Ltd.
 600 Third Avenue, 37th Floor
 New York, New York 10016

Fax: (212) 893-6728

	Attention:	 	Alexandre Behring
		 	Paulo Basilio
		 	Bradley Brown

 Wells Fargo Bank, National Association, 
 as Trustee and Registrar – DAPS Reorg 
 MAC N9303-121 

608 2nd Avenue South 
 Minneapolis, MN 55479

 Telephone No.: (877) 872-4605 
 Fax No.: (866) 969-1290 
 Email: DAPSReorg@wellsfargo.com 

 

	Re:	Hawk Acquisition Sub, Inc. (to be merged with and into H.J. Heinz Company) (the “Issuer”). 

Ladies and Gentlemen: 
 This
certificate is delivered to request a transfer of $[            ] principal amount of the 4.25% Second Lien Senior Secured Notes due 2020 (the “Notes”) of Hawk Acquisition
Sub, Inc. (the “Issuer”). 
 Upon transfer, the Notes would be registered in the name of the new beneficial
owner as follows: 
  

					
	Name:	 	  
	 	
			
	Address:	 	  
	 	
			
	Taxpayer ID Number:	 	  
	 	

 The undersigned represents and warrants to you that: 

1. We are an institutional “accredited investor” (as defined in Rule 501(a)(1), (2), (3) or (7) under the
Securities Act of 1933, as amended (the “Securities Act”)) purchasing for our own account or for the account of such an institutional “accredited investor” at least $250,000 principal amount of the Notes, and we are
acquiring the Notes not with a view to, or for offer or sale in connection with, any distribution in violation of the Securities Act. We have such knowledge and experience in financial and business matters as to be capable of evaluating the merits
and risk of our investment in the Notes and we invest in or purchase securities similar to the Notes in the normal course of our business. We and any accounts for which we are acting are each able to bear the economic risk of our or its investment.

 2. We understand that the Notes have not been registered under the Securities Act and, unless so registered, may not be sold
except as permitted in the following sentence. We agree on our own behalf and on behalf of any investor account for which we are purchasing Notes to offer, sell or otherwise transfer such Notes

  
 G-1

 
prior to the date that is one year after the later of the date of original issue and the last date on which the Issuer or any affiliate of the Issuer was the owner of such Notes (or any
predecessor thereto) (the “Resale Restriction Termination Date”) only (a) to the Issuer or any Subsidiary thereof, (b) pursuant to an effective registration statement under the Securities Act, (c) in a transaction
complying with the requirements of Rule 144A under the Securities Act, to a person we reasonably believe is a “qualified institutional buyer” under Rule 144A of the Securities Act (a “QIB”) that is purchasing for
its own account or for the account of a QIB and to whom notice is given that the transfer is being made in reliance on Rule 144A, (d) pursuant to offers and sales to non-U.S. persons that occur outside the United States within the meaning
of Regulation S under the Securities Act, (e) to an institutional “accredited investor” within the meaning of Rule 501(a)(1), (2), (3) or (7) under the Securities Act that is purchasing for its own account or for
the account of such an institutional “accredited investor,” in each case in a minimum principal amount of Notes of $250,000 for investment purposes and not with a view to or for offer or sale in connection with any distribution in
violation of the Securities Act or (f) pursuant to any other available exemption from the registration requirements of the Securities Act, subject in each of the foregoing cases to any requirement of law that the disposition of our property or
the property of such investor account or accounts be at all times within our or their control and in compliance with any applicable state securities laws. The foregoing restrictions on resale will not apply subsequent to the Resale Restriction
Termination Date. If any resale or other transfer of the Notes is proposed to be made pursuant to clause (e) above prior to the Resale Restriction Termination Date, the transferor shall deliver a letter from the transferee substantially in the
form of this letter to the Issuer and the Trustee, which shall provide, among other things, that the transferee is an institutional “accredited investor” (within the meaning of Rule 501(a)(1), (2), (3) or (7) under the
Securities Act) and that it is acquiring such Notes for investment purposes and not for distribution in violation of the Securities Act. Each purchaser acknowledges that the Issuer and the Trustee reserve the right prior to any offer, sale or other
transfer prior to the Resale Termination Date of the Notes pursuant to clauses (d), (e) or (f) above to require the delivery of an opinion of counsel, certifications and/or other information satisfactory to the Issuer. 

3. We [are][are not] an Affiliate of the Issuer. 

 

			
	TRANSFEREE:	 	  

		
	BY:	 	  

  
 G-2

 EXHIBIT H 
 Form of Certificate to be Delivered in Connection with Transfers Pursuant to Regulation S 
 [Date] 
  

			
	Hawk Acquisition Sub, Inc.
	 c/o 3G Capital Partners Ltd.
 600 Third Avenue, 37th Floor
 New York, New York 10016

Fax: (212) 893-6728

	Attention:	 	Alexandre Behring
		 	Paulo Basilio
		 	Bradley Brown

 Wells Fargo Bank, National Association, 
 as Trustee and Registrar – DAPS Reorg 
 MAC N9303-121 

608 2nd Avenue South 
 Minneapolis, MN 55479

 Telephone No.: (877) 872-4605 
 Fax No.: (866) 969-1290 
 Email: DAPSReorg@wellsfargo.com 

 

	Re:	Hawk Acquisition Sub, Inc. (to be merged with and into H.J. Heinz Company) (the “Issuer”). 

4.25% Second Lien Senior Secured Notes due 2020 (the “Notes”) 
 Ladies and Gentlemen: 
 In connection with our proposed sale of
$[            ] aggregate principal amount of the Notes, we confirm that such sale has been effected pursuant to and in accordance with Regulation S under the United States Securities
Act of 1933, as amended (the “Securities Act”), and, accordingly, we represent that: 
 (a) the
offer of the Notes was not made to a person in the United States; 
 (b) either (i) at the time the buy
order was originated, the transferee was outside the United States or we and any person acting on our behalf reasonably believed that the transferee was outside the United States or (ii) the transaction was executed in, on or through the
facilities of a designated off-shore securities market and neither we nor any person acting on our behalf knows that the transaction has been pre-arranged with a buyer in the United States; 

(c) no directed selling efforts have been made in the United States in contravention of the requirements of
Rule 903(a)(2) or Rule 904(a)(2) of Regulation S, as applicable; and 
 (d) the transaction is not
part of a plan or scheme to evade the registration requirements of the Securities Act. 
 In addition, if the sale is made
during a restricted period and the provisions of Rule 903(b)(2), Rule 903(b)(3) or Rule 904(b)(1) of Regulation S are applicable thereto, we confirm that such sale has been made in accordance with the applicable provisions of
Rule 903(b)(2), Rule 903(b)(3) or Rule 904(b)(1), as the case may be. 
 We also hereby certify that we [are][are
not] an Affiliate of the Issuer and, to our knowledge, the transferee of the Notes [is][is not] an Affiliate of the Issuer. 

  
 H-1

 The Trustee and the Issuer are entitled to conclusively rely upon this letter and are
irrevocably authorized to produce this letter or a copy hereof to any interested party in any administrative or legal proceedings or official inquiry with respect to the matters covered hereby. Terms used in this certificate have the meanings set
forth in Regulation S. 
  

			
	Very truly yours,
	
	[Name of Transferor]
		
	By:	 	  

		 	Authorized Signature

  
 H-2

 EXHIBIT I 
 Form of Certificate to be Delivered in Connection with Transfers to AIs 

[Date] 
  

			
	Hawk Acquisition Sub, Inc.
	 c/o 3G Capital Partners Ltd.
 600 Third Avenue, 37th Floor
 New York, New York 10016

Fax: (212) 893-6728

	Attention:	 	Alexandre Behring
		 	Paulo Basilio
		 	Bradley Brown

 Wells Fargo Bank, National Association, 
 as Trustee and Registrar – DAPS Reorg 
 MAC N9303-121 

608 2nd Avenue South 
 Minneapolis, MN 55479

 Telephone No.: (877) 872-4605 
 Fax No.: (866) 969-1290 
 Email: DAPSReorg@wellsfargo.com 

 

	Re:	Hawk Acquisition Sub, Inc. (to be merged with and into H.J. Heinz Company) (the “Issuer”). 

Ladies and Gentlemen: 
 This
certificate is delivered to request a transfer of $[            ] principal amount of the 4.25% Second Lien Senior Secured Notes due 2020 (the “Notes”) of Hawk Acquisition
Sub, Inc. (the “Issuer”). 
 Upon transfer, the Notes would be registered in the name of the new beneficial
owner as follows: 
  

					
	Name:	 	  
	 	
			
	Address:	 	  
	 	
			
	Taxpayer ID Number:	 	  
	 	

 The undersigned represents and warrants to you that: 

1. I am an “accredited investor” (as defined in Rule 501(a)(4) under the U.S. Securities Act of 1933, as amended (the
“Securities Act”)) and I am acquiring the Notes not with a view to, or for offer or sale in connection with, any distribution in violation of the Securities Act. I have such knowledge and experience in financial and business matters
as to be capable of evaluating the merits and risk of my investment in the Notes and I invest in or purchase securities similar to the Notes in the normal course of my business. I am able to bear the economic risk of my investment. 

2. I understand that the Notes have not been registered under the Securities Act and, unless so registered, may not be sold except as
permitted in the following sentence. I agree on my own behalf to offer, sell or otherwise transfer such Notes prior to the date that is one year after the later of the date of original issue and the last date on which the Issuer or any affiliate of
the Issuer was the owner of such Notes (or any predecessor thereto) (the “Resale Restriction Termination Date”) only (a) to the Issuer or any Subsidiary thereof, (b) pursuant to an effective registration statement under
the Securities Act, (c) in a transaction complying with the requirements of Rule 144A under the Securities Act, to a person I reasonably believe is a “qualified institutional buyer” under Rule 144A of the Securities Act (a
“QIB”) that is purchasing for its own account or for the account of a QIB and to whom notice is 

  
 I-1

 
given that the transfer is being made in reliance on Rule 144A, (d) pursuant to offers and sales to non-U.S. persons that occur outside the United States within the meaning of
Regulation S under the Securities Act, (e) to an institutional “accredited investor” within the meaning of Rule 501(a)(1), (2), (3) or (7) under the Securities Act that is purchasing for its own account or for the
account of such an institutional “accredited investor,” in each case in a minimum principal amount of Notes of $200,000 for investment purposes and not with a view to or for offer or sale in connection with any distribution in violation of
the Securities Act or (f) pursuant to any other available exemption from the registration requirements of the Securities Act, subject in each of the foregoing cases to any requirement of law that the disposition of my property be at all times
within my control and in compliance with any applicable state securities laws. The foregoing restrictions on resale will not apply subsequent to the Resale Restriction Termination Date. Each purchaser acknowledges that the Issuer and the Trustee
reserve the right prior to any offer, sale or other transfer prior to the Resale Termination Date of the Notes pursuant to clauses (d), (e) or (f) above to require the delivery of an opinion of counsel, certifications and/or other
information satisfactory to the Issuer. 
 3. I understand and acknowledge that upon the issuance thereof, and until such time
as the same is no longer required under applicable requirements of the Securities Act or state securities laws, the Notes that I acquire will be certificated Notes that will bear, and all certificates issued in exchange therefor or in substitution
thereof will bear, a restrictive legend set forth in Section 2.1(d) of the Indenture. 
 4. I am an Affiliate of the
Issuer. 
  

			
	TRANSFEREE:	 	  

		
	BY:	 	  

  
 I-2

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00218-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00218-of-00352.parquet"}]]